Virus name	Accession ID	Collection date	Location	Host	Passage	Specimen	Additional host information	Sequencing technology	Assembly method	Comment	Comment type	Lineage	Clade
hCoV-19/Scotland/EDB560/2020	EPI_ISL_426019	2020-04-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Australia/VIC361/2020	EPI_ISL_426669	2020-03-22	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v1 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC362/2020	EPI_ISL_426670	2020-03-22	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v1 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC363/2020	EPI_ISL_426671	2020-03-22	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v1 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC366/2020	EPI_ISL_426674	2020-03-22	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v1 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC394/2020	EPI_ISL_426697	2020-03-24	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v1 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC427/2020	EPI_ISL_426727	2020-03-25	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII4655S/2020	EPI_ISL_427322	2020-04-05	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2 + Ugene v33			B.1.1.370	GR
hCoV-19/Belgium/ULG-10144/2020	EPI_ISL_427388	2020-04-07	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Wales/PHWC-2B6D0/2020	EPI_ISL_445748	2020-04	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-2DF6A/2020	EPI_ISL_446042	2020-04-10	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-2E01B/2020	EPI_ISL_446047	2020-04-10	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus	NS8_Q29stop results in 76.9% truncation of the protein sequence.	info	B.1.1.398	GR
hCoV-19/Wales/PHWC-2F038/2020	EPI_ISL_446190	2020-04-04	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Greece/HPI-6465/2020	EPI_ISL_451311	2020-03-29	Europe / Greece / Athens	Human	Original	Rhino-pharyngeal swab		Illumina NextSeq				B.1.1	GR
hCoV-19/Australia/NSW225/2020	EPI_ISL_451491	2020-03-28	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1	GR
hCoV-19/Switzerland/TI-ETHZ-100098/2020	EPI_ISL_451690	2020-03-13	Europe / Switzerland / Ticino	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BS-ETHZ-100132/2020	EPI_ISL_451716	2020-03-16	Europe / Switzerland / Basel-Stadt	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/GR-ETHZ-100138/2020	EPI_ISL_451722	2020-03-15	Europe / Switzerland / Grisons	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/GR-ETHZ-100147/2020	EPI_ISL_451731	2020-03-16	Europe / Switzerland / Grisons	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-100815/2020	EPI_ISL_451765	2020-03-26	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-101130/2020	EPI_ISL_451797	2020-03-30	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/un-ETHZ-110503/2020	EPI_ISL_451909	2020-04-07	Europe / Switzerland	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/un-ETHZ-110510/2020	EPI_ISL_451916	2020-04-07	Europe / Switzerland	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Russia/SCPM-O-08/2020	EPI_ISL_451970	2020-03-22	Europe / Russia / Moscow	Human	Original			BGISEQ-500	Unicycler v0.4.7	Insertion of 2 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/CAMB-1B0B94/2020	EPI_ISL_452947	2020-05-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B0D16/2020	EPI_ISL_452965	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B0E8C/2020	EPI_ISL_452971	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B0EF5/2020	EPI_ISL_452977	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Canada/ON_QGLO-012/2020	EPI_ISL_459872	2020-03-26	North America / Canada / Ontario	Human	Original			Ion Torrent				B.1.1	GR
hCoV-19/Morocco/6895/2020	EPI_ISL_459973	2020-03-20	Africa / Morocco	Human	Original			Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/Morocco/6899/2020	EPI_ISL_459977	2020-04-21	Africa / Morocco	Human	Original			Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/Morocco/6900/2020	EPI_ISL_459978	2020-04-20	Africa / Morocco	Human	Original			Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/Morocco/6905/2020	EPI_ISL_459983	2020-04-21	Africa / Morocco	Human	Original			Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/England/20119000404/2020	EPI_ISL_465002	2020-03-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20119029504/2020	EPI_ISL_465039	2020-03-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20119031604/2020	EPI_ISL_465044	2020-03-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20119032104/2020	EPI_ISL_465046	2020-03-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20119034404/2020	EPI_ISL_465050	2020-03-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20169001704/2020	EPI_ISL_465167	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20169001804/2020	EPI_ISL_465168	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20169030304/2020	EPI_ISL_465225	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20169036204/2020	EPI_ISL_465241	2020-04-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20169040504/2020	EPI_ISL_465248	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20170036904/2020	EPI_ISL_465287	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20170048904/2020	EPI_ISL_465304	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20172000204/2020	EPI_ISL_465309	2020-04-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20172002504/2020	EPI_ISL_465320	2020-04-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20172002704/2020	EPI_ISL_465322	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20188027704/2020	EPI_ISL_465500	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20190012401/2020	EPI_ISL_465583	2020-04-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20190056901/2020	EPI_ISL_465589	2020-05-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20206139504/2020	EPI_ISL_465665	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.294	GR
hCoV-19/England/20188033304/2020	EPI_ISL_465718	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20142006104/2020	EPI_ISL_465906	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20142025204/2020	EPI_ISL_465936	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20144009404/2020	EPI_ISL_465975	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.221	GR
hCoV-19/England/20144012104/2020	EPI_ISL_465978	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20144023004/2020	EPI_ISL_465993	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Switzerland/TI-ETHZ-100045/2020	EPI_ISL_466968	2020-03-11	Europe / Switzerland / Ticino	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/TI-ETHZ-100069/2020	EPI_ISL_466991	2020-03-12	Europe / Switzerland / Ticino	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/TI-ETHZ-100070/2020	EPI_ISL_466992	2020-03-12	Europe / Switzerland / Ticino	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/England/CAMB-1AABE8/2020	EPI_ISL_470104	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1ABA08/2020	EPI_ISL_470131	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AABBB/2020	EPI_ISL_470185	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AB8E0/2020	EPI_ISL_470197	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AAE1C/2020	EPI_ISL_470260	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AB8C2/2020	EPI_ISL_470281	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AB4EC/2020	EPI_ISL_470290	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AA81E/2020	EPI_ISL_470336	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AB464/2020	EPI_ISL_470343	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7DF10/2020	EPI_ISL_470380	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Russia/Moscow_PMVL-4/2020	EPI_ISL_470898	2020-04-08	Europe / Russia / Moscow	Human	Vero E6	Nasopharyngeal swab		Ion Torrent S5XL	SPAdes v3.13.0, BCFtools v1.8, SAMtools v1.9			B.1.1	GR
hCoV-19/Russia/Moscow_PMVL-10/2020	EPI_ISL_470903	2020-04-10	Europe / Russia / Moscow	Human	Vero E6	Nasopharyngeal swab		Ion Torrent S5XL	SPAdes v3.13.0, BCFtools v1.8, SAMtools v1.9			B.1.1.500	GR
hCoV-19/Gambia/0214/2020	EPI_ISL_471158	2020-03-29	Africa / Gambia / Kombo	Human	Original			Oxford Nanopore GridION	ARTIC protocol			B.1	G
hCoV-19/Gambia/0536/2020	EPI_ISL_471163	2020-04-30	Africa / Gambia / Kombo	Human	Original			Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/0547/2020	EPI_ISL_471164	2020-04-30	Africa / Gambia / Kombo	Human	Original			Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/1094/2020	EPI_ISL_471167	2020-05-04	Africa / Gambia / Kombo	Human	Original			Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/1277/2020	EPI_ISL_471171	2020-05-07	Africa / Gambia / Kombo	Human	Original			Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/England/NORW-EB7BB/2020	EPI_ISL_472317	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NOTT-111EE3/2020	EPI_ISL_472422	2020-05-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/OXON-B1341/2020	EPI_ISL_479006	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1402/2020	EPI_ISL_479012	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B19C7/2020	EPI_ISL_479060	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1CFB/2020	EPI_ISL_479088	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1DF8/2020	EPI_ISL_479094	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1EE6/2020	EPI_ISL_479100	2020-05-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B253B/2020	EPI_ISL_479153	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B26FC/2020	EPI_ISL_479168	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/SHEF-C2116/2020	EPI_ISL_479201	2020-04-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C580F/2020	EPI_ISL_479216	2020-06-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C6CB7/2020	EPI_ISL_479223	2020-05-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C9926/2020	EPI_ISL_479236	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	GR
hCoV-19/England/SHEF-D1509/2020	EPI_ISL_479276	2020-06-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/PHWC-164C7E/2020	EPI_ISL_479365	2020-06-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Canada/NB-234/2020	EPI_ISL_479647	2020-03-25	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Egypt/CUNCI-HGC4I003/2020	EPI_ISL_479699	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.1	GR
hCoV-19/Egypt/CUNCI-HGC4I004/2020	EPI_ISL_479700	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.1	GR
hCoV-19/Egypt/CUNCI-HGC5I001/2020	EPI_ISL_479710	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.1	GR
hCoV-19/Egypt/CUNCI-HGC5I011/2020	EPI_ISL_479712	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.1	GR
hCoV-19/Egypt/CUNCI-HGC4I015/2020	EPI_ISL_479728	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.1	GR
hCoV-19/Egypt/CUNCI-HGC4I023/2020	EPI_ISL_479729	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/P1/2020	EPI_ISL_479785	2020	Europe / United Kingdom / England	Human	unknown			Illumina				B.1.1	GR
hCoV-19/England/SHEF-CFD7F/2020	EPI_ISL_484506	2020-06-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	GR
hCoV-19/England/SHEF-CFFA6/2020	EPI_ISL_484508	2020-06-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D0458/2020	EPI_ISL_484511	2020-06-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR2373/2020	EPI_ISL_484578	2020-04-13	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2665/2020	EPI_ISL_484631	2020-04-17	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-165615/2020	EPI_ISL_484689	2020-06-28	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Wales/PHWC-165633/2020	EPI_ISL_484691	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Belgium/ULG-10209/2020	EPI_ISL_484698	2020-05-14	Europe / Belgium	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Senegal/66458/2020	EPI_ISL_485710	2020-06-15	Africa / Senegal / Dakar	Human	Original	Oropharyngeal swab		Illumina MiSeq	Bowtie2			B.1.1	GR
hCoV-19/Latvia/028/2020	EPI_ISL_486411	2020-05-07	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.1	GR
hCoV-19/Latvia/035/2020	EPI_ISL_486418	2020-05-09	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.1	GR
hCoV-19/Russia/CRIE162398/2020	EPI_ISL_486821	2020-03-31	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.294	GR
hCoV-19/Russia/CRIE164980/2020	EPI_ISL_486824	2020-03-31	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE175960/2020	EPI_ISL_486827	2020-04-01	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/India/UN-UN2/2020	EPI_ISL_486853	2020-06-17	Asia / India	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.306	GR
hCoV-19/Senegal/6751/2020	EPI_ISL_486859	2020-04-21	Africa / Senegal / Dakar	Human	Original	Oropharyngeal swab		Illumina MiSeq	Bowtie2			B.1.1	GR
hCoV-19/Senegal/9392/2020	EPI_ISL_486862	2020-04-25	Africa / Senegal / Dakar	Human	Original	Oropharyngeal swab		Illumina MiSeq	Bowtie2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Senegal/6430/2020	EPI_ISL_486872	2020-04-11	Africa / Senegal / Dakar	Human	Original	Oropharyngeal swab		Illumina MiSeq	Bowtie2			B.1.1	GR
hCoV-19/England/LIVE-A212B/2020	EPI_ISL_490377	2020-05-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A2431/2020	EPI_ISL_490382	2020-05-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORT-294B86/2020	EPI_ISL_490467	2020-03-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29EC6B/2020	EPI_ISL_490478	2020-05-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C1742/2020	EPI_ISL_490581	2020-05-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Wales/PHWC-1659EF/2020	EPI_ISL_490751	2020-06-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-165ACE/2020	EPI_ISL_490763	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-165FFC/2020	EPI_ISL_490825	2020-06-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Ecuador/USFQ-120/2020	EPI_ISL_491932	2020-07-03	South America / Ecuador / Carchi / Reciento	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic Network			B.1.1	GR
hCoV-19/Ecuador/52438/2020	EPI_ISL_491951	2020-06-01	South America / Ecuador / Guayas / Guayaquil	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Wales/PHWC-169444/2020	EPI_ISL_499444	2020-05-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1695AB/2020	EPI_ISL_499459	2020-06-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A5FA6/2020	EPI_ISL_499670	2020-03-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORT-297127/2020	EPI_ISL_499785	2020-04-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29C650/2020	EPI_ISL_499787	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29D288/2020	EPI_ISL_499800	2020-05-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29D455/2020	EPI_ISL_499804	2020-05-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LCST-24D71C9/2020	EPI_ISL_499974	2020-06-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/LCST-24D727B/2020	EPI_ISL_499977	2020-06-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.200	GR
hCoV-19/Zambia/29/2020	EPI_ISL_510529	2020-03-16	Africa / Zambia / Lusaka	Human	Original	Nasopharyngeal and oropharyngeal swab		Sanger dideoxy sequencing				B.1.1	GR
hCoV-19/Sweden/20-51946/2020	EPI_ISL_510860	2020-06-05	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-51997/2020	EPI_ISL_510864	2020-06-05	Europe / Sweden / Kalmar	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.438	GR
hCoV-19/Portugal/PT0635/2020	EPI_ISL_510896	2020-03-25	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0668/2020	EPI_ISL_510927	2020-03-31	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Portugal/PT0669/2020	EPI_ISL_510928	2020-03-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0670/2020	EPI_ISL_510929	2020-03-19	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0672/2020	EPI_ISL_510931	2020-04-13	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Portugal/PT0673/2020	EPI_ISL_510932	2020-03-25	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Portugal/PT0674/2020	EPI_ISL_510933	2020-04-17	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0677/2020	EPI_ISL_510936	2020-03-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0679/2020	EPI_ISL_510938	2020-03-25	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0680/2020	EPI_ISL_510939	2020-03-25	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0681/2020	EPI_ISL_510940	2020-03-28	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0682/2020	EPI_ISL_510941	2020-03-25	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0683/2020	EPI_ISL_510942	2020-03-27	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Portugal/PT0687/2020	EPI_ISL_510946	2020-03-31	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Portugal/PT0689/2020	EPI_ISL_510948	2020-04-15	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Portugal/PT0691/2020	EPI_ISL_510950	2020-04-19	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0692/2020	EPI_ISL_510951	2020-04-23	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0694/2020	EPI_ISL_510953	2020-03-14	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0699/2020	EPI_ISL_510958	2020-03-14	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0704/2020	EPI_ISL_510963	2020-03-20	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0707/2020	EPI_ISL_510966	2020-03-22	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0886/2020	EPI_ISL_511144	2020-03-19	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/India/HR-MW39/2020	EPI_ISL_511928	2020-06-10	Asia / India / Haryana / Gurgaon	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/Russia/SPE-RII-13247V/2020	EPI_ISL_524004	2020-05-12	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Russia/SPE-RII-15320V/2020	EPI_ISL_524009	2020-05-14	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1.370	GR
hCoV-19/Russia/SPE-RII-15911V/2020	EPI_ISL_524010	2020-05-18	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Russia/SPE-RII-21357V/2020	EPI_ISL_524033	2020-06-05	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Russia/SPE-RII-22043V/2020	EPI_ISL_524035	2020-06-08	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1.370	GR
hCoV-19/Russia/SPE-RII-22086V/2020	EPI_ISL_524038	2020-06-08	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Russia/SPE-RII-22311V/2020	EPI_ISL_524043	2020-06-08	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1.370	GR
hCoV-19/Russia/SPE-RII-7388V/2020	EPI_ISL_524049	2020-04-20	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Switzerland/ZH-UZH-1000478320/2020	EPI_ISL_524478	2020-03-02	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	SMALT, 15% ambiguity threshold			B.1.1	GR
hCoV-19/Switzerland/ZH-UZH-1000478554/2020	EPI_ISL_524479	2020-03-03	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	SMALT, 15% ambiguity threshold			B.1.1	GR
hCoV-19/England/BRIS-133883/2020	EPI_ISL_524487	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.349	GR
hCoV-19/England/BRIS-133874/2020	EPI_ISL_524488	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.349	GR
hCoV-19/England/BRIS-133892/2020	EPI_ISL_524490	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.349	GR
hCoV-19/England/BRIS-133838/2020	EPI_ISL_524492	2020-08-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.349	GR
hCoV-19/England/CAMB-7E42F/2020	EPI_ISL_524495	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/GCVR-171E2D/2020	EPI_ISL_524513	2020-03-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/GCVR-171E1E/2020	EPI_ISL_524536	2020-03-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/GCVR-171E0F/2020	EPI_ISL_524539	2020-03-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-126168E/2020	EPI_ISL_524648	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/MD-MDH-0157/2020	EPI_ISL_524884	2020-07-13	North America / USA / Maryland	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/WA-S2743/2020	EPI_ISL_525733	2020-07-17	North America / USA / Washington / King County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1.228	GR
hCoV-19/USA/WA-S2744/2020	EPI_ISL_525734	2020-07-17	North America / USA / Washington / King County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1.228	GR
hCoV-19/England/QEUH-96503D/2020	EPI_ISL_531034	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-964AB8/2020	EPI_ISL_531038	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9653AD/2020	EPI_ISL_531039	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-964BE2/2020	EPI_ISL_531042	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-964AD6/2020	EPI_ISL_531052	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-964AA9/2020	EPI_ISL_531068	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9652EC/2020	EPI_ISL_531109	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-964C49/2020	EPI_ISL_531112	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-969822/2020	EPI_ISL_531118	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9648FA/2020	EPI_ISL_531141	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9654E6/2020	EPI_ISL_531147	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-964FF5/2020	EPI_ISL_531161	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9652FB/2020	EPI_ISL_531180	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-964C3A/2020	EPI_ISL_531201	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-969655/2020	EPI_ISL_531218	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-964FE6/2020	EPI_ISL_531222	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96AEE3/2020	EPI_ISL_531258	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96AF68/2020	EPI_ISL_531268	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96BD21/2020	EPI_ISL_531296	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-96BAB1/2020	EPI_ISL_531299	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96B29B/2020	EPI_ISL_531305	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Canada/ON-OICR-SLB2817/2020	EPI_ISL_538345	2020-04-02	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Singapore/113nan/2020	EPI_ISL_538448	2020-03-17	Asia / Singapore	Human	Original			Nanopore				B.1.1	GR
hCoV-19/USA/NC-SLPH-0007/2020	EPI_ISL_538517	2020-07-30	North America / USA / North Carolina	Human	Original	Nasopharyngeal swab		Illumina	SeqMan NGen/DNASTAR v. 16.0.0			B.1.1.304	GR
hCoV-19/USA/NC-SLPH-0009/2020	EPI_ISL_538519	2020-07-31	North America / USA / North Carolina	Human	Original	Nasopharyngeal swab		Illumina	SeqMan NGen/DNASTAR v. 16.0.0			B.1.1.304	GR
hCoV-19/England/LEED-2AA4BF/2020	EPI_ISL_538832	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2AA2F1/2020	EPI_ISL_538890	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2AA75C/2020	EPI_ISL_538958	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/TX-HMH-4350/2020	EPI_ISL_543551	2020-06-17	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-2872/2020	EPI_ISL_543841	2020-06-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-2944/2020	EPI_ISL_543880	2020-06-09	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-3003/2020	EPI_ISL_543925	2020-05-31	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-5112/2020	EPI_ISL_544533	2020-06-23	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-5269/2020	EPI_ISL_544640	2020-06-21	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.398	GR
hCoV-19/England/MILK-99E0B3/2020	EPI_ISL_550701	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99D1FD/2020	EPI_ISL_550713	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99E38D/2020	EPI_ISL_550720	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-99E183/2020	EPI_ISL_550732	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-99CAF3/2020	EPI_ISL_550742	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99C57A/2020	EPI_ISL_550763	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-99DC47/2020	EPI_ISL_550782	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A9F9A/2020	EPI_ISL_550817	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A98CC/2020	EPI_ISL_550866	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AA97D/2020	EPI_ISL_550867	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9A9FA9/2020	EPI_ISL_550873	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AA825/2020	EPI_ISL_550874	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AAAC5/2020	EPI_ISL_550876	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AA922/2020	EPI_ISL_550879	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6BCC27/2020	EPI_ISL_557955	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6AEDF8/2020	EPI_ISL_557973	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-60FED4/2020	EPI_ISL_557977	2020-07-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-68FF8E/2020	EPI_ISL_557987	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-67361F/2020	EPI_ISL_557995	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-66E0A0/2020	EPI_ISL_558007	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-66C840/2020	EPI_ISL_558036	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-670050/2020	EPI_ISL_558040	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-649D77/2020	EPI_ISL_558046	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-68F4BC/2020	EPI_ISL_558051	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-68FE81/2020	EPI_ISL_558054	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-673C86/2020	EPI_ISL_558066	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-673B7A/2020	EPI_ISL_558075	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-691CFB/2020	EPI_ISL_558092	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-64642A/2020	EPI_ISL_558099	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-64D827/2020	EPI_ISL_558100	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-647EFE/2020	EPI_ISL_558114	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-64B3EC/2020	EPI_ISL_558116	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-66EDE5/2020	EPI_ISL_558118	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-64A30B/2020	EPI_ISL_558124	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-643F1D/2020	EPI_ISL_558148	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-66EE97/2020	EPI_ISL_558154	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-68D8B2/2020	EPI_ISL_558189	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-690193/2020	EPI_ISL_558202	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-673B98/2020	EPI_ISL_558223	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-66C822/2020	EPI_ISL_558233	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-58FF34/2020	EPI_ISL_558254	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-59BC01/2020	EPI_ISL_558288	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-59B2E1/2020	EPI_ISL_558321	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-565D2B/2020	EPI_ISL_558337	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-59AD69/2020	EPI_ISL_558355	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-599474/2020	EPI_ISL_558357	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-56710F/2020	EPI_ISL_558360	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D44B9/2020	EPI_ISL_558412	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5D3818/2020	EPI_ISL_558413	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D0514/2020	EPI_ISL_558420	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D1829/2020	EPI_ISL_558421	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D05D8/2020	EPI_ISL_558433	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D3696/2020	EPI_ISL_558435	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5D3933/2020	EPI_ISL_558463	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D067B/2020	EPI_ISL_558470	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D149E/2020	EPI_ISL_558475	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D92AB/2020	EPI_ISL_558476	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-5C789F/2020	EPI_ISL_558478	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D1461/2020	EPI_ISL_558480	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D1CA5/2020	EPI_ISL_558489	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D1838/2020	EPI_ISL_558493	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D4738/2020	EPI_ISL_558499	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5D0BB8/2020	EPI_ISL_558505	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D58DA/2020	EPI_ISL_558510	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D4E9D/2020	EPI_ISL_558522	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5CFC40/2020	EPI_ISL_558531	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5D0189/2020	EPI_ISL_558534	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D19BD/2020	EPI_ISL_558539	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D3960/2020	EPI_ISL_558541	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D41D0/2020	EPI_ISL_558555	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5C9657/2020	EPI_ISL_558562	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-5D4D72/2020	EPI_ISL_558575	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5CC8B8/2020	EPI_ISL_558584	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D9706/2020	EPI_ISL_558608	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-5A3A0C/2020	EPI_ISL_558620	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5AA9EA/2020	EPI_ISL_558628	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5A6A63/2020	EPI_ISL_558650	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5A3B63/2020	EPI_ISL_558654	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5A67E4/2020	EPI_ISL_558678	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5AAF06/2020	EPI_ISL_558689	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5B4042/2020	EPI_ISL_558711	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5BA228/2020	EPI_ISL_558727	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5C1C6C/2020	EPI_ISL_558735	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5AA65C/2020	EPI_ISL_558736	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5AC292/2020	EPI_ISL_558750	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5A3B90/2020	EPI_ISL_558761	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5AC942/2020	EPI_ISL_558768	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5AB7A3/2020	EPI_ISL_558770	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.136	GR
hCoV-19/England/ALDP-5A48C5/2020	EPI_ISL_558805	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5A219F/2020	EPI_ISL_558816	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5A4494/2020	EPI_ISL_558854	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5A392D/2020	EPI_ISL_558858	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5A4528/2020	EPI_ISL_558884	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5C3866/2020	EPI_ISL_558895	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-59F63C/2020	EPI_ISL_558899	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5A39E1/2020	EPI_ISL_558900	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-519D53/2020	EPI_ISL_558901	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-526421/2020	EPI_ISL_558927	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-50ED60/2020	EPI_ISL_558928	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-51D751/2020	EPI_ISL_558930	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-50C227/2020	EPI_ISL_558934	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-52C40D/2020	EPI_ISL_558958	2020-06-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-526C56/2020	EPI_ISL_558963	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-526FC6/2020	EPI_ISL_558964	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5217D2/2020	EPI_ISL_558972	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-50EF97/2020	EPI_ISL_558980	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-526CB0/2020	EPI_ISL_558991	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-4F7035/2020	EPI_ISL_559110	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-4B8470/2020	EPI_ISL_559194	2020-06-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-4F4F3B/2020	EPI_ISL_559205	2020-06-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-4B43A4/2020	EPI_ISL_559256	2020-06-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-4B2519/2020	EPI_ISL_559263	2020-06-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-506409/2020	EPI_ISL_559273	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-4F40DE/2020	EPI_ISL_559288	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-45ED08/2020	EPI_ISL_559713	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-4691FF/2020	EPI_ISL_559738	2020-05-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GR
hCoV-19/England/QEUH-997C2F/2020	EPI_ISL_559753	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-997C5C/2020	EPI_ISL_559755	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-99B159/2020	EPI_ISL_559766	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-99B168/2020	EPI_ISL_559767	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-99BC1C/2020	EPI_ISL_559770	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-99C01F/2020	EPI_ISL_559779	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-99C0A6/2020	EPI_ISL_559783	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-99C10D/2020	EPI_ISL_559784	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-99C361/2020	EPI_ISL_559794	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/QEUH-9ACCAF/2020	EPI_ISL_559803	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9ACD60/2020	EPI_ISL_559808	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9ACE8B/2020	EPI_ISL_559813	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9ACF79/2020	EPI_ISL_559816	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9AD172/2020	EPI_ISL_559819	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9AD242/2020	EPI_ISL_559822	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9AF1F8/2020	EPI_ISL_559827	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9AF204/2020	EPI_ISL_559828	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9AF301/2020	EPI_ISL_559835	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9AF35C/2020	EPI_ISL_559837	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9AF644/2020	EPI_ISL_559854	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.294	GR
hCoV-19/England/QEUH-9B0CD5/2020	EPI_ISL_559860	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9B0D2D/2020	EPI_ISL_559863	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9B4266/2020	EPI_ISL_559883	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9B43AF/2020	EPI_ISL_559889	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9B4406/2020	EPI_ISL_559891	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/SHEF-C48F1/2020	EPI_ISL_559907	2020-09-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C683B/2020	EPI_ISL_559910	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C69B0/2020	EPI_ISL_559912	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C714E/2020	EPI_ISL_559916	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C7DB3/2020	EPI_ISL_559920	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CC1B2/2020	EPI_ISL_559930	2020-09-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CC1EF/2020	EPI_ISL_559931	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CE350/2020	EPI_ISL_559934	2020-09-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/SHEF-CE44E/2020	EPI_ISL_559935	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-D2B33/2020	EPI_ISL_559946	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR4287/2020	EPI_ISL_559960	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR4290/2020	EPI_ISL_559962	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR4292/2020	EPI_ISL_559964	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR4294/2020	EPI_ISL_559966	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/USA/WA-UW-10442/2020	EPI_ISL_570309	2020-06-05	North America / USA / Washington	Human	Original			Illumina	custom			B.1	GR
hCoV-19/USA/WA-UW-11059/2020	EPI_ISL_570369	2020-06-17	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.304	GR
hCoV-19/USA/WA-UW-11489/2020	EPI_ISL_570422	2020-06-24	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.306	GR
hCoV-19/USA/WA-UW-11571/2020	EPI_ISL_570439	2020-06-22	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.306	GR
hCoV-19/USA/WA-UW-12400/2020	EPI_ISL_570530	2020-06-26	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.228	GR
hCoV-19/USA/WA-UW-22903/2020	EPI_ISL_570733	2020-08-06	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.228	GR
hCoV-19/USA/WA-UW-23206/2020	EPI_ISL_570757	2020-08-07	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.228	GR
hCoV-19/USA/WA-UW-24901/2020	EPI_ISL_570770	2020-08-11	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.228	GR
hCoV-19/USA/WA-UW-13047/2020	EPI_ISL_570844	2020-06-30	North America / USA / Washington	Human	Original			Illumina	custom	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/MILK-991A1C/2020	EPI_ISL_577013	2020-08-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-991B91/2020	EPI_ISL_577028	2020-08-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.160	GR
hCoV-19/England/MILK-991C70/2020	EPI_ISL_577036	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9E1628/2020	EPI_ISL_577078	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/NOTT-1144A2/2020	EPI_ISL_577168	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9AE997/2020	EPI_ISL_577258	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9AE9D3/2020	EPI_ISL_577262	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9D1412/2020	EPI_ISL_577283	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9D3128/2020	EPI_ISL_577310	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9D35A4/2020	EPI_ISL_577340	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9AE77F/2020	EPI_ISL_577371	2020-09-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/QEUH-9AE87C/2020	EPI_ISL_577372	2020-09-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9D1096/2020	EPI_ISL_577376	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/QEUH-9D3252/2020	EPI_ISL_577382	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/PHWC-16D62C/2020	EPI_ISL_577422	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16D6B3/2020	EPI_ISL_577431	2020-09-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16D6C2/2020	EPI_ISL_577432	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16D71A/2020	EPI_ISL_577437	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16D932/2020	EPI_ISL_577467	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16DCB1/2020	EPI_ISL_577518	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16DDAF/2020	EPI_ISL_577533	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/India/MH-NIV-226874/2020	EPI_ISL_577640	2020-09-25	Asia / India / Maharashtra	Human	Original			Ion Torrent				B.1.1.306	GR
hCoV-19/India/MH-NIV-209697/2020	EPI_ISL_577663	2020-09-12	Asia / India / Maharashtra	Human	Original			Ion Torrent				B.1.1.306	GR
hCoV-19/Slovakia/UKBA-203/2020	EPI_ISL_577735	2020-04-06	Europe / Slovakia / Zehra	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC 400bp + 2000bp combination			B.1.1	GR
hCoV-19/Slovakia/UKBA-205/2020	EPI_ISL_577737	2020-04-13	Europe / Slovakia / Zehra	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC 400bp + 2000bp combination			B.1.1	GR
hCoV-19/Netherlands/UT-EMC-79/2020	EPI_ISL_577895	2020-08-28	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.1.37	GR
hCoV-19/Netherlands/ZH-EMC-547/2020	EPI_ISL_577975	2020-09-16	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1.37	GR
hCoV-19/USA/CA-CZB-10832/2020	EPI_ISL_583080	2020-07-15	North America / USA / California / Humboldt County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.304	GR
hCoV-19/Slovakia/UKBA-318/2020	EPI_ISL_583486	2020-09-16	Europe / Slovakia / Surany	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC 400bp + 2000bp combination			B.1.1.170	GR
hCoV-19/Austria/CeMM0179/2020	EPI_ISL_583565	2020-03-08	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0512/2020	EPI_ISL_583597	2020-03-11	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0646/2020	EPI_ISL_583620	2020-03-29	Europe / Austria / Kappl	Human	Original			Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0691/2020	EPI_ISL_583648	2020-03-31	Europe / Austria	Human	Original			Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0853/2020	EPI_ISL_583728	2020-04-04	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0867/2020	EPI_ISL_583732	2020-04-26	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0868/2020	EPI_ISL_583733	2020-04-28	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0872/2020	EPI_ISL_583736	2020-04-30	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0874/2020	EPI_ISL_583737	2020-04-30	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0877/2020	EPI_ISL_583739	2020-05-06	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0878/2020	EPI_ISL_583740	2020-05-06	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0885/2020	EPI_ISL_583741	2020-04-28	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0886/2020	EPI_ISL_583742	2020-04-28	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0887/2020	EPI_ISL_583743	2020-04-29	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM1055/2020	EPI_ISL_583868	2020-04-14	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM1056/2020	EPI_ISL_583869	2020-03-04	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM1057/2020	EPI_ISL_583870	2020-03-06	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM1058/2020	EPI_ISL_583871	2020-03-08	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM1059/2020	EPI_ISL_583872	2020-03-11	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM1060/2020	EPI_ISL_583873	2020-03-12	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM1061/2020	EPI_ISL_583874	2020-03-13	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM1062/2020	EPI_ISL_583875	2020-03-13	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM1063/2020	EPI_ISL_583876	2020-03-13	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM1064/2020	EPI_ISL_583877	2020-03-13	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM1065/2020	EPI_ISL_583878	2020-03-13	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM1066/2020	EPI_ISL_583879	2020-03-15	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM1067/2020	EPI_ISL_583880	2020-03-15	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM1068/2020	EPI_ISL_583881	2020-03-16	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/England/204180261/2020	EPI_ISL_583992	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/ALDP-9CC18C/2020	EPI_ISL_584165	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9E97C3/2020	EPI_ISL_584249	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/ALDP-9E9893/2020	EPI_ISL_584258	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/ALDP-9E98FD/2020	EPI_ISL_584263	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/ALDP-9E9A42/2020	EPI_ISL_584282	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-2A5A85/2020	EPI_ISL_584704	2020-09-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9DF010/2020	EPI_ISL_584842	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9E3653/2020	EPI_ISL_584860	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9E37AB/2020	EPI_ISL_584872	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A005AD/2020	EPI_ISL_584889	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A0114E/2020	EPI_ISL_584903	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A0115D/2020	EPI_ISL_584904	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A0116C/2020	EPI_ISL_584905	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A02602/2020	EPI_ISL_584915	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-A02B12/2020	EPI_ISL_584947	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/CAMC-A58773/2020	EPI_ISL_597002	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A57E51/2020	EPI_ISL_597028	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A5805A/2020	EPI_ISL_597031	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A58CFC/2020	EPI_ISL_597032	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A58861/2020	EPI_ISL_597035	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A57E33/2020	EPI_ISL_597050	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A59095/2020	EPI_ISL_597068	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/CAMC-A581DF/2020	EPI_ISL_597078	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A5939C/2020	EPI_ISL_597106	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A58685/2020	EPI_ISL_597116	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A58A2F/2020	EPI_ISL_597119	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A586D0/2020	EPI_ISL_597124	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A591DE/2020	EPI_ISL_597132	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A58B86/2020	EPI_ISL_597133	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A59499/2020	EPI_ISL_597148	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A58C83/2020	EPI_ISL_597152	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A594B7/2020	EPI_ISL_597162	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A593C9/2020	EPI_ISL_597165	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A58904/2020	EPI_ISL_597212	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A57088/2020	EPI_ISL_597246	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A57B87/2020	EPI_ISL_597250	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/CAMC-A575C5/2020	EPI_ISL_597256	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/QEUH-A5E7B9/2020	EPI_ISL_597261	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A57BF0/2020	EPI_ISL_597283	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A5E50A/2020	EPI_ISL_597299	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A57BA5/2020	EPI_ISL_597325	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A57AD5/2020	EPI_ISL_597345	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A5DFA3/2020	EPI_ISL_597363	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A57440/2020	EPI_ISL_597367	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A59BFE/2020	EPI_ISL_597371	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A57510/2020	EPI_ISL_597375	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A5E35B/2020	EPI_ISL_597384	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A5DEF1/2020	EPI_ISL_597386	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A5DF49/2020	EPI_ISL_597394	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A57A7B/2020	EPI_ISL_597425	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A5770B/2020	EPI_ISL_597432	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A57185/2020	EPI_ISL_597460	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A5E93B/2020	EPI_ISL_597474	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A5DED3/2020	EPI_ISL_597493	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A577CF/2020	EPI_ISL_597497	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-A5E7C8/2020	EPI_ISL_597500	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A5E537/2020	EPI_ISL_597515	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A5E24F/2020	EPI_ISL_597521	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A507D5/2020	EPI_ISL_597538	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A50F0A/2020	EPI_ISL_597543	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A50131/2020	EPI_ISL_597547	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A50298/2020	EPI_ISL_597565	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A4FB28/2020	EPI_ISL_597574	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A50711/2020	EPI_ISL_597624	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A4FEF2/2020	EPI_ISL_597627	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A5016E/2020	EPI_ISL_597647	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A50E85/2020	EPI_ISL_597648	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A50614/2020	EPI_ISL_597654	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A50FFB/2020	EPI_ISL_597665	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A50474/2020	EPI_ISL_597666	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A50B51/2020	EPI_ISL_597707	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A4FDB9/2020	EPI_ISL_597714	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A50B06/2020	EPI_ISL_597730	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A4FD9B/2020	EPI_ISL_597740	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A50FCE/2020	EPI_ISL_597766	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A50F37/2020	EPI_ISL_597767	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A504CF/2020	EPI_ISL_597781	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A50993/2020	EPI_ISL_597783	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A50016/2020	EPI_ISL_597785	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A50070/2020	EPI_ISL_597808	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A502D4/2020	EPI_ISL_597829	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A51060/2020	EPI_ISL_597833	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A50B60/2020	EPI_ISL_597843	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A51103/2020	EPI_ISL_597848	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A509B1/2020	EPI_ISL_597851	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A4FDAA/2020	EPI_ISL_597859	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A501F5/2020	EPI_ISL_597862	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A5074E/2020	EPI_ISL_597865	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A50966/2020	EPI_ISL_597869	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A50B9D/2020	EPI_ISL_597873	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A51428/2020	EPI_ISL_597886	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A52524/2020	EPI_ISL_597887	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/ALDP-A51B50/2020	EPI_ISL_597897	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A52472/2020	EPI_ISL_597903	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A513EF/2020	EPI_ISL_597904	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A5207E/2020	EPI_ISL_597912	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A51F90/2020	EPI_ISL_597931	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A5274C/2020	EPI_ISL_597938	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A5118B/2020	EPI_ISL_597950	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A526F4/2020	EPI_ISL_597974	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A51A9F/2020	EPI_ISL_597975	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A52779/2020	EPI_ISL_597978	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A51D3C/2020	EPI_ISL_597987	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A520AB/2020	EPI_ISL_597988	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A52339/2020	EPI_ISL_597996	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A45B04/2020	EPI_ISL_598720	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A4663F/2020	EPI_ISL_598769	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A45E74/2020	EPI_ISL_598774	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A45946/2020	EPI_ISL_598798	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-A21F6C/2020	EPI_ISL_598834	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1E937/2020	EPI_ISL_598838	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A21807/2020	EPI_ISL_598845	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A1E409/2020	EPI_ISL_598849	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A1E506/2020	EPI_ISL_598865	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Russia/SVE-RII-MH1713S/2020	EPI_ISL_602350	2020-09-17	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/LEN-RII-MH2021S/2020	EPI_ISL_602380	2020-09-24	Europe / Russia / Leningrad / Vsevolozhsk	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.373	GR
hCoV-19/Russia/SVE-RII-MH2024S/2020	EPI_ISL_602382	2020-09-18	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/LEN-RII-MH2053S/2020	EPI_ISL_602390	2020-09-28	Europe / Russia / Leningrad / Kirovsk	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/MUR-RII-MH2065S/2020	EPI_ISL_602400	2020-09-24	Europe / Russia / Murmansk / Murmansk	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/LEN-RII-MH2081S/2020	EPI_ISL_602410	2020-09-20	Europe / Russia / Leningrad / Yanino	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/DA-RII-MH2741S/2020	EPI_ISL_602419	2020-09-26	Europe / Russia / Dagestan / Derbent	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/KK-RII-MH2759S/2020	EPI_ISL_602432	2020-09-25	Europe / Russia / Khakassia / Abakan	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/STA-RII-MH2777S/2020	EPI_ISL_602445	2020-09-21	Europe / Russia / Stavropol / Stavropol	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/South Africa/KRISP-K002829/2020	EPI_ISL_602649	2020-09-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K003476/2020	EPI_ISL_602808	2020-09-14	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K003477/2020	EPI_ISL_602809	2020-09-14	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K003480/2020	EPI_ISL_602812	2020-09-14	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/England/204220520/2020	EPI_ISL_603204	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Switzerland/BE-ETHZ-300234/2020	EPI_ISL_603267	2020-09-30	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.144	GR
hCoV-19/Switzerland/SG-ETHZ-300243/2020	EPI_ISL_603276	2020-10-01	Europe / Switzerland / St Gallen	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.37	GR
hCoV-19/Switzerland/SO-ETHZ-300258/2020	EPI_ISL_603290	2020-10-01	Europe / Switzerland / Solothurn	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe	Gap of 6 nucleotides when compared to the reference sequence.	info	AN.1	G
hCoV-19/Switzerland/BE-ETHZ-300306/2020	EPI_ISL_603338	2020-09-25	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.144	GR
hCoV-19/Switzerland/BE-ETHZ-300325/2020	EPI_ISL_603357	2020-09-26	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.144	GR
hCoV-19/Switzerland/BE-ETHZ-300416/2020	EPI_ISL_603377	2020-09-29	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.144	GR
hCoV-19/Switzerland/BE-ETHZ-300454/2020	EPI_ISL_603406	2020-09-30	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.144	GR
hCoV-19/Switzerland/BE-ETHZ-300455/2020	EPI_ISL_603407	2020-09-30	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.144	GR
hCoV-19/USA/CA-QDX-2033/2020	EPI_ISL_604315	2020-03-18	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/AR-QDX-2132/2020	EPI_ISL_604386	2020-03-17	North America / USA / Arkansas	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/GA-QDX-2558/2020	EPI_ISL_604782	2020-03-14	North America / USA / Georgia	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/Denmark/DCGC-3242/2020	EPI_ISL_616822	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3068/2020	EPI_ISL_616848	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3091/2020	EPI_ISL_616871	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-3244/2020	EPI_ISL_616876	2020-08-24	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3219/2020	EPI_ISL_616879	2020-08-31	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-8007/2020	EPI_ISL_617122	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7990/2020	EPI_ISL_617127	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/Denmark/DCGC-8257/2020	EPI_ISL_617263	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/Denmark/DCGC-8230/2020	EPI_ISL_617281	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/Denmark/DCGC-8346/2020	EPI_ISL_617331	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-8473/2020	EPI_ISL_617390	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-8417/2020	EPI_ISL_617392	2020-10-26	Europe / Denmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-8442/2020	EPI_ISL_617394	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/Denmark/DCGC-8424/2020	EPI_ISL_617402	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2447/2020	EPI_ISL_617407	2020-08-10	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2449/2020	EPI_ISL_617409	2020-08-10	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2451/2020	EPI_ISL_617411	2020-08-10	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2452/2020	EPI_ISL_617412	2020-08-03	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2454/2020	EPI_ISL_617414	2020-08-03	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2459/2020	EPI_ISL_617419	2020-08-03	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2460/2020	EPI_ISL_617420	2020-08-03	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.170	GR
hCoV-19/Denmark/DCGC-2462/2020	EPI_ISL_617422	2020-08-03	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2464/2020	EPI_ISL_617425	2020-08-03	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2149/2020	EPI_ISL_617447	2020-08-10	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2427/2020	EPI_ISL_617522	2020-08-10	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2230/2020	EPI_ISL_617535	2020-08-10	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2402/2020	EPI_ISL_617584	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2418/2020	EPI_ISL_617600	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		NS7a_Q94stop results in 23.1% truncation of the protein sequence.	info	B.1.1.170	GR
hCoV-19/Denmark/DCGC-2265/2020	EPI_ISL_617622	2020-08-10	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2277/2020	EPI_ISL_617635	2020-08-10	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2279/2020	EPI_ISL_617637	2020-08-10	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2290/2020	EPI_ISL_617648	2020-08-10	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2313/2020	EPI_ISL_617650	2020-08-10	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2325/2020	EPI_ISL_617662	2020-08-10	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2326/2020	EPI_ISL_617663	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2327/2020	EPI_ISL_617664	2020-08-10	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2334/2020	EPI_ISL_617672	2020-08-10	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2337/2020	EPI_ISL_617675	2020-08-10	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2344/2020	EPI_ISL_617682	2020-08-10	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2359/2020	EPI_ISL_617699	2020-08-10	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2303/2020	EPI_ISL_617728	2020-08-10	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2476/2020	EPI_ISL_617744	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2488/2020	EPI_ISL_617759	2020-08-10	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2495/2020	EPI_ISL_617766	2020-08-10	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2508/2020	EPI_ISL_617779	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2536/2020	EPI_ISL_617807	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2601/2020	EPI_ISL_617837	2020-08-17	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2606/2020	EPI_ISL_617843	2020-08-17	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION		NS7a_Q94stop results in 23.1% truncation of the protein sequence.	info	B.1.1.170	GR
hCoV-19/Denmark/DCGC-2620/2020	EPI_ISL_617857	2020-08-17	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION		NS7a_Q94stop results in 23.1% truncation of the protein sequence.	info	B.1.1.170	GR
hCoV-19/Denmark/DCGC-2654/2020	EPI_ISL_617874	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.37	GR
hCoV-19/Denmark/DCGC-2681/2020	EPI_ISL_617902	2020-08-17	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2574/2020	EPI_ISL_617905	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7777/2020	EPI_ISL_618696	2020-10-19	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-7739/2020	EPI_ISL_618716	2020-10-19	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-7775/2020	EPI_ISL_618734	2020-10-19	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7899/2020	EPI_ISL_618814	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7905/2020	EPI_ISL_618815	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7908/2020	EPI_ISL_618850	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7880/2020	EPI_ISL_618860	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7870/2020	EPI_ISL_618867	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7945/2020	EPI_ISL_618884	2020-10-26	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-4212/2020	EPI_ISL_622105	2020-09-14	Europe / Denmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-4220/2020	EPI_ISL_622113	2020-09-14	Europe / Denmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-4590/2020	EPI_ISL_622259	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6723/2020	EPI_ISL_622361	2020-04-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-1415/2020	EPI_ISL_622432	2020-04-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-1393/2020	EPI_ISL_622456	2020-04-06	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-1947/2020	EPI_ISL_622529	2020-04-27	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-1869/2020	EPI_ISL_622559	2020-06-29	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.306	GR
hCoV-19/Denmark/DCGC-1863/2020	EPI_ISL_622570	2020-07-06	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.306	GR
hCoV-19/Denmark/DCGC-3758/2020	EPI_ISL_622645	2020-04-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3793/2020	EPI_ISL_622719	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Australia/SA0523/2020	EPI_ISL_622762	2020-10-26	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq				B.1.1.37	GR
hCoV-19/New Zealand/20CV0458/2020	EPI_ISL_622809	2020-10-19	Oceania / New Zealand / Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/New Zealand/20CV0474/2020	EPI_ISL_622812	2020-10-22	Oceania / New Zealand / Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/New Zealand/20CV0496/2020	EPI_ISL_622824	2020-11-01	Oceania / New Zealand / Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/New Zealand/20CV0499/2020	EPI_ISL_622827	2020-10-25	Oceania / New Zealand / South Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/New Zealand/20CV0503/2020	EPI_ISL_622829	2020-10-31	Oceania / New Zealand / Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/New Zealand/20CV0504/2020	EPI_ISL_622830	2020-10-28	Oceania / New Zealand / Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/England/204240984/2020	EPI_ISL_622851	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/Italy/VEN-IZSVe-1-1/2020	EPI_ISL_636464	2020-03-21	Europe / Italy / Veneto / Padova	Human	Original	Oropharyngeal swab		Illumina MiSeq	BWA v0.7.12			B.1.1	GR
hCoV-19/Netherlands/ZE-RIVM-10375/2020	EPI_ISL_636589	2020-09-11	Europe / Netherlands / Zeeland	Human	Original			Nanopore MinION				B.1.1.37	GR
hCoV-19/Netherlands/ZE-RIVM-10376/2020	EPI_ISL_636590	2020-09-07	Europe / Netherlands / Zeeland	Human	Original			Nanopore MinION				B.1.1.37	GR
hCoV-19/England/C200021007/2020	EPI_ISL_636686	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/C200029520/2020	EPI_ISL_636703	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/C200032707/2020	EPI_ISL_636706	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/C200032709/2020	EPI_ISL_636707	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/C200032712/2020	EPI_ISL_636708	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/C200032718/2020	EPI_ISL_636709	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/C200032834/2020	EPI_ISL_636710	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/C200032839/2020	EPI_ISL_636711	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/C200032845/2020	EPI_ISL_636712	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/C200040575/2020	EPI_ISL_636731	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/Lithuania/MR-LUHS-Eilnr192/2020	EPI_ISL_636842	2020-07-28	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01754/2020	EPI_ISL_636907	2020-07	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1.306	GR
hCoV-19/England/QEUH-A36A90/2020	EPI_ISL_638041	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-B0F84A/2020	EPI_ISL_641823	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B142DB/2020	EPI_ISL_641838	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B13E05/2020	EPI_ISL_641843	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B12C93/2020	EPI_ISL_641851	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B106B5/2020	EPI_ISL_641860	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-B13870/2020	EPI_ISL_641879	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B13DDB/2020	EPI_ISL_641888	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0F789/2020	EPI_ISL_641890	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B13C0B/2020	EPI_ISL_641898	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-B140D1/2020	EPI_ISL_641906	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0EB24/2020	EPI_ISL_641921	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B0DB61/2020	EPI_ISL_641922	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0EA63/2020	EPI_ISL_641932	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0E08F/2020	EPI_ISL_641959	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B0F2C4/2020	EPI_ISL_641970	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B0DE68/2020	EPI_ISL_641979	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0E104/2020	EPI_ISL_641982	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B0E061/2020	EPI_ISL_642025	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0FCA8/2020	EPI_ISL_642043	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0E948/2020	EPI_ISL_642044	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0E2A7/2020	EPI_ISL_642049	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B0DFED/2020	EPI_ISL_642065	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0E3D1/2020	EPI_ISL_642066	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0EB15/2020	EPI_ISL_642067	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0DEC2/2020	EPI_ISL_642079	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0DB34/2020	EPI_ISL_642127	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0E2E3/2020	EPI_ISL_642138	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B0E3B3/2020	EPI_ISL_642156	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0DF65/2020	EPI_ISL_642170	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B0E869/2020	EPI_ISL_642174	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0E1C8/2020	EPI_ISL_642175	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B0DF0B/2020	EPI_ISL_642178	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0FCB7/2020	EPI_ISL_642182	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0DFFC/2020	EPI_ISL_642185	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B0E395/2020	EPI_ISL_642199	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B0DCB9/2020	EPI_ISL_642207	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-B10521/2020	EPI_ISL_642208	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B11B88/2020	EPI_ISL_642227	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B10D1A/2020	EPI_ISL_642228	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B118EB/2020	EPI_ISL_642230	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B10EBD/2020	EPI_ISL_642242	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B127FC/2020	EPI_ISL_642254	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-B11BE2/2020	EPI_ISL_642260	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B128AE/2020	EPI_ISL_642270	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B126E0/2020	EPI_ISL_642281	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B11960/2020	EPI_ISL_642293	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B10E44/2020	EPI_ISL_642318	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B121B2/2020	EPI_ISL_642324	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B13218/2020	EPI_ISL_642328	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/QEUH-B10F41/2020	EPI_ISL_642340	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B115A8/2020	EPI_ISL_642377	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B11CC1/2020	EPI_ISL_642394	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B128CC/2020	EPI_ISL_642396	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B10EF9/2020	EPI_ISL_642403	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B11DFB/2020	EPI_ISL_642404	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B10F50/2020	EPI_ISL_642407	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B11906/2020	EPI_ISL_642423	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B10D56/2020	EPI_ISL_642433	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-B11A12/2020	EPI_ISL_642440	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B11942/2020	EPI_ISL_642446	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B12783/2020	EPI_ISL_642470	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B104CA/2020	EPI_ISL_642486	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B1460C/2020	EPI_ISL_642495	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B12A5D/2020	EPI_ISL_642501	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B1436F/2020	EPI_ISL_642509	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-B12DEB/2020	EPI_ISL_642520	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-B12316/2020	EPI_ISL_642524	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B10925/2020	EPI_ISL_642525	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B1211C/2020	EPI_ISL_642526	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B11292/2020	EPI_ISL_642532	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B11256/2020	EPI_ISL_642533	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B11265/2020	EPI_ISL_642538	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B12668/2020	EPI_ISL_642547	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-B1007B/2020	EPI_ISL_642555	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B108DD/2020	EPI_ISL_642558	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B1254D/2020	EPI_ISL_642562	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B12DFA/2020	EPI_ISL_642566	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B11317/2020	EPI_ISL_642570	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B11238/2020	EPI_ISL_642580	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0F24C/2020	EPI_ISL_642587	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B10BC5/2020	EPI_ISL_642588	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-B12817/2020	EPI_ISL_642598	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-B11247/2020	EPI_ISL_642604	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-B11DCE/2020	EPI_ISL_642610	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B143F6/2020	EPI_ISL_642618	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B12677/2020	EPI_ISL_642621	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B10B3E/2020	EPI_ISL_642624	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B143D8/2020	EPI_ISL_642630	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B12E24/2020	EPI_ISL_642637	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B112CF/2020	EPI_ISL_642642	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B10099/2020	EPI_ISL_642643	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-B109AD/2020	EPI_ISL_642658	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B1461B/2020	EPI_ISL_642661	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B123BC/2020	EPI_ISL_642665	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B1454B/2020	EPI_ISL_642666	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B12B96/2020	EPI_ISL_642667	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B120E2/2020	EPI_ISL_642668	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B126B3/2020	EPI_ISL_642675	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-B11326/2020	EPI_ISL_642676	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B1262C/2020	EPI_ISL_642689	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-B1202E/2020	EPI_ISL_642705	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B0F22E/2020	EPI_ISL_642713	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B123E9/2020	EPI_ISL_642717	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B1439C/2020	EPI_ISL_642718	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B100E4/2020	EPI_ISL_642725	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B1455A/2020	EPI_ISL_642737	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B12E9D/2020	EPI_ISL_642739	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B1011E/2020	EPI_ISL_642742	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B11344/2020	EPI_ISL_642752	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B10B6B/2020	EPI_ISL_642754	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B10C3B/2020	EPI_ISL_642757	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B1448A/2020	EPI_ISL_642758	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B0600F/2020	EPI_ISL_642823	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B02197/2020	EPI_ISL_642948	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B0271D/2020	EPI_ISL_642998	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A8B8ED/2020	EPI_ISL_643047	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8BDFD/2020	EPI_ISL_643049	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8BE45/2020	EPI_ISL_643051	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8C442/2020	EPI_ISL_643068	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8B56E/2020	EPI_ISL_643085	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A8BA9C/2020	EPI_ISL_643099	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B0898A/2020	EPI_ISL_643509	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B0B714/2020	EPI_ISL_643553	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B08067/2020	EPI_ISL_643586	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-B0BAB1/2020	EPI_ISL_643600	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B080D0/2020	EPI_ISL_643623	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B08674/2020	EPI_ISL_643744	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B074F3/2020	EPI_ISL_643769	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B07CEC/2020	EPI_ISL_643856	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B09242/2020	EPI_ISL_643862	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B07280/2020	EPI_ISL_643974	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-B46C96/2020	EPI_ISL_656001	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B46EEB/2020	EPI_ISL_656038	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B4622B/2020	EPI_ISL_656066	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B46DFD/2020	EPI_ISL_656076	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-B47336/2020	EPI_ISL_656079	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B45AF7/2020	EPI_ISL_656098	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B463FB/2020	EPI_ISL_656099	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B4649E/2020	EPI_ISL_656118	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B45DD0/2020	EPI_ISL_656222	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B45B12/2020	EPI_ISL_656246	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B45E19/2020	EPI_ISL_656311	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B61FD8/2020	EPI_ISL_656347	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/ALDP-B631FE/2020	EPI_ISL_656358	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/ALDP-B62AF4/2020	EPI_ISL_656363	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B63C2A/2020	EPI_ISL_656422	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-B631EF/2020	EPI_ISL_656460	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/ALDP-B627B1/2020	EPI_ISL_656502	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B63BA5/2020	EPI_ISL_656528	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-B62AE5/2020	EPI_ISL_656560	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B62890/2020	EPI_ISL_656565	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Northern Ireland/ALDP-B63A11/2020	EPI_ISL_656608	2020-11-09	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B6257B/2020	EPI_ISL_656624	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B63307/2020	EPI_ISL_656652	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/ALDP-B620E3/2020	EPI_ISL_656653	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B62A21/2020	EPI_ISL_656676	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B632EC/2020	EPI_ISL_656684	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-B53962/2020	EPI_ISL_656713	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B5359B/2020	EPI_ISL_656726	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B53953/2020	EPI_ISL_656909	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B52E0A/2020	EPI_ISL_657613	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B52AE8/2020	EPI_ISL_657669	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/USA/WI-GMF-32905/2020	EPI_ISL_661168	2020-11-10	North America / USA / Wisconsin / Trempealeau County	Human	Original			Ion Torrent				B.1.1.434	GR
hCoV-19/England/204821174/2020	EPI_ISL_661175	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.294	GR
hCoV-19/Sweden/20-08949/2020	EPI_ISL_661273	2020-07-16	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-22311/2020	EPI_ISL_661279	2020-04-06	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.438	GR
hCoV-19/England/QEUH-B6993C/2020	EPI_ISL_661343	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B67691/2020	EPI_ISL_661363	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B67B56/2020	EPI_ISL_661375	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B6835D/2020	EPI_ISL_661383	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B69A93/2020	EPI_ISL_661384	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B666CF/2020	EPI_ISL_661385	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B692C8/2020	EPI_ISL_661387	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B66243/2020	EPI_ISL_661419	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B6C508/2020	EPI_ISL_661421	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B67EB7/2020	EPI_ISL_661424	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B67AD1/2020	EPI_ISL_661441	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B67BED/2020	EPI_ISL_661446	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-B67B47/2020	EPI_ISL_661449	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B67B1A/2020	EPI_ISL_661451	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B6837B/2020	EPI_ISL_661472	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B67B83/2020	EPI_ISL_661493	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B682AB/2020	EPI_ISL_661497	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B69A57/2020	EPI_ISL_661521	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B67770/2020	EPI_ISL_661528	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-B66568/2020	EPI_ISL_661542	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B68469/2020	EPI_ISL_661544	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-B67BA1/2020	EPI_ISL_661555	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B676FB/2020	EPI_ISL_661577	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-B67C44/2020	EPI_ISL_661593	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B67BFC/2020	EPI_ISL_661603	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B692B9/2020	EPI_ISL_661630	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B782F3/2020	EPI_ISL_661653	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B807F9/2020	EPI_ISL_661674	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B804C5/2020	EPI_ISL_661715	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/QEUH-B7EF41/2020	EPI_ISL_661757	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B78563/2020	EPI_ISL_661761	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7F47E/2020	EPI_ISL_661806	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B7EF50/2020	EPI_ISL_661837	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B77B71/2020	EPI_ISL_661873	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B787D6/2020	EPI_ISL_661900	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7F03E/2020	EPI_ISL_661913	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF50E6/2020	EPI_ISL_663021	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF4CC5/2020	EPI_ISL_663023	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF5BA9/2020	EPI_ISL_663036	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF50B9/2020	EPI_ISL_663085	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B95AF8/2020	EPI_ISL_675115	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B8388A/2020	EPI_ISL_675143	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B84582/2020	EPI_ISL_675158	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8F11A/2020	EPI_ISL_675178	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B83714/2020	EPI_ISL_675182	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B856F7/2020	EPI_ISL_675184	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B82F68/2020	EPI_ISL_675193	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-B837AB/2020	EPI_ISL_675198	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B84151/2020	EPI_ISL_675287	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B845BF/2020	EPI_ISL_675298	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B83C9D/2020	EPI_ISL_675315	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B82F4A/2020	EPI_ISL_675341	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-B83723/2020	EPI_ISL_675344	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B836EA/2020	EPI_ISL_675352	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B8390F/2020	EPI_ISL_675380	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B84124/2020	EPI_ISL_675385	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B85879/2020	EPI_ISL_675410	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B8494A/2020	EPI_ISL_675425	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/ALDP-B83AC0/2020	EPI_ISL_675470	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.153	GR
hCoV-19/England/ALDP-B831AD/2020	EPI_ISL_675519	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B82E4D/2020	EPI_ISL_675580	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/ALDP-B82AC1/2020	EPI_ISL_675603	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B849C2/2020	EPI_ISL_675779	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B849B3/2020	EPI_ISL_675785	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B88AF8/2020	EPI_ISL_675949	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-B88ACB/2020	EPI_ISL_675984	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/ALDP-B85A37/2020	EPI_ISL_675987	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B8C8CD/2020	EPI_ISL_676004	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B944FB/2020	EPI_ISL_676014	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B939DF/2020	EPI_ISL_676122	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B94297/2020	EPI_ISL_676178	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-B93DC4/2020	EPI_ISL_676208	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B96417/2020	EPI_ISL_676260	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B968EE/2020	EPI_ISL_676281	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B66067/2020	EPI_ISL_676382	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-B40036/2020	EPI_ISL_676390	2020-11-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/USA/CO-CDPHE-2008181790/2020	EPI_ISL_677310	2020-08-17	North America / USA / Colorado	Human	Original			Illumina MiSeq				B.1.1.228	GR
hCoV-19/USA/IL-UW-1960/2020	EPI_ISL_677368	2020-09-25	North America / USA / Illinois / Winnebago County	Human	Original	Nasal swab		Nanopore GridION - ARTIC protocol	custom - minimap2			B.1.1	GR
hCoV-19/USA/IL-UW-2080/2020	EPI_ISL_677485	2020-10-19	North America / USA / Illinois / Winnebago County	Human	Original	Nasal swab		Nanopore GridION - ARTIC protocol	custom - minimap2			B.1.1	G
hCoV-19/North Macedonia/9304/2020	EPI_ISL_677724	2020-08-05	Europe / North Macedonia / Shtip	Human	Original	Nasopharyngeal swab		Illumina MiSeq / Respiratory Virus Oligo Panel	Illumina BaseSpace / DRAGEN_RNA_Pathogen_Detection			B.1.1	GR
hCoV-19/Wales/PHWC-48EDB4/2020	EPI_ISL_681005	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48EEA2/2020	EPI_ISL_681017	2020-11-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48F0D8/2020	EPI_ISL_681043	2020-11-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48F66D/2020	EPI_ISL_681120	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48F75B/2020	EPI_ISL_681133	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48FBE6/2020	EPI_ISL_681201	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48FCA7/2020	EPI_ISL_681212	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48FD3B/2020	EPI_ISL_681221	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48FD4A/2020	EPI_ISL_681222	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48FD77/2020	EPI_ISL_681225	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48FF26/2020	EPI_ISL_681250	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-BAB260/2020	EPI_ISL_681496	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-BA99A9/2020	EPI_ISL_681534	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-BABBB0/2020	EPI_ISL_681582	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Ireland/LK-UHL144/2020	EPI_ISL_681734	2020-04-08	Europe / Ireland / Limerick / Limerick City	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/LK-UHL15/2020	EPI_ISL_681736	2020-04-06	Europe / Ireland / Limerick / Limerick City	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/LK-UHL28/2020	EPI_ISL_681739	2020-04-05	Europe / Ireland / Limerick / Limerick City	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/LK-UHL294/2020	EPI_ISL_681742	2020-04-27	Europe / Ireland / Limerick / Limerick County	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/LK-UHL30/2020	EPI_ISL_681744	2020-04-07	Europe / Ireland / Limerick / Limerick City	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/LK-UHL31/2020	EPI_ISL_681749	2020-04-10	Europe / Ireland / Limerick / Limerick County	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/LK-UHL6/2020	EPI_ISL_681757	2020-04-02	Europe / Ireland / Limerick / Limerick City	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/USA/GA-CDC-7327/2020	EPI_ISL_681776	2020-10-22	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7328/2020	EPI_ISL_681777	2020-10-22	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7329/2020	EPI_ISL_681778	2020-10-22	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7345/2020	EPI_ISL_681779	2020-10-22	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7347/2020	EPI_ISL_681780	2020-10-22	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7361/2020	EPI_ISL_681781	2020-10-22	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7364/2020	EPI_ISL_681782	2020-10-22	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7365/2020	EPI_ISL_681783	2020-10-22	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7366/2020	EPI_ISL_681784	2020-10-22	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7369/2020	EPI_ISL_681785	2020-10-22	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7371/2020	EPI_ISL_681786	2020-10-22	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7378/2020	EPI_ISL_681787	2020-10-22	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7388/2020	EPI_ISL_681788	2020-10-22	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7492/2020	EPI_ISL_681789	2020-10-23	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7516/2020	EPI_ISL_681790	2020-10-23	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7519/2020	EPI_ISL_681791	2020-10-23	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7525/2020	EPI_ISL_681792	2020-10-23	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7533/2020	EPI_ISL_681793	2020-10-23	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7543/2020	EPI_ISL_681794	2020-10-23	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7556/2020	EPI_ISL_681795	2020-10-23	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7561/2020	EPI_ISL_681796	2020-10-23	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7591/2020	EPI_ISL_681797	2020-10-25	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7595/2020	EPI_ISL_681798	2020-10-25	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7596/2020	EPI_ISL_681799	2020-10-25	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7669/2020	EPI_ISL_681800	2020-10-27	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7671/2020	EPI_ISL_681801	2020-10-27	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7701/2020	EPI_ISL_681802	2020-10-27	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7704/2020	EPI_ISL_681803	2020-10-27	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7711/2020	EPI_ISL_681804	2020-10-27	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7720/2020	EPI_ISL_681805	2020-10-27	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7724/2020	EPI_ISL_681806	2020-10-27	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7728/2020	EPI_ISL_681807	2020-10-27	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7731/2020	EPI_ISL_681808	2020-10-27	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7733/2020	EPI_ISL_681809	2020-10-27	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7742/2020	EPI_ISL_681810	2020-10-27	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7743/2020	EPI_ISL_681811	2020-10-27	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7744/2020	EPI_ISL_681812	2020-10-27	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7746/2020	EPI_ISL_681813	2020-10-27	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7799/2020	EPI_ISL_681814	2020-10-27	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7823/2020	EPI_ISL_681815	2020-10-27	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7877/2020	EPI_ISL_681816	2020-10-28	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7896/2020	EPI_ISL_681817	2020-10-28	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-8142/2020	EPI_ISL_681818	2020-10-23	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7402/2020	EPI_ISL_681819	2020-10-22	North America / USA / Georgia	Human	Original	Saliva		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7407/2020	EPI_ISL_681820	2020-10-22	North America / USA / Georgia	Human	Original	Saliva		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7459/2020	EPI_ISL_681821	2020-10-23	North America / USA / Georgia	Human	Original	Saliva		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7675/2020	EPI_ISL_681822	2020-10-27	North America / USA / Georgia	Human	Original	Saliva		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7676/2020	EPI_ISL_681823	2020-10-27	North America / USA / Georgia	Human	Original	Saliva		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7679/2020	EPI_ISL_681824	2020-10-27	North America / USA / Georgia	Human	Original	Saliva		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7681/2020	EPI_ISL_681825	2020-10-27	North America / USA / Georgia	Human	Original	Saliva		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7845/2020	EPI_ISL_681826	2020-10-28	North America / USA / Georgia	Human	Original	Saliva		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7860/2020	EPI_ISL_681827	2020-10-28	North America / USA / Georgia	Human	Original	Saliva		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/USA/GA-CDC-7867/2020	EPI_ISL_681828	2020-10-28	North America / USA / Georgia	Human	Original	Saliva		Illumina MiSeq	freebayes 1.3			B.1.1.186	GR
hCoV-19/Switzerland/ZH-UZH-1000477377/2020	EPI_ISL_413020	2020-02-27	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	SMALT			B.1.1	GR
hCoV-19/Switzerland/VD-SNRCI-29965615/2020	EPI_ISL_414023	2020-03-01	Europe / Switzerland / Vaud	Human	Original			unknown				B.1.1	GR
hCoV-19/Australia/VIC858/2020	EPI_ISL_427117	2020-04-05	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1	GR
hCoV-19/Russia/Moscow-25I/2020	EPI_ISL_428851	2020-04-02	Europe / Russia / Moscow	Human	Vero P1	Oropharyngeal swab		Illumina Hiseq				B.1.1	GR
hCoV-19/Wales/PHWC-27470/2020	EPI_ISL_432299	2020-03-31	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-2780B/2020	EPI_ISL_432322	2020-04-01	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-283CD/2020	EPI_ISL_432352	2020-03-27	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-28882/2020	EPI_ISL_432407	2020-03-31	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-2B1B1/2020	EPI_ISL_432418	2020-04-07	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus	NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/England/SHEF-CB5E4/2020	EPI_ISL_432510	2020-03-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/SHEF-C8532/2020	EPI_ISL_432867	2020-03-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Scotland/EDB972/2020	EPI_ISL_432893	2020-04-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7C2AF/2020	EPI_ISL_434021	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-1AD8A2/2020	EPI_ISL_448019	2020-04-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1ADB5E/2020	EPI_ISL_448037	2020-05-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1ADB9A/2020	EPI_ISL_448041	2020-05-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1ADBB8/2020	EPI_ISL_448043	2020-05-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AFF9C/2020	EPI_ISL_448091	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/CAMB-1AFFE7/2020	EPI_ISL_448095	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/CAMB-1B00FF/2020	EPI_ISL_448109	2020-05-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR2771/2020	EPI_ISL_448193	2020-04-20	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E87CD/2020	EPI_ISL_448234	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E87EB/2020	EPI_ISL_448236	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E8842/2020	EPI_ISL_448240	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E88CA/2020	EPI_ISL_448246	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E88D9/2020	EPI_ISL_448247	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E895E/2020	EPI_ISL_448253	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E897C/2020	EPI_ISL_448255	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E89E5/2020	EPI_ISL_448261	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E8A00/2020	EPI_ISL_448263	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E8A3D/2020	EPI_ISL_448266	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E8A5B/2020	EPI_ISL_448268	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E8A88/2020	EPI_ISL_448271	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E8A97/2020	EPI_ISL_448272	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E8AE2/2020	EPI_ISL_448277	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E942F/2020	EPI_ISL_448312	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E960B/2020	EPI_ISL_448322	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E97AE/2020	EPI_ISL_448331	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E9841/2020	EPI_ISL_448338	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E9EF4/2020	EPI_ISL_448380	2020-05-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EA057/2020	EPI_ISL_448387	2020-05-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AC507/2020	EPI_ISL_448457	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AC8FF/2020	EPI_ISL_448492	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-ACEEE/2020	EPI_ISL_448546	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AD08D/2020	EPI_ISL_448557	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AD296/2020	EPI_ISL_448573	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-ADD59/2020	EPI_ISL_448633	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AE6F3/2020	EPI_ISL_448713	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AE990/2020	EPI_ISL_448740	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AEC00/2020	EPI_ISL_448770	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AEEA0/2020	EPI_ISL_448792	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Germany/HE-FFM4/2020	EPI_ISL_452220	2020-03-02	Europe / Germany / Hesse / Frankfurt	Human	Caco-2	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 12, Geneious 10.2.4			B.1.1	GR
hCoV-19/Germany/HE-FFM6/2020	EPI_ISL_452222	2020-03-02	Europe / Germany / Hesse / Frankfurt	Human	Caco-2	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 12, Geneious 10.2.4			B.1.1	GR
hCoV-19/England/CAMB-1AEDC0/2020	EPI_ISL_452864	2020-05-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AEDEE/2020	EPI_ISL_452866	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-2899D5/2020	EPI_ISL_453509	2020-04-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORW-E8F4D/2020	EPI_ISL_453566	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E901C/2020	EPI_ISL_453574	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E9243/2020	EPI_ISL_453584	2020-04-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E9331/2020	EPI_ISL_453592	2020-04-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E9674/2020	EPI_ISL_453610	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NOTT-11127E/2020	EPI_ISL_453638	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-11128D/2020	EPI_ISL_453639	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-11129C/2020	EPI_ISL_453640	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-1112AB/2020	EPI_ISL_453641	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-1112BA/2020	EPI_ISL_453642	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Portugal/PT0105/2020	EPI_ISL_453821	2020-03-20	Europe / Portugal	Human	Original			Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0150/2020	EPI_ISL_453866	2020-03-21	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0274/2020	EPI_ISL_453988	2020-04-05	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/England/20146064004/2020	EPI_ISL_466046	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149001104/2020	EPI_ISL_466081	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149001204/2020	EPI_ISL_466082	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149003004/2020	EPI_ISL_466089	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149003104/2020	EPI_ISL_466090	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149013504/2020	EPI_ISL_466156	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149013604/2020	EPI_ISL_466157	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149013704/2020	EPI_ISL_466158	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149054404/2020	EPI_ISL_466216	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20154003804/2020	EPI_ISL_466252	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20154003904/2020	EPI_ISL_466253	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20154004204/2020	EPI_ISL_466254	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20154004304/2020	EPI_ISL_466255	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	NSP2_Q427stop results in 33.2% truncation of the protein sequence.	info	B.1	GR
hCoV-19/England/20154082104/2020	EPI_ISL_466267	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20154083604/2020	EPI_ISL_466272	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20154083704/2020	EPI_ISL_466273	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201620041/2020	EPI_ISL_466391	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201620042/2020	EPI_ISL_466392	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201620047/2020	EPI_ISL_466393	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20162009704/2020	EPI_ISL_466408	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20162010504/2020	EPI_ISL_466409	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20166012304/2020	EPI_ISL_466530	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20166017804/2020	EPI_ISL_466543	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20168002704/2020	EPI_ISL_466593	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20168003204/2020	EPI_ISL_466596	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20168004104/2020	EPI_ISL_466597	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20168032404/2020	EPI_ISL_466608	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20169000204/2020	EPI_ISL_466623	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20169000804/2020	EPI_ISL_466625	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-078/2020	EPI_ISL_466693	2020-06-01	Asia / Bangladesh / Dhaka	Human	Original	Nasopharyngeal swab		Illumina Nextseq 550	NextSeq (TM) Control Software v4			B.1.1	GR
hCoV-19/India/TG-NGC-CDFD-01/2020	EPI_ISL_466839	2020-05-10	Asia / India / Telangana	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.1.306	GR
hCoV-19/India/TG-NGC-CDFD-12/2020	EPI_ISL_466850	2020-05-26	Asia / India / Telangana	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.1.306	GR
hCoV-19/Ecuador/USFQ-707/2020	EPI_ISL_471269	2020-06-04	South America / Ecuador / Quito	Human	Original			Nanopore MinION	Artic Network			B.1.1	GR
hCoV-19/Ecuador/USFQ-112/2020	EPI_ISL_471270	2020-05-19	South America / Ecuador / Quito	Human	Original			Nanopore MinION	Artic Network			B.1.1	GR
hCoV-19/Ecuador/USFQ-106/2020	EPI_ISL_471271	2020-05-19	South America / Ecuador / Quito	Human	Original			Nanopore MinION	Artic Network			B.1.1	GR
hCoV-19/India/TG-CCMB-L1554/2020	EPI_ISL_471619	2020-05-26	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-L1564/2020	EPI_ISL_471620	2020-05-26	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-L1675/2020	EPI_ISL_471621	2020-05-29	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-L1694/2020	EPI_ISL_471624	2020-05-29	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-L1721/2020	EPI_ISL_471625	2020-05-30	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-L1726/2020	EPI_ISL_471627	2020-05-30	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-L1728/2020	EPI_ISL_471628	2020-05-30	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-L1809/2020	EPI_ISL_471635	2020-06-02	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-L1819/2020	EPI_ISL_471638	2020-06-02	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/Wales/PHWC-162B37/2020	EPI_ISL_473166	2020-05-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-162C70/2020	EPI_ISL_473183	2020-05-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/BIRM-5F187/2020	EPI_ISL_473318	2020-05-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-5FA22/2020	EPI_ISL_473363	2020-05-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-6054B/2020	EPI_ISL_473423	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-60569/2020	EPI_ISL_473424	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B4C42/2020	EPI_ISL_473504	2020-06-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.166	GR
hCoV-19/Scotland/CVR3735/2020	EPI_ISL_473772	2020-05-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR3738/2020	EPI_ISL_473774	2020-05-10	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/USA/VA-DCLS-0556/2020	EPI_ISL_485857	2020-03-18	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/USA/CT-UW-3126/2020	EPI_ISL_485941	2020-03-26	North America / USA / Connecticut	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina				B.1.1	GR
hCoV-19/USA/CA-CZB-1881/2020	EPI_ISL_486180	2020-04-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-1882/2020	EPI_ISL_486181	2020-04-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-1970/2020	EPI_ISL_486242	2020-05-06	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-1984/2020	EPI_ISL_486251	2020-05-07	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.132	GR
hCoV-19/USA/CA-CZB-1985/2020	EPI_ISL_486252	2020-04-29	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-1986/2020	EPI_ISL_486253	2020-04-29	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2011/2020	EPI_ISL_486266	2020-05-01	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2013/2020	EPI_ISL_486267	2020-05-01	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/England/BRIS-12B3C9/2020	EPI_ISL_487570	2020-05-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-D663E/2020	EPI_ISL_487584	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/EDB2692/2020	EPI_ISL_487652	2020-03-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/EDB5543/2020	EPI_ISL_487721	2020-04-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/EDB5584/2020	EPI_ISL_487789	2020-04-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Oman/C-16516/2020	EPI_ISL_491153	2020-05-09	Asia / Oman / Buraymi / Buraymi	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.1	GR
hCoV-19/Scotland/EDB931/2020	EPI_ISL_491602	2020-04-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/202881370/2020	EPI_ISL_491709	2020-05-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/202881376/2020	EPI_ISL_491712	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.485	GR
hCoV-19/England/202881379/2020	EPI_ISL_491714	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/BRIS-185349E/2020	EPI_ISL_492347	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-18531B5/2020	EPI_ISL_492371	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Latvia/061/2020	EPI_ISL_492996	2020-07-07	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina, MiSeq	bowtie2			B.1.1.294	GR
hCoV-19/Saudi Arabia/KAIMRC13/2020	EPI_ISL_507019	2020-03-18	Asia / Saudi Arabia	Human	unknown	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1.1	GR
hCoV-19/England/LOND-124D020/2020	EPI_ISL_507048	2020-03-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124D0A8/2020	EPI_ISL_507052	2020-03-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124D0D5/2020	EPI_ISL_507054	2020-03-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124D14B/2020	EPI_ISL_507057	2020-03-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124D169/2020	EPI_ISL_507059	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124D1A5/2020	EPI_ISL_507062	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124D1B4/2020	EPI_ISL_507063	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124D1D2/2020	EPI_ISL_507065	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124D1E1/2020	EPI_ISL_507066	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124D21B/2020	EPI_ISL_507069	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124D248/2020	EPI_ISL_507071	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124D293/2020	EPI_ISL_507076	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124D2A2/2020	EPI_ISL_507077	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124D3FA/2020	EPI_ISL_507096	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124D4CA/2020	EPI_ISL_507103	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORT-29BA0A/2020	EPI_ISL_507121	2020-06-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Russia/Novy_Urengoy-RII24774S/2020	EPI_ISL_507217	2020-05	Europe / Russia / Yamalo-Nenets	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	O
hCoV-19/Russia/Novy_Urengoy-RII24775S/2020	EPI_ISL_507218	2020-05	Europe / Russia / Yamalo-Nenets	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/Novy_Urengoy-RII24776S/2020	EPI_ISL_507219	2020-05	Europe / Russia / Yamalo-Nenets	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/Novy_Urengoy-RII24786S/2020	EPI_ISL_507222	2020-05	Europe / Russia / Yamalo-Nenets	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/Novy_Urengoy-RII24787S/2020	EPI_ISL_507223	2020-05	Europe / Russia / Yamalo-Nenets	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33	NS6_E54stop results in 13.1% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/Russia/StPetersburg-RII11183S/2020	EPI_ISL_507242	2020-05-02	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII15231S/2020	EPI_ISL_507264	2020-05-12	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII15516S/2020	EPI_ISL_507265	2020-05-15	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1.370	GR
hCoV-19/Russia/StPetersburg-RII15518S/2020	EPI_ISL_507267	2020-05-15	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1.370	GR
hCoV-19/Russia/StPetersburg-RII15673S/2020	EPI_ISL_507270	2020-05-15	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1.370	GR
hCoV-19/Russia/StPetersburg-RII15675S/2020	EPI_ISL_507272	2020-05-15	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1.370	GR
hCoV-19/Russia/StPetersburg-RII15817S/2020	EPI_ISL_507273	2020-05-18	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII16106S/2020	EPI_ISL_507277	2020-05-19	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Portugal/PT1414/2020	EPI_ISL_511373	2020-03-26	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1419/2020	EPI_ISL_511378	2020-03-25	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1422/2020	EPI_ISL_511381	2020-03-26	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1428/2020	EPI_ISL_511387	2020-03-30	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1431/2020	EPI_ISL_511390	2020-03-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1475/2020	EPI_ISL_511434	2020-03-15	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0997/2020	EPI_ISL_511545	2020-03-22	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1024/2020	EPI_ISL_511571	2020-03-23	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1056/2020	EPI_ISL_511603	2020-03-29	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1180/2020	EPI_ISL_511725	2020-03-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Poland/1157821/2020	EPI_ISL_512303	2020-06-09	Europe / Poland / Pomorskie	Human	Original			Illumina MiSeq	BWA-MEM	Gap of 7 nucleotides found at refpos 29756.	info	B.1.1	GR
hCoV-19/Scotland/CVR3933/2020	EPI_ISL_512475	2020-06-24	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1695F6/2020	EPI_ISL_512485	2020-07-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Ukraine/203100337/2020	EPI_ISL_512616	2020-07-10	Europe / Ukraine	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Ukraine/203100355/2020	EPI_ISL_512634	2020-05-28	Europe / Ukraine	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Italy/APU-UniMI-5410/2020	EPI_ISL_525561	2020-04-11	Europe / Italy / Apulia / Brindisi	Human	Original	Oropharyngeal swab		Illumina	SPAdes			B.1.1	GR
hCoV-19/Italy/APU-UniMI-6/2020	EPI_ISL_525570	2020-03-16	Europe / Italy / Apulia / Brindisi	Human	Original	Oropharyngeal swab		Illumina	SPAdes			B.1.1	GR
hCoV-19/England/ALDP-97CC99/2020	EPI_ISL_526312	2020-07-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-980BB3/2020	EPI_ISL_526351	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-98150F/2020	EPI_ISL_526353	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9826CF/2020	EPI_ISL_526366	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/USA/VA-DCLS-1002/2020	EPI_ISL_526901	2020-05-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/USA/WA-S2786/2020	EPI_ISL_530143	2020-08-12	North America / USA / Washington	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1.228	GR
hCoV-19/England/QEUH-98FC75/2020	EPI_ISL_530383	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96E4A1/2020	EPI_ISL_530399	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Scotland/QEUH-96E0BC/2020	EPI_ISL_530410	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-96E359/2020	EPI_ISL_530412	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96F5E9/2020	EPI_ISL_530441	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-96EEEF/2020	EPI_ISL_530483	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96E3D1/2020	EPI_ISL_530496	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96EE3A/2020	EPI_ISL_530498	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96EBAC/2020	EPI_ISL_530515	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96F3A3/2020	EPI_ISL_530521	2020-08-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96E6BA/2020	EPI_ISL_530534	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96E9C0/2020	EPI_ISL_530536	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96E720/2020	EPI_ISL_530544	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96E6F6/2020	EPI_ISL_530547	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-96E9DF/2020	EPI_ISL_530552	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96E7B7/2020	EPI_ISL_530583	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96E061/2020	EPI_ISL_530613	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-96D19C/2020	EPI_ISL_530629	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96DAEC/2020	EPI_ISL_530672	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96D84C/2020	EPI_ISL_530727	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-96CE2D/2020	EPI_ISL_530760	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-96C397/2020	EPI_ISL_530824	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-96C0BE/2020	EPI_ISL_530826	2020-08-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-969CDB/2020	EPI_ISL_530844	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-964DEC/2020	EPI_ISL_530955	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96504C/2020	EPI_ISL_530970	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-964AC7/2020	EPI_ISL_530986	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-964C0D/2020	EPI_ISL_530991	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-960F44/2020	EPI_ISL_532004	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96113E/2020	EPI_ISL_532036	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-960524/2020	EPI_ISL_532047	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-960AAD/2020	EPI_ISL_532122	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-960928/2020	EPI_ISL_532126	2020-08-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-96112F/2020	EPI_ISL_532129	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-55630D/2020	EPI_ISL_532144	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-55336A/2020	EPI_ISL_532157	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-53DABC/2020	EPI_ISL_532160	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-550DC9/2020	EPI_ISL_532162	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-54EC3A/2020	EPI_ISL_532196	2020-05-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-54EE34/2020	EPI_ISL_532202	2020-05-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-538C9D/2020	EPI_ISL_532220	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-53F2EF/2020	EPI_ISL_532238	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54C452/2020	EPI_ISL_532243	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-541FF2/2020	EPI_ISL_532247	2020-05-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-52E78A/2020	EPI_ISL_532255	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54E599/2020	EPI_ISL_532256	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-95F528/2020	EPI_ISL_532310	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-95EE6A/2020	EPI_ISL_532331	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-95EFD0/2020	EPI_ISL_532357	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-95E644/2020	EPI_ISL_532372	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-95FA38/2020	EPI_ISL_532386	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-95F485/2020	EPI_ISL_532409	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-95F564/2020	EPI_ISL_532425	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-95F212/2020	EPI_ISL_532429	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-95ECD9/2020	EPI_ISL_532457	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-95F26D/2020	EPI_ISL_532458	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-961EDD/2020	EPI_ISL_532473	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-95F009/2020	EPI_ISL_532499	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9436BB/2020	EPI_ISL_532541	2020-07-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-943633/2020	EPI_ISL_532584	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9435FA/2020	EPI_ISL_532601	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-943B70/2020	EPI_ISL_532617	2020-07-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-941125/2020	EPI_ISL_532632	2020-07-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/LEED-2A908F/2020	EPI_ISL_539024	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2A8F92/2020	EPI_ISL_539107	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2A8633/2020	EPI_ISL_539131	2020-03-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2A841B/2020	EPI_ISL_539200	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/India/TG-CCMB-AA105/2020	EPI_ISL_539683	2020-08-10	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA28/2020	EPI_ISL_539684	2020-08-10	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA378/2020	EPI_ISL_539685	2020-08-11	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA370/2020	EPI_ISL_539687	2020-08-11	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA371/2020	EPI_ISL_539688	2020-08-11	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA375/2020	EPI_ISL_539689	2020-08-11	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA403/2020	EPI_ISL_539690	2020-08-11	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AB927/2020	EPI_ISL_539691	2020-08-17	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA373/2020	EPI_ISL_539692	2020-08-11	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA770/2020	EPI_ISL_539693	2020-08-13	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA456/2020	EPI_ISL_539694	2020-08-11	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA867/2020	EPI_ISL_539695	2020-08-13	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA868/2020	EPI_ISL_539696	2020-08-13	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA869/2020	EPI_ISL_539697	2020-08-13	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA870/2020	EPI_ISL_539698	2020-08-13	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA789/2020	EPI_ISL_539699	2020-08-13	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AC568/2020	EPI_ISL_539700	2020-08-19	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AB91/2020	EPI_ISL_539701	2020-08-14	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AC214/2020	EPI_ISL_539702	2020-08-18	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AC528/2020	EPI_ISL_539703	2020-08-19	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.340	GR
hCoV-19/India/TG-CCMB-AC329/2020	EPI_ISL_539704	2020-08-19	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.340	GR
hCoV-19/India/TG-CCMB-AB261/2020	EPI_ISL_539705	2020-08-14	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AB16/2020	EPI_ISL_539706	2020-08-14	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AB401/2020	EPI_ISL_539707	2020-08-13	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AB966/2020	EPI_ISL_539708	2020-08-17	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AB182/2020	EPI_ISL_539709	2020-08-14	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AB192/2020	EPI_ISL_539710	2020-08-14	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-R356/2020	EPI_ISL_539711	2020-08-09	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA222/2020	EPI_ISL_539712	2020-08-10	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AB226/2020	EPI_ISL_539713	2020-08-14	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AB215/2020	EPI_ISL_539714	2020-08-14	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AB248/2020	EPI_ISL_539715	2020-08-14	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA311/2020	EPI_ISL_539716	2020-08-11	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.340	GR
hCoV-19/India/TG-CCMB-AC317/2020	EPI_ISL_539717	2020-08-19	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AB344/2020	EPI_ISL_539718	2020-08-13	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.340	GR
hCoV-19/India/TG-CCMB-AA591/2020	EPI_ISL_539719	2020-08-12	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-R296/2020	EPI_ISL_539720	2020-08-09	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.340	GR
hCoV-19/India/TG-CCMB-AB415/2020	EPI_ISL_539721	2020-08-14	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-R338/2020	EPI_ISL_539724	2020-08-09	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AB610/2020	EPI_ISL_539726	2020-08-16	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AB603/2020	EPI_ISL_539728	2020-08-16	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA812/2020	EPI_ISL_539747	2020-08-13	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA340/2020	EPI_ISL_539749	2020-08-11	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA29/2020	EPI_ISL_539753	2020-08-10	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA335/2020	EPI_ISL_539756	2020-08-11	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA372/2020	EPI_ISL_539757	2020-08-11	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA42/2020	EPI_ISL_539758	2020-08-10	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AA617/2020	EPI_ISL_539759	2020-08-12	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-AB247/2020	EPI_ISL_539765	2020-08-14	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.340	GR
hCoV-19/India/TG-CCMB-R325/2020	EPI_ISL_539775	2020-08-09	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.340	GR
hCoV-19/Czech Republic/NRL-5886-1/2020	EPI_ISL_539778	2020-04-08	Europe / Czech Republic / Moravian-Silesian Region / Cesky Tesin	Human	Original	Nasopharyngeal swab		Nanopore MinION	Medaka			B.1.1	GR
hCoV-19/Czech Republic/NRL-5886-2/2020	EPI_ISL_539779	2020-04-08	Europe / Czech Republic / Moravian-Silesian Region / Cesky Tesin	Human	Original	Nasopharyngeal swab		Nanopore MinION	Medaka			B.1.1	GR
hCoV-19/Ecuador/USFQ-226/2020	EPI_ISL_539793	2020-08-15	South America / Ecuador / Loja / Catamayo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic Network			B.1.1	GR
hCoV-19/Sweden/20-52440/2020	EPI_ISL_539884	2020-07-22	Europe / Sweden / Vastra Gotaland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Gap of 6 nucleotides when compared to the reference sequence.	info	AN.1	GR
hCoV-19/England/QEUH-998CB5/2020	EPI_ISL_539911	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-98FCDF/2020	EPI_ISL_539917	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/Scotland/QEUH-98F7A1/2020	EPI_ISL_539919	2020-08-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-998AF7/2020	EPI_ISL_539943	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-98FDEB/2020	EPI_ISL_539973	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-99831A/2020	EPI_ISL_539999	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/Wales/MILK-9A67A4/2020	EPI_ISL_550000	2020-09-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A6944/2020	EPI_ISL_550002	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides found at refpos 12627.	info	B.1.1	GR
hCoV-19/England/MILK-9A8511/2020	EPI_ISL_550004	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides found at refpos 12627.	info	B.1.1	GR
hCoV-19/England/MILK-9A5435/2020	EPI_ISL_550013	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A68CF/2020	EPI_ISL_550015	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A5620/2020	EPI_ISL_550038	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A6689/2020	EPI_ISL_550039	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9A6AD8/2020	EPI_ISL_550040	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-9A8687/2020	EPI_ISL_550046	2020-09-02	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A8C85/2020	EPI_ISL_550050	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A8BB5/2020	EPI_ISL_550063	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A8D46/2020	EPI_ISL_550067	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9A6ECD/2020	EPI_ISL_550084	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A6935/2020	EPI_ISL_550103	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides found at refpos 12627.	info	B.1.1	GR
hCoV-19/England/MILK-9A6777/2020	EPI_ISL_550116	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9A8B3D/2020	EPI_ISL_550120	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9A853F/2020	EPI_ISL_550131	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides found at refpos 12627.	info	B.1.1	GR
hCoV-19/England/MILK-9A6F06/2020	EPI_ISL_550139	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9A84F6/2020	EPI_ISL_550141	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9A6E36/2020	EPI_ISL_550161	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9A84AB/2020	EPI_ISL_550180	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9A5189/2020	EPI_ISL_550183	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9A8D55/2020	EPI_ISL_550215	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9A84C9/2020	EPI_ISL_550218	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9A6C4B/2020	EPI_ISL_550220	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A6883/2020	EPI_ISL_550221	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides found at refpos 12630.	info	B.1.1	GR
hCoV-19/England/MILK-9A69AE/2020	EPI_ISL_550234	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-99A8BF/2020	EPI_ISL_550289	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99A58B/2020	EPI_ISL_550295	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99A7D0/2020	EPI_ISL_550301	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99A2B1/2020	EPI_ISL_550318	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99A169/2020	EPI_ISL_550326	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-999E09/2020	EPI_ISL_550340	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.149	G
hCoV-19/England/MILK-99A530/2020	EPI_ISL_550369	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99A178/2020	EPI_ISL_550376	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99A7EF/2020	EPI_ISL_550378	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-97787C/2020	EPI_ISL_550507	2020-07-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-97877E/2020	EPI_ISL_550508	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-978644/2020	EPI_ISL_550509	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-99DCFC/2020	EPI_ISL_550522	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99C8EA/2020	EPI_ISL_550561	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99DA10/2020	EPI_ISL_550600	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-99DB86/2020	EPI_ISL_550620	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99C440/2020	EPI_ISL_550644	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99DD17/2020	EPI_ISL_550650	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99C8BD/2020	EPI_ISL_550652	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-99E4F3/2020	EPI_ISL_550653	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99CAC6/2020	EPI_ISL_550777	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-99CB0F/2020	EPI_ISL_550785	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99D1DF/2020	EPI_ISL_550791	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AADBD/2020	EPI_ISL_550796	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AA746/2020	EPI_ISL_550920	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AA403/2020	EPI_ISL_550931	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AA6FE/2020	EPI_ISL_550944	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AA719/2020	EPI_ISL_550968	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AA70A/2020	EPI_ISL_550991	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AA6EF/2020	EPI_ISL_550992	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A8EDA/2020	EPI_ISL_550993	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-952121/2020	EPI_ISL_551343	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-951F37/2020	EPI_ISL_551351	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-936615/2020	EPI_ISL_551354	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8FBE60/2020	EPI_ISL_551378	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-90B488/2020	EPI_ISL_551391	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-92DD49/2020	EPI_ISL_551392	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-937B60/2020	EPI_ISL_551395	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-932813/2020	EPI_ISL_551397	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-990B1A/2020	EPI_ISL_551847	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-9912AB/2020	EPI_ISL_551864	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-990CDB/2020	EPI_ISL_551865	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-990C08/2020	EPI_ISL_551893	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-993379/2020	EPI_ISL_551924	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-991706/2020	EPI_ISL_551925	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-99143C/2020	EPI_ISL_551951	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9931E8/2020	EPI_ISL_551952	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides found at refpos 12630.	info	B.1.1	GR
hCoV-19/England/MILK-99376E/2020	EPI_ISL_551998	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-522917/2020	EPI_ISL_559003	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-519D17/2020	EPI_ISL_559014	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-51D44B/2020	EPI_ISL_559029	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-52C230/2020	EPI_ISL_559035	2020-06-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-521893/2020	EPI_ISL_559036	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-525A11/2020	EPI_ISL_559044	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-526209/2020	EPI_ISL_559051	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-51D4E1/2020	EPI_ISL_559054	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-526B0E/2020	EPI_ISL_559072	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5262DC/2020	EPI_ISL_559073	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-51D6FA/2020	EPI_ISL_559079	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-509196/2020	EPI_ISL_559130	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-4BBD54/2020	EPI_ISL_559132	2020-06-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-4F3F2D/2020	EPI_ISL_559135	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-4FA6F4/2020	EPI_ISL_559141	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-502F48/2020	EPI_ISL_559153	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-4A19A8/2020	EPI_ISL_559300	2020-06-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-49AD1F/2020	EPI_ISL_559302	2020-06-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-496B19/2020	EPI_ISL_559304	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4AD775/2020	EPI_ISL_559324	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4AF166/2020	EPI_ISL_559333	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-496B37/2020	EPI_ISL_559338	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4AE99C/2020	EPI_ISL_559348	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-49AC6D/2020	EPI_ISL_559356	2020-06-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-499624/2020	EPI_ISL_559384	2020-05-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-49A456/2020	EPI_ISL_559386	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-49969D/2020	EPI_ISL_559405	2020-05-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-49A3FF/2020	EPI_ISL_559415	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-497CAC/2020	EPI_ISL_559423	2020-06-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-49A447/2020	EPI_ISL_559428	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4A4A57/2020	EPI_ISL_559445	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4A5AA1/2020	EPI_ISL_559452	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4A723E/2020	EPI_ISL_559463	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-4A931B/2020	EPI_ISL_559472	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4A8428/2020	EPI_ISL_559473	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-49EE54/2020	EPI_ISL_559486	2020-05-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-4ADC76/2020	EPI_ISL_559487	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4A8367/2020	EPI_ISL_559493	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4A5DA8/2020	EPI_ISL_559499	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4AE1B2/2020	EPI_ISL_559502	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4A69D0/2020	EPI_ISL_559507	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4AE0C4/2020	EPI_ISL_559512	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4A8376/2020	EPI_ISL_559535	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-4A7456/2020	EPI_ISL_559546	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-49D23B/2020	EPI_ISL_559565	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4A7C21/2020	EPI_ISL_559580	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4A483F/2020	EPI_ISL_559583	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4ADBB5/2020	EPI_ISL_559592	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4A82B5/2020	EPI_ISL_559599	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-4A94FA/2020	EPI_ISL_559617	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4A91C6/2020	EPI_ISL_559620	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4A5B71/2020	EPI_ISL_559626	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4A822E/2020	EPI_ISL_559635	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4A7D88/2020	EPI_ISL_559645	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-4AD793/2020	EPI_ISL_559654	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/MILK-4822C0/2020	EPI_ISL_559674	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Canada/ON-UHTC-0241/2020	EPI_ISL_570009	2020-06-08	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.1	GR
hCoV-19/Canada/ON-UHTC-0238/2020	EPI_ISL_570019	2020-06-07	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.1	GR
hCoV-19/USA/WA-UW-22039/2020	EPI_ISL_571015	2020-08-03	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.228	GR
hCoV-19/USA/NH-QDX-618/2020	EPI_ISL_571389	2020-03-18	North America / USA / New Hampshire	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/WI-WSLH-200113/2020	EPI_ISL_578344	2020-04-06	North America / USA / Wisconsin / Dane County	Human	Original			Nanopore MinION	ARTIC Pipeline			B.1.1	GR
hCoV-19/England/CAMC-9D6E3D/2020	EPI_ISL_584326	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9D70AF/2020	EPI_ISL_584344	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9D7203/2020	EPI_ISL_584352	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9D73D3/2020	EPI_ISL_584367	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.500	GR
hCoV-19/England/CAMC-9D73F1/2020	EPI_ISL_584368	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9D7458/2020	EPI_ISL_584371	2020-09-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9D74FE/2020	EPI_ISL_584377	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMC-9D7537/2020	EPI_ISL_584378	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/CAMC-9EBCE0/2020	EPI_ISL_584413	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9EBDDE/2020	EPI_ISL_584423	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-124DA7D/2020	EPI_ISL_584636	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124DE26/2020	EPI_ISL_584651	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORT-2A534E/2020	EPI_ISL_584687	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-2A5399/2020	EPI_ISL_584688	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-2A53F3/2020	EPI_ISL_584689	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-2A577F/2020	EPI_ISL_584697	2020-09-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-2A578E/2020	EPI_ISL_584698	2020-09-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-2A57AC/2020	EPI_ISL_584699	2020-09-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR4416/2020	EPI_ISL_585290	2020-09-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/CAMC-9D6DF4/2020	EPI_ISL_585620	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/CAMC-9D6E1F/2020	EPI_ISL_585621	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/PHWC-16DE9D/2020	EPI_ISL_585634	2020-09-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16E139/2020	EPI_ISL_585673	2020-10-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16E157/2020	EPI_ISL_585674	2020-09-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16EA7A/2020	EPI_ISL_585812	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16EE32/2020	EPI_ISL_585871	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16EFA8/2020	EPI_ISL_585894	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	G
hCoV-19/Wales/PHWC-16F51E/2020	EPI_ISL_585979	2020-10-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16F657/2020	EPI_ISL_585999	2020-10-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-A51A62/2020	EPI_ISL_598004	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A519ED/2020	EPI_ISL_598019	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A51F72/2020	EPI_ISL_598033	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A51ADB/2020	EPI_ISL_598037	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A51877/2020	EPI_ISL_598039	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A51A80/2020	EPI_ISL_598045	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A51ABD/2020	EPI_ISL_598047	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A51D2D/2020	EPI_ISL_598079	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A522B4/2020	EPI_ISL_598097	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A5208D/2020	EPI_ISL_598103	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A520D8/2020	EPI_ISL_598104	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A51DC3/2020	EPI_ISL_598119	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A51B23/2020	EPI_ISL_598120	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A516AA/2020	EPI_ISL_598121	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A51B05/2020	EPI_ISL_598122	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A51D69/2020	EPI_ISL_598123	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A51A26/2020	EPI_ISL_598125	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A51121/2020	EPI_ISL_598127	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A52023/2020	EPI_ISL_598131	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A51D87/2020	EPI_ISL_598139	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A51FFA/2020	EPI_ISL_598156	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A51A08/2020	EPI_ISL_598170	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A51C8A/2020	EPI_ISL_598179	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A51B14/2020	EPI_ISL_598184	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A511E5/2020	EPI_ISL_598185	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A51A71/2020	EPI_ISL_598188	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A523DF/2020	EPI_ISL_598192	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A5232A/2020	EPI_ISL_598193	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A513B2/2020	EPI_ISL_598203	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A51AEA/2020	EPI_ISL_598205	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A51525/2020	EPI_ISL_598209	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A5109D/2020	EPI_ISL_598210	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A526E5/2020	EPI_ISL_598237	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A5225A/2020	EPI_ISL_598248	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A47ECD/2020	EPI_ISL_598315	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A468EE/2020	EPI_ISL_598321	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-A46C1F/2020	EPI_ISL_598325	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A4806C/2020	EPI_ISL_598340	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-A4708B/2020	EPI_ISL_598351	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A47E90/2020	EPI_ISL_598373	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A469EB/2020	EPI_ISL_598395	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A473A0/2020	EPI_ISL_598399	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A47ABA/2020	EPI_ISL_598402	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-A469AF/2020	EPI_ISL_598417	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A47AE7/2020	EPI_ISL_598449	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A4763E/2020	EPI_ISL_598455	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A47BC6/2020	EPI_ISL_598476	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-A476D4/2020	EPI_ISL_598494	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A470A9/2020	EPI_ISL_598495	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-A47FD9/2020	EPI_ISL_598496	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A45B9B/2020	EPI_ISL_598576	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A45D86/2020	EPI_ISL_598580	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A45955/2020	EPI_ISL_598601	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A45D59/2020	EPI_ISL_598644	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.153	GR
hCoV-19/England/MILK-A45973/2020	EPI_ISL_598669	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A458A3/2020	EPI_ISL_598681	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-A45ABC/2020	EPI_ISL_598752	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-A21861/2020	EPI_ISL_598909	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A1FE28/2020	EPI_ISL_598928	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0C8E4/2020	EPI_ISL_599219	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0BFB3/2020	EPI_ISL_599222	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-A0ADF6/2020	EPI_ISL_599225	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0B469/2020	EPI_ISL_599232	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A0B153/2020	EPI_ISL_599242	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0B4E1/2020	EPI_ISL_599259	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A0B9F1/2020	EPI_ISL_599271	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0AF2D/2020	EPI_ISL_599275	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0AD32/2020	EPI_ISL_599277	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0C3A7/2020	EPI_ISL_599284	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A0B0ED/2020	EPI_ISL_599300	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0AB74/2020	EPI_ISL_599308	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-A0BF68/2020	EPI_ISL_599330	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DCD0D/2020	EPI_ISL_599815	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A067FC/2020	EPI_ISL_599819	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 8 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/MILK-A05890/2020	EPI_ISL_599822	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A0553F/2020	EPI_ISL_599859	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A05ECB/2020	EPI_ISL_599864	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A060A6/2020	EPI_ISL_599869	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/Wales/MILK-A057FD/2020	EPI_ISL_599884	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A0671A/2020	EPI_ISL_599889	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A06A99/2020	EPI_ISL_599893	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A05A4F/2020	EPI_ISL_599905	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A05362/2020	EPI_ISL_599921	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A067ED/2020	EPI_ISL_599925	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A05F5F/2020	EPI_ISL_599934	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A06686/2020	EPI_ISL_599949	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 8 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/MILK-A05E9E/2020	EPI_ISL_599957	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A06853/2020	EPI_ISL_599961	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A06307/2020	EPI_ISL_599994	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Switzerland/BE-ETHZ-310450/2020	EPI_ISL_603522	2020-10-07	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.144	GR
hCoV-19/Switzerland/ZH-ETHZ-310473/2020	EPI_ISL_603544	2020-10-07	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.153	GR
hCoV-19/Switzerland/BE-ETHZ-321352/2020	EPI_ISL_603602	2020-10-13	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.144	GR
hCoV-19/Switzerland/VS-ETHZ-321402/2020	EPI_ISL_603643	2020-10-14	Europe / Switzerland / Valais	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.153	GR
hCoV-19/Switzerland/BE-ETHZ-321406/2020	EPI_ISL_603647	2020-10-14	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.144	GR
hCoV-19/Switzerland/BE-ETHZ-321413/2020	EPI_ISL_603653	2020-10-14	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe	Gap of 6 nucleotides when compared to the reference sequence.	info	AN.1	GR
hCoV-19/Switzerland/VS-ETHZ-321429/2020	EPI_ISL_603666	2020-10-14	Europe / Switzerland / Valais	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.153	GR
hCoV-19/Switzerland/SO-ETHZ-321525/2020	EPI_ISL_603734	2020-10-15	Europe / Switzerland / Solothurn	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.144	GR
hCoV-19/USA/UT-UPHL-2009478/2020	EPI_ISL_605162	2020-07-19	North America / USA / Utah	Human	Original			Illumina NextSeq	minimap2 & freebayes			B.1.1.228	GR
hCoV-19/USA/UT-UPHL-2009605/2020	EPI_ISL_605283	2020-07-18	North America / USA / Utah	Human	Original			Illumina NextSeq	minimap2 & freebayes			B.1.1.304	GR
hCoV-19/USA/UT-UPHL-2009621/2020	EPI_ISL_605298	2020-07-18	North America / USA / Utah	Human	Original			Illumina NextSeq	minimap2 & freebayes	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.228	GR
hCoV-19/USA/UT-UPHL-2009634/2020	EPI_ISL_605310	2020-07-19	North America / USA / Utah	Human	Original			Illumina NextSeq	minimap2 & freebayes			B.1.1.228	GR
hCoV-19/USA/UT-UPHL-2009647/2020	EPI_ISL_605322	2020-07-26	North America / USA / Utah	Human	Original			Illumina NextSeq	minimap2 & freebayes			B.1.1.228	GR
hCoV-19/USA/UT-UPHL-2009681/2020	EPI_ISL_605356	2020-07-25	North America / USA / Utah	Human	Original			Illumina NextSeq	minimap2 & freebayes			B.1.1.228	GR
hCoV-19/USA/UT-UPHL-2009692/2020	EPI_ISL_605366	2020-07-25	North America / USA / Utah	Human	Original			Illumina NextSeq	minimap2 & freebayes			B.1.1.228	GR
hCoV-19/USA/UT-UPHL-2009717/2020	EPI_ISL_605389	2020-07-26	North America / USA / Utah	Human	Original			Illumina NextSeq	minimap2 & freebayes			B.1.1.228	GR
hCoV-19/USA/WI-UW-1668/2020	EPI_ISL_605542	2020-09-17	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1.186	G
hCoV-19/Singapore/1114/2020	EPI_ISL_605823	2020-10-21	Asia / Singapore	Human	Original			Illumina MiSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-A86F1A/2020	EPI_ISL_605947	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A87CF4/2020	EPI_ISL_605973	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A87DA6/2020	EPI_ISL_605993	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Singapore/1083nan/2020	EPI_ISL_610153	2020-09-30	Asia / Singapore	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/England/ALDP-A8585C/2020	EPI_ISL_610621	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.153	GR
hCoV-19/England/CAMC-A821CD/2020	EPI_ISL_610715	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A8228E/2020	EPI_ISL_610726	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A81D06/2020	EPI_ISL_610731	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-A82585/2020	EPI_ISL_610735	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A8242E/2020	EPI_ISL_610765	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A823C7/2020	EPI_ISL_610785	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A81F6A/2020	EPI_ISL_610816	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/CAMC-A81119/2020	EPI_ISL_610823	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A823E5/2020	EPI_ISL_610875	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A81F00/2020	EPI_ISL_610889	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A81E21/2020	EPI_ISL_610896	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A8202A/2020	EPI_ISL_610898	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A81B93/2020	EPI_ISL_610903	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/CAMC-A8238B/2020	EPI_ISL_610905	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A93A55/2020	EPI_ISL_610925	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A92E0F/2020	EPI_ISL_610947	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A93703/2020	EPI_ISL_610948	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A93AA0/2020	EPI_ISL_610950	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A92449/2020	EPI_ISL_610955	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A923D3/2020	EPI_ISL_610962	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A92AA1/2020	EPI_ISL_610973	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A92A38/2020	EPI_ISL_610988	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Denmark/DCGC-1951/2020	EPI_ISL_618247	2020-07-27	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-1952/2020	EPI_ISL_618250	2020-07-20	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2029/2020	EPI_ISL_618257	2020-07-27	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2043/2020	EPI_ISL_618268	2020-07-27	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-1968/2020	EPI_ISL_618289	2020-07-06	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.306	GR
hCoV-19/Denmark/DCGC-2081/2020	EPI_ISL_618337	2020-07-27	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2082/2020	EPI_ISL_618338	2020-07-27	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2087/2020	EPI_ISL_618344	2020-08-03	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2117/2020	EPI_ISL_618379	2020-07-27	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2126/2020	EPI_ISL_618389	2020-07-27	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2127/2020	EPI_ISL_618390	2020-07-27	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2129/2020	EPI_ISL_618392	2020-07-27	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2130/2020	EPI_ISL_618393	2020-07-27	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2131/2020	EPI_ISL_618394	2020-07-27	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2132/2020	EPI_ISL_618395	2020-07-27	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2133/2020	EPI_ISL_618396	2020-07-27	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2134/2020	EPI_ISL_618397	2020-07-27	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2139/2020	EPI_ISL_618402	2020-07-20	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2142/2020	EPI_ISL_618405	2020-07-27	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-7530/2020	EPI_ISL_618462	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/Denmark/DCGC-7550/2020	EPI_ISL_618482	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7533/2020	EPI_ISL_618489	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-7545/2020	EPI_ISL_618490	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7582/2020	EPI_ISL_618495	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/Denmark/DCGC-7637/2020	EPI_ISL_618528	2020-10-19	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-7647/2020	EPI_ISL_618539	2020-10-19	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7071/2020	EPI_ISL_619122	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7096/2020	EPI_ISL_619138	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-7123/2020	EPI_ISL_619153	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-7199/2020	EPI_ISL_619196	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7200/2020	EPI_ISL_619197	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7253/2020	EPI_ISL_619230	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7255/2020	EPI_ISL_619231	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-7257/2020	EPI_ISL_619234	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7264/2020	EPI_ISL_619238	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7267/2020	EPI_ISL_619240	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7297/2020	EPI_ISL_619257	2020-10-12	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7299/2020	EPI_ISL_619259	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7302/2020	EPI_ISL_619300	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7434/2020	EPI_ISL_619324	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7423/2020	EPI_ISL_619352	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-7455/2020	EPI_ISL_619369	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7476/2020	EPI_ISL_619377	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7477/2020	EPI_ISL_619390	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/Denmark/DCGC-6552/2020	EPI_ISL_619452	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6779/2020	EPI_ISL_619475	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/Denmark/DCGC-6645/2020	EPI_ISL_619547	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-6650/2020	EPI_ISL_619552	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6652/2020	EPI_ISL_619554	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6653/2020	EPI_ISL_619555	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-6690/2020	EPI_ISL_619593	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-6573/2020	EPI_ISL_619621	2020-10-12	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6619/2020	EPI_ISL_619668	2020-10-12	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6932/2020	EPI_ISL_619778	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-6957/2020	EPI_ISL_619803	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-6959/2020	EPI_ISL_619805	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6960/2020	EPI_ISL_619806	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7013/2020	EPI_ISL_619860	2020-10-12	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-6226/2020	EPI_ISL_619986	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6233/2020	EPI_ISL_619993	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6234/2020	EPI_ISL_619994	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6235/2020	EPI_ISL_619995	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-6236/2020	EPI_ISL_619996	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6237/2020	EPI_ISL_619997	2020-10-05	Europe / Denmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-6239/2020	EPI_ISL_619999	2020-10-05	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Sweden/20-21503/2020	EPI_ISL_623077	2020-06-21	Europe / Sweden / Uppsala	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-22152/2020	EPI_ISL_623083	2020-06-02	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-52162/2020	EPI_ISL_623091	2020-06-16	Europe / Sweden / Kalmar	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.438	GR
hCoV-19/England/MILK-AB84D4/2020	EPI_ISL_623211	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AB75F0/2020	EPI_ISL_623229	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-AB80A3/2020	EPI_ISL_623249	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AB81DD/2020	EPI_ISL_623250	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AB75E1/2020	EPI_ISL_623279	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-AB760C/2020	EPI_ISL_623280	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-ABB617/2020	EPI_ISL_623284	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AB7F6B/2020	EPI_ISL_623319	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AB8067/2020	EPI_ISL_623324	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.153	GR
hCoV-19/England/MILK-AB83B9/2020	EPI_ISL_623342	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-ABB477/2020	EPI_ISL_623351	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AB761B/2020	EPI_ISL_623353	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-AB7AF1/2020	EPI_ISL_623422	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-AB8340/2020	EPI_ISL_623464	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AB8665/2020	EPI_ISL_623466	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-AB8261/2020	EPI_ISL_623483	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AB0357/2020	EPI_ISL_623489	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-AAFAFC/2020	EPI_ISL_623490	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-AAFA83/2020	EPI_ISL_623531	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/CAMC-AB1E55/2020	EPI_ISL_623547	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AB13B0/2020	EPI_ISL_623550	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AB8744/2020	EPI_ISL_623552	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-AB149F/2020	EPI_ISL_623556	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AB18A2/2020	EPI_ISL_623559	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AB7578/2020	EPI_ISL_623563	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-AB1E73/2020	EPI_ISL_623570	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/CAMC-AB1DA3/2020	EPI_ISL_623605	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AB8638/2020	EPI_ISL_623614	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-AB1DB2/2020	EPI_ISL_623657	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AB87DB/2020	EPI_ISL_623670	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AB879F/2020	EPI_ISL_623687	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AB15C9/2020	EPI_ISL_623721	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-AB21A6/2020	EPI_ISL_623749	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AB751E/2020	EPI_ISL_623767	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-AB14DB/2020	EPI_ISL_623800	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/CAMC-AB1981/2020	EPI_ISL_623812	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AB2197/2020	EPI_ISL_623815	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AB755A/2020	EPI_ISL_623842	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA2EFD/2020	EPI_ISL_623870	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA41A7/2020	EPI_ISL_623879	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA07A9/2020	EPI_ISL_623889	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA40AA/2020	EPI_ISL_623925	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA2F63/2020	EPI_ISL_623929	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-AADC70/2020	EPI_ISL_623930	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/Scotland/QEUH-AAE4FF/2020	EPI_ISL_623944	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-AAE5B0/2020	EPI_ISL_623949	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AADC25/2020	EPI_ISL_623959	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA14B0/2020	EPI_ISL_623962	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA16AB/2020	EPI_ISL_623992	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A94A54/2020	EPI_ISL_624702	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A94B42/2020	EPI_ISL_624706	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A96339/2020	EPI_ISL_624733	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A95367/2020	EPI_ISL_624762	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A95A71/2020	EPI_ISL_624765	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A962E1/2020	EPI_ISL_624771	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A94C5E/2020	EPI_ISL_624781	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A94508/2020	EPI_ISL_624784	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD63A6/2020	EPI_ISL_630005	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC7663/2020	EPI_ISL_630009	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACDA43/2020	EPI_ISL_630046	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC76FA/2020	EPI_ISL_630088	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACE1A7/2020	EPI_ISL_630099	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC76EB/2020	EPI_ISL_630120	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-ACCB14/2020	EPI_ISL_630124	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC7715/2020	EPI_ISL_630139	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-ACE0C8/2020	EPI_ISL_630143	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACDFEA/2020	EPI_ISL_630164	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC752A/2020	EPI_ISL_630168	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-AC7539/2020	EPI_ISL_630173	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-AC751B/2020	EPI_ISL_630198	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-AC94B2/2020	EPI_ISL_630215	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACD120/2020	EPI_ISL_630225	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.153	GR
hCoV-19/England/MILK-ACD09C/2020	EPI_ISL_630229	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 5 nucleotides when compared to the reference sequence.	info	B.1.1.170	GR
hCoV-19/England/MILK-ACCDB4/2020	EPI_ISL_630242	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACCC7B/2020	EPI_ISL_630290	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACDB22/2020	EPI_ISL_630291	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC76AF/2020	EPI_ISL_630292	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC7760/2020	EPI_ISL_630293	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACDCA7/2020	EPI_ISL_630325	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACDC01/2020	EPI_ISL_630330	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACCC3F/2020	EPI_ISL_630338	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACDAF8/2020	EPI_ISL_630340	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/ALDP-A68743/2020	EPI_ISL_630402	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6698B/2020	EPI_ISL_630419	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A66A5B/2020	EPI_ISL_630439	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A68DF6/2020	EPI_ISL_630449	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A6736E/2020	EPI_ISL_630470	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A67A4B/2020	EPI_ISL_630478	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A67137/2020	EPI_ISL_630482	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A66E9B/2020	EPI_ISL_630502	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A66E5F/2020	EPI_ISL_630507	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/ALDP-A672AD/2020	EPI_ISL_630558	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A67C27/2020	EPI_ISL_630560	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A668E8/2020	EPI_ISL_630563	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A66F98/2020	EPI_ISL_630571	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6779F/2020	EPI_ISL_630577	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A67304/2020	EPI_ISL_630593	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A667CD/2020	EPI_ISL_630620	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A671BF/2020	EPI_ISL_630642	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A67410/2020	EPI_ISL_630655	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA3991/2020	EPI_ISL_630726	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AAE240/2020	EPI_ISL_630764	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA26B9/2020	EPI_ISL_630773	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AAF0DC/2020	EPI_ISL_630775	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AAE69F/2020	EPI_ISL_630782	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA2631/2020	EPI_ISL_630792	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA266E/2020	EPI_ISL_630854	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA4040/2020	EPI_ISL_630866	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AAE78D/2020	EPI_ISL_630888	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA1B7F/2020	EPI_ISL_630906	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AAE6EA/2020	EPI_ISL_630933	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA1BD9/2020	EPI_ISL_630935	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AAE7D8/2020	EPI_ISL_630948	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-AA26F5/2020	EPI_ISL_630968	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA3955/2020	EPI_ISL_630969	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA25E9/2020	EPI_ISL_630970	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-ABD211/2020	EPI_ISL_630971	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AC12FC/2020	EPI_ISL_630975	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-ABD31E/2020	EPI_ISL_630976	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/204391073/2020	EPI_ISL_637148	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204641709/2020	EPI_ISL_637190	2020	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204641710/2020	EPI_ISL_637191	2020	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204641713/2020	EPI_ISL_637192	2020	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204641715/2020	EPI_ISL_637193	2020	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204641718/2020	EPI_ISL_637196	2020	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204641724/2020	EPI_ISL_637202	2020	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/QEUH-9F51B7/2020	EPI_ISL_637856	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/Wales/MILK-B050A6/2020	EPI_ISL_639008	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/PHWC-486305/2020	EPI_ISL_639030	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4864A8/2020	EPI_ISL_639050	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48661B/2020	EPI_ISL_639059	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48688E/2020	EPI_ISL_639084	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48695E/2020	EPI_ISL_639093	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-486B49/2020	EPI_ISL_639112	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-486BC1/2020	EPI_ISL_639116	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-486E31/2020	EPI_ISL_639136	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4870A3/2020	EPI_ISL_639163	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4870D0/2020	EPI_ISL_639165	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4871BF/2020	EPI_ISL_639171	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48735F/2020	EPI_ISL_639185	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-487999/2020	EPI_ISL_639258	2020-10-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4879C6/2020	EPI_ISL_639260	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-487BB1/2020	EPI_ISL_639283	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-487DCA/2020	EPI_ISL_639306	2020-10-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-487DD9/2020	EPI_ISL_639307	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-487EF4/2020	EPI_ISL_639323	2020-10-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1	G
hCoV-19/Wales/PHWC-487FD3/2020	EPI_ISL_639335	2020-10-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-488646/2020	EPI_ISL_639417	2020-10-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48887D/2020	EPI_ISL_639438	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-488B65/2020	EPI_ISL_639471	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-488B83/2020	EPI_ISL_639473	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A8BBF3/2020	EPI_ISL_643102	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A8BD0C/2020	EPI_ISL_643126	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-A8BF60/2020	EPI_ISL_643127	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8BFF7/2020	EPI_ISL_643133	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8C819/2020	EPI_ISL_643147	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8B953/2020	EPI_ISL_643153	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A8C512/2020	EPI_ISL_643182	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A8C5D6/2020	EPI_ISL_643191	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8B9CC/2020	EPI_ISL_643203	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8BE36/2020	EPI_ISL_643204	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8BAAB/2020	EPI_ISL_643209	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8BDDF/2020	EPI_ISL_643222	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8BE63/2020	EPI_ISL_643243	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8C0E4/2020	EPI_ISL_643253	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A8BE72/2020	EPI_ISL_643270	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8BE18/2020	EPI_ISL_643277	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8BE54/2020	EPI_ISL_643292	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8BDA2/2020	EPI_ISL_643306	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B0AD7D/2020	EPI_ISL_643345	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B0AF0E/2020	EPI_ISL_643405	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B07B1C/2020	EPI_ISL_643451	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-B0B055/2020	EPI_ISL_643456	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.153	GR
hCoV-19/England/CAMC-B0B27D/2020	EPI_ISL_643470	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B0AD6E/2020	EPI_ISL_643496	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-AD0315/2020	EPI_ISL_644000	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACC9CF/2020	EPI_ISL_644076	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACEE37/2020	EPI_ISL_644084	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA4A51/2020	EPI_ISL_644110	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Ireland/MH-NVRL-AIIDM0073v1/2020	EPI_ISL_644256	2020-05-22	Europe / Ireland / Meath	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/D-NVRL-AIIDV0023v1/2020	EPI_ISL_644267	2020-04-24	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/D-NVRL-AIIDV0346v1/2020	EPI_ISL_644307	2020-05-06	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/France/OCC-SC463/2020	EPI_ISL_644681	2020-02-26	Europe / France / Occitanie / Montpellier	Human	Original	Nasopharyngeal swab		Illumina NextSeq	BWA, samtools, custom			B.1.1	GR
hCoV-19/India/TG-CCMB-OM23/2020	EPI_ISL_644717	2020-09-20	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-OM24/2020	EPI_ISL_644718	2020-09-20	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-OM30/2020	EPI_ISL_644724	2020-09-20	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-OM37/2020	EPI_ISL_644731	2020-04-19	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/USA/VA-DCLS-1673/2020	EPI_ISL_644841	2020-08-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.434	GR
hCoV-19/USA/VA-DCLS-1941/2020	EPI_ISL_644928	2020-09-30	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/England/MILK-B56B3C/2020	EPI_ISL_657016	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B56905/2020	EPI_ISL_657017	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B4019D/2020	EPI_ISL_657060	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B4234A/2020	EPI_ISL_657094	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B401D9/2020	EPI_ISL_657100	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B42553/2020	EPI_ISL_657120	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B42562/2020	EPI_ISL_657204	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B4266F/2020	EPI_ISL_657224	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B4332B/2020	EPI_ISL_657251	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-B4333A/2020	EPI_ISL_657282	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B433EF/2020	EPI_ISL_657300	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B408A7/2020	EPI_ISL_657308	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B40977/2020	EPI_ISL_657327	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B404B2/2020	EPI_ISL_657333	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B4027C/2020	EPI_ISL_657345	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B4240B/2020	EPI_ISL_657349	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-B40090/2020	EPI_ISL_657354	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B52ACA/2020	EPI_ISL_657376	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/MILK-B56149/2020	EPI_ISL_657443	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B54D38/2020	EPI_ISL_657722	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-B513FD/2020	EPI_ISL_657763	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B55380/2020	EPI_ISL_657770	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B551E0/2020	EPI_ISL_657785	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B54BE3/2020	EPI_ISL_657915	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B55168/2020	EPI_ISL_657919	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B55344/2020	EPI_ISL_657973	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B5471C/2020	EPI_ISL_658101	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B55E43/2020	EPI_ISL_658135	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-B5A4F1/2020	EPI_ISL_658154	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B5A2BB/2020	EPI_ISL_658170	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/QEUH-B41800/2020	EPI_ISL_658605	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B417C7/2020	EPI_ISL_658609	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B4118D/2020	EPI_ISL_658637	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B3F489/2020	EPI_ISL_658644	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B3F683/2020	EPI_ISL_658649	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B41AFB/2020	EPI_ISL_658650	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B41606/2020	EPI_ISL_658657	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B41B16/2020	EPI_ISL_658695	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B4176D/2020	EPI_ISL_658737	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B38EBF/2020	EPI_ISL_658770	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-B38D76/2020	EPI_ISL_658786	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B37D77/2020	EPI_ISL_658829	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B3865D/2020	EPI_ISL_658857	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B37E29/2020	EPI_ISL_658916	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-B392FE/2020	EPI_ISL_658920	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-B38C4C/2020	EPI_ISL_658926	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B38918/2020	EPI_ISL_658941	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B381C5/2020	EPI_ISL_658959	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.1.294	GR
hCoV-19/England/CAMC-B37EB0/2020	EPI_ISL_658963	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B39461/2020	EPI_ISL_658984	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B68153/2020	EPI_ISL_662005	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B686FA/2020	EPI_ISL_662028	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B68627/2020	EPI_ISL_662072	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B686EB/2020	EPI_ISL_662084	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B67F87/2020	EPI_ISL_662103	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B74D8D/2020	EPI_ISL_662105	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B66F2E/2020	EPI_ISL_662126	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B67479/2020	EPI_ISL_662136	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B68979/2020	EPI_ISL_662152	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B74CBD/2020	EPI_ISL_662170	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B674D3/2020	EPI_ISL_662189	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B68F77/2020	EPI_ISL_662210	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B686AF/2020	EPI_ISL_662222	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B68A1C/2020	EPI_ISL_662232	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B7452B/2020	EPI_ISL_662272	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B6A6F8/2020	EPI_ISL_662317	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B7347A/2020	EPI_ISL_662327	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B6A6BC/2020	EPI_ISL_662329	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B6AFC0/2020	EPI_ISL_662338	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-B73638/2020	EPI_ISL_662419	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B67260/2020	EPI_ISL_662428	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B6654A/2020	EPI_ISL_662459	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B734E3/2020	EPI_ISL_662468	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B6AA29/2020	EPI_ISL_662506	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B6A4EF/2020	EPI_ISL_662536	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B6A652/2020	EPI_ISL_662574	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B7352C/2020	EPI_ISL_662614	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF00CD/2020	EPI_ISL_662692	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AEFAF0/2020	EPI_ISL_662699	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AEFB93/2020	EPI_ISL_662704	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AEFC45/2020	EPI_ISL_662706	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF00BE/2020	EPI_ISL_662749	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-AF2939/2020	EPI_ISL_662750	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AEFE12/2020	EPI_ISL_662756	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AF0959/2020	EPI_ISL_662764	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF109F/2020	EPI_ISL_662771	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF472E/2020	EPI_ISL_662823	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AEFA69/2020	EPI_ISL_662844	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF4700/2020	EPI_ISL_662862	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AEFD60/2020	EPI_ISL_662882	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF4D68/2020	EPI_ISL_662892	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF4D0E/2020	EPI_ISL_662893	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF666B/2020	EPI_ISL_662895	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF4DFF/2020	EPI_ISL_662902	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AF58FD/2020	EPI_ISL_662911	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF6698/2020	EPI_ISL_662914	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF56F3/2020	EPI_ISL_662915	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF3D3C/2020	EPI_ISL_662923	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AF4DD1/2020	EPI_ISL_662949	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AF4D86/2020	EPI_ISL_662983	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-AF5DFE/2020	EPI_ISL_676482	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-AF4B8C/2020	EPI_ISL_676487	2020-10-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/Sweden/20-53258/2020	EPI_ISL_676515	2020-10-16	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	NS8_E110stop results in 9.9% truncation of the protein sequence. Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.1.446	GR
hCoV-19/Sweden/20-21511/2020	EPI_ISL_676529	2020-07-13	Europe / Sweden / Uppsala	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-53329/2020	EPI_ISL_676538	2020-10-27	Europe / Sweden / Gavleborg	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.170	GR
hCoV-19/France/ARA-24352/2020	EPI_ISL_676545	2020-04-13	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/France/ARA-27101/2020	EPI_ISL_676566	2020-04-18	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/Russia/MOS-RARI-3709/2020	EPI_ISL_678278	2020-03-20	Europe / Russia / Moscow	Human	Original	Nasal swab		IonTorrent	SPAdes v. 3.12			B.1.1	GR
hCoV-19/Belgium/ULG-10862/2020	EPI_ISL_678406	2020-11-13	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.1.37	GR
hCoV-19/France/ARA-29004/2020	EPI_ISL_678535	2020-04-22	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/England/204540240/2020	EPI_ISL_678648	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/204540972/2020	EPI_ISL_678659	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.153	GR
hCoV-19/England/204541124/2020	EPI_ISL_678668	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/ALDP-B5D17F/2020	EPI_ISL_678863	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-B5D591/2020	EPI_ISL_678915	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/ALDP-B745C1/2020	EPI_ISL_678932	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-B748AA/2020	EPI_ISL_678952	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/ALDP-B74E7B/2020	EPI_ISL_678998	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Switzerland/GE-HUG-VD0503/2020	EPI_ISL_415459	2020-02-29	Europe / Switzerland / Geneve	Human	Original			unknown				B.1.1	GR
hCoV-19/Switzerland/TI-HUG-2045/2020	EPI_ISL_415703	2020-03-01	Europe / Switzerland / Ticino	Human	Original			unknown				B.1.1	GR
hCoV-19/Peru/LIM-010/2020	EPI_ISL_415787	2020-03-10	South America / Peru / Lima	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes			B.1.1	GR
hCoV-19/USA/WI-UW-156/2020	EPI_ISL_428252	2020-03-25	North America / USA / Wisconsin / Milwaukee County	Human	Original	Nasopharyngeal swab		unknown				B.1.1	GR
hCoV-19/Luxembourg/LNS5277361/2020	EPI_ISL_429723	2020-03-22	Europe / Luxembourg	Human	Original			Illumina MiniSeq (Amplicon, ARTIC primer set V1)	Bowtie2, BCFtools			B.1.1	GR
hCoV-19/Scotland/EDB2096/2020	EPI_ISL_433194	2020-04-19	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Scotland/EDB726/2020	EPI_ISL_433229	2020-04-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Scotland/EDB766/2020	EPI_ISL_433238	2020-04-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Scotland/EDB795/2020	EPI_ISL_433246	2020-04-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Scotland/EDB838/2020	EPI_ISL_433253	2020-04-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Scotland/CVR1085/2020	EPI_ISL_433508	2020-03-29	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA MiSeq				B.1.1	GR
hCoV-19/Scotland/CVR1101/2020	EPI_ISL_433510	2020-03-29	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA MiSeq				B.1.1	GR
hCoV-19/England/CAMB-73C31/2020	EPI_ISL_433678	2020-04-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-73DB6/2020	EPI_ISL_433697	2020-04-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-78452/2020	EPI_ISL_433734	2020-04-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-79A9B/2020	EPI_ISL_433818	2020-03-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7AA8B/2020	EPI_ISL_433833	2020-04-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7ADBF/2020	EPI_ISL_433876	2020-04-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7AFAA/2020	EPI_ISL_433902	2020-04-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7B1B2/2020	EPI_ISL_433928	2020-04-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7B2BF/2020	EPI_ISL_433937	2020-04-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7B52F/2020	EPI_ISL_433971	2020-04-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/United Arab Emirates/L0879/2020	EPI_ISL_435124	2020-03-16	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1.366	GR
hCoV-19/Italy/ABR-IZSGC-TE14162/2020	EPI_ISL_435154	2020-04-09	Europe / Italy / Abruzzo	Human	Original			ARTIC + Illumina MiniSeq				B.1.1	GR
hCoV-19/Vietnam/VNHN_0418/2020	EPI_ISL_435311	2020-03-10	Asia / Vietnam	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC genomics Workbench 20.0.3			B.1.1	GR
hCoV-19/England/BRIS-121FB0/2020	EPI_ISL_440102	2020-03-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-73FFC/2020	EPI_ISL_440335	2020-03-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-758A4/2020	EPI_ISL_440351	2020-03-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7524C/2020	EPI_ISL_440375	2020-03-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7558F/2020	EPI_ISL_440399	2020-03-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12267E/2020	EPI_ISL_440679	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-122571/2020	EPI_ISL_440732	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-122A81/2020	EPI_ISL_440784	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-122D88/2020	EPI_ISL_440806	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1228E1/2020	EPI_ISL_440808	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LIVE-9A29C/2020	EPI_ISL_440853	2020-04-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-9C959/2020	EPI_ISL_440924	2020-04-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D374D/2020	EPI_ISL_440981	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D37F2/2020	EPI_ISL_440990	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Germany/HE-FFM4clin/2020	EPI_ISL_447610	2020-02	Europe / Germany / Hesse / Frankfurt	Human	Original			Illumina	bwa v. 0.7.17; Geneious prime v. 9.1			B.1.1	GR
hCoV-19/Germany/HE-FFM6clin/2020	EPI_ISL_447612	2020-02	Europe / Germany / Hesse / Frankfurt	Human	Original			Illumina	bwa v. 0.7.17; Geneious prime v. 9.1			B.1.1	GR
hCoV-19/Greece/205_33490/2020	EPI_ISL_447637	2020-03-13	Europe / Greece / Athens	Human	unknown			IonTorrent	Iterative Refinement Meta-Assembler (IRMA)			B.1.1	GR
hCoV-19/Colombia/MET-GVI-97782/2020	EPI_ISL_447803	2020-04-04	South America / Colombia / Meta / Villavicencio	Human	Original	Alveolar lavage fluid		Illumina MiSeq				B.1.1	GR
hCoV-19/Colombia/MET-GVI-97783/2020	EPI_ISL_447804	2020-04-04	South America / Colombia / Meta / Villavicencio	Human	Original	Alveolar lavage fluid		Illumina MiSeq				B.1.1	GR
hCoV-19/England/CAMB-1AD268/2020	EPI_ISL_447983	2020-04-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AD2E0/2020	EPI_ISL_447989	2020-04-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AD602/2020	EPI_ISL_447990	2020-04-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AD6D5/2020	EPI_ISL_447997	2020-05-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORW-E7315/2020	EPI_ISL_449023	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E7333/2020	EPI_ISL_449025	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E738E/2020	EPI_ISL_449029	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E7421/2020	EPI_ISL_449034	2020-05-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E7DF9/2020	EPI_ISL_449091	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E7E05/2020	EPI_ISL_449092	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E7E9C/2020	EPI_ISL_449093	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E7F4E/2020	EPI_ISL_449096	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E839C/2020	EPI_ISL_449144	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E8596/2020	EPI_ISL_449162	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR3202/2020	EPI_ISL_449221	2020-04-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-D3B50/2020	EPI_ISL_449631	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D4BAA/2020	EPI_ISL_449657	2020-04-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D4BB9/2020	EPI_ISL_449658	2020-04-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/USA/WA-S712/2020	EPI_ISL_449882	2020-04-07	North America / USA / Washington / Adams County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1	GR
hCoV-19/Sweden/20-50099/2020	EPI_ISL_454878	2020-03-03	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-50252/2020	EPI_ISL_454895	2020-03-08	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Italy/LOM-INMI-BG-7158/2020	EPI_ISL_460081	2020-02-24	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		Ion Torrent	BWA 0.7.12 + Samtools 1.3.1 + Geneious 2019.2.3			B.1.1	GR
hCoV-19/Spain/AN-IBV-001919/2020	EPI_ISL_467080	2020-03-17	Europe / Spain / Andalusia / Rio San Pedro	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/AN-IBV-001917/2020	EPI_ISL_467081	2020-03-17	Europe / Spain / Andalusia / Cadiz	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Canada/BC_11135150/2020	EPI_ISL_467318	2020-04	North America / Canada / British Columbia	Human	Original			Oxford Nanopore	ARTIC protocol			B.1.1	GR
hCoV-19/USA/CA-QDX-129/2020	EPI_ISL_467812	2020-03-15	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/Wales/PHWC-15D20D/2020	EPI_ISL_472684	2020-05-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-15E59A/2020	EPI_ISL_472821	2020-05-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-15FCD0/2020	EPI_ISL_472845	2020-05-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16029E/2020	EPI_ISL_472914	2020-05-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1608D8/2020	EPI_ISL_472991	2020-05-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16096C/2020	EPI_ISL_472998	2020-05-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-163DA9/2020	EPI_ISL_474081	2020-05-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1645A0/2020	EPI_ISL_474198	2020-05-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-364E7/2020	EPI_ISL_474675	2020-05-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORT-29743D/2020	EPI_ISL_488028	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29E2D2/2020	EPI_ISL_488065	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29EE38/2020	EPI_ISL_488113	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-297075/2020	EPI_ISL_488123	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29EC5C/2020	EPI_ISL_488134	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29D886/2020	EPI_ISL_488158	2020-05-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29E24B/2020	EPI_ISL_488162	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29C9DF/2020	EPI_ISL_488166	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29E22D/2020	EPI_ISL_488171	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29E8A3/2020	EPI_ISL_488172	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12EC70/2020	EPI_ISL_488284	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12F028/2020	EPI_ISL_488316	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12FAEE/2020	EPI_ISL_488325	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12E93D/2020	EPI_ISL_488369	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-294F3F/2020	EPI_ISL_488467	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-294D62/2020	EPI_ISL_488480	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2828B1/2020	EPI_ISL_488495	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-294A10/2020	EPI_ISL_488507	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-282ABB/2020	EPI_ISL_488514	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-295E04/2020	EPI_ISL_488521	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2843DC/2020	EPI_ISL_488527	2020-03-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-283BD5/2020	EPI_ISL_488532	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2952AE/2020	EPI_ISL_488545	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-294E50/2020	EPI_ISL_488552	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2835B9/2020	EPI_ISL_488559	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28355F/2020	EPI_ISL_488560	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-283EDC/2020	EPI_ISL_488589	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-295B49/2020	EPI_ISL_488592	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-295B58/2020	EPI_ISL_488595	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-295B3A/2020	EPI_ISL_488610	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-282D85/2020	EPI_ISL_488617	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-283B7B/2020	EPI_ISL_488621	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-295842/2020	EPI_ISL_488625	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-283197/2020	EPI_ISL_488660	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-295332/2020	EPI_ISL_488665	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-295B2B/2020	EPI_ISL_488698	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29594F/2020	EPI_ISL_488711	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2953AB/2020	EPI_ISL_488712	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2831F1/2020	EPI_ISL_488713	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-283DA2/2020	EPI_ISL_488761	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28157F/2020	EPI_ISL_488766	2020-03-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-283C2D/2020	EPI_ISL_488835	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-185414B/2020	EPI_ISL_492250	2020-04-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-185362F/2020	EPI_ISL_492290	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-18536D4/2020	EPI_ISL_492426	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-18531D3/2020	EPI_ISL_492444	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29950B/2020	EPI_ISL_492450	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12FF67/2020	EPI_ISL_492519	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-130A80/2020	EPI_ISL_492604	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-130525/2020	EPI_ISL_492693	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-130042/2020	EPI_ISL_492699	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-130ADB/2020	EPI_ISL_492726	2020-03-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-130AEA/2020	EPI_ISL_492730	2020-03-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1305BC/2020	EPI_ISL_492734	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-130B9C/2020	EPI_ISL_492735	2020-03-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-13068C/2020	EPI_ISL_492737	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-123CB7/2020	EPI_ISL_492819	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-124C373/2020	EPI_ISL_492885	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-124C3A0/2020	EPI_ISL_492905	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/NORT-28B108/2020	EPI_ISL_492937	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28AD14/2020	EPI_ISL_492962	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28AD23/2020	EPI_ISL_492965	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/FL-BPHL-0521/2020	EPI_ISL_508724	2020-06-18	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1	GR
hCoV-19/USA/FL-BPHL-0522/2020	EPI_ISL_508725	2020-06-18	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1	GR
hCoV-19/France/ARA-16251/2020	EPI_ISL_508907	2020-03-29	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/France/ARA-22592/2020	EPI_ISL_508918	2020-04-09	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-220057/2020	EPI_ISL_512027	2020-07-24	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/USA/AK-PHL621/2020	EPI_ISL_512156	2020-06-25	North America / USA / Alaska	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC			B.1.1.228	GR
hCoV-19/Czech Republic/NRL_4037/2020	EPI_ISL_513512	2020-03-17	Europe / Czech Republic / Zlin / Uhersky Brod	Human	Original	Oropharyngeal swab		Nanopore MinION	RAMPART			B.1.1	GR
hCoV-19/USA/CA-CZB-2159/2020	EPI_ISL_513709	2020-05-21	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2161/2020	EPI_ISL_513711	2020-05-22	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2162/2020	EPI_ISL_513712	2020-05-22	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2164/2020	EPI_ISL_513714	2020-05-22	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2184/2020	EPI_ISL_513734	2020-05-26	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2194/2020	EPI_ISL_513743	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2195/2020	EPI_ISL_513744	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2196/2020	EPI_ISL_513745	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2205/2020	EPI_ISL_513753	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2206/2020	EPI_ISL_513754	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2207/2020	EPI_ISL_513755	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2208/2020	EPI_ISL_513756	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2209/2020	EPI_ISL_513757	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2210/2020	EPI_ISL_513758	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2212/2020	EPI_ISL_513760	2020-05-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.132	GR
hCoV-19/USA/CA-CZB-2213/2020	EPI_ISL_513761	2020-05-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.132	GR
hCoV-19/USA/CA-CZB-2218/2020	EPI_ISL_513766	2020-05-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.132	GR
hCoV-19/USA/CA-CZB-2339/2020	EPI_ISL_513789	2020-05-12	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2344/2020	EPI_ISL_513793	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2346/2020	EPI_ISL_513795	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2347/2020	EPI_ISL_513796	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2350/2020	EPI_ISL_513798	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2353/2020	EPI_ISL_513800	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2354/2020	EPI_ISL_513801	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2355/2020	EPI_ISL_513802	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2356/2020	EPI_ISL_513803	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2357/2020	EPI_ISL_513804	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2391/2020	EPI_ISL_513822	2020-05-18	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2395/2020	EPI_ISL_513824	2020-05-19	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.132	GR
hCoV-19/USA/CA-CZB-2397/2020	EPI_ISL_513826	2020-05-19	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.132	GR
hCoV-19/USA/CA-CZB-2400/2020	EPI_ISL_513828	2020-05-20	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2416/2020	EPI_ISL_513837	2020-05-22	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2417/2020	EPI_ISL_513838	2020-05-22	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/England/NOTT-112F1C/2020	EPI_ISL_526425	2020-08-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/20164006104/2020	EPI_ISL_526538	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20164006804/2020	EPI_ISL_526539	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/QEUH-96B8B7/2020	EPI_ISL_531369	2020-08-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-96BA84/2020	EPI_ISL_531413	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96BA93/2020	EPI_ISL_531429	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/QEUH-96B565/2020	EPI_ISL_531437	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96B1CB/2020	EPI_ISL_531458	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96A821/2020	EPI_ISL_531466	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-96A681/2020	EPI_ISL_531475	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-96A751/2020	EPI_ISL_531480	2020-08-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-962874/2020	EPI_ISL_531482	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-96A548/2020	EPI_ISL_531504	2020-08-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-96A6AF/2020	EPI_ISL_531529	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-963C3B/2020	EPI_ISL_531550	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96A4B4/2020	EPI_ISL_531551	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96A706/2020	EPI_ISL_531555	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9632C0/2020	EPI_ISL_531592	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-962ECD/2020	EPI_ISL_531593	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-962D57/2020	EPI_ISL_531603	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-962391/2020	EPI_ISL_531605	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9626B6/2020	EPI_ISL_531619	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96320C/2020	EPI_ISL_531628	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9634D9/2020	EPI_ISL_531629	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-961F52/2020	EPI_ISL_531645	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-962D66/2020	EPI_ISL_531693	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-962E09/2020	EPI_ISL_531701	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-962DDF/2020	EPI_ISL_531713	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-962522/2020	EPI_ISL_531718	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-962DEE/2020	EPI_ISL_531752	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9628FC/2020	EPI_ISL_531760	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9621F1/2020	EPI_ISL_531800	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96017B/2020	EPI_ISL_531864	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-960199/2020	EPI_ISL_531909	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96018A/2020	EPI_ISL_531922	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-7A7848/2020	EPI_ISL_533032	2020-07-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-79A20E/2020	EPI_ISL_533034	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-78CC4D/2020	EPI_ISL_533076	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-78A76C/2020	EPI_ISL_533080	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/QEUH-7A7A24/2020	EPI_ISL_533100	2020-07-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-7A774B/2020	EPI_ISL_533113	2020-07-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-785C71/2020	EPI_ISL_533157	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-7858C8/2020	EPI_ISL_533168	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-5FFCCF/2020	EPI_ISL_533245	2020-06-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-5E62AB/2020	EPI_ISL_533300	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-5EA5EA/2020	EPI_ISL_533337	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/QEUH-5458A8/2020	EPI_ISL_533357	2020-05-14	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54B8A2/2020	EPI_ISL_533372	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54AA34/2020	EPI_ISL_533385	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-5476CA/2020	EPI_ISL_533390	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54DE08/2020	EPI_ISL_533392	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-54BF25/2020	EPI_ISL_533394	2020-05-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-547378/2020	EPI_ISL_533409	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-548052/2020	EPI_ISL_533414	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-548CD6/2020	EPI_ISL_533417	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54D4BB/2020	EPI_ISL_533422	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54AE65/2020	EPI_ISL_533425	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54723F/2020	EPI_ISL_533426	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Netherlands/UT-RIVM-10148/2020	EPI_ISL_547539	2020-06-09	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Netherlands/ZH-RIVM-10117/2020	EPI_ISL_547564	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/England/MILK-9AB0D1/2020	EPI_ISL_551009	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AB2DB/2020	EPI_ISL_551010	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AB411/2020	EPI_ISL_551017	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A91FE/2020	EPI_ISL_551024	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A962C/2020	EPI_ISL_551027	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9A9B78/2020	EPI_ISL_551038	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-9AB38D/2020	EPI_ISL_551040	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A920A/2020	EPI_ISL_551043	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AB332/2020	EPI_ISL_551053	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AB2CC/2020	EPI_ISL_551086	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9AB0C2/2020	EPI_ISL_551103	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A9AB7/2020	EPI_ISL_551119	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A9000/2020	EPI_ISL_551129	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AB499/2020	EPI_ISL_551130	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AB2EA/2020	EPI_ISL_551131	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A9273/2020	EPI_ISL_551145	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AB44E/2020	EPI_ISL_551151	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A9747/2020	EPI_ISL_551157	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A9C2A/2020	EPI_ISL_551169	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				M.3	GR
hCoV-19/England/MILK-9AB2BD/2020	EPI_ISL_551173	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A9D27/2020	EPI_ISL_551183	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AB129/2020	EPI_ISL_551194	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A957A/2020	EPI_ISL_551202	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AB45D/2020	EPI_ISL_551229	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A9738/2020	EPI_ISL_551233	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AB235/2020	EPI_ISL_551237	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AB47B/2020	EPI_ISL_551253	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AB305/2020	EPI_ISL_551255	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A8ECB/2020	EPI_ISL_551258	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AAEAB/2020	EPI_ISL_551271	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-951F19/2020	EPI_ISL_551307	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-951D97/2020	EPI_ISL_551314	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.370	GR
hCoV-19/England/ALDP-951F28/2020	EPI_ISL_551322	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-951EEF/2020	EPI_ISL_551326	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-93AA24/2020	EPI_ISL_551403	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-92FFAB/2020	EPI_ISL_551424	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-923B3A/2020	EPI_ISL_551429	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-9364FD/2020	EPI_ISL_551438	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-923E8C/2020	EPI_ISL_551444	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-938B32/2020	EPI_ISL_551457	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-917A78/2020	EPI_ISL_551458	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-917A5A/2020	EPI_ISL_551474	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-92CF44/2020	EPI_ISL_551486	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-923F4D/2020	EPI_ISL_551494	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-92D022/2020	EPI_ISL_551498	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8FC272/2020	EPI_ISL_551528	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-91DA72/2020	EPI_ISL_551529	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-907765/2020	EPI_ISL_551560	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-99584B/2020	EPI_ISL_551594	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-993E3C/2020	EPI_ISL_551615	2020-08-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-995A36/2020	EPI_ISL_551644	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides found at refpos 12630.	info	B.1.1	GR
hCoV-19/England/MILK-993F93/2020	EPI_ISL_551676	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-993E5A/2020	EPI_ISL_551684	2020-08-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-993EA5/2020	EPI_ISL_551713	2020-08-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/MILK-995A27/2020	EPI_ISL_551720	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides found at refpos 12630.	info	B.1.1	GR
hCoV-19/England/ALDP-6898E3/2020	EPI_ISL_551759	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-689810/2020	EPI_ISL_551762	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-689AFC/2020	EPI_ISL_551784	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9C8D7D/2020	EPI_ISL_567017	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C837B/2020	EPI_ISL_567018	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9C90FB/2020	EPI_ISL_567021	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C8AB2/2020	EPI_ISL_567038	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C8214/2020	EPI_ISL_567046	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C919E/2020	EPI_ISL_567053	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C8DD7/2020	EPI_ISL_567057	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C8320/2020	EPI_ISL_567072	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C86DC/2020	EPI_ISL_567076	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C9125/2020	EPI_ISL_567082	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9C7FF0/2020	EPI_ISL_567104	2020-09-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C86BE/2020	EPI_ISL_567116	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C84F0/2020	EPI_ISL_567129	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C90DD/2020	EPI_ISL_567131	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9C884F/2020	EPI_ISL_567133	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C8C43/2020	EPI_ISL_567141	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/QEUH-9C8C16/2020	EPI_ISL_567145	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9C800B/2020	EPI_ISL_567147	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C8478/2020	EPI_ISL_567152	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C9107/2020	EPI_ISL_567157	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C7B0B/2020	EPI_ISL_567164	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C87CA/2020	EPI_ISL_567167	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C889A/2020	EPI_ISL_567171	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C7F87/2020	EPI_ISL_567172	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9C7E99/2020	EPI_ISL_567188	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9C9134/2020	EPI_ISL_567190	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C8117/2020	EPI_ISL_567194	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C8250/2020	EPI_ISL_567196	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9C8FC2/2020	EPI_ISL_567206	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/QEUH-9C833F/2020	EPI_ISL_567215	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9C9143/2020	EPI_ISL_567222	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C891F/2020	EPI_ISL_567245	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C80A1/2020	EPI_ISL_567246	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C8627/2020	EPI_ISL_567259	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C895B/2020	EPI_ISL_567262	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C8A67/2020	EPI_ISL_567264	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C80ED/2020	EPI_ISL_567267	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C95FC/2020	EPI_ISL_567275	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CA3F1/2020	EPI_ISL_567285	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C9750/2020	EPI_ISL_567287	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9C9617/2020	EPI_ISL_567288	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C9C7F/2020	EPI_ISL_567292	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/USA/WA-UW-21727/2020	EPI_ISL_570994	2020-08-05	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.228	GR
hCoV-19/USA/NY-QDX-1234/2020	EPI_ISL_572010	2020-03-17	North America / USA / New York	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-QDX-1444/2020	EPI_ISL_572095	2020-03-17	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/VA-DCLS-1460/2020	EPI_ISL_572201	2020-08-21	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/USA/VA-DCLS-1461/2020	EPI_ISL_572202	2020-08-21	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/USA/VA-DCLS-1462/2020	EPI_ISL_572203	2020-08-21	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/USA/VA-DCLS-1463/2020	EPI_ISL_572204	2020-08-21	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/USA/VA-DCLS-1465/2020	EPI_ISL_572205	2020-08-21	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/USA/VA-DCLS-1466/2020	EPI_ISL_572206	2020-08-21	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/USA/VA-DCLS-1468/2020	EPI_ISL_572207	2020-08-21	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/USA/VA-DCLS-1469/2020	EPI_ISL_572208	2020-08-21	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/USA/VA-DCLS-1678/2020	EPI_ISL_572219	2020-09-03	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/USA/VA-DCLS-1312/2020	EPI_ISL_572254	2020-07-24	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/USA/VA-DCLS-1332/2020	EPI_ISL_572261	2020-06-30	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/USA/VA-DCLS-1212/2020	EPI_ISL_572281	2020-06-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/England/ALDP-9CC614/2020	EPI_ISL_572711	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/SHEF-D3121/2020	EPI_ISL_572848	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-9CC0F8/2020	EPI_ISL_572939	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-9CC1C8/2020	EPI_ISL_572940	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-9B3A9C/2020	EPI_ISL_572945	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-9B5CA3/2020	EPI_ISL_572962	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9B5EAD/2020	EPI_ISL_572971	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9B6264/2020	EPI_ISL_572994	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9B6273/2020	EPI_ISL_572995	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9B62EC/2020	EPI_ISL_572997	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/New Zealand/20VR2577/2020	EPI_ISL_579308	2020-03-26	Oceania / New Zealand / Counties Manukau	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1	GR
hCoV-19/New Zealand/20VR3032/2020	EPI_ISL_579396	2020	Oceania / New Zealand / Combined Wellington	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1	GR
hCoV-19/New Zealand/20VR3033/2020	EPI_ISL_579397	2020	Oceania / New Zealand / Combined Wellington	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1	GR
hCoV-19/New Zealand/20VR3154/2020	EPI_ISL_579444	2020-03-23	Oceania / New Zealand / Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1	GR
hCoV-19/Canada/NS-NML-895/2020	EPI_ISL_579544	2020-03-20	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/England/QEUH-9E49B3/2020	EPI_ISL_579767	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9E4EC3/2020	EPI_ISL_579777	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9E4C8D/2020	EPI_ISL_579784	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9E4E3C/2020	EPI_ISL_579814	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9E479B/2020	EPI_ISL_579815	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9E4AA1/2020	EPI_ISL_579817	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9E4A0B/2020	EPI_ISL_579823	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9E53D2/2020	EPI_ISL_579841	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9E535A/2020	EPI_ISL_579851	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9E47C8/2020	EPI_ISL_579856	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9E4B80/2020	EPI_ISL_579859	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9E4E69/2020	EPI_ISL_579864	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9E49E0/2020	EPI_ISL_579868	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9E4C14/2020	EPI_ISL_579869	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9E4212/2020	EPI_ISL_579870	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9E41BB/2020	EPI_ISL_579876	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9E4C9C/2020	EPI_ISL_579889	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9E3E79/2020	EPI_ISL_579894	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9E509F/2020	EPI_ISL_579895	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9E475F/2020	EPI_ISL_579896	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9E4DB7/2020	EPI_ISL_579913	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E9B9A/2020	EPI_ISL_579938	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9EAE18/2020	EPI_ISL_579957	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9EA3A0/2020	EPI_ISL_579961	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9E9AF7/2020	EPI_ISL_579972	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9EAE09/2020	EPI_ISL_579973	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E9C88/2020	EPI_ISL_579976	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9EADEE/2020	EPI_ISL_579980	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9EA3DD/2020	EPI_ISL_579983	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9EA364/2020	EPI_ISL_579991	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-CA3CD/2020	EPI_ISL_585039	2020-09-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CBF13/2020	EPI_ISL_585046	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CD306/2020	EPI_ISL_585059	2020-09-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CE5A5/2020	EPI_ISL_585068	2020-09-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.307	GR
hCoV-19/England/SHEF-CE6A2/2020	EPI_ISL_585069	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CF119/2020	EPI_ISL_585073	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-D131E/2020	EPI_ISL_585079	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Northern Ireland/NIRE-10709F/2020	EPI_ISL_585103	2020-03-27	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/ALDP-A2E66A/2020	EPI_ISL_586586	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2E49D/2020	EPI_ISL_586613	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2E07B/2020	EPI_ISL_586640	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A2E7B2/2020	EPI_ISL_586646	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A2D64D/2020	EPI_ISL_586649	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2E6E2/2020	EPI_ISL_586656	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2DAD8/2020	EPI_ISL_586670	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2D319/2020	EPI_ISL_586674	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2D6A7/2020	EPI_ISL_586695	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2DCB4/2020	EPI_ISL_586696	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2D3CE/2020	EPI_ISL_586707	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2D917/2020	EPI_ISL_586716	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2D874/2020	EPI_ISL_586726	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A2D62F/2020	EPI_ISL_586734	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2D22B/2020	EPI_ISL_586737	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A2E275/2020	EPI_ISL_586743	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2D407/2020	EPI_ISL_586745	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2D6F2/2020	EPI_ISL_586783	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2D14C/2020	EPI_ISL_586795	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2E14B/2020	EPI_ISL_586800	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/ALDP-A2DC87/2020	EPI_ISL_586820	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A2DA14/2020	EPI_ISL_586822	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2DBD5/2020	EPI_ISL_586823	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2D1E2/2020	EPI_ISL_586834	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2D7D1/2020	EPI_ISL_586853	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2D610/2020	EPI_ISL_586854	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2E4E8/2020	EPI_ISL_586865	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2D425/2020	EPI_ISL_586870	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A2D7A4/2020	EPI_ISL_586900	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2D7FF/2020	EPI_ISL_586916	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A2D795/2020	EPI_ISL_586934	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9D0738/2020	EPI_ISL_590007	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9D1148/2020	EPI_ISL_590012	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CE75B/2020	EPI_ISL_590027	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CF277/2020	EPI_ISL_590029	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CEB40/2020	EPI_ISL_590031	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CEE65/2020	EPI_ISL_590032	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CEC01/2020	EPI_ISL_590045	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Wales/QEUH-9CF2B3/2020	EPI_ISL_590065	2020-09-15	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CF6B7/2020	EPI_ISL_590067	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CE73D/2020	EPI_ISL_590078	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CE71F/2020	EPI_ISL_590081	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9CF70F/2020	EPI_ISL_590087	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CEB22/2020	EPI_ISL_590105	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9CECF2/2020	EPI_ISL_590120	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CE22D/2020	EPI_ISL_590128	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-9CF9BE/2020	EPI_ISL_590135	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CED0E/2020	EPI_ISL_590136	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CE8B2/2020	EPI_ISL_590142	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CE23C/2020	EPI_ISL_590148	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CE700/2020	EPI_ISL_590151	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CED68/2020	EPI_ISL_590154	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CF5D8/2020	EPI_ISL_590159	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CF75A/2020	EPI_ISL_590165	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CE8C1/2020	EPI_ISL_590166	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CE65E/2020	EPI_ISL_590170	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B5098/2020	EPI_ISL_590183	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B54AB/2020	EPI_ISL_590184	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B4A22/2020	EPI_ISL_590188	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.263	GR
hCoV-19/England/QEUH-9B466A/2020	EPI_ISL_590189	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B4DA1/2020	EPI_ISL_590212	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B4B10/2020	EPI_ISL_590217	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B4FD8/2020	EPI_ISL_590218	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9B5757/2020	EPI_ISL_590225	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B55D5/2020	EPI_ISL_590232	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B56C3/2020	EPI_ISL_590237	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9B4952/2020	EPI_ISL_590242	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B48CE/2020	EPI_ISL_590251	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9B4DDE/2020	EPI_ISL_590268	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B564B/2020	EPI_ISL_590270	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B4A04/2020	EPI_ISL_590281	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9B46A6/2020	EPI_ISL_590302	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B4D1A/2020	EPI_ISL_590310	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B55F3/2020	EPI_ISL_590325	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9B4E17/2020	EPI_ISL_590338	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B4F9C/2020	EPI_ISL_590342	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B5599/2020	EPI_ISL_590354	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9B5748/2020	EPI_ISL_590355	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B4D56/2020	EPI_ISL_590371	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B514A/2020	EPI_ISL_590378	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B4943/2020	EPI_ISL_590382	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B5687/2020	EPI_ISL_590394	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B4C95/2020	EPI_ISL_590396	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.160	G
hCoV-19/England/ALDP-9B5CEF/2020	EPI_ISL_590397	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9B5845/2020	EPI_ISL_590405	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B5669/2020	EPI_ISL_590406	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B48A0/2020	EPI_ISL_590414	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B4767/2020	EPI_ISL_590421	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9B59BB/2020	EPI_ISL_590422	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B5308/2020	EPI_ISL_590426	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B504D/2020	EPI_ISL_590428	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B50A7/2020	EPI_ISL_590434	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B563C/2020	EPI_ISL_590439	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B4D47/2020	EPI_ISL_590455	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B4AAA/2020	EPI_ISL_590458	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B51D1/2020	EPI_ISL_590460	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B77DD/2020	EPI_ISL_590463	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B72AF/2020	EPI_ISL_590469	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B7940/2020	EPI_ISL_590477	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B7EF6/2020	EPI_ISL_590480	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B798C/2020	EPI_ISL_590482	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B7421/2020	EPI_ISL_590488	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B7BFF/2020	EPI_ISL_590490	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B7430/2020	EPI_ISL_590492	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9B7773/2020	EPI_ISL_590498	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B79F5/2020	EPI_ISL_590499	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B7218/2020	EPI_ISL_590502	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B7913/2020	EPI_ISL_590514	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B7C65/2020	EPI_ISL_590519	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B752E/2020	EPI_ISL_590525	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B7FD5/2020	EPI_ISL_590535	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9B7F7B/2020	EPI_ISL_590538	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B7F02/2020	EPI_ISL_590555	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B7EAB/2020	EPI_ISL_590559	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B72CD/2020	EPI_ISL_590562	2020-09-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B7193/2020	EPI_ISL_590568	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B7A4D/2020	EPI_ISL_590571	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B7FF3/2020	EPI_ISL_590581	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B751F/2020	EPI_ISL_590584	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B7816/2020	EPI_ISL_590588	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B7CED/2020	EPI_ISL_590596	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B705A/2020	EPI_ISL_590622	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B6EF7/2020	EPI_ISL_590640	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B71A2/2020	EPI_ISL_590646	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9B7DF9/2020	EPI_ISL_590656	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B7EC9/2020	EPI_ISL_590658	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B77FB/2020	EPI_ISL_590665	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-9B7F5D/2020	EPI_ISL_590676	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B7852/2020	EPI_ISL_590683	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B7834/2020	EPI_ISL_590686	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B7290/2020	EPI_ISL_590687	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A21087/2020	EPI_ISL_599000	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A1F7F0/2020	EPI_ISL_599023	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A1FC00/2020	EPI_ISL_599066	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A203E9/2020	EPI_ISL_599068	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0B94C/2020	EPI_ISL_599138	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A0B083/2020	EPI_ISL_599150	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0B0DE/2020	EPI_ISL_599174	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A0B214/2020	EPI_ISL_599182	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0ACAE/2020	EPI_ISL_599202	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A0BAB2/2020	EPI_ISL_599348	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0B6CD/2020	EPI_ISL_599352	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A0B4F0/2020	EPI_ISL_599355	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A0B171/2020	EPI_ISL_599368	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0BE01/2020	EPI_ISL_599371	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A0BA49/2020	EPI_ISL_599374	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A0B4B4/2020	EPI_ISL_599376	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A0AE20/2020	EPI_ISL_599377	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0C082/2020	EPI_ISL_599392	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A0BFC2/2020	EPI_ISL_599401	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A0B3C6/2020	EPI_ISL_599417	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A0BA2B/2020	EPI_ISL_599470	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A0AD05/2020	EPI_ISL_599482	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-9DE66A/2020	EPI_ISL_599493	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DE0D5/2020	EPI_ISL_599498	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DD9BD/2020	EPI_ISL_599499	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DDE72/2020	EPI_ISL_599512	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DD874/2020	EPI_ISL_599513	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DD971/2020	EPI_ISL_599517	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DD71D/2020	EPI_ISL_599529	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DE56D/2020	EPI_ISL_599541	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DE002/2020	EPI_ISL_599542	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DDECD/2020	EPI_ISL_599543	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DD883/2020	EPI_ISL_599551	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DDB6C/2020	EPI_ISL_599580	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DE2B1/2020	EPI_ISL_599582	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DDEFA/2020	EPI_ISL_599600	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DE65B/2020	EPI_ISL_599614	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DD865/2020	EPI_ISL_599618	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DD021/2020	EPI_ISL_599619	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DDE09/2020	EPI_ISL_599631	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DD5C8/2020	EPI_ISL_599645	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DD64D/2020	EPI_ISL_599660	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DD9CC/2020	EPI_ISL_599661	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DDA50/2020	EPI_ISL_599665	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DDAAB/2020	EPI_ISL_599666	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DD838/2020	EPI_ISL_599675	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DDFE8/2020	EPI_ISL_599687	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DD601/2020	EPI_ISL_599694	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DDA32/2020	EPI_ISL_599708	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-9DD63E/2020	EPI_ISL_599709	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DDE81/2020	EPI_ISL_599715	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DE4BB/2020	EPI_ISL_599727	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DCBE5/2020	EPI_ISL_599732	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DD0D6/2020	EPI_ISL_599734	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DDD1B/2020	EPI_ISL_599736	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DE05D/2020	EPI_ISL_599741	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DD06D/2020	EPI_ISL_599750	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DE309/2020	EPI_ISL_599757	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DD9EA/2020	EPI_ISL_599769	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9DD59B/2020	EPI_ISL_599770	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DE0A8/2020	EPI_ISL_599775	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DD0E5/2020	EPI_ISL_599792	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DDDC0/2020	EPI_ISL_599795	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DD030/2020	EPI_ISL_599799	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/USA/CA-QDX-2645/2020	EPI_ISL_604907	2020-03-15	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/NV-QDX-2627/2020	EPI_ISL_604950	2020-03-15	North America / USA / Nevada	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/England/ALDP-A873E0/2020	EPI_ISL_606020	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A87B8E/2020	EPI_ISL_606060	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A86F65/2020	EPI_ISL_606070	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A863B4/2020	EPI_ISL_606077	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A87122/2020	EPI_ISL_606159	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A86202/2020	EPI_ISL_606265	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A872F2/2020	EPI_ISL_606283	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7D65D/2020	EPI_ISL_606296	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7AD88/2020	EPI_ISL_606299	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7A7B7/2020	EPI_ISL_606315	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7D74B/2020	EPI_ISL_606328	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7AAAF/2020	EPI_ISL_606331	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-A7CA61/2020	EPI_ISL_606339	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7A82D/2020	EPI_ISL_606341	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7A80F/2020	EPI_ISL_606350	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7C25A/2020	EPI_ISL_606357	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7D7D2/2020	EPI_ISL_606372	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7D4CC/2020	EPI_ISL_606384	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7D329/2020	EPI_ISL_606397	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7D347/2020	EPI_ISL_606399	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7C6F4/2020	EPI_ISL_606406	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7ADA6/2020	EPI_ISL_606432	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7C296/2020	EPI_ISL_606438	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7AF28/2020	EPI_ISL_606466	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7C5E8/2020	EPI_ISL_606501	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7C74C/2020	EPI_ISL_606510	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7D514/2020	EPI_ISL_606518	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7A83C/2020	EPI_ISL_606527	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7A887/2020	EPI_ISL_606540	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7AAFA/2020	EPI_ISL_606567	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-A7DB21/2020	EPI_ISL_606570	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7D66C/2020	EPI_ISL_606579	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7A85A/2020	EPI_ISL_606599	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7974F/2020	EPI_ISL_606606	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7CF80/2020	EPI_ISL_606660	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-A7CFAE/2020	EPI_ISL_606689	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7A061/2020	EPI_ISL_606704	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7A3D1/2020	EPI_ISL_606705	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7A140/2020	EPI_ISL_606716	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7CFCC/2020	EPI_ISL_606727	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7CF17/2020	EPI_ISL_606751	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7A1B9/2020	EPI_ISL_606752	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-A79FED/2020	EPI_ISL_606760	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A79CE6/2020	EPI_ISL_606787	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.153	GR
hCoV-19/England/MILK-A7975E/2020	EPI_ISL_606816	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A79CF5/2020	EPI_ISL_606834	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7CF35/2020	EPI_ISL_606835	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/MILK-A7ACC7/2020	EPI_ISL_606841	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7A052/2020	EPI_ISL_606847	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/MILK-A7A08F/2020	EPI_ISL_606851	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A798F1/2020	EPI_ISL_606852	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7A18C/2020	EPI_ISL_606855	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-A79703/2020	EPI_ISL_606891	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7A535/2020	EPI_ISL_606906	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7A553/2020	EPI_ISL_606907	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6FBD7/2020	EPI_ISL_606951	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/ALDP-A6EADB/2020	EPI_ISL_606952	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6E640/2020	EPI_ISL_606962	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6FB7D/2020	EPI_ISL_606968	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6F14E/2020	EPI_ISL_606970	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6EB50/2020	EPI_ISL_606986	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6E622/2020	EPI_ISL_606991	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6E3A3/2020	EPI_ISL_606995	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6FC10/2020	EPI_ISL_606999	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/MI-UM-10036399786/2020	EPI_ISL_610050	2020-10-12	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036457372/2020	EPI_ISL_610052	2020-10-15	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036345655/2020	EPI_ISL_610054	2020-10-08	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036428041/2020	EPI_ISL_610074	2020-10-13	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036409812/2020	EPI_ISL_610078	2020-10-12	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036396778/2020	EPI_ISL_610084	2020-10-12	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036416305/2020	EPI_ISL_610089	2020-10-13	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/USA/MI-UM-10036448224/2020	EPI_ISL_610101	2020-10-14	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036448245/2020	EPI_ISL_610103	2020-10-14	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036467524/2020	EPI_ISL_610105	2020-10-15	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.186	GR
hCoV-19/Russia/CRIE7158368/2020	EPI_ISL_610243	2020-08-24	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.349	GR
hCoV-19/Russia/CRIE7249896/2020	EPI_ISL_610244	2020-08-25	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.294	GR
hCoV-19/England/ALDP-A85EF0/2020	EPI_ISL_610290	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A8568F/2020	EPI_ISL_610310	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A852B8/2020	EPI_ISL_610311	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A8492D/2020	EPI_ISL_610330	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/ALDP-A84B45/2020	EPI_ISL_610335	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A84C42/2020	EPI_ISL_610352	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A85485/2020	EPI_ISL_610364	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/ALDP-A84978/2020	EPI_ISL_610380	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A85670/2020	EPI_ISL_610385	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A84A1B/2020	EPI_ISL_610404	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/ALDP-A85E78/2020	EPI_ISL_610421	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A850FA/2020	EPI_ISL_610422	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A85ACF/2020	EPI_ISL_610434	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A84D12/2020	EPI_ISL_610496	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A84B72/2020	EPI_ISL_610520	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A8528B/2020	EPI_ISL_610539	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A857E6/2020	EPI_ISL_610564	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A85379/2020	EPI_ISL_610570	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A84D7C/2020	EPI_ISL_610586	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/PHWC-481328/2020	EPI_ISL_611973	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina		NS6_F22stop results in 65.6% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-AA51C4/2020	EPI_ISL_624017	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/Scotland/QEUH-AAE4E0/2020	EPI_ISL_624032	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA1632/2020	EPI_ISL_624035	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA412F/2020	EPI_ISL_624048	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA173F/2020	EPI_ISL_624051	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA14ED/2020	EPI_ISL_624055	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA41F2/2020	EPI_ISL_624062	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-AA1298/2020	EPI_ISL_624082	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA140B/2020	EPI_ISL_624099	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA12F2/2020	EPI_ISL_624103	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-AAEEF1/2020	EPI_ISL_624112	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-AAE4C2/2020	EPI_ISL_624114	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA1368/2020	EPI_ISL_624116	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-AA417A/2020	EPI_ISL_624153	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA079A/2020	EPI_ISL_624160	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-AA3D68/2020	EPI_ISL_624230	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA4BE5/2020	EPI_ISL_624234	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.153	GR
hCoV-19/England/ALDP-AA3B31/2020	EPI_ISL_624236	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA3C10/2020	EPI_ISL_624310	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA3A52/2020	EPI_ISL_624313	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA0FB0/2020	EPI_ISL_624318	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA3DE0/2020	EPI_ISL_624320	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA421D/2020	EPI_ISL_624326	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA472D/2020	EPI_ISL_624346	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA1ACD/2020	EPI_ISL_624384	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA3B40/2020	EPI_ISL_624432	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-AA3C7A/2020	EPI_ISL_624434	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA108F/2020	EPI_ISL_624458	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA42B3/2020	EPI_ISL_624463	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA2868/2020	EPI_ISL_624482	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA3AE9/2020	EPI_ISL_624526	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA3C01/2020	EPI_ISL_624531	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA277A/2020	EPI_ISL_624532	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A95E66/2020	EPI_ISL_624561	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A94F55/2020	EPI_ISL_624565	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A94CE5/2020	EPI_ISL_624567	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A964BE/2020	EPI_ISL_624570	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A94CB8/2020	EPI_ISL_624606	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A96366/2020	EPI_ISL_624610	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A96481/2020	EPI_ISL_624616	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A94113/2020	EPI_ISL_624665	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A963A2/2020	EPI_ISL_624668	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A955BC/2020	EPI_ISL_624679	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A94A36/2020	EPI_ISL_624735	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A94AFA/2020	EPI_ISL_624739	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A94B15/2020	EPI_ISL_624829	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A9625A/2020	EPI_ISL_624833	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A94EA3/2020	EPI_ISL_624836	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A96445/2020	EPI_ISL_624878	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A94B60/2020	EPI_ISL_624882	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A957B6/2020	EPI_ISL_624892	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A94E76/2020	EPI_ISL_624906	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA33DF/2020	EPI_ISL_624932	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA0B25/2020	EPI_ISL_624943	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA0B07/2020	EPI_ISL_624949	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA0B9E/2020	EPI_ISL_624956	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA0D2F/2020	EPI_ISL_624961	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA0B61/2020	EPI_ISL_624964	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA1DB5/2020	EPI_ISL_624968	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-AA5416/2020	EPI_ISL_624972	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA0C8C/2020	EPI_ISL_624977	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA5759/2020	EPI_ISL_624981	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA36B8/2020	EPI_ISL_624982	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Denmark/DCGC-8640/2020	EPI_ISL_626003	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-8732/2020	EPI_ISL_626026	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-8757/2020	EPI_ISL_626037	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-8799/2020	EPI_ISL_626070	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/Denmark/DCGC-8787/2020	EPI_ISL_626073	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/Denmark/DCGC-8883/2020	EPI_ISL_626140	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/Denmark/DCGC-8884/2020	EPI_ISL_626147	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/Denmark/DCGC-8878/2020	EPI_ISL_626157	2020-11-02	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/England/MILK-ABBDF4/2020	EPI_ISL_631000	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ABBE00/2020	EPI_ISL_631013	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AC5DE8/2020	EPI_ISL_631014	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ABBC51/2020	EPI_ISL_631051	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-ABD27B/2020	EPI_ISL_631057	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AC120B/2020	EPI_ISL_631096	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ABB547/2020	EPI_ISL_631100	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/ALDP-ABD220/2020	EPI_ISL_631202	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/CAMC-AAF713/2020	EPI_ISL_631208	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-ABD2C6/2020	EPI_ISL_631212	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-AAF7F5/2020	EPI_ISL_631219	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-AAF704/2020	EPI_ISL_631224	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ABC0FA/2020	EPI_ISL_631238	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AAF92C/2020	EPI_ISL_631245	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ABC124/2020	EPI_ISL_631264	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/CAMC-AAF564/2020	EPI_ISL_631272	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/Germany/NW-HHU-304/2020	EPI_ISL_631307	2020-10-05	Europe / Germany / North Rhine-Westphalia / Düsseldorf	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.1	GR
hCoV-19/Germany/NW-HHU-307/2020	EPI_ISL_631310	2020-10-05	Europe / Germany / North Rhine-Westphalia / Düsseldorf	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Germany/NW-HHU-313/2020	EPI_ISL_631316	2020-10-06	Europe / Germany / North Rhine-Westphalia / Düsseldorf	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.1	GR
hCoV-19/England/ALDP-9E769B/2020	EPI_ISL_638210	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/ALDP-9E7DE1/2020	EPI_ISL_638230	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/ALDP-9E8339/2020	EPI_ISL_638245	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9E8515/2020	EPI_ISL_638252	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9E8919/2020	EPI_ISL_638265	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9E8982/2020	EPI_ISL_638269	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/ALDP-9E8991/2020	EPI_ISL_638270	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/ALDP-9E8A43/2020	EPI_ISL_638274	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9E8A52/2020	EPI_ISL_638275	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/ALDP-9E8A70/2020	EPI_ISL_638277	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/ALDP-9E8ABC/2020	EPI_ISL_638280	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/ALDP-9E8C7A/2020	EPI_ISL_638286	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B6EA4/2020	EPI_ISL_638293	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B6F56/2020	EPI_ISL_638295	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B70AD/2020	EPI_ISL_638301	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B7377/2020	EPI_ISL_638317	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B73B3/2020	EPI_ISL_638318	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B73FF/2020	EPI_ISL_638319	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B7483/2020	EPI_ISL_638321	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B76C9/2020	EPI_ISL_638328	2020-10-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B7702/2020	EPI_ISL_638329	2020-10-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B778A/2020	EPI_ISL_638332	2020-10-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B77A8/2020	EPI_ISL_638333	2020-10-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B7896/2020	EPI_ISL_638337	2020-10-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B78B4/2020	EPI_ISL_638338	2020-10-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B7B9D/2020	EPI_ISL_638364	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B7DA6/2020	EPI_ISL_638374	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.153	GR
hCoV-19/England/CAMB-1B858F/2020	EPI_ISL_638399	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.153	GR
hCoV-19/England/CAMC-9DF62D/2020	EPI_ISL_638415	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9DF6A5/2020	EPI_ISL_638417	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9DF70C/2020	EPI_ISL_638418	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9DF775/2020	EPI_ISL_638422	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.307	GR
hCoV-19/England/CAMC-9DF809/2020	EPI_ISL_638424	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9DF827/2020	EPI_ISL_638425	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9DF845/2020	EPI_ISL_638427	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9DF8FA/2020	EPI_ISL_638435	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9DF924/2020	EPI_ISL_638436	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9DFA5E/2020	EPI_ISL_638438	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9D51EA/2020	EPI_ISL_638454	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-A7DA42/2020	EPI_ISL_638463	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-A7DBA9/2020	EPI_ISL_638468	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-A7DBB8/2020	EPI_ISL_638469	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-A7DD2B/2020	EPI_ISL_638473	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-A7DE46/2020	EPI_ISL_638479	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.434	GR
hCoV-19/England/MILK-A91064/2020	EPI_ISL_638501	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-A9119E/2020	EPI_ISL_638507	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/NORT-1B61139/2020	EPI_ISL_638555	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-1B61193/2020	EPI_ISL_638556	2020-10-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-1B61254/2020	EPI_ISL_638557	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-1B613D9/2020	EPI_ISL_638559	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-2864C8/2020	EPI_ISL_638563	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-28662C/2020	EPI_ISL_638565	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/England/QEUH-9ADF2D/2020	EPI_ISL_638615	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9ADFA5/2020	EPI_ISL_638617	2020-09-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9AE232/2020	EPI_ISL_638630	2020-09-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9AE27E/2020	EPI_ISL_638631	2020-09-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9AE3F3/2020	EPI_ISL_638638	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9F4DE1/2020	EPI_ISL_638644	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9F5023/2020	EPI_ISL_638648	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9F5050/2020	EPI_ISL_638650	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9F50E7/2020	EPI_ISL_638655	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9F520F/2020	EPI_ISL_638659	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9F5427/2020	EPI_ISL_638675	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9F5436/2020	EPI_ISL_638676	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9F5445/2020	EPI_ISL_638677	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A36ADC/2020	EPI_ISL_638694	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A36CE5/2020	EPI_ISL_638707	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A36CF4/2020	EPI_ISL_638708	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A36DA6/2020	EPI_ISL_638715	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A36E3A/2020	EPI_ISL_638719	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A370AC/2020	EPI_ISL_638725	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A370BB/2020	EPI_ISL_638726	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A375E9/2020	EPI_ISL_638728	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A4B148/2020	EPI_ISL_638734	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-A78133/2020	EPI_ISL_638744	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A78A0B/2020	EPI_ISL_638773	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A78A56/2020	EPI_ISL_638775	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A7909F/2020	EPI_ISL_638783	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A79211/2020	EPI_ISL_638789	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.434	GR
hCoV-19/England/QEUH-A79509/2020	EPI_ISL_638808	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A89C10/2020	EPI_ISL_638816	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A89C98/2020	EPI_ISL_638820	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.170	GR
hCoV-19/England/QEUH-A89CE3/2020	EPI_ISL_638822	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.153	GR
hCoV-19/England/QEUH-A89ECF/2020	EPI_ISL_638829	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A8A8EE/2020	EPI_ISL_638858	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A8AB5E/2020	EPI_ISL_638875	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A3681E/2020	EPI_ISL_638928	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A4B430/2020	EPI_ISL_638938	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A7785D/2020	EPI_ISL_638946	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A782C7/2020	EPI_ISL_638968	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/CAMC-B37348/2020	EPI_ISL_645352	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B3D290/2020	EPI_ISL_645393	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B368A4/2020	EPI_ISL_645427	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B368B3/2020	EPI_ISL_645462	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B3E903/2020	EPI_ISL_645503	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/CAMC-B37621/2020	EPI_ISL_645521	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B362A6/2020	EPI_ISL_645522	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B1BBBB/2020	EPI_ISL_645569	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B1D050/2020	EPI_ISL_645573	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-B1B025/2020	EPI_ISL_645587	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B1AF56/2020	EPI_ISL_645624	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B1AFFC/2020	EPI_ISL_645629	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B1BAEB/2020	EPI_ISL_645651	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B1B4CF/2020	EPI_ISL_645808	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				M.3	GR
hCoV-19/England/CAMC-B223B9/2020	EPI_ISL_645826	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B22322/2020	EPI_ISL_645840	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B1F9BD/2020	EPI_ISL_645845	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B1B8D2/2020	EPI_ISL_645867	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B1F7C2/2020	EPI_ISL_645909	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B1B878/2020	EPI_ISL_645929	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B1F5F5/2020	EPI_ISL_645944	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B222AD/2020	EPI_ISL_645945	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/ALDP-B1DBB9/2020	EPI_ISL_645955	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B1F56E/2020	EPI_ISL_645957	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B54BA7/2020	EPI_ISL_658023	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B54D92/2020	EPI_ISL_658042	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-B512A5/2020	EPI_ISL_658048	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-B51409/2020	EPI_ISL_658052	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B5169A/2020	EPI_ISL_658063	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B5A41F/2020	EPI_ISL_658204	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B5461F/2020	EPI_ISL_658212	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B55FC8/2020	EPI_ISL_658216	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B5A831/2020	EPI_ISL_658223	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-B5A619/2020	EPI_ISL_658295	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B51BE6/2020	EPI_ISL_658304	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/CAMC-B51A16/2020	EPI_ISL_658330	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/MILK-B5601F/2020	EPI_ISL_658354	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B411F6/2020	EPI_ISL_658406	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B3F586/2020	EPI_ISL_658420	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B3F2CB/2020	EPI_ISL_658425	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B416F7/2020	EPI_ISL_658442	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B3F225/2020	EPI_ISL_658448	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B4175E/2020	EPI_ISL_658491	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B417B8/2020	EPI_ISL_658503	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B4186A/2020	EPI_ISL_658511	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B3FAE1/2020	EPI_ISL_658531	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B415AF/2020	EPI_ISL_658542	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B418B5/2020	EPI_ISL_658553	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-B41949/2020	EPI_ISL_658555	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B3FAC3/2020	EPI_ISL_658572	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B2F6D1/2020	EPI_ISL_659926	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2D381/2020	EPI_ISL_659935	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B30AC2/2020	EPI_ISL_659945	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2DFAB/2020	EPI_ISL_659956	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2F729/2020	EPI_ISL_659975	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2D688/2020	EPI_ISL_659981	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B2EC67/2020	EPI_ISL_659983	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2CD57/2020	EPI_ISL_659991	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF49CE/2020	EPI_ISL_663117	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AF5408/2020	EPI_ISL_663132	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF5338/2020	EPI_ISL_663134	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF4CF2/2020	EPI_ISL_663138	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF4BD7/2020	EPI_ISL_663149	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AF4AE9/2020	EPI_ISL_663166	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF5198/2020	EPI_ISL_663168	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF530B/2020	EPI_ISL_663175	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF4A52/2020	EPI_ISL_663177	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF53DE/2020	EPI_ISL_663181	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF66E3/2020	EPI_ISL_663186	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF61D3/2020	EPI_ISL_663189	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AF4B5F/2020	EPI_ISL_663202	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/CAMB-1BB452/2020	EPI_ISL_665009	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1BB768/2020	EPI_ISL_665019	2020-11-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/LOND-124F4D7/2020	EPI_ISL_665158	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124F71A/2020	EPI_ISL_665167	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124F862/2020	EPI_ISL_665175	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124FB1E/2020	EPI_ISL_665183	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124FB2D/2020	EPI_ISL_665184	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124FB5A/2020	EPI_ISL_665186	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124FB78/2020	EPI_ISL_665187	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-12503D6/2020	EPI_ISL_665209	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-12504C4/2020	EPI_ISL_665213	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-1250549/2020	EPI_ISL_665215	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-1250585/2020	EPI_ISL_665217	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-1250734/2020	EPI_ISL_665229	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-1250761/2020	EPI_ISL_665231	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/LOND-12507CB/2020	EPI_ISL_665234	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-125093E/2020	EPI_ISL_665240	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Denmark/DCGC-11081/2020	EPI_ISL_670382	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-11226/2020	EPI_ISL_670552	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.153	GR
hCoV-19/Denmark/DCGC-11525/2020	EPI_ISL_670553	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.153	GR
hCoV-19/Denmark/DCGC-11579/2020	EPI_ISL_670554	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.153	GR
hCoV-19/Denmark/DCGC-11678/2020	EPI_ISL_670556	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.153	GR
hCoV-19/Denmark/DCGC-11716/2020	EPI_ISL_670557	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.153	GR
hCoV-19/Denmark/DCGC-11268/2020	EPI_ISL_670803	2020-11-02	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-11289/2020	EPI_ISL_670815	2020-11-02	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-11290/2020	EPI_ISL_670816	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-11390/2020	EPI_ISL_670884	2020-11-02	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-11414/2020	EPI_ISL_670903	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1	G
hCoV-19/Denmark/DCGC-11425/2020	EPI_ISL_670912	2020-11-02	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.170	GR
hCoV-19/Denmark/DCGC-11449/2020	EPI_ISL_670928	2020-11-02	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.170	GR
hCoV-19/Denmark/DCGC-11489/2020	EPI_ISL_670953	2020-11-02	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.229	GR
hCoV-19/England/BIRM-6A268/2020	EPI_ISL_679033	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-6A365/2020	EPI_ISL_679045	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.144	GR
hCoV-19/England/BIRM-6C06C/2020	EPI_ISL_679132	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.307	GR
hCoV-19/England/LOND-1251593/2020	EPI_ISL_679412	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-12515DF/2020	EPI_ISL_679415	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-B39E81/2020	EPI_ISL_679674	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-B3A916/2020	EPI_ISL_679690	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-B3A9CB/2020	EPI_ISL_679698	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-B3AA31/2020	EPI_ISL_679703	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-B3AD38/2020	EPI_ISL_679726	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.434	GR
hCoV-19/England/MILK-B3B46F/2020	EPI_ISL_679759	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-B3B7A2/2020	EPI_ISL_679770	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.153	GR
hCoV-19/England/MILK-B3BBA6/2020	EPI_ISL_679789	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-B3BBD3/2020	EPI_ISL_679792	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/MILK-B3CC39/2020	EPI_ISL_679823	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/NOTT-117366/2020	EPI_ISL_679925	2020-10-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/Wales/PHW04/2020	EPI_ISL_415041	2020-03-07	Europe / United Kingdom / Wales	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Spain/VC-FISABIO-7/2020	EPI_ISL_416486	2020-03-02	Europe / Spain / Comunitat Valenciana / Valencia	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic pipeline			B.1.1	GR
hCoV-19/England/SHEF-BFD18/2020	EPI_ISL_416736	2020-03-09	Europe / United Kingdom / England / South Yorkshire	Human	Original	Throat swab		Nanopore		Stretches of NNNs (2.91% of overall sequence).		B.1.1	GR
hCoV-19/USA/VA-DCLS-0042/2020	EPI_ISL_420023	2020-03-25	North America / USA / Virginia	Human	Original			Illumina MiSeq	Minimap2/ivar			B.1.1	GR
hCoV-19/England/SHEF-C07AD/2020	EPI_ISL_420155	2020-03-27	Europe / United Kingdom / England / South Yorkshire	Human	Original			Nanopore		Stretches of NNNs (1.30% of overall sequence).		B.1.1	GR
hCoV-19/England/SHEF-C02CA/2020	EPI_ISL_420180	2020-03-27	Europe / United Kingdom / England / South Yorkshire	Human	Original			Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C078F/2020	EPI_ISL_420265	2020-03-23	Europe / United Kingdom / England / South Yorkshire	Human	Original	Nose-Throat		Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C05A3/2020	EPI_ISL_420279	2020-03-21	Europe / United Kingdom / England / South Yorkshire	Human	Original	Nose-Throat		Nanopore				B.1.1	GR
hCoV-19/Belgium/QOJ-030751/2020	EPI_ISL_420316	2020-03-07	Europe / Belgium / Dilbeek	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/TG-030757/2020	EPI_ISL_420318	2020-03-07	Europe / Belgium / Arbre	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/030959/2020	EPI_ISL_420320	2020-03-09	Europe / Belgium / Ukkel	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/DNS-0324176/2020	EPI_ISL_420433	2020-03-24	Europe / Belgium / Fontaine-l'Eveque	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/RA-030664/2020	EPI_ISL_420441	2020-03-06	Europe / Belgium / Sint-Genesius-Rode	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/DJ-030452/2020	EPI_ISL_420447	2020-03-04	Europe / Belgium / Dendermonde	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/KN-030756/2020	EPI_ISL_420450	2020-03-07	Europe / Belgium / Sint-Agatha-Berchem	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/HC-030760/2020	EPI_ISL_420451	2020-03-07	Europe / Belgium / Mons	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1.371	GR
hCoV-19/Wales/PHWC-26D49/2020	EPI_ISL_422022	2020-03-30	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-26DD0/2020	EPI_ISL_422031	2020-03-30	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-2649F/2020	EPI_ISL_422032	2020-03-27	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-26A15/2020	EPI_ISL_422036	2020-03-29	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-26C00/2020	EPI_ISL_422103	2020-03-29	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-26C5B/2020	EPI_ISL_422119	2020-03-27	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-26927/2020	EPI_ISL_422166	2020-03-28	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE6571/2020	EPI_ISL_429231	2020-03-24	Europe / Italy / Abruzzo	Human	Original							B.1.1	GR
hCoV-19/Italy/ABR-AMVRC-TE7859/2020	EPI_ISL_429236	2020-03-28	Europe / Italy / Abruzzo	Human	Original							B.1.1	GR
hCoV-19/Sweden/20-07171/2020	EPI_ISL_434666	2020-04-08	Europe / Sweden / Vasterbotten	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Thailand/NIH-1889/2020	EPI_ISL_434697	2020-03-03	Asia / Thailand / Nonthaburi	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 12, Geneious 10.2.4			B.1.1	GR
hCoV-19/USA/VI-CDC-1993/2020	EPI_ISL_436046	2020-04-01	North America / USA / Virgin Islands	Human	Original	Nasopharyngeal swab		Nanopore, Sanger	minimap 2.17, Sequencher 5.4.6			B.1.1	GR
hCoV-19/USA/WI-UW-336/2020	EPI_ISL_436630	2020-03-25	North America / USA / Wisconsin / Milwaukee County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1	GR
hCoV-19/USA/MI-MDHHS-SC20162/2020	EPI_ISL_436803	2020-03-10	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FB42A/2020	EPI_ISL_441422	2020-03-18	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/CAMB-7B923/2020	EPI_ISL_441583	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7D903/2020	EPI_ISL_441668	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7D52D/2020	EPI_ISL_441721	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NOTT-1109B6/2020	EPI_ISL_441881	2020-04-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-1109C5/2020	EPI_ISL_441882	2020-04-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-D0FB1/2020	EPI_ISL_448908	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FB1BA/2020	EPI_ISL_448945	2020-03-24	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E6E8E/2020	EPI_ISL_448985	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Portugal/PT0389b/2020	EPI_ISL_454106	2020-04-18	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0399a/2020	EPI_ISL_454122	2020-04-19	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0399b/2020	EPI_ISL_454123	2020-04-21	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0417/2020	EPI_ISL_454141	2020-03-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0418/2020	EPI_ISL_454142	2020-03-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0624/2020	EPI_ISL_454347	2020-03-26	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Sweden/20-08096/2020	EPI_ISL_454468	2020-03-06	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-08099/2020	EPI_ISL_454470	2020-03-06	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-08123/2020	EPI_ISL_454493	2020-03-09	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Netherlands/NoordHolland_23/2020	EPI_ISL_461213	2020-05-06	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Netherlands/ZuidHolland_126/2020	EPI_ISL_461299	2020-04-24	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B3B73/2020	EPI_ISL_461580	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR3049/2020	EPI_ISL_461637	2020-04-24	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORT-28597F/2020	EPI_ISL_461793	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-120191/2020	EPI_ISL_468266	2020-04-27	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.464	GR
hCoV-19/Switzerland/ZH-ETHZ-120206/2020	EPI_ISL_468279	2020-04-27	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.464	GR
hCoV-19/USA/CA-CZB-1678/2020	EPI_ISL_468618	2020-03-30	North America / USA / California / Contra Costa County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/Canada/BC_16588829/2020	EPI_ISL_468683	2020-04	North America / Canada / British Columbia	Human	Original			Oxford Nanopore	ARTIC protocol			B.1.1	GR
hCoV-19/Spain/PV-IBV-2141/2020	EPI_ISL_468866	2020-04-12	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2148/2020	EPI_ISL_468930	2020-04-12	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2092/2020	EPI_ISL_468934	2020-04-10	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/IB-IBV-h2551/2020	EPI_ISL_468999	2020-03-20	Europe / Spain / Balear Islands / Palma de Mallorca	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Scotland/EDB5733/2020	EPI_ISL_473850	2020-04-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Wales/PHWC-1636CC/2020	EPI_ISL_473981	2020-04-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Israel/CVL-n-7501/2020	EPI_ISL_475012	2020-04-11	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina NextSeq	BWA			B.1.1	GR
hCoV-19/Sweden/20-50362/2020	EPI_ISL_475095	2020-03-16	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/England/PORT-2CFEB6/2020	EPI_ISL_475244	2020-05-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C9470/2020	EPI_ISL_475420	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Sweden/20-07382/2020	EPI_ISL_475540	2020-04-15	Europe / Sweden / Kalmar	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.438	GR
hCoV-19/Sweden/20-50237/2020	EPI_ISL_475560	2020-03-10	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Austria/CeMM0187/2020	EPI_ISL_475770	2020-03-12	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0227/2020	EPI_ISL_475771	2020-03-18	Europe / Austria / Vienna	Human	Original	Tracheal secretion		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0401/2020	EPI_ISL_475836	2020-02-28	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0481/2020	EPI_ISL_475884	2020-03-27	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/England/CAMB-1AC4AF/2020	EPI_ISL_489428	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AC5AC/2020	EPI_ISL_489431	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AC5E8/2020	EPI_ISL_489432	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AD699/2020	EPI_ISL_489435	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AC463/2020	EPI_ISL_489438	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AC58E/2020	EPI_ISL_489444	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1ACD4A/2020	EPI_ISL_489467	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AC5CA/2020	EPI_ISL_489481	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AD417/2020	EPI_ISL_489487	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AC560/2020	EPI_ISL_489498	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AD67B/2020	EPI_ISL_489517	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AC9EC/2020	EPI_ISL_489552	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AC612/2020	EPI_ISL_489559	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1ACF80/2020	EPI_ISL_489575	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/GCVR-170F1C/2020	EPI_ISL_489602	2020-03-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BIRM-61674/2020	EPI_ISL_493449	2020-04-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-298821/2020	EPI_ISL_493468	2020-04-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-2993E3/2020	EPI_ISL_493487	2020-04-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29E366/2020	EPI_ISL_493512	2020-05-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29E5AC/2020	EPI_ISL_493519	2020-05-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29E7A6/2020	EPI_ISL_493527	2020-04-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29EBC8/2020	EPI_ISL_493535	2020-05-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29EE56/2020	EPI_ISL_493540	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-112820/2020	EPI_ISL_493550	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C17D9/2020	EPI_ISL_493669	2020-07-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C43A5/2020	EPI_ISL_493678	2020-05-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C5CB8/2020	EPI_ISL_493683	2020-07-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C6051/2020	EPI_ISL_493684	2020-07-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CA275/2020	EPI_ISL_493693	2020-07-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CA9F8/2020	EPI_ISL_493696	2020-06-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CB6F0/2020	EPI_ISL_493702	2020-06-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CD069/2020	EPI_ISL_493709	2020-06-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CDC83/2020	EPI_ISL_493716	2020-07-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CF5FF/2020	EPI_ISL_493724	2020-07-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D285A/2020	EPI_ISL_493735	2020-07-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/PHWC-166359/2020	EPI_ISL_493985	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1663A4/2020	EPI_ISL_493990	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1663C2/2020	EPI_ISL_493992	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1663D1/2020	EPI_ISL_493993	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/India/GJ-GBRC290b/2020	EPI_ISL_495028	2020-06-15	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12	Spike_Q493stop results in 61.4% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/WSFT-25C1598/2020	EPI_ISL_495084	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/WSFT-25C1659/2020	EPI_ISL_495095	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/India/TG-CCMB-L1657/2020	EPI_ISL_495163	2020-05-29	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-L1892/2020	EPI_ISL_495168	2020-06-03	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.326	GR
hCoV-19/India/TG-CCMB-L1930/2020	EPI_ISL_495170	2020-06-04	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-L1959/2020	EPI_ISL_495174	2020-06-04	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-L1963/2020	EPI_ISL_495175	2020-06-04	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-L1967/2020	EPI_ISL_495177	2020-06-04	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M151/2020	EPI_ISL_495186	2020-06-06	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M170/2020	EPI_ISL_495188	2020-06-06	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M25/2020	EPI_ISL_495196	2020-06-04	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M357/2020	EPI_ISL_495199	2020-06-08	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/Australia/NSW2013/2020	EPI_ISL_500599	2020-03-22	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.1	GR
hCoV-19/Norway/2852/2020	EPI_ISL_500775	2020-07-03	Europe / Norway	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq; ARTIC v.3	Assembly by reference based mapping using Tanoti			B.1.1.306	GR
hCoV-19/USA/IL-UW-979/2020	EPI_ISL_509804	2020-07-19	North America / USA / Illinois / Winnebago County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1.228	GR
hCoV-19/Germany/BY-UHR-2ZK/2020	EPI_ISL_513299	2020-03-20	Europe / Germany / Bavaria	Human	Viral culture			Illumina	DRAGEN RNA Pathogen Detection v.: 3.5.14			B.1.1	GR
hCoV-19/Germany/BY-UHR-9ZK/2020	EPI_ISL_513306	2020-03-29	Europe / Germany / Bavaria	Human	Viral culture			Illumina	DRAGEN RNA Pathogen Detection v.: 3.5.14			B.1.1	GR
hCoV-19/United Arab Emirates/L2005036083/2020	EPI_ISL_520675	2020-05-15	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq		Gap of 8 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/United Arab Emirates/L2005036714/2020	EPI_ISL_520676	2020-05-30	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Australia/NSW2497/2020	EPI_ISL_527026	2020-06-29	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.1	GR
hCoV-19/USA/PR-B2DR/2020	EPI_ISL_527382	2020-08-04	North America / USA / Puerto Rico / Ponce	Human	Original	Nasopharyngeal		Ion Torrent	IRMAreport			B.1.1	GR
hCoV-19/USA/PR-B2K5/2020	EPI_ISL_527384	2020-08-04	North America / USA / Puerto Rico / Ponce	Human	Original	Nasopharyngeal		Ion Torrent	IRMAreport			B.1.1	GR
hCoV-19/USA/GA-CDC-6435/2020	EPI_ISL_527664	2020-07-29	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bcftools 1.9,bowtie2 2.3.3.1			B.1.1.186	GR
hCoV-19/Ecuador/USFQ-193/2020	EPI_ISL_527809	2020-08-04	South America / Ecuador / Bolivar / Guaranda	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic Network			B.1.1	GR
hCoV-19/Ecuador/USFQ-201/2020	EPI_ISL_527815	2020-08-20	South America / Ecuador / Esmeraldas / Esmeraldas	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic Network			B.1.1	GR
hCoV-19/Ecuador/USFQ-203/2020	EPI_ISL_527816	2020-08-20	South America / Ecuador / Esmeraldas / Esmeraldas	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic Network			B.1.1	GR
hCoV-19/Ecuador/USFQ-206/2020	EPI_ISL_527818	2020-08-14	South America / Ecuador / Guayas / Guayaquil	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic Network			B.1.1	GR
hCoV-19/Ecuador/USFQ-207/2020	EPI_ISL_527819	2020-04-07	South America / Ecuador / Guayas / Guayaquil	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic Network			B.1.1	GR
hCoV-19/Nigeria/ED1010-CV215/2020	EPI_ISL_527879	2020-05-04	Africa / Nigeria / Edo	Human	Original			Illumina MiSeq	viral-ngs			B.1.1	GR
hCoV-19/Nigeria/ED46-CV165/2020	EPI_ISL_527884	2020-04-24	Africa / Nigeria / Edo	Human	Original			Illumina MiSeq	viral-ngs			B.1.1	GR
hCoV-19/Switzerland/BL-UHB-42185206/2020	EPI_ISL_527984	2020-03-10	Europe / Switzerland / Basel-Land	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE77497/2020	EPI_ISL_529006	2020-06-09	Europe / Italy / Abruzzo	Human	Original			ARTIC protocol+Illumina MiniSeq				B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE79445/2020	EPI_ISL_529007	2020-06-13	Europe / Italy / Abruzzo	Human	Original			ARTIC protocol+Illumina MiniSeq				B.1.1	GR
hCoV-19/England/QEUH-881BC2/2020	EPI_ISL_532675	2020-07-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-884804/2020	EPI_ISL_532737	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-7B078B/2020	EPI_ISL_532876	2020-07-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/QEUH-7B8F21/2020	EPI_ISL_532954	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-768694/2020	EPI_ISL_532966	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/Sweden/20-52284/2020	EPI_ISL_534234	2020-07-02	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Russia/CRIE4924360/2020	EPI_ISL_534337	2020-07-15	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina MiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.294	GR
hCoV-19/Russia/CRIE5027243/2020	EPI_ISL_534340	2020-07-16	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina MiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.294	GR
hCoV-19/Russia/CRIE166582/2020	EPI_ISL_534349	2020-03-31	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.294	GR
hCoV-19/Scotland/QEUH-969FF0/2020	EPI_ISL_534390	2020-08-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E8A5/2020	EPI_ISL_534456	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EA54/2020	EPI_ISL_534459	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E553/2020	EPI_ISL_534461	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EA63/2020	EPI_ISL_534462	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EBE8/2020	EPI_ISL_534465	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E8B4/2020	EPI_ISL_534468	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E1C8/2020	EPI_ISL_534469	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E975/2020	EPI_ISL_534470	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EB15/2020	EPI_ISL_534472	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EB8E/2020	EPI_ISL_534473	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E984/2020	EPI_ISL_534474	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E26B/2020	EPI_ISL_534476	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96F024/2020	EPI_ISL_534478	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EF28/2020	EPI_ISL_534480	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E32C/2020	EPI_ISL_534481	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E939/2020	EPI_ISL_534482	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E957/2020	EPI_ISL_534488	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EBBB/2020	EPI_ISL_534491	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E298/2020	EPI_ISL_534495	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-96E91B/2020	EPI_ISL_534503	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E1B9/2020	EPI_ISL_534505	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E8E1/2020	EPI_ISL_534506	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E1F5/2020	EPI_ISL_534507	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E948/2020	EPI_ISL_534508	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EB24/2020	EPI_ISL_534509	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EB51/2020	EPI_ISL_534511	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D93A/2020	EPI_ISL_534515	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D448/2020	EPI_ISL_534516	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CEC3/2020	EPI_ISL_534517	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D0CC/2020	EPI_ISL_534520	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D949/2020	EPI_ISL_534521	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D967/2020	EPI_ISL_534522	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CEF0/2020	EPI_ISL_534524	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CF48/2020	EPI_ISL_534526	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CF1B/2020	EPI_ISL_534527	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CCD8/2020	EPI_ISL_534528	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CD7B/2020	EPI_ISL_534529	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D78B/2020	EPI_ISL_534530	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CCE7/2020	EPI_ISL_534531	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D536/2020	EPI_ISL_534534	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D484/2020	EPI_ISL_534536	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D6E8/2020	EPI_ISL_534537	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D91C/2020	EPI_ISL_534538	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D642/2020	EPI_ISL_534541	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D712/2020	EPI_ISL_534542	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96DBBC/2020	EPI_ISL_534544	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D42A/2020	EPI_ISL_534545	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D5BE/2020	EPI_ISL_534548	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D475/2020	EPI_ISL_534551	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CD6C/2020	EPI_ISL_534553	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D493/2020	EPI_ISL_534554	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D114/2020	EPI_ISL_534555	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D615/2020	EPI_ISL_534556	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D74F/2020	EPI_ISL_534557	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CF75/2020	EPI_ISL_534560	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D8E2/2020	EPI_ISL_534562	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D68E/2020	EPI_ISL_534563	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96C8A7/2020	EPI_ISL_534564	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D81F/2020	EPI_ISL_534565	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D69D/2020	EPI_ISL_534567	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D0AE/2020	EPI_ISL_534568	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CD8A/2020	EPI_ISL_534573	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CFEE/2020	EPI_ISL_534575	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CD4E/2020	EPI_ISL_534576	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CEB4/2020	EPI_ISL_534577	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D800/2020	EPI_ISL_534578	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D92B/2020	EPI_ISL_534579	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D105/2020	EPI_ISL_534580	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D958/2020	EPI_ISL_534581	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CDF3/2020	EPI_ISL_534582	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D457/2020	EPI_ISL_534585	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CDD5/2020	EPI_ISL_534586	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CE0F/2020	EPI_ISL_534587	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CDA8/2020	EPI_ISL_534590	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D879/2020	EPI_ISL_534591	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D7F4/2020	EPI_ISL_534596	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D721/2020	EPI_ISL_534597	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D85B/2020	EPI_ISL_534598	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96DE1D/2020	EPI_ISL_534599	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CF0C/2020	EPI_ISL_534602	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D75E/2020	EPI_ISL_534605	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D730/2020	EPI_ISL_534606	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D509/2020	EPI_ISL_534607	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D4EE/2020	EPI_ISL_534609	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D76D/2020	EPI_ISL_534610	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D527/2020	EPI_ISL_534611	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D5CD/2020	EPI_ISL_534613	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D0F9/2020	EPI_ISL_534614	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CF57/2020	EPI_ISL_534616	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D7B8/2020	EPI_ISL_534619	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D518/2020	EPI_ISL_534620	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CF2A/2020	EPI_ISL_534623	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CDC6/2020	EPI_ISL_534624	2020-08-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D4FD/2020	EPI_ISL_534625	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D6BB/2020	EPI_ISL_534627	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D67F/2020	EPI_ISL_534628	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CD20/2020	EPI_ISL_534629	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D572/2020	EPI_ISL_534630	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96C898/2020	EPI_ISL_534631	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-96CC05/2020	EPI_ISL_534633	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CF66/2020	EPI_ISL_534638	2020-08-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D0BD/2020	EPI_ISL_534640	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D6F7/2020	EPI_ISL_534641	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CF39/2020	EPI_ISL_534642	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B741/2020	EPI_ISL_534648	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B3C5/2020	EPI_ISL_534656	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B547/2020	EPI_ISL_534657	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B495/2020	EPI_ISL_534659	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B51A/2020	EPI_ISL_534663	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B0EC/2020	EPI_ISL_534668	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96AAD0/2020	EPI_ISL_534672	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96BF49/2020	EPI_ISL_534673	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96AAC1/2020	EPI_ISL_534674	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B76F/2020	EPI_ISL_534675	2020-08-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B6DB/2020	EPI_ISL_534677	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B9A5/2020	EPI_ISL_534681	2020-08-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B538/2020	EPI_ISL_534690	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/203690348/2020	EPI_ISL_534723	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/203690351/2020	EPI_ISL_534724	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/203690354/2020	EPI_ISL_534725	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/203690358/2020	EPI_ISL_534726	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/203690360/2020	EPI_ISL_534727	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/203690361/2020	EPI_ISL_534728	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/203690368/2020	EPI_ISL_534729	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/OXON-B2F5B/2020	EPI_ISL_534829	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B3075/2020	EPI_ISL_534835	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B3CAE/2020	EPI_ISL_534909	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B46FA/2020	EPI_ISL_534967	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B47CA/2020	EPI_ISL_534973	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B4A58/2020	EPI_ISL_534988	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B4AC1/2020	EPI_ISL_534993	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Sweden/20-52355/2020	EPI_ISL_548256	2020-07-07	Europe / Sweden / Varmland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Gap of 6 nucleotides when compared to the reference sequence.	info	AN.1	GR
hCoV-19/USA/CA-CZB-3351/2020	EPI_ISL_548273	2020-07-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-3332/2020	EPI_ISL_548276	2020-07-10	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-3352/2020	EPI_ISL_548285	2020-07-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-3350/2020	EPI_ISL_548298	2020-07-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-3338/2020	EPI_ISL_548300	2020-07-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.228	GR
hCoV-19/USA/CA-CZB-3353/2020	EPI_ISL_548309	2020-07-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-3354/2020	EPI_ISL_548315	2020-07-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/Canada/ON-PHL-20-01319/2020	EPI_ISL_548922	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/United Arab Emirates/DU-A-S2-3_S2/2020	EPI_ISL_548967	2020-04-23	Asia / United Arab Emirates / Dubai	Human	Original	Oropharyngeal swab		Illumina MiSeq	Abiomix Amplicon analysis			B.1.1.366	O
hCoV-19/England/MILK-992B81/2020	EPI_ISL_552004	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-991593/2020	EPI_ISL_552008	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-993027/2020	EPI_ISL_552038	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-991636/2020	EPI_ISL_552065	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9929A5/2020	EPI_ISL_552077	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides found at refpos 12630.	info	B.1.1	GR
hCoV-19/England/MILK-9931F7/2020	EPI_ISL_552084	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides found at refpos 12630.	info	B.1.1	GR
hCoV-19/England/MILK-993388/2020	EPI_ISL_552089	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9926DB/2020	EPI_ISL_552110	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99350A/2020	EPI_ISL_552140	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-991584/2020	EPI_ISL_552166	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99335B/2020	EPI_ISL_552175	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9926CC/2020	EPI_ISL_552176	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9949B2/2020	EPI_ISL_552195	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-991CBC/2020	EPI_ISL_552255	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99482E/2020	EPI_ISL_552291	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-991CAD/2020	EPI_ISL_552327	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-993D7B/2020	EPI_ISL_552344	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-994FA1/2020	EPI_ISL_552402	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-994AFB/2020	EPI_ISL_552419	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-994FDE/2020	EPI_ISL_552426	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides found at refpos 12630.	info	B.1.1	GR
hCoV-19/England/MILK-994E1D/2020	EPI_ISL_552442	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-993A47/2020	EPI_ISL_552443	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9751FB/2020	EPI_ISL_552445	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-975216/2020	EPI_ISL_552499	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-982B93/2020	EPI_ISL_552540	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-97529E/2020	EPI_ISL_552557	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-97528F/2020	EPI_ISL_552558	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-982A2D/2020	EPI_ISL_552639	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-982832/2020	EPI_ISL_552642	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-982B84/2020	EPI_ISL_552669	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-974E9B/2020	EPI_ISL_552675	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-982823/2020	EPI_ISL_552681	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-981CEC/2020	EPI_ISL_552723	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-981FE3/2020	EPI_ISL_552726	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-981D8F/2020	EPI_ISL_552785	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9768F5/2020	EPI_ISL_552795	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-91D650/2020	EPI_ISL_552839	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-91D68D/2020	EPI_ISL_552894	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-939CC5/2020	EPI_ISL_552928	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-93D10E/2020	EPI_ISL_552939	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-931FC4/2020	EPI_ISL_552951	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-939ECF/2020	EPI_ISL_552957	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-932084/2020	EPI_ISL_552958	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-933BBF/2020	EPI_ISL_552964	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-933A76/2020	EPI_ISL_552988	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/202660056/2020	EPI_ISL_566057	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/Russia/MOW-RII-MH251S/2020	EPI_ISL_566079	2020-06-19	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/MOW-RII-MH252S/2020	EPI_ISL_566080	2020-06-25	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/MOW-RII-MH256S/2020	EPI_ISL_566083	2020-06-18	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.294	GR
hCoV-19/England/ALDP-9CCDA6/2020	EPI_ISL_566119	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CCF37/2020	EPI_ISL_566145	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CDCA8/2020	EPI_ISL_566155	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CDA26/2020	EPI_ISL_566159	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CD16D/2020	EPI_ISL_566166	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CDD5A/2020	EPI_ISL_566168	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CDD78/2020	EPI_ISL_566171	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CD18B/2020	EPI_ISL_566191	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CD437/2020	EPI_ISL_566197	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CDE57/2020	EPI_ISL_566203	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CDE2A/2020	EPI_ISL_566218	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CD200/2020	EPI_ISL_566222	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CD8D1/2020	EPI_ISL_566225	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CDB8D/2020	EPI_ISL_566227	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CD6B9/2020	EPI_ISL_566229	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9CDE48/2020	EPI_ISL_566231	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CD1C7/2020	EPI_ISL_566257	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CD868/2020	EPI_ISL_566259	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CD428/2020	EPI_ISL_566262	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CD0D9/2020	EPI_ISL_566269	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CD1F4/2020	EPI_ISL_566277	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CD974/2020	EPI_ISL_566298	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9CD14F/2020	EPI_ISL_566318	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CCEA3/2020	EPI_ISL_566322	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CDBAB/2020	EPI_ISL_566329	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CDDA5/2020	EPI_ISL_566334	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CD1A9/2020	EPI_ISL_566347	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CD983/2020	EPI_ISL_566352	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9CD886/2020	EPI_ISL_566367	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CD6E6/2020	EPI_ISL_566374	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CDB32/2020	EPI_ISL_566381	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CD877/2020	EPI_ISL_566388	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CDCE4/2020	EPI_ISL_566392	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C2308/2020	EPI_ISL_566431	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9C1E71/2020	EPI_ISL_566451	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C2353/2020	EPI_ISL_566465	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C2890/2020	EPI_ISL_566468	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/MILK-9C2CA3/2020	EPI_ISL_566477	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C2CEF/2020	EPI_ISL_566496	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/MILK-9C2CD0/2020	EPI_ISL_566522	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Wales/MILK-9C26C3/2020	EPI_ISL_566553	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C2C2B/2020	EPI_ISL_566557	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C2344/2020	EPI_ISL_566573	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C27DF/2020	EPI_ISL_566583	2020-09-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-9B1D0E/2020	EPI_ISL_566586	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C1E08/2020	EPI_ISL_566595	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-9C2845/2020	EPI_ISL_566600	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C2E52/2020	EPI_ISL_566601	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C2DFB/2020	EPI_ISL_566643	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9C21B3/2020	EPI_ISL_566644	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C1FF6/2020	EPI_ISL_566656	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C31EF/2020	EPI_ISL_566679	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-9C3D18/2020	EPI_ISL_566685	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9C453D/2020	EPI_ISL_566699	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/MILK-9C3835/2020	EPI_ISL_566704	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C39F6/2020	EPI_ISL_566731	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C3C39/2020	EPI_ISL_566749	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9C32A0/2020	EPI_ISL_566754	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9C3E8E/2020	EPI_ISL_566765	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C3D63/2020	EPI_ISL_566809	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9C39BA/2020	EPI_ISL_566833	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C3ED9/2020	EPI_ISL_566839	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C30C4/2020	EPI_ISL_566871	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C3DDC/2020	EPI_ISL_566879	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C4245/2020	EPI_ISL_566892	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9C306A/2020	EPI_ISL_566907	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C3DFA/2020	EPI_ISL_566923	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9C3FF4/2020	EPI_ISL_566924	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C3B4B/2020	EPI_ISL_566960	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C311C/2020	EPI_ISL_566975	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C4430/2020	EPI_ISL_566993	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BDC23/2020	EPI_ISL_568001	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9BED89/2020	EPI_ISL_568004	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BD9C2/2020	EPI_ISL_568019	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BE053/2020	EPI_ISL_568041	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BDF75/2020	EPI_ISL_568059	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BE7C7/2020	EPI_ISL_568063	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BDED2/2020	EPI_ISL_568064	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BEC04/2020	EPI_ISL_568085	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BE7D6/2020	EPI_ISL_568092	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BE730/2020	EPI_ISL_568111	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BDE1E/2020	EPI_ISL_568132	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9BDD11/2020	EPI_ISL_568135	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9BE7A9/2020	EPI_ISL_568138	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BDA74/2020	EPI_ISL_568147	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BE976/2020	EPI_ISL_568165	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BE6E8/2020	EPI_ISL_568173	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BC8A8/2020	EPI_ISL_568183	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BECF5/2020	EPI_ISL_568185	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9BE703/2020	EPI_ISL_568186	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BDD7B/2020	EPI_ISL_568196	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9BC76F/2020	EPI_ISL_568198	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BC90F/2020	EPI_ISL_568207	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9BC77E/2020	EPI_ISL_568219	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9B8912/2020	EPI_ISL_568248	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9B8718/2020	EPI_ISL_568277	2020-09-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9B9E5E/2020	EPI_ISL_568282	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-990673/2020	EPI_ISL_568292	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-98FE33/2020	EPI_ISL_568297	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-98FA7B/2020	EPI_ISL_568308	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-998DB2/2020	EPI_ISL_568310	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-98FAD5/2020	EPI_ISL_568311	2020-08-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-998B7C/2020	EPI_ISL_568313	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-998D0D/2020	EPI_ISL_568319	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-98F598/2020	EPI_ISL_568322	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-98FCB1/2020	EPI_ISL_568328	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-98FF03/2020	EPI_ISL_568330	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-998A7F/2020	EPI_ISL_568331	2020-08-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-99042E/2020	EPI_ISL_568332	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-98FF12/2020	EPI_ISL_568336	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9983A1/2020	EPI_ISL_568337	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-98F756/2020	EPI_ISL_568341	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-998D58/2020	EPI_ISL_568347	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-998A8E/2020	EPI_ISL_568352	2020-08-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-998347/2020	EPI_ISL_568353	2020-08-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-98F765/2020	EPI_ISL_568358	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9A473D/2020	EPI_ISL_568371	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/CAMC-9914C3/2020	EPI_ISL_568385	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/MILK-993C8D/2020	EPI_ISL_568386	2020-08-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-96F6B9/2020	EPI_ISL_568404	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FB7E/2020	EPI_ISL_568406	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96F69B/2020	EPI_ISL_568408	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FEEE/2020	EPI_ISL_568411	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FE66/2020	EPI_ISL_568413	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FD78/2020	EPI_ISL_568416	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FBC9/2020	EPI_ISL_568417	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96F6AA/2020	EPI_ISL_568418	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96F9FC/2020	EPI_ISL_568424	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/Scotland/QEUH-96FB05/2020	EPI_ISL_568426	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FE48/2020	EPI_ISL_568427	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FC99/2020	EPI_ISL_568429	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FF45/2020	EPI_ISL_568430	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-98F02E/2020	EPI_ISL_568432	2020-08-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-98EFC8/2020	EPI_ISL_568433	2020-08-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/CAMC-9907BC/2020	EPI_ISL_568436	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-98F5F2/2020	EPI_ISL_568439	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-98F352/2020	EPI_ISL_568448	2020-08-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-98F38F/2020	EPI_ISL_568449	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-98EE61/2020	EPI_ISL_568450	2020-08-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-98EE25/2020	EPI_ISL_568451	2020-08-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/CAMC-99093E/2020	EPI_ISL_568453	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/CAMC-990FF0/2020	EPI_ISL_568454	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/CAMC-990FE1/2020	EPI_ISL_568458	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/CAMC-990AC2/2020	EPI_ISL_568461	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-98F39E/2020	EPI_ISL_568463	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Brazil/PE-FIOCRUZ-IAM1309/2020	EPI_ISL_572386	2020-05-10	South America / Brazil / Pernambuco / Ipojuca	Human	Original			Illumina MiSeq	Bowtie2 2.2.6/bedtools v2.25.0			B.1.1	GR
hCoV-19/England/CAMC-9C1837/2020	EPI_ISL_573206	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/CAMC-9C1846/2020	EPI_ISL_573207	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/CAMC-9C18A0/2020	EPI_ISL_573208	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/CAMC-9C19AD/2020	EPI_ISL_573211	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/CAMC-9C1CC2/2020	EPI_ISL_573228	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/CAMC-9C1DDE/2020	EPI_ISL_573235	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/LIVE-1D6DA1/2020	EPI_ISL_573246	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.307	GR
hCoV-19/England/MILK-9C4685/2020	EPI_ISL_573253	2020-09-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9C4764/2020	EPI_ISL_573255	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9C47FB/2020	EPI_ISL_573257	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9C72F7/2020	EPI_ISL_573295	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9C734F/2020	EPI_ISL_573298	2020-09-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9C735E/2020	EPI_ISL_573299	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.294	GR
hCoV-19/England/MILK-9C737C/2020	EPI_ISL_573301	2020-09-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9C738B/2020	EPI_ISL_573302	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9C745B/2020	EPI_ISL_573306	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9C746A/2020	EPI_ISL_573307	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-29C3E0/2020	EPI_ISL_573357	2020-07-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-2A45C1/2020	EPI_ISL_573376	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-2A4716/2020	EPI_ISL_573381	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-2A4831/2020	EPI_ISL_573383	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-2A488C/2020	EPI_ISL_573386	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-2A489B/2020	EPI_ISL_573387	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-2A497A/2020	EPI_ISL_573391	2020-09-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-2A4B83/2020	EPI_ISL_573398	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-2A4DF6/2020	EPI_ISL_573408	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-113713/2020	EPI_ISL_573422	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NOTT-1137C8/2020	EPI_ISL_573430	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NOTT-113977/2020	EPI_ISL_573447	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NOTT-113A74/2020	EPI_ISL_573452	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NOTT-113B9F/2020	EPI_ISL_573463	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9AEC8F/2020	EPI_ISL_573491	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9AED6E/2020	EPI_ISL_573500	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9AEEF2/2020	EPI_ISL_573513	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9AEF2C/2020	EPI_ISL_573514	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9AEF3B/2020	EPI_ISL_573515	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9AEF4A/2020	EPI_ISL_573516	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9AEF86/2020	EPI_ISL_573519	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9AEFC2/2020	EPI_ISL_573522	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9AEFFF/2020	EPI_ISL_573525	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9B3AD8/2020	EPI_ISL_573528	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9B3B20/2020	EPI_ISL_573532	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.307	GR
hCoV-19/England/QEUH-9B3B8A/2020	EPI_ISL_573535	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9B3BA8/2020	EPI_ISL_573537	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9B3CB4/2020	EPI_ISL_573544	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.307	GR
hCoV-19/England/QEUH-9B3E45/2020	EPI_ISL_573552	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.307	GR
hCoV-19/England/QEUH-9B9F5B/2020	EPI_ISL_573567	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/QEUH-9BA048/2020	EPI_ISL_573572	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/QEUH-9BA066/2020	EPI_ISL_573573	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/QEUH-9BA093/2020	EPI_ISL_573576	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9BA242/2020	EPI_ISL_573586	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9BA725/2020	EPI_ISL_573598	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/SHEF-C531D/2020	EPI_ISL_573701	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C5562/2020	EPI_ISL_573702	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C5CC7/2020	EPI_ISL_573705	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C7445/2020	EPI_ISL_573710	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.307	GR
hCoV-19/England/SHEF-C7DC2/2020	EPI_ISL_573714	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C8972/2020	EPI_ISL_573715	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CBE61/2020	EPI_ISL_573731	2020-09-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.307	GR
hCoV-19/England/SHEF-CF0A3/2020	EPI_ISL_573743	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CF3AA/2020	EPI_ISL_573745	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9AF064/2020	EPI_ISL_573805	2020-09-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9BA6CE/2020	EPI_ISL_573824	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/QEUH-9BAFF0/2020	EPI_ISL_573855	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9D1A89/2020	EPI_ISL_573861	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/MILK-9C73E5/2020	EPI_ISL_573872	2020-09-08	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Wales/PHWC-16B749/2020	EPI_ISL_573895	2020-09-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16B819/2020	EPI_ISL_573907	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16B8BF/2020	EPI_ISL_573913	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16B907/2020	EPI_ISL_573917	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16B9E9/2020	EPI_ISL_573927	2020-09-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16BF50/2020	EPI_ISL_573992	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16F824/2020	EPI_ISL_586025	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16F87F/2020	EPI_ISL_586029	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47CF68/2020	EPI_ISL_586075	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47CFD1/2020	EPI_ISL_586082	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47D1AD/2020	EPI_ISL_586107	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47D1F8/2020	EPI_ISL_586111	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47D231/2020	EPI_ISL_586115	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47D26E/2020	EPI_ISL_586118	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47D4E0/2020	EPI_ISL_586153	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47D79C/2020	EPI_ISL_586190	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47D7AB/2020	EPI_ISL_586191	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47D91E/2020	EPI_ISL_586209	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47DA75/2020	EPI_ISL_586231	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/USA/AK-PHL647/2020	EPI_ISL_586250	2020-06-26	North America / USA / Alaska / Anchorage-Mat Su	Human	Original	Upper Respiratory		Illumina MiSeq				B.1.1.228	GR
hCoV-19/USA/AK-PHL648/2020	EPI_ISL_586251	2020-06-26	North America / USA / Alaska / Anchorage-Mat Su	Human	Original	Upper Respiratory		Illumina MiSeq				B.1.1.228	GR
hCoV-19/Canada/ON-S1283/2020	EPI_ISL_586332	2020-04-28	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.1	GR
hCoV-19/Canada/ON-S1286/2020	EPI_ISL_586334	2020-04-15	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.1	GR
hCoV-19/Canada/ON-S750/2020	EPI_ISL_586437	2020-04-10	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Canada/ON-S855/2020	EPI_ISL_586460	2020-04-11	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Canada/ON-S889/2020	EPI_ISL_586471	2020-04-12	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/England/ALDP-A2FD64/2020	EPI_ISL_586940	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2EA9B/2020	EPI_ISL_586942	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2F2DE/2020	EPI_ISL_586946	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2FD46/2020	EPI_ISL_586949	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2E9BC/2020	EPI_ISL_586950	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2EA13/2020	EPI_ISL_586956	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2EA5F/2020	EPI_ISL_586961	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2F6F0/2020	EPI_ISL_586975	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2E9E9/2020	EPI_ISL_586980	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2F186/2020	EPI_ISL_586983	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2EAD7/2020	EPI_ISL_586997	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FD182/2020	EPI_ISL_587817	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FD1CE/2020	EPI_ISL_587821	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FCD8F/2020	EPI_ISL_587827	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9FC8CA/2020	EPI_ISL_587840	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FD53B/2020	EPI_ISL_587843	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9FDEB8/2020	EPI_ISL_587875	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FCB85/2020	EPI_ISL_587876	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9FDB48/2020	EPI_ISL_587897	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FD559/2020	EPI_ISL_587901	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FDF00/2020	EPI_ISL_587905	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FCF3E/2020	EPI_ISL_587906	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9FCD9E/2020	EPI_ISL_587908	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FCAF1/2020	EPI_ISL_587910	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FDF2E/2020	EPI_ISL_587916	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FC8E8/2020	EPI_ISL_587920	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FD173/2020	EPI_ISL_587921	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FCA4C/2020	EPI_ISL_587927	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FD085/2020	EPI_ISL_587936	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FDF88/2020	EPI_ISL_587946	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FD5C2/2020	EPI_ISL_587953	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9FDBEE/2020	EPI_ISL_587954	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FD999/2020	EPI_ISL_587970	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9FD4A7/2020	EPI_ISL_587971	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9FE01B/2020	EPI_ISL_587978	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Norway/3897/2020	EPI_ISL_591014	2020-09-30	Europe / Norway / Trondelag	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.170	GR
hCoV-19/Canada/ON-S754/2020	EPI_ISL_591159	2020-04-10	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Canada/ON-S737/2020	EPI_ISL_591210	2020-04-09	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1.485	GR
hCoV-19/Canada/ON-S753/2020	EPI_ISL_591216	2020-04-10	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Canada/ON-S776/2020	EPI_ISL_591224	2020-04-10	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Canada/ON-S778/2020	EPI_ISL_591225	2020-04-10	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Canada/ON-S850/2020	EPI_ISL_591247	2020-04-11	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Canada/ON-S883/2020	EPI_ISL_591254	2020-04-12	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Canada/ON-S910/2020	EPI_ISL_591259	2020-04-13	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Japan/IC-0029/2020	EPI_ISL_591373	2020-05-26	Asia / Japan	Human	Original		COVID-19 positive case who entered from Canada.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Japan/IC-0039/2020	EPI_ISL_591381	2020-05-28	Asia / Japan	Human	Original		COVID-19 positive case who entered from Pakistan.	Illumina iSeq	SKESA v. 2.3.0			B.1.1.370	GR
hCoV-19/Japan/IC-0058/2020	EPI_ISL_591400	2020-06-09	Asia / Japan	Human	Original		COVID-19 positive case who entered from Pakistan.	Illumina NextSeq500	A5-miseq v. 20140604			B.1.1	GR
hCoV-19/Japan/IC-0077/2020	EPI_ISL_591419	2020-07-09	Asia / Japan	Human	Original		COVID-19 positive case who entered from Philippines.	Illumina NextSeq2000	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Japan/IC-0093/2020	EPI_ISL_591434	2020-07-16	Asia / Japan	Human	Original		COVID-19 positive case who entered from Philippines.	Illumina NextSeq2000	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Japan/IC-0120/2020	EPI_ISL_591461	2020-08-04	Asia / Japan	Human	Original		COVID-19 positive case who entered from Philippines.	Illumina NextSeq2000	A5-miseq v. 20140604			B.1.1	GR
hCoV-19/England/ALDP-A87131/2020	EPI_ISL_606103	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A8642A/2020	EPI_ISL_606111	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A87C03/2020	EPI_ISL_606163	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A87BE8/2020	EPI_ISL_606184	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A87456/2020	EPI_ISL_606188	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6EC7B/2020	EPI_ISL_607006	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6D957/2020	EPI_ISL_607036	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6FA8F/2020	EPI_ISL_607056	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6DDC4/2020	EPI_ISL_607074	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6FDA4/2020	EPI_ISL_607091	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6FCB6/2020	EPI_ISL_607094	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6F1C6/2020	EPI_ISL_607111	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6C976/2020	EPI_ISL_607115	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A6F74C/2020	EPI_ISL_607117	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6D5EA/2020	EPI_ISL_607129	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6E288/2020	EPI_ISL_607136	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A6CAEC/2020	EPI_ISL_607157	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A6C74F/2020	EPI_ISL_607166	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6FD2C/2020	EPI_ISL_607184	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6E543/2020	EPI_ISL_607193	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.306	GR
hCoV-19/England/ALDP-A6E516/2020	EPI_ISL_607215	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6E6C8/2020	EPI_ISL_607217	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6E534/2020	EPI_ISL_607243	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6CA37/2020	EPI_ISL_607263	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6D5BD/2020	EPI_ISL_607265	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A6C7D6/2020	EPI_ISL_607276	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7B73E/2020	EPI_ISL_607295	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7B80E/2020	EPI_ISL_607317	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7BD0F/2020	EPI_ISL_607321	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-A7CAE9/2020	EPI_ISL_607344	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7BCF3/2020	EPI_ISL_607374	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-A7C955/2020	EPI_ISL_607381	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7CC10/2020	EPI_ISL_607389	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7BBC9/2020	EPI_ISL_607399	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7C90A/2020	EPI_ISL_607402	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7BC3F/2020	EPI_ISL_607560	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7AFBF/2020	EPI_ISL_607567	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7C8FE/2020	EPI_ISL_607576	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6DE67/2020	EPI_ISL_607632	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A70414/2020	EPI_ISL_607641	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6E455/2020	EPI_ISL_607648	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6E060/2020	EPI_ISL_607663	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A6DEC1/2020	EPI_ISL_607672	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6E033/2020	EPI_ISL_607697	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A6E7C5/2020	EPI_ISL_607706	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6D896/2020	EPI_ISL_607721	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6FA52/2020	EPI_ISL_607746	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A6DF28/2020	EPI_ISL_607778	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6E507/2020	EPI_ISL_607816	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A70423/2020	EPI_ISL_607827	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6DC21/2020	EPI_ISL_607838	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6E006/2020	EPI_ISL_607882	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A6F9DD/2020	EPI_ISL_607890	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6F454/2020	EPI_ISL_607907	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6EA53/2020	EPI_ISL_607913	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6E90B/2020	EPI_ISL_607949	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6F57F/2020	EPI_ISL_607956	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6EA08/2020	EPI_ISL_607968	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A6EA71/2020	EPI_ISL_607969	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6D1AA/2020	EPI_ISL_607984	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A93FB0/2020	EPI_ISL_611002	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A92704/2020	EPI_ISL_611036	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A928D4/2020	EPI_ISL_611054	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A93FA1/2020	EPI_ISL_611097	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A9368E/2020	EPI_ISL_611102	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A93967/2020	EPI_ISL_611104	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A93F47/2020	EPI_ISL_611128	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A93A19/2020	EPI_ISL_611172	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A93A64/2020	EPI_ISL_611177	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A936BB/2020	EPI_ISL_611201	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A9481E/2020	EPI_ISL_611216	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A9250A/2020	EPI_ISL_611220	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A93A0A/2020	EPI_ISL_611223	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A948D2/2020	EPI_ISL_611231	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A9367F/2020	EPI_ISL_611232	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A93DC5/2020	EPI_ISL_611250	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A93B25/2020	EPI_ISL_611279	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A9E9E4/2020	EPI_ISL_611293	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-A9B756/2020	EPI_ISL_611320	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A9F0C0/2020	EPI_ISL_611336	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A9ED15/2020	EPI_ISL_611337	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A9F34F/2020	EPI_ISL_611361	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A9B6A4/2020	EPI_ISL_611363	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A9F2CA/2020	EPI_ISL_611364	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A9F3C7/2020	EPI_ISL_611367	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A9F707/2020	EPI_ISL_611380	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A9EC27/2020	EPI_ISL_611382	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A9F479/2020	EPI_ISL_611383	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A9F38B/2020	EPI_ISL_611390	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A9EC90/2020	EPI_ISL_611398	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A9EDE8/2020	EPI_ISL_611400	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A9B71A/2020	EPI_ISL_611407	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A9F35E/2020	EPI_ISL_611409	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AA02C6/2020	EPI_ISL_611434	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A9B6D1/2020	EPI_ISL_611453	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A9FB38/2020	EPI_ISL_611455	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A9EB84/2020	EPI_ISL_611469	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A9ED51/2020	EPI_ISL_611474	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA219A/2020	EPI_ISL_625052	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA1E76/2020	EPI_ISL_625098	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-AA55F5/2020	EPI_ISL_625122	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA0ADD/2020	EPI_ISL_625129	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA2CB7/2020	EPI_ISL_625165	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA1DD3/2020	EPI_ISL_625174	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AA0A55/2020	EPI_ISL_625188	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA0A91/2020	EPI_ISL_625196	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-AA366D/2020	EPI_ISL_625232	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA53A0/2020	EPI_ISL_625233	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-AA38B2/2020	EPI_ISL_625248	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA2D3C/2020	EPI_ISL_625250	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-AA2C99/2020	EPI_ISL_625264	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/CAMC-A82066/2020	EPI_ISL_625300	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/CAMC-A8245B/2020	EPI_ISL_625301	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/CAMC-A81C81/2020	EPI_ISL_625309	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Wales/CAMC-A82479/2020	EPI_ISL_625314	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-A9EDCA/2020	EPI_ISL_625320	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-A9EA3C/2020	EPI_ISL_625321	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A9E823/2020	EPI_ISL_625333	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-A9B3F8/2020	EPI_ISL_625363	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A9B932/2020	EPI_ISL_625378	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A9B48C/2020	EPI_ISL_625394	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/ALDP-A67EA9/2020	EPI_ISL_625429	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/ALDP-A683C7/2020	EPI_ISL_625435	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/CAMC-A3E6C1/2020	EPI_ISL_625444	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Denmark/DCGC-8632/2020	EPI_ISL_625781	2020-10-26	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/Denmark/DCGC-8520/2020	EPI_ISL_625895	2020-10-26	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-8565/2020	EPI_ISL_625940	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-8598/2020	EPI_ISL_625946	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-8651/2020	EPI_ISL_625994	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Wales/PHWC-4831D1/2020	EPI_ISL_627097	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.1.307	GR
hCoV-19/England/MILK-A18E01/2020	EPI_ISL_627203	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Wales/QEUH-A335A1/2020	EPI_ISL_627253	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Wales/CVR4746/2020	EPI_ISL_627337	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR5225/2020	EPI_ISL_627397	2020-10-19	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR5228/2020	EPI_ISL_627399	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR5239/2020	EPI_ISL_627406	2020-10-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/LOND-1262E49/2020	EPI_ISL_627462	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-A18CDA/2020	EPI_ISL_627480	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-A190DD/2020	EPI_ISL_627485	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-A19116/2020	EPI_ISL_627486	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-ABC054/2020	EPI_ISL_631106	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-ABD2E4/2020	EPI_ISL_631127	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-ABD25D/2020	EPI_ISL_631128	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ABB8B7/2020	EPI_ISL_631145	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/ALDP-AC5DAC/2020	EPI_ISL_631150	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/CAMC-AAF7AA/2020	EPI_ISL_631155	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.307	GR
hCoV-19/England/ALDP-ABD2F3/2020	EPI_ISL_631173	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ABC212/2020	EPI_ISL_631176	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-ABBD4F/2020	EPI_ISL_631193	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Netherlands/GE-EMC-316/2020	EPI_ISL_632647	2020-10-06	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.1.37	GR
hCoV-19/Gibraltar/204462910/2020	EPI_ISL_632808	2020-10-29	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/USA/NY-NYCPHL-000948/2020	EPI_ISL_632986	2020-09-29	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/Wales/PHWC-4890DE/2020	EPI_ISL_639534	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-489593/2020	EPI_ISL_639589	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4896DC/2020	EPI_ISL_639606	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/QEUH-A783B5/2020	EPI_ISL_639627	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/QEUH-A89C5C/2020	EPI_ISL_639628	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/QEUH-A89C6B/2020	EPI_ISL_639629	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Latvia/147/2020	EPI_ISL_639644	2020-09-23	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.1.37	GR
hCoV-19/Latvia/149/2020	EPI_ISL_639646	2020-09-23	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.1.37	GR
hCoV-19/Latvia/171/2020	EPI_ISL_639668	2020-09-28	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.1.37	GR
hCoV-19/Latvia/172/2020	EPI_ISL_639669	2020-10-05	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.1.37	GR
hCoV-19/Latvia/174/2020	EPI_ISL_639671	2020-10-02	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.1.37	GR
hCoV-19/Latvia/175/2020	EPI_ISL_639672	2020-10-07	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.1.37	GR
hCoV-19/Latvia/185/2020	EPI_ISL_639682	2020-10-01	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.1.37	GR
hCoV-19/Latvia/191/2020	EPI_ISL_639688	2020-10-04	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.1.37	GR
hCoV-19/Latvia/193/2020	EPI_ISL_639690	2020-10-08	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.1.294	GR
hCoV-19/Latvia/195/2020	EPI_ISL_639692	2020-10-06	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.1.37	GR
hCoV-19/Latvia/197/2020	EPI_ISL_639694	2020-10-12	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.1.37	G
hCoV-19/Romania/BUCHAREST-IMT-1/2020	EPI_ISL_639739	2020-07-20	Europe / Romania	Human	Original	Nasopharyngeal swab / Respiratory swab		Illumina	Bowtie2 v. 2.3.4.3	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Australia/QLD1231/2020	EPI_ISL_639819	2020-10-29	Oceania / Australia / Queensland	Human	Original			Illumina	Samtools / iVar			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-1564S/2020	EPI_ISL_639913	2020-06-30	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-916S/2020	EPI_ISL_639945	2020-06-26	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/MOS-RII-MH2804S/2020	EPI_ISL_639953	2020-09-27	Europe / Russia / Moscow / Sergiyev Posad	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/MOS-RII-MH2808S/2020	EPI_ISL_639957	2020-09-27	Europe / Russia / Moscow / Sergiyev Posad	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/PER-RII-MH2816S/2020	EPI_ISL_639963	2020-09-24	Europe / Russia / Perm / Perm	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/RYA-RII-MH2823S/2020	EPI_ISL_639967	2020-09-24	Europe / Russia / Ryazan / Ryazan	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.349	GR
hCoV-19/England/ALDP-B1BB7F/2020	EPI_ISL_645706	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B1BA45/2020	EPI_ISL_645727	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-B1A1C9/2020	EPI_ISL_645730	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B1A651/2020	EPI_ISL_645733	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B1BB33/2020	EPI_ISL_645787	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/QEUH-B2C917/2020	EPI_ISL_646608	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2B58D/2020	EPI_ISL_646609	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2B471/2020	EPI_ISL_646636	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B2B4DB/2020	EPI_ISL_646646	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2B6A8/2020	EPI_ISL_646647	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-B2B347/2020	EPI_ISL_646650	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B24D22/2020	EPI_ISL_646665	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2B383/2020	EPI_ISL_646680	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B25240/2020	EPI_ISL_646708	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B2631F/2020	EPI_ISL_646724	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-B2B2C2/2020	EPI_ISL_646728	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B24DB9/2020	EPI_ISL_646744	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B263C4/2020	EPI_ISL_646768	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B2DCD1/2020	EPI_ISL_646818	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B2379E/2020	EPI_ISL_646863	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-B23840/2020	EPI_ISL_646881	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B247D9/2020	EPI_ISL_646898	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B24627/2020	EPI_ISL_646900	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B242BA/2020	EPI_ISL_646908	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B24135/2020	EPI_ISL_646958	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2EC94/2020	EPI_ISL_646960	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B23813/2020	EPI_ISL_646962	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B24760/2020	EPI_ISL_646987	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/MI-UM-10036589901/2020	EPI_ISL_650002	2020-10-23	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036613887/2020	EPI_ISL_650006	2020-10-25	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036587365/2020	EPI_ISL_650007	2020-10-23	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036587651/2020	EPI_ISL_650008	2020-10-23	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036593790/2020	EPI_ISL_650011	2020-10-23	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036592138/2020	EPI_ISL_650012	2020-10-23	North America / USA / Michigan	Human	Original			Illumina MiSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.1.304	GR
hCoV-19/USA/MI-UM-10036630690/2020	EPI_ISL_650020	2020-10-26	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036625640/2020	EPI_ISL_650023	2020-10-26	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036626781/2020	EPI_ISL_650024	2020-10-26	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036647686/2020	EPI_ISL_650031	2020-10-27	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036619926/2020	EPI_ISL_650035	2020-10-26	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036631770/2020	EPI_ISL_650038	2020-10-26	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036633901/2020	EPI_ISL_650046	2020-10-26	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036643724/2020	EPI_ISL_650048	2020-10-27	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036661466/2020	EPI_ISL_650049	2020-10-28	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036648902/2020	EPI_ISL_650051	2020-10-27	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036672505/2020	EPI_ISL_650056	2020-10-28	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036652302/2020	EPI_ISL_650065	2020-10-27	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036674506/2020	EPI_ISL_650073	2020-10-28	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/Scotland/EDB8886/2020	EPI_ISL_652017	2020-10-28	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/EDB8993/2020	EPI_ISL_652030	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/EDB8994/2020	EPI_ISL_652031	2020-11-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/EDB9243/2020	EPI_ISL_652052	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-ACFC1E/2020	EPI_ISL_652127	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-ACFE36/2020	EPI_ISL_652139	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-ACFE81/2020	EPI_ISL_652141	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-ACFEBE/2020	EPI_ISL_652143	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-AD003C/2020	EPI_ISL_652147	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/MILK-B02E45/2020	EPI_ISL_652152	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/MILK-B048BE/2020	EPI_ISL_652172	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-B05880/2020	EPI_ISL_652201	2020-10-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.170	GR
hCoV-19/England/MILK-B058DB/2020	EPI_ISL_652203	2020-10-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-B05A3F/2020	EPI_ISL_652215	2020-10-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-B05C1B/2020	EPI_ISL_652220	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/MILK-B063F7/2020	EPI_ISL_652230	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/MILK-B064E5/2020	EPI_ISL_652235	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.153	GR
hCoV-19/Wales/MILK-B064F4/2020	EPI_ISL_652236	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-B067BF/2020	EPI_ISL_652247	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-B06AC5/2020	EPI_ISL_652259	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48985E/2020	EPI_ISL_652415	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4898D6/2020	EPI_ISL_652422	2020-10-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-489900/2020	EPI_ISL_652424	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48995B/2020	EPI_ISL_652429	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4899B5/2020	EPI_ISL_652434	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4899C4/2020	EPI_ISL_652435	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4899D3/2020	EPI_ISL_652436	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-489A1C/2020	EPI_ISL_652439	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-489A58/2020	EPI_ISL_652443	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-489B0A/2020	EPI_ISL_652454	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-B386C6/2020	EPI_ISL_659004	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B38C00/2020	EPI_ISL_659038	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B38471/2020	EPI_ISL_659047	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B37E56/2020	EPI_ISL_659083	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B3336A/2020	EPI_ISL_659186	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B325DE/2020	EPI_ISL_659203	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-B3244A/2020	EPI_ISL_659205	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B325CF/2020	EPI_ISL_659261	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.153	GR
hCoV-19/England/CAMC-B33B26/2020	EPI_ISL_659306	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B32F76/2020	EPI_ISL_659314	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B335FB/2020	EPI_ISL_659337	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B335CE/2020	EPI_ISL_659359	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B33528/2020	EPI_ISL_659381	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B33722/2020	EPI_ISL_659402	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B32574/2020	EPI_ISL_659407	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-B34457/2020	EPI_ISL_659461	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B357C6/2020	EPI_ISL_659467	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.153	GR
hCoV-19/England/CAMC-B350AD/2020	EPI_ISL_659473	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/CAMC-B3477C/2020	EPI_ISL_659477	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B32C42/2020	EPI_ISL_659480	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B35508/2020	EPI_ISL_659483	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B32D8B/2020	EPI_ISL_659507	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B328B7/2020	EPI_ISL_659611	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B349EF/2020	EPI_ISL_659614	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/CAMC-B34475/2020	EPI_ISL_659644	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B32A75/2020	EPI_ISL_659697	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B3468E/2020	EPI_ISL_659719	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B345CD/2020	EPI_ISL_659727	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B34AA0/2020	EPI_ISL_659743	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B2DA5F/2020	EPI_ISL_659791	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2F695/2020	EPI_ISL_659811	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2EB3D/2020	EPI_ISL_659818	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B2D4F7/2020	EPI_ISL_659821	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2D697/2020	EPI_ISL_659827	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2D61F/2020	EPI_ISL_659828	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B2EF13/2020	EPI_ISL_659829	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B2DF50/2020	EPI_ISL_659843	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B2E942/2020	EPI_ISL_659855	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-B2EC1C/2020	EPI_ISL_659871	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2CD39/2020	EPI_ISL_659881	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/EXET-1391CE/2020	EPI_ISL_664603	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/LOND-1250B1A/2020	EPI_ISL_664755	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-B73E8B/2020	EPI_ISL_664895	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/ALDP-B75A49/2020	EPI_ISL_664929	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.434	GR
hCoV-19/England/CAMB-1B9C2F/2020	EPI_ISL_664964	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1BA1A7/2020	EPI_ISL_664974	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1BA3CF/2020	EPI_ISL_664978	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1BA444/2020	EPI_ISL_664982	2020-11-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-AF0DA8/2020	EPI_ISL_666005	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/QEUH-A61416/2020	EPI_ISL_666086	2020-10-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/ALDP-B1CACC/2020	EPI_ISL_666108	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/PHWC-48AA1B/2020	EPI_ISL_666112	2020-10-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48AAFD/2020	EPI_ISL_666121	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48ACD9/2020	EPI_ISL_666146	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48ADC7/2020	EPI_ISL_666158	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48AF3A/2020	EPI_ISL_666175	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48B160/2020	EPI_ISL_666199	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48B29A/2020	EPI_ISL_666215	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48B42B/2020	EPI_ISL_666235	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48B467/2020	EPI_ISL_666238	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48B519/2020	EPI_ISL_666248	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48B69E/2020	EPI_ISL_666267	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48B87A/2020	EPI_ISL_666292	2020-10-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48BAA1/2020	EPI_ISL_666319	2020-10-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48BBEA/2020	EPI_ISL_666334	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48BF39/2020	EPI_ISL_666371	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48BFC0/2020	EPI_ISL_666376	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48C0EA/2020	EPI_ISL_666392	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48C1F6/2020	EPI_ISL_666406	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48C23F/2020	EPI_ISL_666409	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48C2C6/2020	EPI_ISL_666414	2020-11-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48C3D2/2020	EPI_ISL_666425	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48C457/2020	EPI_ISL_666430	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48C660/2020	EPI_ISL_666452	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48C9C1/2020	EPI_ISL_666491	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48CF38/2020	EPI_ISL_666556	2020-11-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/C200043931/2020	EPI_ISL_666748	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.307	GR
hCoV-19/England/C200043942/2020	EPI_ISL_666749	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.307	GR
hCoV-19/England/C200043952/2020	EPI_ISL_666750	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.307	GR
hCoV-19/Denmark/DCGC-10493/2020	EPI_ISL_670014	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-10510/2020	EPI_ISL_670025	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-10523/2020	EPI_ISL_670032	2020-11-02	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.170	GR
hCoV-19/Denmark/DCGC-10569/2020	EPI_ISL_670056	2020-11-02	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.170	GR
hCoV-19/Denmark/DCGC-10591/2020	EPI_ISL_670074	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-10604/2020	EPI_ISL_670081	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-10649/2020	EPI_ISL_670114	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-10704/2020	EPI_ISL_670149	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-10725/2020	EPI_ISL_670163	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-10737/2020	EPI_ISL_670171	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-10769/2020	EPI_ISL_670197	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.170	GR
hCoV-19/Denmark/DCGC-10793/2020	EPI_ISL_670212	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.170	GR
hCoV-19/Denmark/DCGC-11230/2020	EPI_ISL_670780	2020-11-02	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/USA/NY-NYCPHL-001093/2020	EPI_ISL_671683	2020-10-22	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001094/2020	EPI_ISL_671684	2020-10-22	North America / USA / New York / New York	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001100/2020	EPI_ISL_671685	2020-10-22	North America / USA / New York / New York	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001104/2020	EPI_ISL_671687	2020-10-18	North America / USA / New York / New York	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001107/2020	EPI_ISL_671690	2020-10-19	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001112/2020	EPI_ISL_671695	2020-10-20	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001117/2020	EPI_ISL_671700	2020-10-21	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001120/2020	EPI_ISL_671703	2020-10-22	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001127/2020	EPI_ISL_671710	2020-10-26	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001138/2020	EPI_ISL_671721	2020-10-23	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001141/2020	EPI_ISL_671724	2020-10-23	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001144/2020	EPI_ISL_671726	2020-10-23	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001146/2020	EPI_ISL_671728	2020-10-25	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001153/2020	EPI_ISL_671735	2020-10-27	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001171/2020	EPI_ISL_671751	2020-10-29	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001172/2020	EPI_ISL_671752	2020-10-29	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001174/2020	EPI_ISL_671754	2020-10-29	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/Ireland/CO-NVRL-75IRL73629/2020	EPI_ISL_671878	2020-10-11	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/CO-NVRL-75IRL73676/2020	EPI_ISL_671879	2020-10-11	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/LS-NVRL-75IRL70478/2020	EPI_ISL_671921	2020-10-12	Europe / Ireland / Laois	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Portugal/PT0007/2020	EPI_ISL_417992	2020-03-07	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0010/2020	EPI_ISL_417995	2020-03-08	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Belgium/ULG-10046/2020	EPI_ISL_421213	2020-03-31	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Portugal/PT0062/2020	EPI_ISL_421465	2020-03-19	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0079/2020	EPI_ISL_421482	2020-03-18	Europe / Portugal	Human	Original	Nasopharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0081/2020	EPI_ISL_421484	2020-03-19	Europe / Portugal	Human	Original	Nasopharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/England/201360289/2020	EPI_ISL_421773	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201380030/2020	EPI_ISL_421797	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201380037/2020	EPI_ISL_421801	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201380054/2020	EPI_ISL_421809	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20144012204/2020	EPI_ISL_421930	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20144067504/2020	EPI_ISL_421957	2020-03-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20134004904/2020	EPI_ISL_423065	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20134006504/2020	EPI_ISL_423070	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20134007004/2020	EPI_ISL_423073	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20134007104/2020	EPI_ISL_423074	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20134016902/2020	EPI_ISL_423092	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201360206/2020	EPI_ISL_423241	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201360224/2020	EPI_ISL_423254	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20138019104/2020	EPI_ISL_423292	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20140070304/2020	EPI_ISL_423406	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20140071404/2020	EPI_ISL_423412	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20142002704/2020	EPI_ISL_423424	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20144002904/2020	EPI_ISL_423479	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Ireland/un-NVRL-20W268/2020	EPI_ISL_437686	2020-04	Europe / Ireland	Human	Original			Nanopore MinION	Artic Network protocol			B.1.1	GR
hCoV-19/Ireland/un-NVRL-20W270/2020	EPI_ISL_437688	2020-04	Europe / Ireland	Human	Original			Nanopore MinION	Artic Network protocol			B.1.1	GR
hCoV-19/Greece/218_35009/2020	EPI_ISL_437886	2020-03-17	Europe / Greece / Athens	Human	Original	Nasopharyngeal swab		Ion Torrent	IRMA v1.0			B.1.1	GR
hCoV-19/Austria/CeMM0078/2020	EPI_ISL_437946	2020-03-24	Europe / Austria / Innsbruck	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0098/2020	EPI_ISL_437959	2020-03-20	Europe / Austria / Kematen In Tirol	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0103/2020	EPI_ISL_437964	2020-03-19	Europe / Austria / Innsbruck	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0137/2020	EPI_ISL_437990	2020-03-13	Europe / Austria / Ischgl	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0143/2020	EPI_ISL_437993	2020-02-27	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0146/2020	EPI_ISL_437994	2020-02-28	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0147/2020	EPI_ISL_437995	2020-02-28	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0148/2020	EPI_ISL_437996	2020-03-02	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0149/2020	EPI_ISL_437997	2020-03-03	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0150/2020	EPI_ISL_437998	2020-03-03	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/England/CAMB-780A9/2020	EPI_ISL_441118	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-77E91/2020	EPI_ISL_441125	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-78CB4/2020	EPI_ISL_441170	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7A818/2020	EPI_ISL_441249	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-79B4D/2020	EPI_ISL_441335	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-101F3E/2020	EPI_ISL_441357	2020-03-23	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/CAMB-7EE21/2020	EPI_ISL_442956	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.220	GR
hCoV-19/England/CAMB-7F075/2020	EPI_ISL_442970	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7F594/2020	EPI_ISL_442995	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Romania/284489/2020	EPI_ISL_455470	2020-05-14	Europe / Romania / Bucuresti	Human	Original	Nasopharyngeal swab		Illumina MiSeq	DNASTAR Lasergene, Sequencer			B.1.1	GR
hCoV-19/Vietnam/VNHN_1528/2020	EPI_ISL_455697	2020-03-22	Asia / Vietnam / Hanoi	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20.0.3			B.1.1	GR
hCoV-19/Vietnam/VNHN_4189/2020	EPI_ISL_455707	2020-04-02	Asia / Vietnam / Hanoi	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20.0.3			B.1.1	GR
hCoV-19/Sweden/20-50238/2020	EPI_ISL_455880	2020-03-07	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-50242/2020	EPI_ISL_455883	2020-03-07	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-50244/2020	EPI_ISL_455884	2020-03-08	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-50245/2020	EPI_ISL_455885	2020-03-07	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-50246/2020	EPI_ISL_455886	2020-03-07	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Netherlands/NA_588/2020	EPI_ISL_460752	2020	Europe / Netherlands	Human	Original			Nanopore		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Netherlands/Friesland_38/2020	EPI_ISL_460853	2020-04-14	Europe / Netherlands / Friesland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Singapore/311/2020	EPI_ISL_462429	2020-03-17	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Bosnia and Herzegovina/ChVir7361/2020	EPI_ISL_462464	2020-03-25	Europe / Bosnia and Herzegovina / Ilidza	Human	Original			Illumina NextSeq	bowtie2			B.1.1.438	GR
hCoV-19/Sweden/20-14317/2020	EPI_ISL_469056	2020-05-05	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.438	GR
hCoV-19/Sweden/20-14318/2020	EPI_ISL_469057	2020-05-05	Europe / Sweden / Kalmar	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/England/NORT-28B153/2020	EPI_ISL_469314	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1273AF/2020	EPI_ISL_469579	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-127390/2020	EPI_ISL_469586	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1273BE/2020	EPI_ISL_469692	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1277B2/2020	EPI_ISL_469771	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-127381/2020	EPI_ISL_469779	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-127E17/2020	EPI_ISL_469803	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/GCVR-171634/2020	EPI_ISL_469945	2020-03-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/PORT-2D0EFE/2020	EPI_ISL_475303	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/PORT-2D116D/2020	EPI_ISL_475333	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C3B08/2020	EPI_ISL_475372	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	GR
hCoV-19/Australia/VIC2020/2020	EPI_ISL_480662	2020-06-03	Oceania / Australia / Victoria	Human	Original			Illumina iSeq	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2089/2020	EPI_ISL_480701	2020-06-12	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2090/2020	EPI_ISL_480702	2020-06-14	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2102/2020	EPI_ISL_480710	2020-06-15	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2112/2020	EPI_ISL_480718	2020-06-17	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2130/2020	EPI_ISL_480729	2020-06-19	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2126/2020	EPI_ISL_480735	2020-06-18	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2065/2020	EPI_ISL_480755	2020-06-15	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2066/2020	EPI_ISL_480756	2020-06-12	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2067/2020	EPI_ISL_480757	2020-06-12	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2160/2020	EPI_ISL_480760	2020-06-16	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2149/2020	EPI_ISL_480764	2020-06-17	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2151/2020	EPI_ISL_480765	2020-06-18	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2150/2020	EPI_ISL_480766	2020-06-17	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Wales/PHWC-166474/2020	EPI_ISL_494001	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1664FC/2020	EPI_ISL_494008	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166517/2020	EPI_ISL_494010	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1665CC/2020	EPI_ISL_494020	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16666F/2020	EPI_ISL_494026	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16668D/2020	EPI_ISL_494028	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16676C/2020	EPI_ISL_494036	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1667F3/2020	EPI_ISL_494043	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16680F/2020	EPI_ISL_494044	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16683C/2020	EPI_ISL_494047	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166869/2020	EPI_ISL_494050	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166896/2020	EPI_ISL_494053	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1668E1/2020	EPI_ISL_494057	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1668F0/2020	EPI_ISL_494058	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16690C/2020	EPI_ISL_494059	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16691B/2020	EPI_ISL_494060	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166957/2020	EPI_ISL_494062	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166A72/2020	EPI_ISL_494075	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166ABE/2020	EPI_ISL_494077	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166ACD/2020	EPI_ISL_494078	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166AEB/2020	EPI_ISL_494080	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166B8E/2020	EPI_ISL_494088	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166BCA/2020	EPI_ISL_494091	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166C03/2020	EPI_ISL_494094	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166C30/2020	EPI_ISL_494096	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166C8B/2020	EPI_ISL_494099	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166D2E/2020	EPI_ISL_494106	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166D6A/2020	EPI_ISL_494109	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166DD3/2020	EPI_ISL_494115	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166E1C/2020	EPI_ISL_494118	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166E58/2020	EPI_ISL_494121	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166F0A/2020	EPI_ISL_494130	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166F64/2020	EPI_ISL_494133	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-167060/2020	EPI_ISL_494146	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1681A8/2020	EPI_ISL_494208	2020-05-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16831B/2020	EPI_ISL_494226	2020-04-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1686A9/2020	EPI_ISL_494270	2020-05-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1686B8/2020	EPI_ISL_494271	2020-04-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1689A0/2020	EPI_ISL_494312	2020-04-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-168DE0/2020	EPI_ISL_494368	2020-04-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/USA/CA-ALSR-1138/2020	EPI_ISL_494384	2020-04-27	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-ALSR-1379/2020	EPI_ISL_494570	2020-06-23	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 9 nucleotides when compared to the reference sequence. NSP11 without BLAST coverage.	warn	B.1.1.132	GR
hCoV-19/USA/WA-S1660/2020	EPI_ISL_496086	2020-05-29	North America / USA / Washington / Yakima County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1	GR
hCoV-19/USA/WA-S1848/2020	EPI_ISL_496274	2020-05-27	North America / USA / Washington / Yakima County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1	GR
hCoV-19/England/LIVE-A299C/2020	EPI_ISL_500014	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A3C65/2020	EPI_ISL_500018	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A3C92/2020	EPI_ISL_500020	2020-05-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A3D44/2020	EPI_ISL_500024	2020-05-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A4736/2020	EPI_ISL_500037	2020-03-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A47EB/2020	EPI_ISL_500044	2020-03-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A48CA/2020	EPI_ISL_500052	2020-03-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A4D70/2020	EPI_ISL_500086	2020-03-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A4FC5/2020	EPI_ISL_500100	2020-03-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Australia/NSW2175/2020	EPI_ISL_500646	2020-03-18	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.1	GR
hCoV-19/Australia/NSW2207/2020	EPI_ISL_500665	2020-03-21	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.1	GR
hCoV-19/Australia/NSW2249/2020	EPI_ISL_500688	2020-03-23	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.1	GR
hCoV-19/Australia/NSW2266/2020	EPI_ISL_500701	2020-03-22	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.1	GR
hCoV-19/USA/un-CDC-7462/2020	EPI_ISL_514071	2020-04-21	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq, Sanger	bcftools 1.9,bowtie2 2.3.3.1, Sequencher 5.4.6			B.1.1	GR
hCoV-19/USA/un-CDC-7480/2020	EPI_ISL_514074	2020-04-22	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bcftools 1.9,bowtie2 2.3.3.1			B.1.1	GR
hCoV-19/USA/FL-BPHL-0816/2020	EPI_ISL_514162	2020-06-08	North America / USA / Florida	Human	Original			Illumina NextSeq	bwa v0.7.17; ivar v1.2.2			B.1.1.304	GR
hCoV-19/England/NOTT-112EF1/2020	EPI_ISL_514454	2020-08-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/PORT-2D1974/2020	EPI_ISL_514475	2020-04-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/PORT-2D19ED/2020	EPI_ISL_514479	2020-04-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/PORT-2D1A53/2020	EPI_ISL_514484	2020-04-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Australia/VIC2582/2020	EPI_ISL_521456	2020-07-01	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2644/2020	EPI_ISL_521490	2020-06-26	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2673/2020	EPI_ISL_521515	2020-07-02	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2674/2020	EPI_ISL_521516	2020-07-01	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2147/2020	EPI_ISL_521916	2020-06-19	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2148/2020	EPI_ISL_521917	2020-06-20	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2171/2020	EPI_ISL_521920	2020-06-23	Oceania / Australia / Victoria	Human	Original			Illumina iSeq	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2173/2020	EPI_ISL_521922	2020-06-24	Oceania / Australia / Victoria	Human	Original			Illumina iSeq	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2181/2020	EPI_ISL_521927	2020-06-22	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2189/2020	EPI_ISL_521935	2020-06-23	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2197/2020	EPI_ISL_521943	2020-06-24	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2198/2020	EPI_ISL_521944	2020-06-24	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2235/2020	EPI_ISL_521972	2020-06-23	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2245/2020	EPI_ISL_521978	2020-06-23	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2270/2020	EPI_ISL_521992	2020-06-24	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Switzerland/BS-UHB-42189861/2020	EPI_ISL_528053	2020-03-13	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1.331	GR
hCoV-19/Switzerland/BS-UHB-42198593/2020	EPI_ISL_528222	2020-03-19	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1	GR
hCoV-19/England/20166019504/2020	EPI_ISL_528400	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20342000104/2020	EPI_ISL_528438	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/India/TG-CDFD-C1325/2020	EPI_ISL_528555	2020-06-06	Asia / India / Telangana	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.1.306	GR
hCoV-19/India/TG-CDFD-C1327/2020	EPI_ISL_528556	2020-06-06	Asia / India / Telangana	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.1.306	GR
hCoV-19/India/TG-CDFD-C1391/2020	EPI_ISL_528560	2020-06-08	Asia / India / Telangana	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.1.306	GR
hCoV-19/India/TG-CDFD-C1408/2020	EPI_ISL_528562	2020-06-08	Asia / India / Telangana	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.1.306	GR
hCoV-19/India/TG-CDFD-C2169/2020	EPI_ISL_528576	2020-06-17	Asia / India / Telangana	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.1.306	GR
hCoV-19/India/TG-CDFD-C2529/2020	EPI_ISL_528581	2020-06-18	Asia / India / Telangana	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.1.306	GR
hCoV-19/India/TG-CDFD-C2910/2020	EPI_ISL_528586	2020-06-19	Asia / India / Telangana	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.1.306	GR
hCoV-19/United Arab Emirates/16/2020	EPI_ISL_528689	2020-05-05	Asia / United Arab Emirates / Abu Dhabi	Human	Original			Illumina NextSeq 500				B.1.1.263	GR
hCoV-19/United Arab Emirates/195/2020	EPI_ISL_528691	2020-06-07	Asia / United Arab Emirates / Abu Dhabi	Human	Original			Illumina NextSeq 500				B.1.1.263	GR
hCoV-19/United Arab Emirates/2/2020	EPI_ISL_528692	2020-05-02	Asia / United Arab Emirates / Abu Dhabi	Human	Original			Illumina NextSeq 500				B.1.1	GR
hCoV-19/United Arab Emirates/313/2020	EPI_ISL_528696	2020-06-02	Asia / United Arab Emirates / Dubai	Human	Original			Illumina NextSeq 500				B.1.1.366	GR
hCoV-19/United Arab Emirates/42/2020	EPI_ISL_528699	2020-05-12	Asia / United Arab Emirates / Abu Dhabi	Human	Original			Illumina NextSeq 500				B.1.1	GR
hCoV-19/United Arab Emirates/44/2020	EPI_ISL_528701	2020-05-11	Asia / United Arab Emirates / Abu Dhabi	Human	Original			Illumina NextSeq 500				B.1.1.263	GR
hCoV-19/United Arab Emirates/54/2020	EPI_ISL_528704	2020-05-14	Asia / United Arab Emirates / Abu Dhabi	Human	Original			Illumina NextSeq 500				B.1.1.263	GR
hCoV-19/United Arab Emirates/56/2020	EPI_ISL_528706	2020-05-14	Asia / United Arab Emirates / Abu Dhabi	Human	Original			Illumina NextSeq 500				B.1.1.263	GR
hCoV-19/United Arab Emirates/H1/2020	EPI_ISL_528709	2020-04-30	Asia / United Arab Emirates / Abu Dhabi	Human	Original			Illumina NextSeq 500				B.1.1.263	GR
hCoV-19/United Arab Emirates/H10/2020	EPI_ISL_528710	2020-04-25	Asia / United Arab Emirates / Abu Dhabi	Human	Original			Illumina NextSeq 500				B.1.1.263	GR
hCoV-19/United Arab Emirates/H13/2020	EPI_ISL_528712	2020-04-26	Asia / United Arab Emirates / Abu Dhabi	Human	Original			Illumina NextSeq 500				B.1.1.263	GR
hCoV-19/United Arab Emirates/H18/2020	EPI_ISL_528713	2020-04-24	Asia / United Arab Emirates / Abu Dhabi	Human	Original			Illumina NextSeq 500				B.1.1.263	GR
hCoV-19/United Arab Emirates/H23/2020	EPI_ISL_528717	2020-04-26	Asia / United Arab Emirates / Abu Dhabi	Human	Original			Illumina NextSeq 500				B.1.1	GR
hCoV-19/United Arab Emirates/H27/2020	EPI_ISL_528718	2020-04-30	Asia / United Arab Emirates / Abu Dhabi	Human	Original			Illumina NextSeq 500				B.1.1.263	GR
hCoV-19/United Arab Emirates/H9/2020	EPI_ISL_528721	2020-04-24	Asia / United Arab Emirates / Abu Dhabi	Human	Original			Illumina NextSeq 500				B.1.1.263	GR
hCoV-19/India/TG-CCMB-W855/2020	EPI_ISL_528827	2020-07-14	Asia / India / Telangana / Karimnagar	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-W863/2020	EPI_ISL_528828	2020-07-14	Asia / India / Telangana / Karimnagar	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-W897/2020	EPI_ISL_528831	2020-07-14	Asia / India / Telangana / Karimnagar	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.340	GR
hCoV-19/India/TG-CCMB-W899/2020	EPI_ISL_528832	2020-07-14	Asia / India / Telangana / Karimnagar	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-W990/2020	EPI_ISL_528838	2020-07-14	Asia / India / Telangana / Nalgonda	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-X102/2020	EPI_ISL_528843	2020-07-15	Asia / India / Telangana / Karimnagar	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.340	GR
hCoV-19/India/TG-CCMB-X111/2020	EPI_ISL_528846	2020-07-15	Asia / India / Telangana / Karimnagar	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-X113/2020	EPI_ISL_528848	2020-07-15	Asia / India / Telangana / Karimnagar	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-X15/2020	EPI_ISL_528852	2020-07-14	Asia / India / Telangana / Nalgonda	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-X42/2020	EPI_ISL_528854	2020-07-14	Asia / India / Telangana / Nalgonda	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-X43/2020	EPI_ISL_528855	2020-07-14	Asia / India / Telangana / Nalgonda	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-X44/2020	EPI_ISL_528856	2020-07-14	Asia / India / Telangana / Nalgonda	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-X59/2020	EPI_ISL_528861	2020-07-14	Asia / India / Telangana / Nalgonda	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.340	GR
hCoV-19/India/TG-CCMB-X76/2020	EPI_ISL_528864	2020-07-14	Asia / India / Telangana / Nalgonda	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/England/SHEF-D281E/2020	EPI_ISL_535100	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR4008/2020	EPI_ISL_535108	2020-08-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR4012/2020	EPI_ISL_535111	2020-08-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR4034/2020	EPI_ISL_535132	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/PHWC-16A11F/2020	EPI_ISL_535203	2020-09-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16A188/2020	EPI_ISL_535209	2020-09-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Canada/QC-LSPQ-L00214023/2020	EPI_ISL_535723	2020-03-10	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00214050/2020	EPI_ISL_535724	2020-03-10	North America / Canada / Quebec	Human	Original			MGI CleanPlex				B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00214488/2020	EPI_ISL_535727	2020-03-11	North America / Canada / Quebec	Human	Original			MGI CleanPlex				B.1.1	GR
hCoV-19/Canada/QC-LSPQ-L00215977/2020	EPI_ISL_535742	2020-03-12	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Canada/QC-LSPQ-L00215981/2020	EPI_ISL_535743	2020-03-12	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Canada/QC-LSPQ-L00217024/2020	EPI_ISL_535756	2020-03-13	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Canada/QC-LSPQ-L00217032/2020	EPI_ISL_535757	2020-03-13	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Canada/QC-LSPQ-L00217534/2020	EPI_ISL_535763	2020-03-13	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Canada/QC-LSPQ-L00219618/2020	EPI_ISL_535794	2020-03-14	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Canada/QC-LSPQ-L00229741/2020	EPI_ISL_535902	2020-03-21	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Canada/QC-LSPQ-L00230351/2020	EPI_ISL_535916	2020-03-21	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/New Zealand/20VR3852/2020	EPI_ISL_548142	2020	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol	Gap of 9 nucleotides found at refpos 686.	info	B.1.1.306	GR
hCoV-19/USA/CA-CZB-4099/2020	EPI_ISL_548666	2020-08-15	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.228	GR
hCoV-19/England/QEUH-9B8596/2020	EPI_ISL_549708	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B9A3C/2020	EPI_ISL_549710	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B9313/2020	EPI_ISL_549712	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B8C37/2020	EPI_ISL_549713	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9B9F6A/2020	EPI_ISL_549728	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9B8C0A/2020	EPI_ISL_549730	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B99A8/2020	EPI_ISL_549731	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9B8693/2020	EPI_ISL_549737	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B85B4/2020	EPI_ISL_549738	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-9B8499/2020	EPI_ISL_549800	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-99CFD6/2020	EPI_ISL_549812	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99CE8E/2020	EPI_ISL_549819	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99CCC0/2020	EPI_ISL_549834	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-99D0F0/2020	EPI_ISL_549840	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99CEBB/2020	EPI_ISL_549847	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99D0E1/2020	EPI_ISL_549860	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99CB96/2020	EPI_ISL_549869	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99D03C/2020	EPI_ISL_549877	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides found at refpos 12627.	info	B.1.1	GR
hCoV-19/England/MILK-99D685/2020	EPI_ISL_549882	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99CEAC/2020	EPI_ISL_549899	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9718BE/2020	EPI_ISL_553031	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-922193/2020	EPI_ISL_553273	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-92239D/2020	EPI_ISL_553278	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9221DF/2020	EPI_ISL_553281	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-92248B/2020	EPI_ISL_553288	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-922CFC/2020	EPI_ISL_553307	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9151DF/2020	EPI_ISL_553333	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-915184/2020	EPI_ISL_553342	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-922500/2020	EPI_ISL_553343	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95A5B4/2020	EPI_ISL_553379	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94D499/2020	EPI_ISL_553380	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9550D6/2020	EPI_ISL_553388	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95A87F/2020	EPI_ISL_553390	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95A806/2020	EPI_ISL_553394	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-954B8B/2020	EPI_ISL_553431	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-954B7C/2020	EPI_ISL_553469	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95A350/2020	EPI_ISL_553518	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94D4B7/2020	EPI_ISL_553522	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95CB56/2020	EPI_ISL_553523	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9550E5/2020	EPI_ISL_553526	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-954E64/2020	EPI_ISL_553540	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95CB38/2020	EPI_ISL_553552	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95CB92/2020	EPI_ISL_553570	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95CB65/2020	EPI_ISL_553580	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95CBA1/2020	EPI_ISL_553592	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-954FF8/2020	EPI_ISL_553630	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9520AC/2020	EPI_ISL_553631	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-953919/2020	EPI_ISL_553635	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-952E39/2020	EPI_ISL_553638	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9520CA/2020	EPI_ISL_553683	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-93A875/2020	EPI_ISL_553707	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9537A6/2020	EPI_ISL_553756	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-953973/2020	EPI_ISL_553764	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-953955/2020	EPI_ISL_553765	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9542D1/2020	EPI_ISL_553767	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95412F/2020	EPI_ISL_553781	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-953964/2020	EPI_ISL_553783	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9538A3/2020	EPI_ISL_553785	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-953B40/2020	EPI_ISL_553786	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-954462/2020	EPI_ISL_553788	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-953B04/2020	EPI_ISL_553792	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-954444/2020	EPI_ISL_553793	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-954101/2020	EPI_ISL_553830	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-953F17/2020	EPI_ISL_553836	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95381C/2020	EPI_ISL_553837	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95371F/2020	EPI_ISL_553838	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9537B5/2020	EPI_ISL_553856	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-95417A/2020	EPI_ISL_553857	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-954453/2020	EPI_ISL_553859	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95372E/2020	EPI_ISL_553860	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-957502/2020	EPI_ISL_553889	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-955D39/2020	EPI_ISL_553891	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q94stop results in 23.1% truncation of the protein sequence.	info	B.1.1.200	GR
hCoV-19/England/ALDP-9560E4/2020	EPI_ISL_553892	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9578FA/2020	EPI_ISL_553896	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-957854/2020	EPI_ISL_553897	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9566F1/2020	EPI_ISL_553902	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-955D66/2020	EPI_ISL_553931	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-956390/2020	EPI_ISL_553943	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-952789/2020	EPI_ISL_553950	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9527F2/2020	EPI_ISL_553951	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95269B/2020	EPI_ISL_553962	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95658B/2020	EPI_ISL_553966	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9527A7/2020	EPI_ISL_553975	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95273E/2020	EPI_ISL_553977	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9573F9/2020	EPI_ISL_553983	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-952956/2020	EPI_ISL_553988	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-955CC3/2020	EPI_ISL_553995	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-959EE7/2020	EPI_ISL_555029	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95C206/2020	EPI_ISL_555033	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-959D35/2020	EPI_ISL_555043	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94D5D2/2020	EPI_ISL_555044	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C3C7/2020	EPI_ISL_555058	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-94E780/2020	EPI_ISL_555060	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C628/2020	EPI_ISL_555075	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C3A9/2020	EPI_ISL_555076	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95CD6F/2020	EPI_ISL_555092	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-95C145/2020	EPI_ISL_555107	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C619/2020	EPI_ISL_555110	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95CAC2/2020	EPI_ISL_555113	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95D01A/2020	EPI_ISL_555117	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95CCCC/2020	EPI_ISL_555119	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-94F87D/2020	EPI_ISL_555132	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94FA0E/2020	EPI_ISL_555135	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94FC53/2020	EPI_ISL_555158	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-950493/2020	EPI_ISL_555174	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-950581/2020	EPI_ISL_555177	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94FB38/2020	EPI_ISL_555182	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9504A2/2020	EPI_ISL_555199	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9506E8/2020	EPI_ISL_555223	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-94FCDB/2020	EPI_ISL_555241	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-94F95C/2020	EPI_ISL_555254	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9504EE/2020	EPI_ISL_555256	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94F85F/2020	EPI_ISL_555260	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95041B/2020	EPI_ISL_555281	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94FC44/2020	EPI_ISL_555285	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94F840/2020	EPI_ISL_555286	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94FB65/2020	EPI_ISL_555297	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/PHWC-16AEAF/2020	EPI_ISL_560213	2020-09-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16AEEB/2020	EPI_ISL_560217	2020-09-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16AF24/2020	EPI_ISL_560221	2020-09-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16B1A5/2020	EPI_ISL_560255	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16B1B4/2020	EPI_ISL_560256	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16B257/2020	EPI_ISL_560264	2020-09-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16B318/2020	EPI_ISL_560273	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Sweden/20-52279/2020	EPI_ISL_560982	2020-07-05	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Gambia/3671/2020	EPI_ISL_560994	2020-07-30	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/3673/2020	EPI_ISL_560995	2020-07-30	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	G
hCoV-19/England/QEUH-9C9BFA/2020	EPI_ISL_567302	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9C93D4/2020	EPI_ISL_567306	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CA1CA/2020	EPI_ISL_567314	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9CA625/2020	EPI_ISL_567324	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9C943B/2020	EPI_ISL_567332	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C9E2E/2020	EPI_ISL_567337	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CA93B/2020	EPI_ISL_567341	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C9C51/2020	EPI_ISL_567348	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C9F49/2020	EPI_ISL_567358	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9C935C/2020	EPI_ISL_567364	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CA4FE/2020	EPI_ISL_567389	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CA300/2020	EPI_ISL_567392	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9C9BDC/2020	EPI_ISL_567401	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9C986C/2020	EPI_ISL_567410	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C95B0/2020	EPI_ISL_567427	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9CA230/2020	EPI_ISL_567434	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C9A84/2020	EPI_ISL_567440	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9C944A/2020	EPI_ISL_567442	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C97F6/2020	EPI_ISL_567455	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C988A/2020	EPI_ISL_567462	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C99A5/2020	EPI_ISL_567477	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C9574/2020	EPI_ISL_567483	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C991E/2020	EPI_ISL_567489	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C98B7/2020	EPI_ISL_567493	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C9BAF/2020	EPI_ISL_567495	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9C9301/2020	EPI_ISL_567505	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CA4D0/2020	EPI_ISL_567511	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/QEUH-9CA4A3/2020	EPI_ISL_567514	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/ALDP-9C5D9E/2020	EPI_ISL_567539	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C55E1/2020	EPI_ISL_567543	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5BFE/2020	EPI_ISL_567547	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C52F9/2020	EPI_ISL_567550	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4EAB/2020	EPI_ISL_567554	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4E23/2020	EPI_ISL_567557	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C50C2/2020	EPI_ISL_567558	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	G
hCoV-19/England/ALDP-9C4E7E/2020	EPI_ISL_567564	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/ALDP-9C5156/2020	EPI_ISL_567569	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9C63C8/2020	EPI_ISL_567574	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C61DD/2020	EPI_ISL_567577	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4D44/2020	EPI_ISL_567580	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C54A8/2020	EPI_ISL_567586	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C50D1/2020	EPI_ISL_567587	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9C5684/2020	EPI_ISL_567596	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5077/2020	EPI_ISL_567597	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5C0A/2020	EPI_ISL_567599	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C55D2/2020	EPI_ISL_567601	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5B2B/2020	EPI_ISL_567609	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C55C3/2020	EPI_ISL_567613	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5086/2020	EPI_ISL_567619	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9C4C65/2020	EPI_ISL_567624	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4E8D/2020	EPI_ISL_567628	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9C504A/2020	EPI_ISL_567648	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5D8F/2020	EPI_ISL_567650	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4E41/2020	EPI_ISL_567653	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4D26/2020	EPI_ISL_567666	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/England/ALDP-9C5C82/2020	EPI_ISL_567671	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C53AB/2020	EPI_ISL_567673	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4D08/2020	EPI_ISL_567674	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C58D9/2020	EPI_ISL_567675	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4FA8/2020	EPI_ISL_567683	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5666/2020	EPI_ISL_567692	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9C4E32/2020	EPI_ISL_567693	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4DCC/2020	EPI_ISL_567702	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C50B3/2020	EPI_ISL_567709	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9C59F4/2020	EPI_ISL_567712	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5639/2020	EPI_ISL_567715	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9C5CDD/2020	EPI_ISL_567717	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5754/2020	EPI_ISL_567722	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	G
hCoV-19/England/ALDP-9C6331/2020	EPI_ISL_567733	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9C59C7/2020	EPI_ISL_567740	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9C5129/2020	EPI_ISL_567751	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5AB5/2020	EPI_ISL_567755	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5CEC/2020	EPI_ISL_567757	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5262/2020	EPI_ISL_567763	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5059/2020	EPI_ISL_567774	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4F99/2020	EPI_ISL_567778	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4DEA/2020	EPI_ISL_567781	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C594F/2020	EPI_ISL_567783	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4D53/2020	EPI_ISL_567790	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/England/ALDP-9C56DF/2020	EPI_ISL_567795	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9C5CFB/2020	EPI_ISL_567798	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5569/2020	EPI_ISL_567800	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9C53D8/2020	EPI_ISL_567801	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4D71/2020	EPI_ISL_567806	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C501D/2020	EPI_ISL_567814	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5D16/2020	EPI_ISL_567819	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C642F/2020	EPI_ISL_567829	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4C38/2020	EPI_ISL_567839	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4E14/2020	EPI_ISL_567842	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9C5930/2020	EPI_ISL_567844	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4E6F/2020	EPI_ISL_567849	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9C4ED8/2020	EPI_ISL_567850	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4D9F/2020	EPI_ISL_567852	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C63E6/2020	EPI_ISL_567863	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C56B1/2020	EPI_ISL_567864	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9C599A/2020	EPI_ISL_567869	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C54E4/2020	EPI_ISL_567882	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C59D6/2020	EPI_ISL_567884	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C555A/2020	EPI_ISL_567885	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9BE062/2020	EPI_ISL_567889	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BE150/2020	EPI_ISL_567901	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9BDE4B/2020	EPI_ISL_567904	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9BEACE/2020	EPI_ISL_567908	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BE2A8/2020	EPI_ISL_567909	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BDACF/2020	EPI_ISL_567929	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BDFFD/2020	EPI_ISL_567946	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9BDE78/2020	EPI_ISL_567955	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9BE27B/2020	EPI_ISL_567957	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9BE4DF/2020	EPI_ISL_567966	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BE044/2020	EPI_ISL_567969	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9BE42A/2020	EPI_ISL_567973	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BDC14/2020	EPI_ISL_567977	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BEB25/2020	EPI_ISL_567988	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BE3F0/2020	EPI_ISL_567992	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9BE78B/2020	EPI_ISL_567993	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/France/PAC-IHU-0018/2020	EPI_ISL_569247	2020-03-08	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-9064S/2020	EPI_ISL_569750	2020-05-19	Europe / Russia / Omsk / Moskalenki	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-1296S/2020	EPI_ISL_569758	2020-05-24	Europe / Russia / Omsk / Moskalenki	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-3012S/2020	EPI_ISL_569779	2020-07-06	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-5042S/2020	EPI_ISL_569785	2020-07-11	Europe / Russia / Omsk / Muromtsevo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-4882S/2020	EPI_ISL_569804	2020-07-10	Europe / Russia / Omsk / Novovarshavka	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-1631S/2020	EPI_ISL_569827	2020-06-29	Europe / Russia / Omsk / Moskalenki	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-9661S/2020	EPI_ISL_569843	2020-06-22	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-7598S/2020	EPI_ISL_569851	2020-06-12	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-4890S/2020	EPI_ISL_569854	2020-05-03	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-9060S/2020	EPI_ISL_569856	2020-05-19	Europe / Russia / Omsk / Moskalenki	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/England/ALDP-9BC9B4/2020	EPI_ISL_573039	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/ALDP-9BC9E1/2020	EPI_ISL_573040	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/ALDP-9BCA2A/2020	EPI_ISL_573041	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/ALDP-9BCA48/2020	EPI_ISL_573042	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/ALDP-9BCB45/2020	EPI_ISL_573054	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9BCCE8/2020	EPI_ISL_573071	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/ALDP-9BCD5E/2020	EPI_ISL_573073	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/ALDP-9BCE2E/2020	EPI_ISL_573078	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9CC1F5/2020	EPI_ISL_573091	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9CC508/2020	EPI_ISL_573112	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/CAMC-9BFFFB/2020	EPI_ISL_573165	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/CAMC-9C006D/2020	EPI_ISL_573168	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/CAMC-9C0364/2020	EPI_ISL_573180	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9BA95C/2020	EPI_ISL_573612	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9BA9A7/2020	EPI_ISL_573614	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9BAB29/2020	EPI_ISL_573622	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/QEUH-9BAB47/2020	EPI_ISL_573623	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9BAC53/2020	EPI_ISL_573631	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9BAFA5/2020	EPI_ISL_573644	2020-09-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9BB029/2020	EPI_ISL_573645	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9D1737/2020	EPI_ISL_573656	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9D1807/2020	EPI_ISL_573661	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9D1870/2020	EPI_ISL_573665	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9D18E9/2020	EPI_ISL_573669	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9D19E6/2020	EPI_ISL_573674	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9D19F5/2020	EPI_ISL_573675	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9D1A10/2020	EPI_ISL_573677	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9D1B1D/2020	EPI_ISL_573681	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9D1C83/2020	EPI_ISL_573684	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.44	GR
hCoV-19/England/SHEF-C12F6/2020	EPI_ISL_573688	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C37AA/2020	EPI_ISL_573696	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR4356/2020	EPI_ISL_573785	2020-09-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9EAA41/2020	EPI_ISL_580006	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9E9BF4/2020	EPI_ISL_580022	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E7622/2020	EPI_ISL_580037	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9EAB6C/2020	EPI_ISL_580046	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E9CB5/2020	EPI_ISL_580048	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9EAECD/2020	EPI_ISL_580055	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9EA56E/2020	EPI_ISL_580058	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9EA407/2020	EPI_ISL_580063	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9EA58C/2020	EPI_ISL_580068	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9EAF60/2020	EPI_ISL_580071	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9EA9DB/2020	EPI_ISL_580074	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E76B9/2020	EPI_ISL_580081	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9EA847/2020	EPI_ISL_580085	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E9C5B/2020	EPI_ISL_580093	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E9D0D/2020	EPI_ISL_580105	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E9DFE/2020	EPI_ISL_580109	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E9E28/2020	EPI_ISL_580139	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9E9C79/2020	EPI_ISL_580141	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E9DA3/2020	EPI_ISL_580145	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9EAF7F/2020	EPI_ISL_580161	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9EA3BF/2020	EPI_ISL_580182	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9EA59B/2020	EPI_ISL_580199	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9EA21C/2020	EPI_ISL_580203	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9EADFD/2020	EPI_ISL_580223	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9EAE63/2020	EPI_ISL_580233	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E9A60/2020	EPI_ISL_580262	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9EA962/2020	EPI_ISL_580265	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E6BE8/2020	EPI_ISL_580284	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E6D88/2020	EPI_ISL_580289	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E70E8/2020	EPI_ISL_580297	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9EC283/2020	EPI_ISL_580299	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2EA7D/2020	EPI_ISL_587000	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2F4C9/2020	EPI_ISL_587003	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A2F6B4/2020	EPI_ISL_587004	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-A2FDFB/2020	EPI_ISL_587010	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2EAB9/2020	EPI_ISL_587012	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2EB01/2020	EPI_ISL_587017	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2FD0A/2020	EPI_ISL_587024	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2F7FD/2020	EPI_ISL_587026	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2EA40/2020	EPI_ISL_587028	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2ECFF/2020	EPI_ISL_587039	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2F98E/2020	EPI_ISL_587050	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2FAA9/2020	EPI_ISL_587052	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2FC3A/2020	EPI_ISL_587059	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2E9CB/2020	EPI_ISL_587067	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2EA8C/2020	EPI_ISL_587070	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2EAC8/2020	EPI_ISL_587071	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2F5C6/2020	EPI_ISL_587086	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2EB10/2020	EPI_ISL_587089	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2F696/2020	EPI_ISL_587091	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2E9F8/2020	EPI_ISL_587097	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2F890/2020	EPI_ISL_587108	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/ALDP-A2EE53/2020	EPI_ISL_587115	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2EB5C/2020	EPI_ISL_587116	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2F62D/2020	EPI_ISL_587125	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2E98F/2020	EPI_ISL_587133	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2FB79/2020	EPI_ISL_587141	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2F72A/2020	EPI_ISL_587142	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2FCB2/2020	EPI_ISL_587145	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/ALDP-A2F511/2020	EPI_ISL_587152	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2EA31/2020	EPI_ISL_587158	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2EAAA/2020	EPI_ISL_587164	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2F0D4/2020	EPI_ISL_587167	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2EFD8/2020	EPI_ISL_587172	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2F8CD/2020	EPI_ISL_587179	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2FD19/2020	EPI_ISL_587186	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2F58A/2020	EPI_ISL_587190	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2F63C/2020	EPI_ISL_587200	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2F687/2020	EPI_ISL_587218	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2F4AB/2020	EPI_ISL_587223	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2F678/2020	EPI_ISL_587234	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2EB4D/2020	EPI_ISL_587236	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2F2B0/2020	EPI_ISL_587247	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2F06B/2020	EPI_ISL_587259	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2E9AD/2020	EPI_ISL_587279	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2F5D5/2020	EPI_ISL_587296	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1E1A8/2020	EPI_ISL_587305	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-A1EE65/2020	EPI_ISL_587306	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1DD69/2020	EPI_ISL_587314	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1DAEA/2020	EPI_ISL_587319	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-A1DEA2/2020	EPI_ISL_587324	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E973/2020	EPI_ISL_587326	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A21843/2020	EPI_ISL_587331	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E8C1/2020	EPI_ISL_587332	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E21E/2020	EPI_ISL_587334	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E9A0/2020	EPI_ISL_587338	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A21667/2020	EPI_ISL_587340	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A223C9/2020	EPI_ISL_587345	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1DE75/2020	EPI_ISL_587357	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1E964/2020	EPI_ISL_587359	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A2188F/2020	EPI_ISL_587360	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1DEB1/2020	EPI_ISL_587364	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E8B2/2020	EPI_ISL_587368	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1DE39/2020	EPI_ISL_587373	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A21913/2020	EPI_ISL_587376	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E991/2020	EPI_ISL_587379	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1E982/2020	EPI_ISL_587381	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E8FE/2020	EPI_ISL_587388	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1DF63/2020	EPI_ISL_587398	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A21F7B/2020	EPI_ISL_587399	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A21834/2020	EPI_ISL_587404	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E928/2020	EPI_ISL_587407	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1DA62/2020	EPI_ISL_587408	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A2238D/2020	EPI_ISL_587411	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1DE84/2020	EPI_ISL_587413	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A218DA/2020	EPI_ISL_587415	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1EE29/2020	EPI_ISL_587419	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A21F99/2020	EPI_ISL_587421	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1DFBE/2020	EPI_ISL_587422	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E384/2020	EPI_ISL_587430	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E1B7/2020	EPI_ISL_587432	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A2189E/2020	EPI_ISL_587433	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1E24B/2020	EPI_ISL_587434	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E1D5/2020	EPI_ISL_587438	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1DEEE/2020	EPI_ISL_587440	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-A1E90A/2020	EPI_ISL_587445	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1F4DB/2020	EPI_ISL_587446	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A21360/2020	EPI_ISL_587450	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1DBF6/2020	EPI_ISL_587453	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E779/2020	EPI_ISL_587455	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-A1E946/2020	EPI_ISL_587456	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1DAF9/2020	EPI_ISL_587463	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1E3A2/2020	EPI_ISL_587465	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1DEC0/2020	EPI_ISL_587467	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1DF18/2020	EPI_ISL_587473	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1E57F/2020	EPI_ISL_587478	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E1C6/2020	EPI_ISL_587479	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1DF45/2020	EPI_ISL_587481	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E22D/2020	EPI_ISL_587483	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E75B/2020	EPI_ISL_587488	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1DFFA/2020	EPI_ISL_587489	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1DB50/2020	EPI_ISL_587494	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1E9BF/2020	EPI_ISL_587504	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A218F8/2020	EPI_ISL_587505	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E014/2020	EPI_ISL_587511	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1DF72/2020	EPI_ISL_587512	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A21F4E/2020	EPI_ISL_587514	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A213CA/2020	EPI_ISL_587516	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A22305/2020	EPI_ISL_587519	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1DE93/2020	EPI_ISL_587528	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A21175/2020	EPI_ISL_587530	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E8EF/2020	EPI_ISL_587533	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A21FA8/2020	EPI_ISL_587538	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A21FC6/2020	EPI_ISL_587539	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A218BC/2020	EPI_ISL_587546	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A21FB7/2020	EPI_ISL_587547	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E955/2020	EPI_ISL_587548	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A21F5D/2020	EPI_ISL_587558	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A22323/2020	EPI_ISL_587560	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1DF36/2020	EPI_ISL_587562	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1E4CD/2020	EPI_ISL_587564	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1DE66/2020	EPI_ISL_587565	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A21904/2020	EPI_ISL_587569	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1DF81/2020	EPI_ISL_587572	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-A210A5/2020	EPI_ISL_587576	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A224D5/2020	EPI_ISL_587577	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A202CE/2020	EPI_ISL_587580	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A21263/2020	EPI_ISL_587581	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A21DEA/2020	EPI_ISL_587582	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1FCB5/2020	EPI_ISL_587583	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A20932/2020	EPI_ISL_587584	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A215D3/2020	EPI_ISL_587585	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A215F1/2020	EPI_ISL_587588	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A209C9/2020	EPI_ISL_587589	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A2046E/2020	EPI_ISL_587592	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A22235/2020	EPI_ISL_587598	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A2243F/2020	EPI_ISL_587601	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1FCF1/2020	EPI_ISL_587602	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A224B7/2020	EPI_ISL_587605	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A215A6/2020	EPI_ISL_587606	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A2244E/2020	EPI_ISL_587609	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A20352/2020	EPI_ISL_587611	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A202FB/2020	EPI_ISL_587612	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A20334/2020	EPI_ISL_587614	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A20246/2020	EPI_ISL_587615	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A2105A/2020	EPI_ISL_587616	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A21EC9/2020	EPI_ISL_587618	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A20237/2020	EPI_ISL_587621	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A2246C/2020	EPI_ISL_587622	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A208EA/2020	EPI_ISL_587626	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A20756/2020	EPI_ISL_587629	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A21E6F/2020	EPI_ISL_587631	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A209AB/2020	EPI_ISL_587632	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A2101E/2020	EPI_ISL_587634	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/QEUH-A204E6/2020	EPI_ISL_587636	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A2052F/2020	EPI_ISL_587638	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A20273/2020	EPI_ISL_587641	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A20291/2020	EPI_ISL_587644	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A2047D/2020	EPI_ISL_587645	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A2099C/2020	EPI_ISL_587647	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A21E32/2020	EPI_ISL_587648	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A202DD/2020	EPI_ISL_587652	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A20282/2020	EPI_ISL_587655	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A21EAB/2020	EPI_ISL_587657	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A2160D/2020	EPI_ISL_587658	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A20729/2020	EPI_ISL_587659	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A21E50/2020	EPI_ISL_587660	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A20264/2020	EPI_ISL_587661	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A2098D/2020	EPI_ISL_587662	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A21E9C/2020	EPI_ISL_587664	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A2161C/2020	EPI_ISL_587665	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A2038F/2020	EPI_ISL_587668	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A226DF/2020	EPI_ISL_587670	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A204B9/2020	EPI_ISL_587671	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A21E05/2020	EPI_ISL_587673	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A22420/2020	EPI_ISL_587674	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A21E8D/2020	EPI_ISL_587676	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A202A0/2020	EPI_ISL_587677	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A22226/2020	EPI_ISL_587680	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/England/QEUH-A20765/2020	EPI_ISL_587684	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A208AE/2020	EPI_ISL_587686	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A212CD/2020	EPI_ISL_587687	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A2054D/2020	EPI_ISL_587688	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A20914/2020	EPI_ISL_587689	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A1FCA6/2020	EPI_ISL_587690	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A208CC/2020	EPI_ISL_587694	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A21E7E/2020	EPI_ISL_587698	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A1F9EB/2020	EPI_ISL_587699	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A20325/2020	EPI_ISL_587703	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A22402/2020	EPI_ISL_587705	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A21E14/2020	EPI_ISL_587706	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A20738/2020	EPI_ISL_587709	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A20343/2020	EPI_ISL_587710	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9FCE31/2020	EPI_ISL_587711	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FD0D0/2020	EPI_ISL_587716	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9FCEF5/2020	EPI_ISL_587727	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9FCD70/2020	EPI_ISL_587742	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9FD146/2020	EPI_ISL_587752	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9FCE40/2020	EPI_ISL_587776	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FCAC4/2020	EPI_ISL_587782	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9FDE8B/2020	EPI_ISL_587787	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FD4D4/2020	EPI_ISL_587794	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Ecuador/USFQ-1026/2020	EPI_ISL_594118	2020-08-14	South America / Ecuador / Guayas / Guayaquil	Human	Original			Nanopore MinION	Artic Nanopore			B.1.1	GR
hCoV-19/Sweden/20-08986/2020	EPI_ISL_594149	2020-09-16	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Gap of 6 nucleotides when compared to the reference sequence.	info	AN.1	GR
hCoV-19/Sweden/20-08988/2020	EPI_ISL_594151	2020-09-16	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.438	GR
hCoV-19/Sweden/20-08994/2020	EPI_ISL_594153	2020-09-16	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Gap of 6 nucleotides when compared to the reference sequence.	info	AN.1	GR
hCoV-19/England/ALDP-9E7428/2020	EPI_ISL_594468	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/ALDP-9E7437/2020	EPI_ISL_594469	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/ALDP-9E7543/2020	EPI_ISL_594477	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/BIRM-645CF/2020	EPI_ISL_594496	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-6477E/2020	EPI_ISL_594512	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-64E79/2020	EPI_ISL_594525	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-64F0D/2020	EPI_ISL_594531	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-64F3A/2020	EPI_ISL_594533	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-655FB/2020	EPI_ISL_594570	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-657E6/2020	EPI_ISL_594584	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-6587A/2020	EPI_ISL_594589	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-6594A/2020	EPI_ISL_594598	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9EC9F7/2020	EPI_ISL_594634	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/CAMC-9ECB97/2020	EPI_ISL_594643	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR4851/2020	EPI_ISL_594651	2020-10-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.294	GR
hCoV-19/Scotland/CVR4950/2020	EPI_ISL_594714	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR4964/2020	EPI_ISL_594728	2020-10-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR4974/2020	EPI_ISL_594737	2020-10-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/LOND-1262896/2020	EPI_ISL_594878	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/MILK-9EF04A/2020	EPI_ISL_594895	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-A7B83B/2020	EPI_ISL_607469	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7B6AA/2020	EPI_ISL_607494	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7C991/2020	EPI_ISL_607522	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	G
hCoV-19/England/MILK-A7B2D3/2020	EPI_ISL_607582	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A68B56/2020	EPI_ISL_608606	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A64B2D/2020	EPI_ISL_608641	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A69126/2020	EPI_ISL_608658	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A64ED9/2020	EPI_ISL_608666	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A68B74/2020	EPI_ISL_608669	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A67EF4/2020	EPI_ISL_608677	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A658AD/2020	EPI_ISL_608683	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6892F/2020	EPI_ISL_608694	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A6AFB2/2020	EPI_ISL_608713	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A6ABEB/2020	EPI_ISL_608719	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-A6B28B/2020	EPI_ISL_608733	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A18D31/2020	EPI_ISL_612121	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 8 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Wales/PHWC-48059C/2020	EPI_ISL_612203	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Wales/PHWC-480A33/2020	EPI_ISL_612204	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Wales/PHWC-480A51/2020	EPI_ISL_612205	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Wales/PHWC-480D76/2020	EPI_ISL_612206	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/BIRM-65AFC/2020	EPI_ISL_612207	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-65DF3/2020	EPI_ISL_612230	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B6B43/2020	EPI_ISL_612273	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR4659/2020	EPI_ISL_612297	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/EDB8457/2020	EPI_ISL_612366	2020-10-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/LOND-D9B69/2020	EPI_ISL_612452	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-A18DE6/2020	EPI_ISL_612462	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-A190A0/2020	EPI_ISL_612480	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-A190CE/2020	EPI_ISL_612481	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.434	GR
hCoV-19/England/MILK-A1936B/2020	EPI_ISL_612506	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/MILK-A22815/2020	EPI_ISL_612523	2020-10-02	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/MILK-A22A00/2020	EPI_ISL_612537	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/MILK-A22A2E/2020	EPI_ISL_612538	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-1B6BF17/2020	EPI_ISL_612553	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-1B6C0D7/2020	EPI_ISL_612562	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Wales/PHWC-47EF93/2020	EPI_ISL_612610	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47F017/2020	EPI_ISL_612617	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47F09F/2020	EPI_ISL_612625	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47F123/2020	EPI_ISL_612632	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47F17E/2020	EPI_ISL_612637	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47F1BA/2020	EPI_ISL_612641	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47F2B7/2020	EPI_ISL_612656	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	G
hCoV-19/Wales/PHWC-47F2E4/2020	EPI_ISL_612659	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47F32D/2020	EPI_ISL_612661	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47F3D2/2020	EPI_ISL_612670	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47F3F0/2020	EPI_ISL_612672	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47F475/2020	EPI_ISL_612679	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47F518/2020	EPI_ISL_612688	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47F6D9/2020	EPI_ISL_612713	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47F75E/2020	EPI_ISL_612720	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47FB8F/2020	EPI_ISL_612779	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47FCAA/2020	EPI_ISL_612796	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47FD98/2020	EPI_ISL_612808	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-47FE68/2020	EPI_ISL_612820	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47FF65/2020	EPI_ISL_612833	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-480347/2020	EPI_ISL_612876	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-480471/2020	EPI_ISL_612888	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4804F9/2020	EPI_ISL_612895	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4805F6/2020	EPI_ISL_612909	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-480602/2020	EPI_ISL_612910	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-480620/2020	EPI_ISL_612912	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4806E4/2020	EPI_ISL_612921	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48075A/2020	EPI_ISL_612926	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-480796/2020	EPI_ISL_612930	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-480981/2020	EPI_ISL_612955	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4809EB/2020	EPI_ISL_612959	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-480A15/2020	EPI_ISL_612960	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-480A24/2020	EPI_ISL_612961	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-480A60/2020	EPI_ISL_612963	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-480A7F/2020	EPI_ISL_612964	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/Wales/PHWC-480B21/2020	EPI_ISL_612973	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-480C5B/2020	EPI_ISL_612987	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-480D0D/2020	EPI_ISL_612994	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-480D94/2020	EPI_ISL_612999	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/USA/MI-MDHHS-SC22127/2020	EPI_ISL_614178	2020-09-30	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.1	GR
hCoV-19/Belgium/ULG-10604/2020	EPI_ISL_626249	2020-09-04	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/New Zealand/20CV0515/2020	EPI_ISL_626353	2020-10-30	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/New Zealand/20CV0516/2020	EPI_ISL_626354	2020-10-30	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/Czech Republic/NRL_9885/2020	EPI_ISL_626615	2020-10-11	Europe / Czech Republic / Central Bohemian Region / Bášť	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC-Medaka			B.1.1.294	GR
hCoV-19/Singapore/1122/2020	EPI_ISL_626633	2020-10-26	Asia / Singapore	Human	Original			Illumina MiSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/Wales/PHWC-4846A4/2020	EPI_ISL_628032	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.153	GR
hCoV-19/Wales/PHWC-4846C2/2020	EPI_ISL_628033	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4846FF/2020	EPI_ISL_628035	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4847DE/2020	EPI_ISL_628045	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-484A6C/2020	EPI_ISL_628071	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-484A7B/2020	EPI_ISL_628072	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-484BA5/2020	EPI_ISL_628085	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-484DDC/2020	EPI_ISL_628112	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-484F7C/2020	EPI_ISL_628129	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-484F8B/2020	EPI_ISL_628130	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4850C3/2020	EPI_ISL_628144	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48552E/2020	EPI_ISL_628188	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4857CE/2020	EPI_ISL_628220	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-485B1D/2020	EPI_ISL_628252	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-485E9C/2020	EPI_ISL_628289	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-486059/2020	EPI_ISL_628304	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/PORT-2D7246/2020	EPI_ISL_628328	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A322AB/2020	EPI_ISL_628340	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A322C9/2020	EPI_ISL_628342	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A322E7/2020	EPI_ISL_628344	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A3236C/2020	EPI_ISL_628348	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A3238A/2020	EPI_ISL_628349	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A3285E/2020	EPI_ISL_628360	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A334E0/2020	EPI_ISL_628386	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-A33529/2020	EPI_ISL_628390	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A335ED/2020	EPI_ISL_628396	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A34EB4/2020	EPI_ISL_628422	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A34F2A/2020	EPI_ISL_628427	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A49A12/2020	EPI_ISL_628445	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A49AA9/2020	EPI_ISL_628451	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A4B9AA/2020	EPI_ISL_628498	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A4BA6B/2020	EPI_ISL_628506	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A4BD26/2020	EPI_ISL_628525	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/QEUH-A4BE6F/2020	EPI_ISL_628531	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A4BFC6/2020	EPI_ISL_628535	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A4C147/2020	EPI_ISL_628546	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/QEUH-A4C95E/2020	EPI_ISL_628581	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/QEUH-A4C98B/2020	EPI_ISL_628582	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A4D1EC/2020	EPI_ISL_628590	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A4D5B3/2020	EPI_ISL_628605	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A4D771/2020	EPI_ISL_628611	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A615C8/2020	EPI_ISL_628620	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A615E6/2020	EPI_ISL_628621	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A61795/2020	EPI_ISL_628633	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A618CF/2020	EPI_ISL_628640	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A61A14/2020	EPI_ISL_628646	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A61D84/2020	EPI_ISL_628651	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A61E63/2020	EPI_ISL_628654	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A61E81/2020	EPI_ISL_628656	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A63FB9/2020	EPI_ISL_628680	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A63FD7/2020	EPI_ISL_628682	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A6401F/2020	EPI_ISL_628684	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A643BC/2020	EPI_ISL_628693	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AE319D/2020	EPI_ISL_633601	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AE2F1C/2020	EPI_ISL_633674	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AE3009/2020	EPI_ISL_633685	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AE2644/2020	EPI_ISL_633691	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B222BC/2020	EPI_ISL_646131	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B310DE/2020	EPI_ISL_646143	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B3195B/2020	EPI_ISL_646171	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B31D7D/2020	EPI_ISL_646183	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B31C16/2020	EPI_ISL_646194	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B23DF6/2020	EPI_ISL_646204	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-B31E98/2020	EPI_ISL_646216	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B318C7/2020	EPI_ISL_646217	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B23E5D/2020	EPI_ISL_646249	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/QEUH-B2F7ED/2020	EPI_ISL_646259	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B2E238/2020	EPI_ISL_646286	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B31BA0/2020	EPI_ISL_646289	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B32107/2020	EPI_ISL_646293	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B31CF8/2020	EPI_ISL_646331	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B31BFB/2020	EPI_ISL_646338	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B32116/2020	EPI_ISL_646339	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B31DC8/2020	EPI_ISL_646341	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B320FB/2020	EPI_ISL_646348	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2DD83/2020	EPI_ISL_646357	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-B3119F/2020	EPI_ISL_646374	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B31CAD/2020	EPI_ISL_646438	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2BAD9/2020	EPI_ISL_646456	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2C8A1/2020	EPI_ISL_646457	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2BA9D/2020	EPI_ISL_646460	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B264B2/2020	EPI_ISL_646467	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B250A0/2020	EPI_ISL_646485	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B2B6E4/2020	EPI_ISL_646498	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.170	GR
hCoV-19/England/ALDP-B26494/2020	EPI_ISL_646500	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2B65D/2020	EPI_ISL_646507	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B261E8/2020	EPI_ISL_646508	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2B699/2020	EPI_ISL_646562	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B24F1D/2020	EPI_ISL_646591	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AACA59/2020	EPI_ISL_651417	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-AAAF2F/2020	EPI_ISL_651471	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-AADE4D/2020	EPI_ISL_651478	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-AAECCA/2020	EPI_ISL_651481	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/BIRM-675EA/2020	EPI_ISL_651619	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B8A08/2020	EPI_ISL_651674	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-B23084/2020	EPI_ISL_651715	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR4867/2020	EPI_ISL_651735	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR5310/2020	EPI_ISL_651749	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR5358/2020	EPI_ISL_651777	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR5412/2020	EPI_ISL_651807	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/EDB8481/2020	EPI_ISL_651958	2020-10-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/EDB8483/2020	EPI_ISL_651959	2020-10-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-AAED03/2020	EPI_ISL_653000	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-AAEDD6/2020	EPI_ISL_653007	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AAF045/2020	EPI_ISL_653012	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-AAF485/2020	EPI_ISL_653025	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AF5F43/2020	EPI_ISL_653034	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AF5FE9/2020	EPI_ISL_653041	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/SHEF-C334C/2020	EPI_ISL_653062	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D3200/2020	EPI_ISL_653097	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Italy/APU-IZSPB_198PT/2020	EPI_ISL_653763	2020-08-28	Europe / Italy / Apulia / Bari	Human	Original	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1.229	GR
hCoV-19/Italy/APU-IZSPB_200PT/2020	EPI_ISL_653764	2020-08-28	Europe / Italy / Apulia / Bari	Human	Original	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1.229	GR
hCoV-19/England/LOND-1250D32/2020	EPI_ISL_665811	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.434	GR
hCoV-19/England/NORT-28CDD6/2020	EPI_ISL_665872	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-28D072/2020	EPI_ISL_665874	2020-10-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A493CC/2020	EPI_ISL_665960	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A4D0EF/2020	EPI_ISL_665963	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A7635D/2020	EPI_ISL_665971	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A7636C/2020	EPI_ISL_665972	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A9C95F/2020	EPI_ISL_665980	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A9FA1D/2020	EPI_ISL_665987	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A9FC26/2020	EPI_ISL_665993	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/USA/CA-ALSR-4598/2020	EPI_ISL_667030	2020-07-10	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/USA/OR-OHSU-4446/2020	EPI_ISL_667537	2020-11-05	North America / USA / Oregon	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1.186	GR
hCoV-19/Japan/IC-0171/2020	EPI_ISL_667600	2020-09-26	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	SKESA v. 2.3.0	NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/Japan/IC-0212/2020	EPI_ISL_667641	2020-06-22	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Japan/IC-0213/2020	EPI_ISL_667642	2020-06-22	Asia / Japan	Human	Original		COVID-19 positive case who entered from Philippines.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Japan/IC-0229/2020	EPI_ISL_667658	2020-08-07	Asia / Japan	Human	Original		COVID-19 positive case who entered from Russia.	Illumina NextSeq500	A5-miseq v. 20140604			B.1.1	GR
hCoV-19/Japan/IC-0292/2020	EPI_ISL_667721	2020-11-09	Asia / Japan	Human	Original		COVID-19 positive case who entered from Austria.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.1.170	GR
hCoV-19/England/CAMC-B79D00/2020	EPI_ISL_667870	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B79DA6/2020	EPI_ISL_667901	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B7EEEA/2020	EPI_ISL_667977	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B78C5F/2020	EPI_ISL_667991	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Denmark/DCGC-11669/2020	EPI_ISL_671057	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-11722/2020	EPI_ISL_671094	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-11737/2020	EPI_ISL_671105	2020-10-26	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-11760/2020	EPI_ISL_671116	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-11763/2020	EPI_ISL_671119	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-11764/2020	EPI_ISL_671120	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.170	GR
hCoV-19/Denmark/DCGC-11773/2020	EPI_ISL_671127	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-11791/2020	EPI_ISL_671139	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-11824/2020	EPI_ISL_671157	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	G
hCoV-19/Denmark/DCGC-11825/2020	EPI_ISL_671158	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.170	GR
hCoV-19/Denmark/DCGC-11890/2020	EPI_ISL_671199	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-11994/2020	EPI_ISL_671241	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Gibraltar/204841743/2020	EPI_ISL_671310	2020	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204841757/2020	EPI_ISL_671324	2020	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Ireland/D-NVRL-MPA24205/2020	EPI_ISL_671337	2020-05-01	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/CE-NVRL-MPW96382/2020	EPI_ISL_671352	2020-05-13	Europe / Ireland / Clare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/D-NVRL-MPP89189/2020	EPI_ISL_671356	2020-04-23	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/WW-NVRL-20Z06465/2020	EPI_ISL_671372	2020-04-17	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/WW-NVRL-20Z06456/2020	EPI_ISL_671389	2020-04-17	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/WW-NVRL-20Z06457/2020	EPI_ISL_671392	2020-04-17	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/WW-NVRL-20Z06466/2020	EPI_ISL_671393	2020-04-17	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Hungary/UD-56626/2020	EPI_ISL_671430	2020-09-01	Europe / Hungary / Borsod-Abauj-Zemplen County	Human	Original	Oropharyngeal swab		Nanopore MinION, Sanger	Geneious 10.2.4			B.1.1	GR
hCoV-19/Hungary/UD-57974/2020	EPI_ISL_671443	2020-09-02	Europe / Hungary / Borsod-Abauj-Zemplen County	Human	Original	Oropharyngeal swab		Nanopore MinION, Sanger	Geneious 10.2.4			B.1.1	GR
hCoV-19/England/20106005403/2020	EPI_ISL_417244	2020-03-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20109099006/2020	EPI_ISL_417297	2020-03-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20109099106/2020	EPI_ISL_417298	2020-03-08	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20109099206/2020	EPI_ISL_417299	2020-03-08	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Iceland/4/2020	EPI_ISL_417845	2020-03-13	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/Netherlands/Friesland_7/2020	EPI_ISL_422572	2020-03-28	Europe / Netherlands / Friesland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Germany/BY-MVP-0107/2020	EPI_ISL_437297	2020-04-13	Europe / Germany / Bavaria / Munich	Human	Original	Nasopharyngeal swab		Illumina Hiseq 1500	ARTIC V3 amplicons, Nextera XT library, bwa v0.7.17, iVar v1.2.2			B.1.1	GR
hCoV-19/England/CAMB-7BC0C/2020	EPI_ISL_442089	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7BD54/2020	EPI_ISL_442122	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7BE33/2020	EPI_ISL_442126	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7BDFA/2020	EPI_ISL_442163	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7BC57/2020	EPI_ISL_442176	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7D38D/2020	EPI_ISL_442252	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7D183/2020	EPI_ISL_442339	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/BRIS-1232A6/2020	EPI_ISL_442630	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12381D/2020	EPI_ISL_442638	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1236D7/2020	EPI_ISL_442660	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12380E/2020	EPI_ISL_442682	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-123B9C/2020	EPI_ISL_442688	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1234A0/2020	EPI_ISL_442727	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-123974/2020	EPI_ISL_442747	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12325B/2020	EPI_ISL_442758	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/BRIS-123B50/2020	EPI_ISL_442789	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-123A62/2020	EPI_ISL_442797	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-123B6F/2020	EPI_ISL_442802	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7D04A/2020	EPI_ISL_442811	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-808C4/2020	EPI_ISL_442885	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/New Zealand/20VR1018/2020	EPI_ISL_456183	2020-03-20	Oceania / New Zealand / Combined Wellington	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/New Zealand/20VR1773/2020	EPI_ISL_456244	2020-03-26	Oceania / New Zealand / Southern	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/New Zealand/20VR2475/2020	EPI_ISL_456379	2020-04-15	Oceania / New Zealand / Auckland	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/New Zealand/20VR3045/2020	EPI_ISL_456402	2020-04-25	Oceania / New Zealand / Combined Wellington	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Australia/VIC1372/2020	EPI_ISL_456414	2020-04-14	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V3 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.2.1, samtools v1.10			B.1.1	GR
hCoV-19/England/BIRM-5F327/2020	EPI_ISL_456671	2020-05-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B2EB7/2020	EPI_ISL_456731	2020-05-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR3368/2020	EPI_ISL_456798	2020-05-03	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E98E7/2020	EPI_ISL_461836	2020-04-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EA646/2020	EPI_ISL_461860	2020-05-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EA804/2020	EPI_ISL_461868	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/SHEF-C0EF3/2020	EPI_ISL_462000	2020-04-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C1F59/2020	EPI_ISL_462004	2020-04-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C2459/2020	EPI_ISL_462005	2020-05-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C92D0/2020	EPI_ISL_462038	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CB739/2020	EPI_ISL_462050	2020-04-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Russia/CRIE162784/2020	EPI_ISL_462150	2020-03-31	Europe / Russia / Moscow	Human	Original			Illumina MiSeq	Spades3.13			B.1.1.294	GR
hCoV-19/Belgium/LAM-0325339/2020	EPI_ISL_462193	2020-03-25	Europe / Belgium / Blankenberge	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/VAJ-0328370/2020	EPI_ISL_462224	2020-03-28	Europe / Belgium / Bevere	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/VGM-0402374/2020	EPI_ISL_462228	2020-04-02	Europe / Belgium / Vlamertinge	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-140002/2020	EPI_ISL_476081	2020-05-15	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.464	GR
hCoV-19/Switzerland/ZH-ETHZ-140028/2020	EPI_ISL_476093	2020-05-21	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.464	GR
hCoV-19/Sweden/20-51759/2020	EPI_ISL_476138	2020-05-27	Europe / Sweden / Uppsala	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/India/OR-ILSCV35750/2020	EPI_ISL_481205	2020-06-12	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1.1.340	GR
hCoV-19/Belgium/UGent-128/2020	EPI_ISL_481224	2020-05-15	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Ecuador/USFQ-054/2020	EPI_ISL_481246	2020-04-17	South America / Ecuador / Los Rios / Babahoyo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic Network			B.1.1	GR
hCoV-19/Ecuador/USFQ-066/2020	EPI_ISL_481248	2020-04-17	South America / Ecuador / Los Rios / Babahoyo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic Network			B.1.1	GR
hCoV-19/Japan/NGS-CD-010/2020	EPI_ISL_481255	2020-04-23	Asia / Japan / Nagasaki	Human	Vero			Illumina MiSeq	CLC Genomics Workbench			B.1.1	GR
hCoV-19/Japan/NGS-CD-024/2020	EPI_ISL_481257	2020-04-23	Asia / Japan / Nagasaki	Human	Vero			Illumina MiSeq	CLC Genomics Workbench			B.1.1	GR
hCoV-19/Japan/NGS-CD-107/2020	EPI_ISL_481258	2020-04-23	Asia / Japan / Nagasaki	Human	Vero			Illumina MiSeq	CLC Genomics Workbench			B.1.1.465	GR
hCoV-19/Japan/NGS-CD-235/2020	EPI_ISL_481259	2020-04-24	Asia / Japan / Nagasaki	Human	Vero			Illumina MiSeq	CLC Genomics Workbench			B.1.1.465	GR
hCoV-19/Japan/NGS-CD-292/2020	EPI_ISL_481260	2020-04-24	Asia / Japan / Nagasaki	Human	Vero			Illumina MiSeq	CLC Genomics Workbench			B.1.1.465	GR
hCoV-19/Japan/NGS-CD-361/2020	EPI_ISL_481261	2020-04-24	Asia / Japan / Nagasaki	Human	Vero			Illumina MiSeq	CLC Genomics Workbench			B.1.1.465	GR
hCoV-19/Japan/NGS-CD-365/2020	EPI_ISL_481263	2020-04-24	Asia / Japan / Nagasaki	Human	Vero			Illumina MiSeq	CLC Genomics Workbench	NS7a_E92stop results in 24.8% truncation of the protein sequence.	info	B.1.1.465	GR
hCoV-19/Finland/29M60S1/2020	EPI_ISL_481646	2020-03-29	Europe / Finland / Uusimaa	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.1	GR
hCoV-19/England/BRIS-12CBDF/2020	EPI_ISL_481818	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/India/TG-CCMB-M441/2020	EPI_ISL_495204	2020-06-09	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M465/2020	EPI_ISL_495209	2020-06-09	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M466/2020	EPI_ISL_495210	2020-06-09	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M489/2020	EPI_ISL_495212	2020-06-10	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M64/2020	EPI_ISL_495218	2020-06-05	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M651/2020	EPI_ISL_495219	2020-06-11	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M652/2020	EPI_ISL_495220	2020-06-11	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M696/2020	EPI_ISL_495224	2020-06-11	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M697/2020	EPI_ISL_495225	2020-06-11	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M700/2020	EPI_ISL_495228	2020-06-11	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M711/2020	EPI_ISL_495229	2020-06-11	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M712/2020	EPI_ISL_495230	2020-06-11	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M717/2020	EPI_ISL_495231	2020-06-11	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M740/2020	EPI_ISL_495235	2020-06-11	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M750/2020	EPI_ISL_495236	2020-06-12	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M785/2020	EPI_ISL_495241	2020-06-12	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M817/2020	EPI_ISL_495248	2020-06-12	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M818/2020	EPI_ISL_495249	2020-06-12	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M882/2020	EPI_ISL_495259	2020-06-12	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M892/2020	EPI_ISL_495261	2020-06-12	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-M950/2020	EPI_ISL_495266	2020-06-13	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-OM10/2020	EPI_ISL_495276	2020-05-15	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-OM18/2020	EPI_ISL_495284	2020-05-17	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-OM2/2020	EPI_ISL_495286	2020-05-13	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-OM2-ONT/2020	EPI_ISL_495287	2020-05-13	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-OM5/2020	EPI_ISL_495292	2020-05-14	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-OM6/2020	EPI_ISL_495293	2020-05-14	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-OM6-ONT/2020	EPI_ISL_495294	2020-05-14	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION	Reference based			B.1.1.306	GR
hCoV-19/USA/FL-BPHL-0494/2020	EPI_ISL_495400	2020-03-25	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1	GR
hCoV-19/England/BRIS-130EC0/2020	EPI_ISL_501597	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/WSFT-25C15F2/2020	EPI_ISL_501602	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/EKHU-260F18A/2020	EPI_ISL_501616	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Belgium/ULG-10267/2020	EPI_ISL_515074	2020-07-07	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Belgium/ULG-10268/2020	EPI_ISL_515075	2020-07-19	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Belgium/ULG-10269/2020	EPI_ISL_515076	2020-07-20	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Ghana/35012_S17/2020	EPI_ISL_515090	2020-05-23	Africa / Ghana	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA v. 0.7.17			B.1.1.485	GR
hCoV-19/Ghana/84430_S51/2020	EPI_ISL_515110	2020-05-25	Africa / Ghana	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA v. 0.7.17			B.1.1	GR
hCoV-19/South Africa/KRISP-K002309/2020	EPI_ISL_515685	2020-07-23	Africa / South Africa / KwaZulu-Natal / Amajuba	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/United Arab Emirates/L3290248480/2020	EPI_ISL_520693	2020-05-19	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1.263	GR
hCoV-19/United Arab Emirates/L3290263078/2020	EPI_ISL_520702	2020-05-20	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1.263	GR
hCoV-19/United Arab Emirates/L3290361549/2020	EPI_ISL_520708	2020-05-30	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1.366	GR
hCoV-19/United Arab Emirates/L3290362429/2020	EPI_ISL_520709	2020-05-30	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1.263	GR
hCoV-19/United Arab Emirates/L3300061195/2020	EPI_ISL_520713	2020-06-07	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1.366	GR
hCoV-19/United Arab Emirates/L920632111/2020	EPI_ISL_520720	2020-03-29	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/United Arab Emirates/L920633851/2020	EPI_ISL_520726	2020-03-31	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1.366	GR
hCoV-19/Australia/VIC3036/2020	EPI_ISL_520749	2020-06-28	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/USA/SC-DHEC-0534/2020	EPI_ISL_529082	2020-06-04	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina	DRAGEN v. 3.5.14			B.1	G
hCoV-19/England/ALDP-97F1C4/2020	EPI_ISL_529530	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-97F20D/2020	EPI_ISL_529531	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9805C4/2020	EPI_ISL_529540	2020-08-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-980B77/2020	EPI_ISL_529543	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-981FA7/2020	EPI_ISL_529549	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-982AB4/2020	EPI_ISL_529552	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9846AF/2020	EPI_ISL_529561	2020-07-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9846BE/2020	EPI_ISL_529562	2020-07-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9846CD/2020	EPI_ISL_529563	2020-07-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9846DC/2020	EPI_ISL_529564	2020-07-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9846EB/2020	EPI_ISL_529565	2020-07-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9846FA/2020	EPI_ISL_529566	2020-07-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-984D04/2020	EPI_ISL_529568	2020-08-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-985BDC/2020	EPI_ISL_529572	2020-08-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-987651/2020	EPI_ISL_529578	2020-08-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9877A9/2020	EPI_ISL_529581	2020-08-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-61ED6/2020	EPI_ISL_529616	2020-03-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-61F1F/2020	EPI_ISL_529617	2020-03-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-112FA3/2020	EPI_ISL_529667	2020-08-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C1092/2020	EPI_ISL_529675	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C666E/2020	EPI_ISL_529680	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	GR
hCoV-19/England/SHEF-C6EB1/2020	EPI_ISL_529681	2020-05-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	GR
hCoV-19/Scotland/CVR3977/2020	EPI_ISL_529688	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/South Africa/KRISP-K002805/2020	EPI_ISL_529799	2020-08-24	Africa / South Africa / KwaZulu-Natal / uThukela	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/England/SHEF-C0FE1/2020	EPI_ISL_535044	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C1487/2020	EPI_ISL_535047	2020-05-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	GR
hCoV-19/England/SHEF-C4114/2020	EPI_ISL_535052	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C6419/2020	EPI_ISL_535060	2020-05-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C64DD/2020	EPI_ISL_535061	2020-05-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C8B7C/2020	EPI_ISL_535064	2020-05-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CAC3B/2020	EPI_ISL_535071	2020-08-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CD9D7/2020	EPI_ISL_535080	2020-05-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CE11A/2020	EPI_ISL_535084	2020-05-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CEBEF/2020	EPI_ISL_535087	2020-05-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CF79F/2020	EPI_ISL_535089	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D1B25/2020	EPI_ISL_535095	2020-05-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D1CC8/2020	EPI_ISL_535096	2020-05-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-D1EB3/2020	EPI_ISL_535097	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR4073/2020	EPI_ISL_535164	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/PHWC-169FDA/2020	EPI_ISL_535184	2020-09-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/South Africa/KRISP-K002601/2020	EPI_ISL_535465	2020-07-30	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/Switzerland/BL-ETHZ-250090/2020	EPI_ISL_535608	2020-08-19	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/USA/CA-CDC-4687/2020	EPI_ISL_535665	2020-06-02	North America / USA / California	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1	GR
hCoV-19/USA/CA-CDC-4689/2020	EPI_ISL_535667	2020-06-02	North America / USA / California	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1	GR
hCoV-19/USA/CA-CDC-4690/2020	EPI_ISL_535668	2020-06-02	North America / USA / California	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1	GR
hCoV-19/USA/CA-CDC-4707/2020	EPI_ISL_535684	2020-06-04	North America / USA / California	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1	GR
hCoV-19/USA/CA-CDC-4710/2020	EPI_ISL_535686	2020-06-04	North America / USA / California	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1	GR
hCoV-19/USA/CA-CDC-4712/2020	EPI_ISL_535688	2020-06-04	North America / USA / California	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1	GR
hCoV-19/USA/CA-CDC-4715/2020	EPI_ISL_535691	2020-06-04	North America / USA / California	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1.1	GR
hCoV-19/England/QEUH-98F941/2020	EPI_ISL_540009	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-98F56B/2020	EPI_ISL_540019	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-99038B/2020	EPI_ISL_540025	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/QEUH-98F659/2020	EPI_ISL_540032	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-998505/2020	EPI_ISL_540041	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-98FFD6/2020	EPI_ISL_540058	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-98FCFD/2020	EPI_ISL_540060	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-98F8EA/2020	EPI_ISL_540062	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-98FC84/2020	EPI_ISL_540075	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-98F7B0/2020	EPI_ISL_540081	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-98FD45/2020	EPI_ISL_540097	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-98F932/2020	EPI_ISL_540123	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-98F64A/2020	EPI_ISL_540128	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9A4603/2020	EPI_ISL_540144	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9A40E7/2020	EPI_ISL_540146	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9A4427/2020	EPI_ISL_540149	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9A43FD/2020	EPI_ISL_540157	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9A40D8/2020	EPI_ISL_540164	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9A45D9/2020	EPI_ISL_540203	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-9A408D/2020	EPI_ISL_540205	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9A4515/2020	EPI_ISL_540218	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9A45E8/2020	EPI_ISL_540221	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-9A407E/2020	EPI_ISL_540230	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9A44EB/2020	EPI_ISL_540231	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96FADB/2020	EPI_ISL_540239	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-96FA26/2020	EPI_ISL_540246	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-96FA17/2020	EPI_ISL_540252	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-96FCC6/2020	EPI_ISL_540253	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96FACC/2020	EPI_ISL_540265	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-97015A/2020	EPI_ISL_540288	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96FABD/2020	EPI_ISL_540290	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-96F8FF/2020	EPI_ISL_540291	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-96FA62/2020	EPI_ISL_540303	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-96FA80/2020	EPI_ISL_540311	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-96FA08/2020	EPI_ISL_540312	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9700A8/2020	EPI_ISL_540314	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96F90B/2020	EPI_ISL_540320	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-96FA71/2020	EPI_ISL_540326	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-96F877/2020	EPI_ISL_540340	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-98F0B5/2020	EPI_ISL_540348	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-98F3BC/2020	EPI_ISL_540349	2020-08-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-98EFAA/2020	EPI_ISL_540411	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96B046/2020	EPI_ISL_540419	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/LIVE-ABCB8/2020	EPI_ISL_540629	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/MILK-99225F/2020	EPI_ISL_540663	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/SHEF-C0B65/2020	EPI_ISL_540719	2020-08-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C184F/2020	EPI_ISL_540720	2020-08-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C24FF/2020	EPI_ISL_540722	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C483D/2020	EPI_ISL_540728	2020-05-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C509E/2020	EPI_ISL_540729	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C5896/2020	EPI_ISL_540732	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C5D5B/2020	EPI_ISL_540733	2020-08-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C6E75/2020	EPI_ISL_540735	2020-08-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C7111/2020	EPI_ISL_540736	2020-08-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C96D4/2020	EPI_ISL_540744	2020-08-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C9D2A/2020	EPI_ISL_540746	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/SHEF-CAA31/2020	EPI_ISL_540751	2020-08-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CDDAE/2020	EPI_ISL_540756	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CE8BB/2020	EPI_ISL_540758	2020-08-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CF243/2020	EPI_ISL_540760	2020-08-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D0C6F/2020	EPI_ISL_540767	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-D1141/2020	EPI_ISL_540768	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR3994/2020	EPI_ISL_540791	2020-09-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR4146/2020	EPI_ISL_540833	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR4166/2020	EPI_ISL_540847	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR4182/2020	EPI_ISL_540858	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/EDB7739/2020	EPI_ISL_540882	2020-09-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Norway/3208/2020	EPI_ISL_549036	2020-08-26	Europe / Norway / Viken	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.170	GR
hCoV-19/England/CAMC-9B1F26/2020	EPI_ISL_549403	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/CAMC-9B1FEA/2020	EPI_ISL_549404	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9A871B/2020	EPI_ISL_549415	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9A8793/2020	EPI_ISL_549420	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9A87DF/2020	EPI_ISL_549423	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9A87FD/2020	EPI_ISL_549425	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9A8933/2020	EPI_ISL_549434	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9A8951/2020	EPI_ISL_549436	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9AB578/2020	EPI_ISL_549443	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9AB61B/2020	EPI_ISL_549449	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9AB745/2020	EPI_ISL_549457	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9AB772/2020	EPI_ISL_549458	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9AB781/2020	EPI_ISL_549459	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9C4807/2020	EPI_ISL_549466	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9C4834/2020	EPI_ISL_549468	2020-09-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9C498C/2020	EPI_ISL_549471	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORW-EE6D9/2020	EPI_ISL_549478	2020-04-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORW-EFC7C/2020	EPI_ISL_549487	2020-04-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-11335B/2020	EPI_ISL_549499	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NOTT-113591/2020	EPI_ISL_549516	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-997A61/2020	EPI_ISL_549540	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9B8BFE/2020	EPI_ISL_549551	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B8578/2020	EPI_ISL_549555	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B8BA3/2020	EPI_ISL_549557	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9B86C0/2020	EPI_ISL_549576	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B9058/2020	EPI_ISL_549579	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9B8F4D/2020	EPI_ISL_549583	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B83AB/2020	EPI_ISL_549599	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B8D16/2020	EPI_ISL_549605	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B887F/2020	EPI_ISL_549627	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9B9CFA/2020	EPI_ISL_549643	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9B92E9/2020	EPI_ISL_549648	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B8666/2020	EPI_ISL_549657	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B83D8/2020	EPI_ISL_549658	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/QEUH-9B9B57/2020	EPI_ISL_549682	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B9DF7/2020	EPI_ISL_549696	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B8B94/2020	EPI_ISL_549780	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B8D9E/2020	EPI_ISL_549787	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B8BC1/2020	EPI_ISL_549793	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B8CA0/2020	EPI_ISL_549796	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99CBF0/2020	EPI_ISL_549911	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99D0A5/2020	EPI_ISL_549916	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99CECA/2020	EPI_ISL_549918	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99CC0C/2020	EPI_ISL_549922	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99D05A/2020	EPI_ISL_549923	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99CF30/2020	EPI_ISL_549925	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99D0B4/2020	EPI_ISL_549926	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99D667/2020	EPI_ISL_549932	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99D0C3/2020	EPI_ISL_549935	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A6D84/2020	EPI_ISL_549948	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A6759/2020	EPI_ISL_549955	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A55C9/2020	EPI_ISL_549958	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A6EDC/2020	EPI_ISL_549962	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A505F/2020	EPI_ISL_549969	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9A6926/2020	EPI_ISL_549973	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/MILK-9A8696/2020	EPI_ISL_549979	2020-09-02	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A848D/2020	EPI_ISL_549980	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A571E/2020	EPI_ISL_549990	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/ALDP-9560D5/2020	EPI_ISL_554016	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95276B/2020	EPI_ISL_554023	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-956169/2020	EPI_ISL_554031	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-955C78/2020	EPI_ISL_554032	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-955B11/2020	EPI_ISL_554036	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-952507/2020	EPI_ISL_554041	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9564F7/2020	EPI_ISL_554050	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95614B/2020	EPI_ISL_554061	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9594D6/2020	EPI_ISL_554065	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-952A44/2020	EPI_ISL_554085	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.263	GR
hCoV-19/England/ALDP-95659A/2020	EPI_ISL_554086	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9565B8/2020	EPI_ISL_554090	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-9562A2/2020	EPI_ISL_554095	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9573DB/2020	EPI_ISL_554099	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95280E/2020	EPI_ISL_554117	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-951061/2020	EPI_ISL_554136	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-956E53/2020	EPI_ISL_554137	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9569E9/2020	EPI_ISL_554173	2020-06-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9510AD/2020	EPI_ISL_554174	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9511AA/2020	EPI_ISL_554188	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-957B3D/2020	EPI_ISL_554200	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-951034/2020	EPI_ISL_554202	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-957AC7/2020	EPI_ISL_554223	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-957B2E/2020	EPI_ISL_554226	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-951070/2020	EPI_ISL_554227	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9510BC/2020	EPI_ISL_554233	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/MILK-956B7A/2020	EPI_ISL_554237	2020-06-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95117D/2020	EPI_ISL_554263	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95108F/2020	EPI_ISL_554270	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-956B98/2020	EPI_ISL_554271	2020-06-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95116E/2020	EPI_ISL_554279	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-951007/2020	EPI_ISL_554280	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95109E/2020	EPI_ISL_554282	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-956AB9/2020	EPI_ISL_554290	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9570B6/2020	EPI_ISL_554294	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95082E/2020	EPI_ISL_554323	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95367C/2020	EPI_ISL_554345	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95375B/2020	EPI_ISL_554355	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-953418/2020	EPI_ISL_554364	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-950BF8/2020	EPI_ISL_554365	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95374C/2020	EPI_ISL_554368	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-954374/2020	EPI_ISL_554374	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-950800/2020	EPI_ISL_554379	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-950A46/2020	EPI_ISL_554383	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-953779/2020	EPI_ISL_554399	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-950C7D/2020	EPI_ISL_554405	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-955452/2020	EPI_ISL_554417	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-953427/2020	EPI_ISL_554443	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9558DE/2020	EPI_ISL_554444	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9532B4/2020	EPI_ISL_554452	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-953FDB/2020	EPI_ISL_554454	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95086A/2020	EPI_ISL_554469	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-953788/2020	EPI_ISL_554474	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9534DC/2020	EPI_ISL_554503	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9507E5/2020	EPI_ISL_554504	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-954277/2020	EPI_ISL_554508	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-950C31/2020	EPI_ISL_554514	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-950C40/2020	EPI_ISL_554521	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-953ABC/2020	EPI_ISL_554531	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-955443/2020	EPI_ISL_554533	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9533FD/2020	EPI_ISL_554534	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-950C22/2020	EPI_ISL_554535	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9533EE/2020	EPI_ISL_554544	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95085B/2020	EPI_ISL_554558	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9508B5/2020	EPI_ISL_554575	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-950879/2020	EPI_ISL_554592	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9554AD/2020	EPI_ISL_554595	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9540AA/2020	EPI_ISL_554610	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-943FA1/2020	EPI_ISL_554626	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-958862/2020	EPI_ISL_554633	2020-06-13	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-957E16/2020	EPI_ISL_554673	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-944623/2020	EPI_ISL_554696	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94426B/2020	EPI_ISL_554708	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-944298/2020	EPI_ISL_554727	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9442C5/2020	EPI_ISL_554757	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9443A4/2020	EPI_ISL_554759	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9586A4/2020	EPI_ISL_554768	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9586E0/2020	EPI_ISL_554784	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9586B3/2020	EPI_ISL_554790	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-944650/2020	EPI_ISL_554794	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-944641/2020	EPI_ISL_554804	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94423E/2020	EPI_ISL_554808	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94424D/2020	EPI_ISL_554809	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9441AA/2020	EPI_ISL_554812	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9443E0/2020	EPI_ISL_554813	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/MILK-9583BC/2020	EPI_ISL_554821	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-943F47/2020	EPI_ISL_554830	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94427A/2020	EPI_ISL_554841	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-957F31/2020	EPI_ISL_554843	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95CD9C/2020	EPI_ISL_554871	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-95CD41/2020	EPI_ISL_554873	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-95CE02/2020	EPI_ISL_554874	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-95CE20/2020	EPI_ISL_554880	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-95A0B3/2020	EPI_ISL_554901	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94D5A5/2020	EPI_ISL_554911	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C36D/2020	EPI_ISL_554915	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-95CFE1/2020	EPI_ISL_554917	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95A61B/2020	EPI_ISL_554918	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C38B/2020	EPI_ISL_554920	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-95C1EB/2020	EPI_ISL_554934	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C109/2020	EPI_ISL_554945	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C637/2020	EPI_ISL_554951	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C646/2020	EPI_ISL_554985	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C682/2020	EPI_ISL_554998	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6CA497/2020	EPI_ISL_556107	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C066/2020	EPI_ISL_556110	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6C6AC6/2020	EPI_ISL_556114	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6CA109/2020	EPI_ISL_556122	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6D6489/2020	EPI_ISL_556147	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6D6665/2020	EPI_ISL_556153	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6C44E8/2020	EPI_ISL_556167	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-99C370/2020	EPI_ISL_560003	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-9ACC45/2020	EPI_ISL_560004	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9AD066/2020	EPI_ISL_560017	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9B0D87/2020	EPI_ISL_560042	2020-09-03	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.306	GR
hCoV-19/Scotland/QEUH-9B3A50/2020	EPI_ISL_560056	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9B3C78/2020	EPI_ISL_560061	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/PHWC-16A7D1/2020	EPI_ISL_560106	2020-09-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16AA23/2020	EPI_ISL_560141	2020-09-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/Wales/PHWC-16AB3F/2020	EPI_ISL_560158	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Russia/SVE-RII-MH199S/2020	EPI_ISL_560313	2020-07-16	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/SVE-RII-MH200S/2020	EPI_ISL_560314	2020-07-17	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Switzerland/BE-ETHZ-280195/2020	EPI_ISL_560445	2020-09-09	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.144	GR
hCoV-19/Switzerland/BL-ETHZ-280150/2020	EPI_ISL_560459	2020-09-09	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-280073/2020	EPI_ISL_560542	2020-09-07	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.144	GR
hCoV-19/Switzerland/ZH-ETHZ-280174/2020	EPI_ISL_560549	2020-09-08	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/USA/AK-PHL477/2020	EPI_ISL_560562	2020-06-12	North America / USA / Alaska / Anchorage-Mat Su	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.228	GR
hCoV-19/USA/AK-PHL534/2020	EPI_ISL_560566	2020-06-18	North America / USA / Alaska / Anchorage-Mat Su	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.228	GR
hCoV-19/England/GSTT-5179/2020	EPI_ISL_560656	2020-03-18	Europe / United Kingdom / England / London	Human	Original			Oxford Nanopore	Artic v1.0 nanopolish			B.1.1	GR
hCoV-19/England/GSTT-5203/2020	EPI_ISL_560661	2020-03-19	Europe / United Kingdom / England / London	Human	Original			Oxford Nanopore	Artic v1.0 nanopolish			B.1.1	GR
hCoV-19/USA/FL-BPHL-1505/2020	EPI_ISL_568603	2020-07-24	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1.186	GR
hCoV-19/Wales/PHWC-16BFE7/2020	EPI_ISL_574000	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16C13B/2020	EPI_ISL_574014	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16C195/2020	EPI_ISL_574019	2020-09-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16C2CF/2020	EPI_ISL_574035	2020-09-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16C326/2020	EPI_ISL_574041	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16C405/2020	EPI_ISL_574053	2020-09-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16C5A8/2020	EPI_ISL_574069	2020-09-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16C5B7/2020	EPI_ISL_574070	2020-09-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16C7A2/2020	EPI_ISL_574092	2020-09-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16C942/2020	EPI_ISL_574113	2020-09-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16CB6A/2020	EPI_ISL_574139	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16CB88/2020	EPI_ISL_574141	2020-09-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16CE43/2020	EPI_ISL_574175	2020-09-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16CFE6/2020	EPI_ISL_574194	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16D1D0/2020	EPI_ISL_574210	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16D228/2020	EPI_ISL_574214	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Ecuador/USFQ-253/2020	EPI_ISL_574431	2020-09-14	South America / Ecuador / Los Rios / Babahoyo	Human	Original			Nanopore MinION	ARTIC Network			B.1.1	GR
hCoV-19/Singapore/1025/2020	EPI_ISL_574510	2020-03-23	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/USA/SC-DHEC-1132/2020	EPI_ISL_574558	2020-07-10	North America / USA / South Carolina / Georgetown County	Human	Original	Nasopharyngeal swab		Illumina	DRAGEN v. 3.5.15			B.1	G
hCoV-19/USA/SC-DHEC-1133/2020	EPI_ISL_574559	2020-07-10	North America / USA / South Carolina / Georgetown County	Human	Original	Nasopharyngeal swab		Illumina	DRAGEN v. 3.5.15			B.1	G
hCoV-19/Switzerland/BE-ETHZ-100378/2020	EPI_ISL_574929	2020-03-20	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/GR-ETHZ-100156/2020	EPI_ISL_574944	2020-03-17	Europe / Switzerland / Grisons	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/England/ALDP-9FDCFA/2020	EPI_ISL_588006	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FD47A/2020	EPI_ISL_588009	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FDF1F/2020	EPI_ISL_588024	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FCDAD/2020	EPI_ISL_588034	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9FDA0F/2020	EPI_ISL_588041	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9FDFE2/2020	EPI_ISL_588046	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FC763/2020	EPI_ISL_588048	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FA4B9/2020	EPI_ISL_588064	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FA765/2020	EPI_ISL_588071	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FAE33/2020	EPI_ISL_588072	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FAB1E/2020	EPI_ISL_588081	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FA6D1/2020	EPI_ISL_588088	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9FADBE/2020	EPI_ISL_588094	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FB2DC/2020	EPI_ISL_588098	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FB00F/2020	EPI_ISL_588099	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FB087/2020	EPI_ISL_588102	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FB096/2020	EPI_ISL_588108	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FAAB7/2020	EPI_ISL_588109	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FB315/2020	EPI_ISL_588111	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FA8BD/2020	EPI_ISL_588117	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FB342/2020	EPI_ISL_588122	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9FAA8A/2020	EPI_ISL_588123	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FB272/2020	EPI_ISL_588129	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FB166/2020	EPI_ISL_588133	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FB157/2020	EPI_ISL_588136	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FAA5D/2020	EPI_ISL_588138	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9FAECA/2020	EPI_ISL_588139	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FAB87/2020	EPI_ISL_588140	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FB324/2020	EPI_ISL_588141	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FB2EB/2020	EPI_ISL_588142	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FB139/2020	EPI_ISL_588146	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FAAC6/2020	EPI_ISL_588151	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FAE8E/2020	EPI_ISL_588155	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FB0D2/2020	EPI_ISL_588162	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FAFD6/2020	EPI_ISL_588163	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FB0C3/2020	EPI_ISL_588165	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FB01E/2020	EPI_ISL_588192	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FAFB8/2020	EPI_ISL_588195	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FAFC7/2020	EPI_ISL_588196	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FB069/2020	EPI_ISL_588197	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FA352/2020	EPI_ISL_588202	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FB290/2020	EPI_ISL_588203	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FAE42/2020	EPI_ISL_588210	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9FB0A5/2020	EPI_ISL_588212	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FABB4/2020	EPI_ISL_588219	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FB04B/2020	EPI_ISL_588222	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FABC3/2020	EPI_ISL_588227	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FAFF4/2020	EPI_ISL_588229	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FB11B/2020	EPI_ISL_588230	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FAC48/2020	EPI_ISL_588231	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FAF5E/2020	EPI_ISL_588232	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FB12A/2020	EPI_ISL_588235	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FA7CF/2020	EPI_ISL_588251	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FAF30/2020	EPI_ISL_588253	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FB588/2020	EPI_ISL_588257	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FA71A/2020	EPI_ISL_588258	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9FA817/2020	EPI_ISL_588260	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FAC2A/2020	EPI_ISL_588261	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FB2BE/2020	EPI_ISL_588267	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FA826/2020	EPI_ISL_588271	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FAFA9/2020	EPI_ISL_588273	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FB333/2020	EPI_ISL_588274	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F5E92/2020	EPI_ISL_588282	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F4965/2020	EPI_ISL_588283	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F6A42/2020	EPI_ISL_588303	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F4A9F/2020	EPI_ISL_588304	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F6A60/2020	EPI_ISL_588310	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F4C20/2020	EPI_ISL_588316	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F6AAC/2020	EPI_ISL_588319	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F4C3F/2020	EPI_ISL_588322	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F6A9D/2020	EPI_ISL_588344	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F5849/2020	EPI_ISL_588345	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-9F47B6/2020	EPI_ISL_588352	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F4B23/2020	EPI_ISL_588359	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F4561/2020	EPI_ISL_588364	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F480E/2020	EPI_ISL_588365	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F69DC/2020	EPI_ISL_588383	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F491A/2020	EPI_ISL_588403	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F45AD/2020	EPI_ISL_588409	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F47E3/2020	EPI_ISL_588420	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9F6A24/2020	EPI_ISL_588427	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F4B50/2020	EPI_ISL_588439	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F5278/2020	EPI_ISL_588444	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-9F4B32/2020	EPI_ISL_588447	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9F4D0F/2020	EPI_ISL_588467	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F5D95/2020	EPI_ISL_588468	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F34B0/2020	EPI_ISL_588483	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F2E1D/2020	EPI_ISL_588485	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-9F3359/2020	EPI_ISL_588487	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F4112/2020	EPI_ISL_588488	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F2EB3/2020	EPI_ISL_588504	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F382D/2020	EPI_ISL_588514	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F3C9A/2020	EPI_ISL_588517	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F3A18/2020	EPI_ISL_588518	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F35AE/2020	EPI_ISL_588524	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F3FEC/2020	EPI_ISL_588525	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F3BBB/2020	EPI_ISL_588528	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F34A1/2020	EPI_ISL_588531	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F3EC1/2020	EPI_ISL_588533	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F2EE0/2020	EPI_ISL_588538	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F40CA/2020	EPI_ISL_588539	2020-08-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/QEUH-9F54CD/2020	EPI_ISL_588552	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-9F4121/2020	EPI_ISL_588553	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F366F/2020	EPI_ISL_588555	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F4385/2020	EPI_ISL_588558	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F3571/2020	EPI_ISL_588561	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F37F3/2020	EPI_ISL_588566	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F3E3A/2020	EPI_ISL_588567	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F39A2/2020	EPI_ISL_588573	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F4051/2020	EPI_ISL_588582	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9F430D/2020	EPI_ISL_588590	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F4033/2020	EPI_ISL_588604	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F31AA/2020	EPI_ISL_588607	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F40AC/2020	EPI_ISL_588608	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F3CB8/2020	EPI_ISL_588620	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F3ACD/2020	EPI_ISL_588622	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F3562/2020	EPI_ISL_588623	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F3E94/2020	EPI_ISL_588624	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F3A09/2020	EPI_ISL_588627	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F41F4/2020	EPI_ISL_588630	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F4376/2020	EPI_ISL_588633	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F5560/2020	EPI_ISL_588649	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9F3C5E/2020	EPI_ISL_588651	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F4358/2020	EPI_ISL_588661	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F3614/2020	EPI_ISL_588666	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F40E8/2020	EPI_ISL_588668	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F557F/2020	EPI_ISL_588678	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F3544/2020	EPI_ISL_588686	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F391B/2020	EPI_ISL_588696	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/QEUH-9F55BB/2020	EPI_ISL_588699	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F419A/2020	EPI_ISL_588702	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F3386/2020	EPI_ISL_588709	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F41B8/2020	EPI_ISL_588712	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F3EEF/2020	EPI_ISL_588716	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F3878/2020	EPI_ISL_588719	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9F3AAF/2020	EPI_ISL_588720	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F3D88/2020	EPI_ISL_588722	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-9F81F0/2020	EPI_ISL_588725	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F82B1/2020	EPI_ISL_588732	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F88EC/2020	EPI_ISL_588733	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8239/2020	EPI_ISL_588746	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8020/2020	EPI_ISL_588747	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F7C96/2020	EPI_ISL_588753	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8C0E/2020	EPI_ISL_588755	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F82DF/2020	EPI_ISL_588756	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F573D/2020	EPI_ISL_588760	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F5F35/2020	EPI_ISL_588763	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F8002/2020	EPI_ISL_588764	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7F9D/2020	EPI_ISL_588768	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F87D0/2020	EPI_ISL_588771	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8433/2020	EPI_ISL_588774	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F90A7/2020	EPI_ISL_588780	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AN.1	GR
hCoV-19/England/QEUH-9F8318/2020	EPI_ISL_588782	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F8309/2020	EPI_ISL_588785	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F623B/2020	EPI_ISL_588787	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9F8E71/2020	EPI_ISL_588790	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8327/2020	EPI_ISL_588791	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8284/2020	EPI_ISL_588798	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F92CF/2020	EPI_ISL_588804	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F8275/2020	EPI_ISL_588810	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7FF7/2020	EPI_ISL_588813	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F7CB4/2020	EPI_ISL_588815	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F8BF2/2020	EPI_ISL_588817	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7F60/2020	EPI_ISL_588820	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F56D6/2020	EPI_ISL_588822	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F6031/2020	EPI_ISL_588829	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8257/2020	EPI_ISL_588833	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F82A2/2020	EPI_ISL_588835	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8B89/2020	EPI_ISL_588837	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8776/2020	EPI_ISL_588838	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F82C0/2020	EPI_ISL_588843	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F63DE/2020	EPI_ISL_588852	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7D1B/2020	EPI_ISL_588857	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8943/2020	EPI_ISL_588863	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8C1D/2020	EPI_ISL_588864	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F804E/2020	EPI_ISL_588865	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7F7F/2020	EPI_ISL_588869	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F8CFF/2020	EPI_ISL_588871	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8354/2020	EPI_ISL_588874	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F903E/2020	EPI_ISL_588880	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F86D3/2020	EPI_ISL_588887	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F60E6/2020	EPI_ISL_588889	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8E08/2020	EPI_ISL_588895	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8D38/2020	EPI_ISL_588898	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F56F4/2020	EPI_ISL_588900	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F576A/2020	EPI_ISL_588903	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8C86/2020	EPI_ISL_588904	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8248/2020	EPI_ISL_588906	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F8D1A/2020	EPI_ISL_588915	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F6347/2020	EPI_ISL_588918	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8C3B/2020	EPI_ISL_588926	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F5A07/2020	EPI_ISL_588934	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9F86B5/2020	EPI_ISL_588935	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F9423/2020	EPI_ISL_588937	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F8C68/2020	EPI_ISL_588944	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F5779/2020	EPI_ISL_588948	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8372/2020	EPI_ISL_588949	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8D0B/2020	EPI_ISL_588950	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F821B/2020	EPI_ISL_588955	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F805D/2020	EPI_ISL_588965	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F5700/2020	EPI_ISL_588968	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7FAC/2020	EPI_ISL_588972	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F82FD/2020	EPI_ISL_588977	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F907A/2020	EPI_ISL_588978	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F8E17/2020	EPI_ISL_588981	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F8363/2020	EPI_ISL_588982	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F87A3/2020	EPI_ISL_588987	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F822A/2020	EPI_ISL_588991	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F56E5/2020	EPI_ISL_588994	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Australia/NSW1041/2020	EPI_ISL_593693	2020-06-29	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1	GR
hCoV-19/England/204221403/2020	EPI_ISL_593797	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/204221432/2020	EPI_ISL_593808	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.170	GR
hCoV-19/England/204221433/2020	EPI_ISL_593809	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.170	GR
hCoV-19/England/204221437/2020	EPI_ISL_593811	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.170	GR
hCoV-19/England/204221444/2020	EPI_ISL_593815	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.170	GR
hCoV-19/England/204221446/2020	EPI_ISL_593817	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.170	GR
hCoV-19/France/OCC-62/2020	EPI_ISL_593877	2020-07-29	Europe / France / Occitanie	Human	Original	Nasopharyngeal swab		Pacific Biosciences Sequel I	Minimap2, bcftools			B.1.1	GR
hCoV-19/France/OCC-69/2020	EPI_ISL_593883	2020-07-22	Europe / France / Occitanie	Human	Original	Nasopharyngeal swab		Pacific Biosciences Sequel I	Minimap2, bcftools			B.1.1	GR
hCoV-19/France/OCC-70/2020	EPI_ISL_593884	2020-08-02	Europe / France / Occitanie	Human	Original	Nasopharyngeal swab		Pacific Biosciences Sequel I	Minimap2, bcftools			B.1.1	GR
hCoV-19/France/OCC-71/2020	EPI_ISL_593885	2020-08-01	Europe / France / Occitanie	Human	Original	Nasopharyngeal swab		Pacific Biosciences Sequel I	Minimap2, bcftools			B.1.1	GR
hCoV-19/France/OCC-72/2020	EPI_ISL_593886	2020-08-01	Europe / France / Occitanie	Human	Original	Nasopharyngeal swab		Pacific Biosciences Sequel I	Minimap2, bcftools			B.1.1	GR
hCoV-19/England/QEUH-9F77D1/2020	EPI_ISL_595703	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F77E0/2020	EPI_ISL_595704	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F780B/2020	EPI_ISL_595705	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F781A/2020	EPI_ISL_595706	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F7829/2020	EPI_ISL_595707	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F7838/2020	EPI_ISL_595708	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F78B0/2020	EPI_ISL_595710	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F78FC/2020	EPI_ISL_595711	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F7926/2020	EPI_ISL_595712	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F7971/2020	EPI_ISL_595713	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F79DB/2020	EPI_ISL_595715	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F79EA/2020	EPI_ISL_595716	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-A70872/2020	EPI_ISL_608004	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6D0CB/2020	EPI_ISL_608007	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6D25C/2020	EPI_ISL_608009	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6C81F/2020	EPI_ISL_608018	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A707B1/2020	EPI_ISL_608026	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6D8D2/2020	EPI_ISL_608038	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A6D104/2020	EPI_ISL_608055	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6D4DE/2020	EPI_ISL_608063	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6FAF8/2020	EPI_ISL_608065	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6D140/2020	EPI_ISL_608071	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6FE29/2020	EPI_ISL_608075	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6D0DA/2020	EPI_ISL_608076	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 8 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A6C4EE/2020	EPI_ISL_608103	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A6C40C/2020	EPI_ISL_608108	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6FECF/2020	EPI_ISL_608110	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6FA9E/2020	EPI_ISL_608121	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6D18C/2020	EPI_ISL_608129	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A708BE/2020	EPI_ISL_608131	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6D298/2020	EPI_ISL_608134	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6C466/2020	EPI_ISL_608143	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A6CCD7/2020	EPI_ISL_608159	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6C33C/2020	EPI_ISL_608164	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.307	GR
hCoV-19/England/ALDP-A6D2F2/2020	EPI_ISL_608167	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6C3D2/2020	EPI_ISL_608180	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6D043/2020	EPI_ISL_608185	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6C69D/2020	EPI_ISL_608186	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6D19B/2020	EPI_ISL_608203	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6D052/2020	EPI_ISL_608229	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6CB9E/2020	EPI_ISL_608244	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6FB04/2020	EPI_ISL_608246	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A707C0/2020	EPI_ISL_608248	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6D30E/2020	EPI_ISL_608254	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A70784/2020	EPI_ISL_608257	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6C68E/2020	EPI_ISL_608261	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6C563/2020	EPI_ISL_608275	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6D2A7/2020	EPI_ISL_608276	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6C651/2020	EPI_ISL_608282	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6CFDE/2020	EPI_ISL_608284	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6D2C5/2020	EPI_ISL_608288	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6C606/2020	EPI_ISL_608299	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6FE92/2020	EPI_ISL_608301	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6CE95/2020	EPI_ISL_608302	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6FE47/2020	EPI_ISL_608308	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6C3F0/2020	EPI_ISL_608317	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A6FE56/2020	EPI_ISL_608319	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6FE74/2020	EPI_ISL_608320	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A70881/2020	EPI_ISL_608321	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-A6C509/2020	EPI_ISL_608331	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6FE65/2020	EPI_ISL_608333	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6D1B9/2020	EPI_ISL_608335	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6FEDE/2020	EPI_ISL_608338	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6C5EB/2020	EPI_ISL_608339	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6D007/2020	EPI_ISL_608340	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A685C1/2020	EPI_ISL_608378	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A64ECA/2020	EPI_ISL_608397	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A69153/2020	EPI_ISL_608445	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A64E8E/2020	EPI_ISL_608450	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A64EF7/2020	EPI_ISL_608451	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A68558/2020	EPI_ISL_608452	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A68585/2020	EPI_ISL_608453	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A64E42/2020	EPI_ISL_608498	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A691CC/2020	EPI_ISL_608505	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A64D63/2020	EPI_ISL_608508	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/ALDP-A68BED/2020	EPI_ISL_608589	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A65324/2020	EPI_ISL_608607	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A68C9F/2020	EPI_ISL_608610	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/ALDP-A6893E/2020	EPI_ISL_608622	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A68549/2020	EPI_ISL_608625	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A69D31/2020	EPI_ISL_608772	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A6AC06/2020	EPI_ISL_608775	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-A6AC42/2020	EPI_ISL_608778	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-A6B573/2020	EPI_ISL_608782	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A6BD20/2020	EPI_ISL_608861	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A68312/2020	EPI_ISL_608878	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6933F/2020	EPI_ISL_608916	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A69311/2020	EPI_ISL_608934	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A69029/2020	EPI_ISL_608941	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A645D4/2020	EPI_ISL_608958	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A64C66/2020	EPI_ISL_608960	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A645B6/2020	EPI_ISL_608982	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A64A5D/2020	EPI_ISL_608996	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A6489F/2020	EPI_ISL_608997	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/PHWC-480DC1/2020	EPI_ISL_613002	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4813A0/2020	EPI_ISL_613062	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-481513/2020	EPI_ISL_613080	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48155F/2020	EPI_ISL_613084	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-4815C8/2020	EPI_ISL_613090	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4815E6/2020	EPI_ISL_613092	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48172C/2020	EPI_ISL_613101	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-481759/2020	EPI_ISL_613104	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-481786/2020	EPI_ISL_613106	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-481795/2020	EPI_ISL_613107	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48180B/2020	EPI_ISL_613114	2020-10-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-481838/2020	EPI_ISL_613116	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-481865/2020	EPI_ISL_613119	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-4819CC/2020	EPI_ISL_613132	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4819EA/2020	EPI_ISL_613134	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-481D66/2020	EPI_ISL_613168	2020-10-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-481D75/2020	EPI_ISL_613169	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-481E36/2020	EPI_ISL_613177	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-481F15/2020	EPI_ISL_613185	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48210F/2020	EPI_ISL_613199	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4822A2/2020	EPI_ISL_613210	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48248E/2020	EPI_ISL_613222	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4824AC/2020	EPI_ISL_613223	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-482873/2020	EPI_ISL_613249	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-482882/2020	EPI_ISL_613250	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-4829DA/2020	EPI_ISL_613257	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A766CD/2020	EPI_ISL_613327	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A78009/2020	EPI_ISL_613351	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A78054/2020	EPI_ISL_613355	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-D094A/2020	EPI_ISL_613398	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D2966/2020	EPI_ISL_613406	2020-10-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-D3419/2020	EPI_ISL_613408	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/204262693/2020	EPI_ISL_613590	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.307	GR
hCoV-19/England/204290511/2020	EPI_ISL_613612	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/Gibraltar/204421172/2020	EPI_ISL_613636	2020-10-27	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204421174/2020	EPI_ISL_613637	2020-10-27	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204421192/2020	EPI_ISL_613653	2020-10-27	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204421224/2020	EPI_ISL_613684	2020-10-27	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204421227/2020	EPI_ISL_613687	2020-10-27	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204421239/2020	EPI_ISL_613698	2020-10-27	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/USA/FL-BPHL-1789/2020	EPI_ISL_613891	2020-07-31	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1.304	GR
hCoV-19/England/MILK-A6A51A/2020	EPI_ISL_627510	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/MILK-A6A78D/2020	EPI_ISL_627517	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.307	GR
hCoV-19/England/NOTT-1196E3/2020	EPI_ISL_627712	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/PHWC-16D185/2020	EPI_ISL_627731	2020-09-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-482EDB/2020	EPI_ISL_627752	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-483362/2020	EPI_ISL_627807	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48339F/2020	EPI_ISL_627810	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-4834F6/2020	EPI_ISL_627828	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4836D2/2020	EPI_ISL_627848	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-483924/2020	EPI_ISL_627873	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-483C0D/2020	EPI_ISL_627909	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-483C1C/2020	EPI_ISL_627910	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-483D0A/2020	EPI_ISL_627921	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-483D19/2020	EPI_ISL_627922	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-483E61/2020	EPI_ISL_627938	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-483E8F/2020	EPI_ISL_627940	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48412B/2020	EPI_ISL_627968	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/USA/NY-NYCPHL-000974/2020	EPI_ISL_633004	2020-09-30	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-000979/2020	EPI_ISL_633007	2020-10-01	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-000994/2020	EPI_ISL_633019	2020-10-01	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001010/2020	EPI_ISL_633030	2020-10-06	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001014/2020	EPI_ISL_633033	2020-10-07	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001015/2020	EPI_ISL_633034	2020-10-08	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001020/2020	EPI_ISL_633038	2020-09-17	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001021/2020	EPI_ISL_633039	2020-09-18	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001047/2020	EPI_ISL_633059	2020-10-08	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001071/2020	EPI_ISL_633072	2020-10-15	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.467	GR
hCoV-19/USA/NY-NYCPHL-001075/2020	EPI_ISL_633076	2020-10-15	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001077/2020	EPI_ISL_633078	2020-10-16	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.434	GR
hCoV-19/USA/NY-NYCPHL-001078/2020	EPI_ISL_633079	2020-10-16	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/NY-NYCPHL-001079/2020	EPI_ISL_633080	2020-10-16	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.467	GR
hCoV-19/England/QEUH-AE4DA7/2020	EPI_ISL_633112	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/CAMC-AEA819/2020	EPI_ISL_633124	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AEAF50/2020	EPI_ISL_633127	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AE5465/2020	EPI_ISL_633160	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AE4D01/2020	EPI_ISL_633180	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AE4F74/2020	EPI_ISL_633202	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AE4A19/2020	EPI_ISL_633207	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AEAFF6/2020	EPI_ISL_633211	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AEACFF/2020	EPI_ISL_633215	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				M.3	GR
hCoV-19/England/CAMC-AEB02F/2020	EPI_ISL_633220	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AE4C5F/2020	EPI_ISL_633228	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AEA7B2/2020	EPI_ISL_633234	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AE5025/2020	EPI_ISL_633237	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AEA9DA/2020	EPI_ISL_633260	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AE4EFF/2020	EPI_ISL_633279	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/CAMC-AEA7EF/2020	EPI_ISL_633281	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AE4F0B/2020	EPI_ISL_633289	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AEB20B/2020	EPI_ISL_633299	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AE5131/2020	EPI_ISL_633317	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AEA7C1/2020	EPI_ISL_633324	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-AEB1E0/2020	EPI_ISL_633347	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AE51AA/2020	EPI_ISL_633351	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-AEA80A/2020	EPI_ISL_633356	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AEACD1/2020	EPI_ISL_633373	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/QEUH-AE4A91/2020	EPI_ISL_633391	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AE2565/2020	EPI_ISL_633420	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AE27F6/2020	EPI_ISL_633438	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-AE2028/2020	EPI_ISL_633481	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AE2653/2020	EPI_ISL_633487	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AE26F9/2020	EPI_ISL_633493	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AE1EA7/2020	EPI_ISL_633517	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AE2556/2020	EPI_ISL_633521	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/QEUH-AE23D4/2020	EPI_ISL_633536	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AE29A5/2020	EPI_ISL_633537	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AE1CDA/2020	EPI_ISL_633557	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AE2CBB/2020	EPI_ISL_633559	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-AE2C7F/2020	EPI_ISL_633587	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AE23B6/2020	EPI_ISL_633598	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD0A6B/2020	EPI_ISL_633707	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.307	GR
hCoV-19/England/QEUH-AD0A2F/2020	EPI_ISL_633721	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-AD0B86/2020	EPI_ISL_633726	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD1B94/2020	EPI_ISL_633757	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD10A4/2020	EPI_ISL_633796	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD089E/2020	EPI_ISL_633798	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD11FC/2020	EPI_ISL_633811	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD1569/2020	EPI_ISL_633816	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD28BA/2020	EPI_ISL_633818	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/QEUH-AD3619/2020	EPI_ISL_633856	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-AD54D1/2020	EPI_ISL_633862	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD4F3B/2020	EPI_ISL_633864	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD0816/2020	EPI_ISL_633866	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD59B4/2020	EPI_ISL_633868	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD1183/2020	EPI_ISL_633869	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD27CC/2020	EPI_ISL_633883	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD2832/2020	EPI_ISL_633919	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD1271/2020	EPI_ISL_633946	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD551A/2020	EPI_ISL_633952	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD5969/2020	EPI_ISL_633956	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD11CF/2020	EPI_ISL_633963	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD0AA7/2020	EPI_ISL_633966	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD54E0/2020	EPI_ISL_633975	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD5495/2020	EPI_ISL_633978	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD3093/2020	EPI_ISL_633984	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD12AE/2020	EPI_ISL_633991	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-AD15D2/2020	EPI_ISL_633997	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD35FE/2020	EPI_ISL_633998	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B24B46/2020	EPI_ISL_647074	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.307	GR
hCoV-19/England/QEUH-B2DA9B/2020	EPI_ISL_647102	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B21A4C/2020	EPI_ISL_647169	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B22CBE/2020	EPI_ISL_647174	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B217EB/2020	EPI_ISL_647228	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B217FA/2020	EPI_ISL_647231	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B21077/2020	EPI_ISL_647241	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B2297B/2020	EPI_ISL_647253	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B21CA0/2020	EPI_ISL_647256	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B22E8B/2020	EPI_ISL_647257	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B218BB/2020	EPI_ISL_647266	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/CAMC-B22DAC/2020	EPI_ISL_647267	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B21AE2/2020	EPI_ISL_647281	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B21CDD/2020	EPI_ISL_647290	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B228D8/2020	EPI_ISL_647308	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B2162A/2020	EPI_ISL_647316	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B22B84/2020	EPI_ISL_647340	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B21C82/2020	EPI_ISL_647347	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B21CCE/2020	EPI_ISL_647362	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B21D70/2020	EPI_ISL_647365	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B2147B/2020	EPI_ISL_647432	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B2143F/2020	EPI_ISL_647454	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B21CBF/2020	EPI_ISL_647460	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B1FC0F/2020	EPI_ISL_647489	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-B2056A/2020	EPI_ISL_647495	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B1AA64/2020	EPI_ISL_647506	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B1FD75/2020	EPI_ISL_647520	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/CAMC-B21138/2020	EPI_ISL_647523	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B1A976/2020	EPI_ISL_647536	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B20588/2020	EPI_ISL_647539	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B20A7A/2020	EPI_ISL_647547	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B20579/2020	EPI_ISL_647610	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B1FD57/2020	EPI_ISL_647613	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B1FBE4/2020	EPI_ISL_647684	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-B20EC9/2020	EPI_ISL_647744	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B1FE09/2020	EPI_ISL_647779	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B211DE/2020	EPI_ISL_647782	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/Wales/MILK-B0259B/2020	EPI_ISL_647818	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Wales/MILK-B02B8A/2020	EPI_ISL_647830	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-B01DA3/2020	EPI_ISL_647844	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-B02C4B/2020	EPI_ISL_647849	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/QEUH-A8B294/2020	EPI_ISL_647858	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/QEUH-AE2091/2020	EPI_ISL_647889	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/QEUH-AD5802/2020	EPI_ISL_647931	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/QEUH-AD3F2D/2020	EPI_ISL_647933	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/QEUH-AD5723/2020	EPI_ISL_647938	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/QEUH-AD10E0/2020	EPI_ISL_647953	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/PHWC-489C52/2020	EPI_ISL_652473	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-489C8F/2020	EPI_ISL_652475	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.153	GR
hCoV-19/Wales/PHWC-489CAD/2020	EPI_ISL_652477	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-489CDA/2020	EPI_ISL_652480	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-489D22/2020	EPI_ISL_652484	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-489DB9/2020	EPI_ISL_652491	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-489DD7/2020	EPI_ISL_652492	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-489DF5/2020	EPI_ISL_652494	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-489FE0/2020	EPI_ISL_652515	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48A3F2/2020	EPI_ISL_652552	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48A486/2020	EPI_ISL_652557	2020-10-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48A592/2020	EPI_ISL_652570	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A9C306/2020	EPI_ISL_652628	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/QEUH-A9C39D/2020	EPI_ISL_652635	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A9C3BB/2020	EPI_ISL_652637	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A9CE6F/2020	EPI_ISL_652642	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A9CF3F/2020	EPI_ISL_652647	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A9D97C/2020	EPI_ISL_652662	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-A9D9C7/2020	EPI_ISL_652666	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-AA05AF/2020	EPI_ISL_652710	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-AAAE31/2020	EPI_ISL_652748	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AAAEC8/2020	EPI_ISL_652752	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AAAF7A/2020	EPI_ISL_652759	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AAB03A/2020	EPI_ISL_652767	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AAB674/2020	EPI_ISL_652803	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-AAB6A1/2020	EPI_ISL_652805	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.434	GR
hCoV-19/England/QEUH-AAB814/2020	EPI_ISL_652815	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AABD15/2020	EPI_ISL_652825	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-AABFB5/2020	EPI_ISL_652839	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-AABFE2/2020	EPI_ISL_652842	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AAC02A/2020	EPI_ISL_652843	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AAC5FE/2020	EPI_ISL_652858	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-AAC831/2020	EPI_ISL_652875	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-AAC8C8/2020	EPI_ISL_652880	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/QEUH-AACBFC/2020	EPI_ISL_652906	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AACEE4/2020	EPI_ISL_652923	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/QEUH-AAD0CF/2020	EPI_ISL_652938	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/QEUH-AAD153/2020	EPI_ISL_652945	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AADDD7/2020	EPI_ISL_652950	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AADDE6/2020	EPI_ISL_652951	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AADE01/2020	EPI_ISL_652953	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AADE5C/2020	EPI_ISL_652956	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AAE1E9/2020	EPI_ISL_652964	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-AAE732/2020	EPI_ISL_652975	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-AAEADF/2020	EPI_ISL_652982	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-AAEBBE/2020	EPI_ISL_652989	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-AAEBCD/2020	EPI_ISL_652990	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/USA/WA-OHSU-2883/2020	EPI_ISL_667384	2020-09-04	North America / USA / Washington / Clark County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1.186	GR
hCoV-19/USA/WA-OHSU-2909/2020	EPI_ISL_667408	2020-09-04	North America / USA / Washington / Clark County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1.186	GR
hCoV-19/USA/OR-OHSU-3079/2020	EPI_ISL_667472	2020-10-01	North America / USA / Oregon / Washington County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1.186	GR
hCoV-19/USA/OR-OHSU-3091/2020	EPI_ISL_667478	2020-10-01	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1.186	GR
hCoV-19/USA/OR-OHSU-3095/2020	EPI_ISL_667480	2020-10-01	North America / USA / Oregon / Columbia County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1.186	GR
hCoV-19/USA/CA-CZB-10015/2020	EPI_ISL_672191	2020-07-10	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.228	GR
hCoV-19/USA/CA-CZB-10202/2020	EPI_ISL_672258	2020-05-11	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.463	GR
hCoV-19/England/QEUH-BA29DD/2020	EPI_ISL_672824	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-BA2A16/2020	EPI_ISL_672903	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-BA1F09/2020	EPI_ISL_672908	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B09998/2020	EPI_ISL_672915	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B09057/2020	EPI_ISL_672922	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/CAMC-B09B74/2020	EPI_ISL_672927	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B09AB3/2020	EPI_ISL_672976	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B08F6A/2020	EPI_ISL_672993	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Canada/ON-PHL-8539/2020	EPI_ISL_418369	2020-03	North America / Canada / Ontario	Human	Original			Illumina NextSeq	CLC Genomics Workbench 8.5.3			B.1.1	GR
hCoV-19/Canada/ON-PHL-0654/2020	EPI_ISL_418370	2020-03	North America / Canada / Ontario	Human	Original			Illumina NextSeq	CLC Genomics Workbench 8.5.3			B.1.1	GR
hCoV-19/Canada/ON-PHL-8458/2020	EPI_ISL_418372	2020-03	North America / Canada / Ontario	Human	Original			Illumina NextSeq	CLC Genomics Workbench 8.5.3			B.1.1	GR
hCoV-19/England/20124030802/2020	EPI_ISL_418708	2020-03-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20132026904/2020	EPI_ISL_423761	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20132104104/2020	EPI_ISL_423837	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20132104404/2020	EPI_ISL_423838	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20132107304/2020	EPI_ISL_423844	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20129035304/2020	EPI_ISL_424028	2020-03-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20129174804/2020	EPI_ISL_424152	2020-03-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/USA/WA-UW-1917/2020	EPI_ISL_424332	2020-03-22	North America / USA / Washington	Human	Original			unknown				B.1.1	GR
hCoV-19/Iceland/351/2020	EPI_ISL_424375	2020-03	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Iceland/508/2020	EPI_ISL_424530	2020-03-20	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/Iceland/509/2020	EPI_ISL_424531	2020-03-20	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/Iceland/542/2020	EPI_ISL_424562	2020-03-26	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/Austria/CeMM0157/2020	EPI_ISL_438003	2020-03-04	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0158/2020	EPI_ISL_438004	2020-03-04	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0159/2020	EPI_ISL_438005	2020-03-04	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0160/2020	EPI_ISL_438006	2020-03-04	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0161/2020	EPI_ISL_438007	2020-03-05	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0162/2020	EPI_ISL_438008	2020-03-05	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0165/2020	EPI_ISL_438010	2020-03-06	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0166/2020	EPI_ISL_438011	2020-03-06	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0168/2020	EPI_ISL_438013	2020-03-07	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0169/2020	EPI_ISL_438014	2020-03-07	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0170/2020	EPI_ISL_438015	2020-03-07	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0171/2020	EPI_ISL_438016	2020-03-07	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0172/2020	EPI_ISL_438017	2020-03-07	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0175/2020	EPI_ISL_438018	2020-03-08	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0176/2020	EPI_ISL_438019	2020-03-08	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0177/2020	EPI_ISL_438020	2020-03-08	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0178/2020	EPI_ISL_438021	2020-03-08	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0180/2020	EPI_ISL_438022	2020-03-09	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0181/2020	EPI_ISL_438023	2020-03-09	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0182/2020	EPI_ISL_438024	2020-03-09	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0183/2020	EPI_ISL_438025	2020-03-10	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0185/2020	EPI_ISL_438027	2020-03-11	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0190/2020	EPI_ISL_438031	2020-03-13	Europe / Austria / Vienna	Human	Original	Respiratory secretion		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0197/2020	EPI_ISL_438038	2020-03-14	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0200/2020	EPI_ISL_438041	2020-03-15	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0205/2020	EPI_ISL_438044	2020-03-15	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0213/2020	EPI_ISL_438049	2020-03-16	Europe / Austria / Vienna	Human	Original	Respiratory secretion		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0217/2020	EPI_ISL_438051	2020-03-16	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0218/2020	EPI_ISL_438052	2020-03-16	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0219/2020	EPI_ISL_438053	2020-03-16	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0225/2020	EPI_ISL_438059	2020-03-17	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0239/2020	EPI_ISL_438069	2020-03-19	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0241/2020	EPI_ISL_438071	2020-03-20	Europe / Austria / Vienna	Human	Original	Tracheal secretion		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0244/2020	EPI_ISL_438074	2020-03-20	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0245/2020	EPI_ISL_438075	2020-03-20	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0256/2020	EPI_ISL_438085	2020-03-22	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Austria/CeMM0277/2020	EPI_ISL_438104	2020-03-25	Europe / Austria / Vienna	Human	Original	Respiratory secretion		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/USA/MD-HP00085/2020	EPI_ISL_438240	2020-03-26	North America / USA / Maryland	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC 1.0.0			B.1.1	GR
hCoV-19/England/CAMB-75B7E/2020	EPI_ISL_438278	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-767C4/2020	EPI_ISL_438427	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-76409/2020	EPI_ISL_438440	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-766C7/2020	EPI_ISL_438466	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-76DE0/2020	EPI_ISL_438524	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-77383/2020	EPI_ISL_438544	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-80F83/2020	EPI_ISL_438550	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-81061/2020	EPI_ISL_438560	2020-04-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-8115F/2020	EPI_ISL_438573	2020-04-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-8214F/2020	EPI_ISL_438623	2020-04-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-83D1D/2020	EPI_ISL_438684	2020-04-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-83D77/2020	EPI_ISL_438688	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-83D86/2020	EPI_ISL_438689	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-83E29/2020	EPI_ISL_438698	2020-04-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-83EB0/2020	EPI_ISL_438705	2020-04-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR2770/2020	EPI_ISL_438978	2020-04-20	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/USA/MN-UMGC-1/2020	EPI_ISL_443183	2020-04-05	North America / USA / Minnesota	Human	Original			Illumina MiSeq	iVar 1.2.2			B.1.1	GR
hCoV-19/Singapore/113/2020	EPI_ISL_443205	2020-03-18	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/England/CAMB-83AF8/2020	EPI_ISL_443342	2020-04-16	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-83867/2020	EPI_ISL_443391	2020-04-15	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-833DF/2020	EPI_ISL_443415	2020-04-14	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-82895/2020	EPI_ISL_443495	2020-04-13	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-83111/2020	EPI_ISL_443548	2020-04-15	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-827D4/2020	EPI_ISL_443581	2020-04-13	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-82701/2020	EPI_ISL_443586	2020-04-14	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AA377/2020	EPI_ISL_443662	2020-04-16	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-8268C/2020	EPI_ISL_443674	2020-04-13	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-125295/2020	EPI_ISL_443803	2020-03-27	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1251C5/2020	EPI_ISL_443805	2020-03-26	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-125F34/2020	EPI_ISL_443838	2020-03-30	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-125D2B/2020	EPI_ISL_443840	2020-03-30	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-125787/2020	EPI_ISL_443847	2020-03-29	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1250D7/2020	EPI_ISL_443873	2020-03-27	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-125392/2020	EPI_ISL_443879	2020-03-27	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-124973/2020	EPI_ISL_443911	2020-03-26	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-125F43/2020	EPI_ISL_443962	2020-03-30	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-124BC8/2020	EPI_ISL_443988	2020-03-26	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/EXET-135A21/2020	EPI_ISL_457127	2020-03-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-135B00/2020	EPI_ISL_457134	2020-04-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-135C0D/2020	EPI_ISL_457146	2020-03-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-135C2B/2020	EPI_ISL_457148	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-135C76/2020	EPI_ISL_457150	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-135CD0/2020	EPI_ISL_457155	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-135EAD/2020	EPI_ISL_457176	2020-03-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-135ECB/2020	EPI_ISL_457178	2020-04-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D59CD/2020	EPI_ISL_457287	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/USA/MD-HP00048/2020	EPI_ISL_457792	2020-03-15	North America / USA / Maryland	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC v1.0.0_20cab1a			B.1.1	GR
hCoV-19/India/TG-CCMB-L1085/2020	EPI_ISL_458056	2020-05-13	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-L1090/2020	EPI_ISL_458058	2020-05-13	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-L1100/2020	EPI_ISL_458059	2020-05-13	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.340	GR
hCoV-19/India/TG-CCMB-L1103/2020	EPI_ISL_458060	2020-05-13	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/TG-CCMB-L1108/2020	EPI_ISL_458061	2020-05-13	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.1.306	GR
hCoV-19/India/OR-ILSCV15547/2020	EPI_ISL_463036	2020-05-11	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1.1.306	GR
hCoV-19/India/OR-ILSCV15552/2020	EPI_ISL_463037	2020-05-11	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1.1.306	GR
hCoV-19/India/OR-ILSCV16514/2020	EPI_ISL_463052	2020-05-12	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1.1.306	GR
hCoV-19/USA/VA-DCLS-0366/2020	EPI_ISL_463126	2020-04-30	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/USA/VA-DCLS-0371/2020	EPI_ISL_463127	2020-05-08	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/USA/VA-DCLS-0372/2020	EPI_ISL_463128	2020-05-08	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/USA/VA-DCLS-0373/2020	EPI_ISL_463129	2020-05-08	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/Canada/BC_26628654/2020	EPI_ISL_463247	2020-03	North America / Canada / British Columbia	Human	Original			Oxford Nanopore	ARTIC protocol			B.1.1	GR
hCoV-19/USA/WA-S965/2020	EPI_ISL_463455	2020-05-01	North America / USA / Washington / Yakima County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1	GR
hCoV-19/USA/WA-S1040/2020	EPI_ISL_463530	2020-05-03	North America / USA / Washington / Yakima County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1	GR
hCoV-19/USA/WA-S1209/2020	EPI_ISL_463699	2020-05-07	North America / USA / Washington / Yakima County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1	GR
hCoV-19/Canada/BC_23246810/2020	EPI_ISL_477035	2020-04	North America / Canada / British Columbia	Human	Original			Oxford Nanopore	ARTIC protocol			B.1.1	GR
hCoV-19/Canada/BC_23252816/2020	EPI_ISL_477036	2020-04	North America / Canada / British Columbia	Human	Original			Oxford Nanopore	ARTIC protocol			B.1.1	GR
hCoV-19/Canada/BC_23279341/2020	EPI_ISL_477037	2020-04	North America / Canada / British Columbia	Human	Original			Oxford Nanopore	ARTIC protocol			B.1.1	GR
hCoV-19/Italy/APU-UniMI-694/2020	EPI_ISL_477203	2020-03-19	Europe / Italy / Apulia	Human	Original	Nasopharyngeal swab		Illumina	SPAdes	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/BIRM-61128/2020	EPI_ISL_477752	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR2494/2020	EPI_ISL_477955	2020-04-15	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-103F0F/2020	EPI_ISL_482134	2020-04-08	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Egypt/MASRI-027/2020	EPI_ISL_482773	2020-05-08	Africa / Egypt	Human	Original			Ion Torrent				B.1.1	GR
hCoV-19/Senegal/68458/2020	EPI_ISL_482878	2020-06-18	Africa / Senegal / Dakar	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Bowtie2			B.1.1	GR
hCoV-19/Australia/SA0350/2020	EPI_ISL_483125	2020-03-23	Oceania / Australia / South Australia	Human	Original			Illumina NextSeq 550				B.1.1	GR
hCoV-19/USA/WA-S2574/2020	EPI_ISL_497206	2020-06-17	North America / USA / Washington / Yakima County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1	GR
hCoV-19/USA/VA-DCLS-0369/2020	EPI_ISL_516692	2020-05-07	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/USA/VA-DCLS-0370/2020	EPI_ISL_516693	2020-05-07	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/England/LOND-12609D1/2020	EPI_ISL_516858	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LIVE-A73C6/2020	EPI_ISL_517014	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.366	GR
hCoV-19/Australia/VIC2280/2020	EPI_ISL_522002	2020-06-27	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Australia/VIC2505/2020	EPI_ISL_522200	2020-06-27	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.136	GR
hCoV-19/Germany/BY-UHR-2O/2020	EPI_ISL_522407	2020-03-20	Europe / Germany / Bavaria	Human	Original	Swab		Illumina	DRAGEN RNA Pathogen Detection v. 3.5.13			B.1.1	GR
hCoV-19/South Korea/KCDC2710/2020	EPI_ISL_522489	2020-07-08	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1.294	GR
hCoV-19/South Korea/KCDC2736/2020	EPI_ISL_522515	2020-07-16	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1.370	GR
hCoV-19/Italy/VEN-IZSVe-51635/2020	EPI_ISL_522859	2020-05-01	Europe / Italy / Veneto / Verona	Human	Original	Oropharyngeal swab		Illumina MiSeq	BWA v0.7.12			B.1.1	GR
hCoV-19/USA/MD-MDH-0124/2020	EPI_ISL_522871	2020-05-28	North America / USA / Maryland	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Mexico/CMX-INMEGEN-07/2020	EPI_ISL_522878	2020-08-01	North America / Mexico / Mexico City	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00234333/2020	EPI_ISL_536051	2020-03-23	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00235218/2020	EPI_ISL_536090	2020-03-24	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00236396/2020	EPI_ISL_536127	2020-03-24	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00241862/2020	EPI_ISL_536291	2020-03-28	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00242891/2020	EPI_ISL_536339	2020-03-30	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1	GR
hCoV-19/USA/WI-UW-1202/2020	EPI_ISL_536575	2020-08-06	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1.186	GR
hCoV-19/USA/WI-UW-1336/2020	EPI_ISL_536707	2020-09-04	North America / USA / Wisconsin / Jefferson County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1	GR
hCoV-19/USA/WI-UW-1337/2020	EPI_ISL_536708	2020-09-04	North America / USA / Wisconsin / Monroe County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1	GR
hCoV-19/USA/WI-UW-1372/2020	EPI_ISL_536743	2020-09-08	North America / USA / Wisconsin / Rock County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1	GR
hCoV-19/USA/WI-UW-1393/2020	EPI_ISL_536764	2020-09-04	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1	G
hCoV-19/England/QEUH-9641C2/2020	EPI_ISL_536821	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96457B/2020	EPI_ISL_536833	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-963F6F/2020	EPI_ISL_536838	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96456C/2020	EPI_ISL_536848	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9646A5/2020	EPI_ISL_536855	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96A320/2020	EPI_ISL_536866	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9651A3/2020	EPI_ISL_536944	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-964784/2020	EPI_ISL_536961	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-95E3A7/2020	EPI_ISL_536963	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-95DF0E/2020	EPI_ISL_536970	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/India/MH-NIV-10418/2020	EPI_ISL_541682	2020-04-16	Asia / India / Maharashtra	Human	Original			Ion Torrent, Gene Studio				B.1	GR
hCoV-19/India/MH-NIV-174910/2020	EPI_ISL_541715	2020-08-23	Asia / India / Maharashtra	Human	Original			Ion Torrent, Gene Studio				B.1.1.306	GR
hCoV-19/India/MH-NIV-78532/2020	EPI_ISL_541744	2020-06-24	Asia / India / Maharashtra	Human	Original			Ion Torrent, Gene Studio				B.1.1.306	GR
hCoV-19/India/MH-NIV-81270/2020	EPI_ISL_541747	2020-06-25	Asia / India / Maharashtra	Human	Original			Ion Torrent, Gene Studio				B.1.1.306	GR
hCoV-19/England/BHRT-24B3E17/2020	EPI_ISL_541773	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/ALDP-955BF3/2020	EPI_ISL_555417	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-954884/2020	EPI_ISL_555427	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-954839/2020	EPI_ISL_555458	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-955C1E/2020	EPI_ISL_555482	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-954866/2020	EPI_ISL_555494	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95AB49/2020	EPI_ISL_555523	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95B00D/2020	EPI_ISL_555533	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94476C/2020	EPI_ISL_555534	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-94E1FB/2020	EPI_ISL_555535	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95AFE3/2020	EPI_ISL_555572	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94DC55/2020	EPI_ISL_555576	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95AF6B/2020	EPI_ISL_555587	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95AE22/2020	EPI_ISL_555592	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9524CE/2020	EPI_ISL_555622	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94D921/2020	EPI_ISL_555627	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94480F/2020	EPI_ISL_555662	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94D97C/2020	EPI_ISL_555672	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6661A5/2020	EPI_ISL_555686	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-95AF4D/2020	EPI_ISL_555694	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94DC28/2020	EPI_ISL_555727	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-666828/2020	EPI_ISL_555730	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94B686/2020	EPI_ISL_555771	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94C9D7/2020	EPI_ISL_556002	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94C597/2020	EPI_ISL_556004	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94CF99/2020	EPI_ISL_556008	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94CB3B/2020	EPI_ISL_556016	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94C9B9/2020	EPI_ISL_556038	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94CB1D/2020	EPI_ISL_556048	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94D420/2020	EPI_ISL_556065	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-95DA67/2020	EPI_ISL_556075	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6CE475/2020	EPI_ISL_556082	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6CAC62/2020	EPI_ISL_556089	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6D56DF/2020	EPI_ISL_556099	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_E95stop results in 22.3% truncation of the protein sequence.	info	B.1.1.200	GR
hCoV-19/England/ALDP-6CA3A9/2020	EPI_ISL_556174	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-6412E9/2020	EPI_ISL_556197	2020-07-04	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/MILK-632922/2020	EPI_ISL_556198	2020-07-04	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6CE92B/2020	EPI_ISL_556215	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6D67DB/2020	EPI_ISL_556217	2020-07-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6D4351/2020	EPI_ISL_556222	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6D68D8/2020	EPI_ISL_556230	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-63CBF5/2020	EPI_ISL_556265	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-63B7A7/2020	EPI_ISL_556279	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-63C6D6/2020	EPI_ISL_556281	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6CE985/2020	EPI_ISL_556292	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6CE879/2020	EPI_ISL_556295	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94D305/2020	EPI_ISL_556312	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94D3AB/2020	EPI_ISL_556319	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94A05C/2020	EPI_ISL_556327	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-949B2F/2020	EPI_ISL_556331	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94EE03/2020	EPI_ISL_556337	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9498A0/2020	EPI_ISL_556352	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94A4F6/2020	EPI_ISL_556355	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-94EDE8/2020	EPI_ISL_556387	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94B8EA/2020	EPI_ISL_556391	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94A04D/2020	EPI_ISL_556395	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94A56C/2020	EPI_ISL_556400	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94EE5E/2020	EPI_ISL_556413	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94B8F9/2020	EPI_ISL_556415	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94B255/2020	EPI_ISL_556417	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94A450/2020	EPI_ISL_556421	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94D1ED/2020	EPI_ISL_556422	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94D39C/2020	EPI_ISL_556441	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-94A6D2/2020	EPI_ISL_556450	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94AEE9/2020	EPI_ISL_556454	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-94ABC4/2020	EPI_ISL_556456	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94B8DB/2020	EPI_ISL_556462	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94A836/2020	EPI_ISL_556469	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94D0B3/2020	EPI_ISL_556485	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94F330/2020	EPI_ISL_556489	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94D38D/2020	EPI_ISL_556498	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94EEB8/2020	EPI_ISL_556502	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-947AF7/2020	EPI_ISL_556534	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-94870E/2020	EPI_ISL_556549	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8C12B2/2020	EPI_ISL_556598	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Gambia/3725/2020	EPI_ISL_561004	2020-07-30	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-1527/2020	EPI_ISL_561022	2020-05-16	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-3165/2020	EPI_ISL_561043	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3192/2020	EPI_ISL_561046	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	G
hCoV-19/Gambia/GC19-3214/2020	EPI_ISL_561051	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/GC19-3255/2020	EPI_ISL_561054	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	G
hCoV-19/Gambia/GC19-3317/2020	EPI_ISL_561060	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1	G
hCoV-19/Gambia/GC19-3358/2020	EPI_ISL_561062	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3776/2020	EPI_ISL_561076	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3792/2020	EPI_ISL_561077	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3806/2020	EPI_ISL_561084	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3807/2020	EPI_ISL_561085	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3812/2020	EPI_ISL_561086	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3813/2020	EPI_ISL_561087	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3816/2020	EPI_ISL_561089	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/GC19-3818/2020	EPI_ISL_561090	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-3820/2020	EPI_ISL_561091	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3831/2020	EPI_ISL_561095	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3835/2020	EPI_ISL_561096	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3842/2020	EPI_ISL_561099	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3846/2020	EPI_ISL_561100	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3854/2020	EPI_ISL_561102	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-2427/2020	EPI_ISL_561105	2020-07-21	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/GC19-2459/2020	EPI_ISL_561108	2020-07-21	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/GC19-2525/2020	EPI_ISL_561113	2020-07-21	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC192602/2020	EPI_ISL_561120	2020-07-21	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC192610/2020	EPI_ISL_561121	2020-07-21	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-2663/2020	EPI_ISL_561133	2020-07-21	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-2707/2020	EPI_ISL_561134	2020-07-21	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/GC19-2731/2020	EPI_ISL_561137	2020-07-21	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC192772/2020	EPI_ISL_561140	2020-07-22	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC192778/2020	EPI_ISL_561141	2020-07-22	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	G
hCoV-19/Gambia/GC192786/2020	EPI_ISL_561144	2020-07-22	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC192812/2020	EPI_ISL_561148	2020-07-22	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-2842/2020	EPI_ISL_561151	2020-07-24	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-2904/2020	EPI_ISL_561154	2020-07-24	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-2973/2020	EPI_ISL_561156	2020-07-24	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-2977/2020	EPI_ISL_561157	2020-07-24	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-2991/2020	EPI_ISL_561159	2020-07-24	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	G
hCoV-19/Gambia/GC19-3064/2020	EPI_ISL_561160	2020-07-25	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-3081/2020	EPI_ISL_561162	2020-07-25	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-3085/2020	EPI_ISL_561163	2020-07-25	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/GC19-3110/2020	EPI_ISL_561165	2020-07-25	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3113/2020	EPI_ISL_561167	2020-07-25	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3114/2020	EPI_ISL_561168	2020-07-25	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-3145/2020	EPI_ISL_561170	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-3399/2020	EPI_ISL_561172	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	G
hCoV-19/Gambia/GC19-3533/2020	EPI_ISL_561193	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.466	GR
hCoV-19/Gambia/GC19-3659/2020	EPI_ISL_561202	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	G
hCoV-19/Gambia/NPHL-038/2020	EPI_ISL_561205	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-1645/2020	EPI_ISL_561236	2020-08-04	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/NPHL-1711/2020	EPI_ISL_561237	2020-08-04	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-1746/2020	EPI_ISL_561238	2020-07-20	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-1921/2020	EPI_ISL_561239	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-1968/2020	EPI_ISL_561240	2020-07-16	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-2037/2020	EPI_ISL_561241	2020-07-15	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-244/2020	EPI_ISL_561247	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-245/2020	EPI_ISL_561251	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-247/2020	EPI_ISL_561257	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-253/2020	EPI_ISL_561270	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-255/2020	EPI_ISL_561273	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-256/2020	EPI_ISL_561277	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-2588/2020	EPI_ISL_561282	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-2615/2020	EPI_ISL_561283	2020-08-18	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-2626/2020	EPI_ISL_561284	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/NPHL-2729/2020	EPI_ISL_561290	2020-07-23	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-2767/2020	EPI_ISL_561294	2020-07-25	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-2768/2020	EPI_ISL_561295	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-2790/2020	EPI_ISL_561298	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-287/2020	EPI_ISL_561300	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-290/2020	EPI_ISL_561303	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-2909/2020	EPI_ISL_561304	2020-07-26	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-295/2020	EPI_ISL_561305	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-297/2020	EPI_ISL_561306	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-2984/2020	EPI_ISL_561307	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-299/2020	EPI_ISL_561308	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-3206/2020	EPI_ISL_561313	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-748/2020	EPI_ISL_561324	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-760/2020	EPI_ISL_561327	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1	G
hCoV-19/England/ALDP-9CBE77/2020	EPI_ISL_575407	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CBE4A/2020	EPI_ISL_575425	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9CB8A6/2020	EPI_ISL_575433	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-9CB9EF/2020	EPI_ISL_575439	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CB81F/2020	EPI_ISL_575457	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CB92B/2020	EPI_ISL_575465	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CCCA9/2020	EPI_ISL_575477	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CB84C/2020	EPI_ISL_575500	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CBB34/2020	EPI_ISL_575502	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9CAC8D/2020	EPI_ISL_575505	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9CAF84/2020	EPI_ISL_575510	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CB527/2020	EPI_ISL_575514	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CBD4D/2020	EPI_ISL_575515	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CB30F/2020	EPI_ISL_575518	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CAB08/2020	EPI_ISL_575542	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9CB1C9/2020	EPI_ISL_575551	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CB985/2020	EPI_ISL_575560	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9CBF56/2020	EPI_ISL_575569	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-9CAEC3/2020	EPI_ISL_575572	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CAC41/2020	EPI_ISL_575587	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CB5EB/2020	EPI_ISL_575596	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CB518/2020	EPI_ISL_575600	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CB74F/2020	EPI_ISL_575612	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CBE95/2020	EPI_ISL_575615	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CAED2/2020	EPI_ISL_575616	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CBAEC/2020	EPI_ISL_575628	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CA9D1/2020	EPI_ISL_575644	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CBA46/2020	EPI_ISL_575649	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CB369/2020	EPI_ISL_575651	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CBB25/2020	EPI_ISL_575652	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CB572/2020	EPI_ISL_575654	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CB75E/2020	EPI_ISL_575688	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CB32D/2020	EPI_ISL_575706	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9CB5FA/2020	EPI_ISL_575711	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CCCB8/2020	EPI_ISL_575730	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CAB62/2020	EPI_ISL_575751	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9745E1/2020	EPI_ISL_575786	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-97489D/2020	EPI_ISL_575817	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9746DF/2020	EPI_ISL_575825	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9731DF/2020	EPI_ISL_575880	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9746C0/2020	EPI_ISL_575890	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-976664/2020	EPI_ISL_575897	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-976682/2020	EPI_ISL_575910	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-97496D/2020	EPI_ISL_575970	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/MILK-9C412A/2020	EPI_ISL_575986	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/MILK-9C2F31/2020	EPI_ISL_575988	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/MILK-9C3783/2020	EPI_ISL_575991	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E6CD6/2020	EPI_ISL_580326	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E725B/2020	EPI_ISL_580331	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E6508/2020	EPI_ISL_580337	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-9EC06B/2020	EPI_ISL_580338	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E6D3D/2020	EPI_ISL_580346	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E70AC/2020	EPI_ISL_580360	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-9EC793/2020	EPI_ISL_580364	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E6CF4/2020	EPI_ISL_580388	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E70D9/2020	EPI_ISL_580390	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9EC0F2/2020	EPI_ISL_580396	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E6D5B/2020	EPI_ISL_580427	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-9EC4F6/2020	EPI_ISL_580435	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E66D8/2020	EPI_ISL_580443	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E69C0/2020	EPI_ISL_580472	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-9EC53F/2020	EPI_ISL_580480	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9EC04D/2020	EPI_ISL_580481	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E6939/2020	EPI_ISL_580496	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E6F0A/2020	EPI_ISL_580500	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E668D/2020	EPI_ISL_580517	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E6CA9/2020	EPI_ISL_580520	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E6975/2020	EPI_ISL_580522	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E71E5/2020	EPI_ISL_580527	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E690C/2020	EPI_ISL_580534	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9E6E49/2020	EPI_ISL_580543	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/CAMC-9EC49C/2020	EPI_ISL_580565	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9EC55D/2020	EPI_ISL_580569	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E66AB/2020	EPI_ISL_580583	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E7103/2020	EPI_ISL_580584	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E68C3/2020	EPI_ISL_580599	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E6F64/2020	EPI_ISL_580608	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9EC405/2020	EPI_ISL_580610	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9E6D2E/2020	EPI_ISL_580616	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E6CC7/2020	EPI_ISL_580617	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-9EC65A/2020	EPI_ISL_580621	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9EE8F8/2020	EPI_ISL_580670	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-9F05ED/2020	EPI_ISL_580704	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DC787/2020	EPI_ISL_581001	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DC21D/2020	EPI_ISL_581005	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DC6C6/2020	EPI_ISL_581022	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E10B1/2020	EPI_ISL_581023	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DCDFE/2020	EPI_ISL_581033	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E0EC7/2020	EPI_ISL_581065	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DC66C/2020	EPI_ISL_581070	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DC796/2020	EPI_ISL_581108	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-9E29F1/2020	EPI_ISL_581153	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E2D40/2020	EPI_ISL_581157	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/MILK-9E29A6/2020	EPI_ISL_581160	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E2A49/2020	EPI_ISL_581211	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E2F68/2020	EPI_ISL_581221	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E1F4B/2020	EPI_ISL_581240	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E1EA8/2020	EPI_ISL_581264	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9E1F3C/2020	EPI_ISL_581265	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DECA4/2020	EPI_ISL_581267	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9E3486/2020	EPI_ISL_581288	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E29B5/2020	EPI_ISL_581300	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DEC77/2020	EPI_ISL_581344	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E2BEC/2020	EPI_ISL_581349	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9D4725/2020	EPI_ISL_581372	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9D4734/2020	EPI_ISL_581373	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99DE9C/2020	EPI_ISL_581386	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-95016F/2020	EPI_ISL_581414	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/VA-DCLS-1533/2020	EPI_ISL_581529	2020-08-08	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/USA/VA-DCLS-1426/2020	EPI_ISL_581549	2020-07-12	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/USA/VA-DCLS-1432/2020	EPI_ISL_581554	2020-07-13	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/USA/VA-DCLS-1436/2020	EPI_ISL_581557	2020-07-13	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.434	GR
hCoV-19/USA/VA-DCLS-1485/2020	EPI_ISL_581562	2020-07-26	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.304	GR
hCoV-19/England/QEUH-9F820C/2020	EPI_ISL_589001	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8E35/2020	EPI_ISL_589003	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F62C2/2020	EPI_ISL_589007	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9F8CD1/2020	EPI_ISL_589014	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7D93/2020	EPI_ISL_589027	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7AE7/2020	EPI_ISL_589035	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F7935/2020	EPI_ISL_589042	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7BC6/2020	EPI_ISL_589047	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7C0F/2020	EPI_ISL_589053	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7BA8/2020	EPI_ISL_589065	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F7443/2020	EPI_ISL_589068	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F2053/2020	EPI_ISL_589077	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7B6C/2020	EPI_ISL_589078	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/MILK-9F232D/2020	EPI_ISL_589080	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F20EA/2020	EPI_ISL_589081	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9F7B4E/2020	EPI_ISL_589082	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7504/2020	EPI_ISL_589084	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7B02/2020	EPI_ISL_589089	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7BD5/2020	EPI_ISL_589096	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9F08A8/2020	EPI_ISL_589574	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F13A6/2020	EPI_ISL_589583	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9F13C4/2020	EPI_ISL_589589	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F0C9D/2020	EPI_ISL_589604	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9F1995/2020	EPI_ISL_589618	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9F129A/2020	EPI_ISL_589625	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-9F1494/2020	EPI_ISL_589631	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9F0C33/2020	EPI_ISL_589648	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9F0C7F/2020	EPI_ISL_589667	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F1EC3/2020	EPI_ISL_589674	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F1E96/2020	EPI_ISL_589693	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F1106/2020	EPI_ISL_589700	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F15EC/2020	EPI_ISL_589703	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9F1027/2020	EPI_ISL_589745	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9F10FA/2020	EPI_ISL_589748	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F0D6D/2020	EPI_ISL_589760	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9E40AF/2020	EPI_ISL_589774	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/ALDP-9EA0B8/2020	EPI_ISL_589780	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/ALDP-9EA09A/2020	EPI_ISL_589785	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/MILK-9E2BFB/2020	EPI_ISL_589791	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-9E2E3E/2020	EPI_ISL_589795	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CFD58/2020	EPI_ISL_589804	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9D0343/2020	EPI_ISL_589808	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9D0765/2020	EPI_ISL_589814	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9CFCA6/2020	EPI_ISL_589818	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CFD67/2020	EPI_ISL_589823	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9D04B9/2020	EPI_ISL_589829	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CFE64/2020	EPI_ISL_589840	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9D0B3C/2020	EPI_ISL_589843	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CF9AF/2020	EPI_ISL_589848	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CF8EE/2020	EPI_ISL_589849	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9D052F/2020	EPI_ISL_589856	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9D0316/2020	EPI_ISL_589859	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9D0307/2020	EPI_ISL_589880	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9D0C48/2020	EPI_ISL_589890	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9D013A/2020	EPI_ISL_589907	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CFF61/2020	EPI_ISL_589916	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CF954/2020	EPI_ISL_589919	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9D1175/2020	EPI_ISL_589927	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9D0F8B/2020	EPI_ISL_589943	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9D055C/2020	EPI_ISL_589945	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9CFAAC/2020	EPI_ISL_589950	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9D00E2/2020	EPI_ISL_589951	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CFE46/2020	EPI_ISL_589960	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9D0DAF/2020	EPI_ISL_589965	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CFBF4/2020	EPI_ISL_589992	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9D061D/2020	EPI_ISL_589996	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9EFAB5/2020	EPI_ISL_594976	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-A17E3F/2020	EPI_ISL_594992	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.434	G
hCoV-19/England/MILK-A1836C/2020	EPI_ISL_595025	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-A1D455/2020	EPI_ISL_595058	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/MILK-A1D4DD/2020	EPI_ISL_595064	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/MILK-A1D7B6/2020	EPI_ISL_595085	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-A1D956/2020	EPI_ISL_595098	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/MILK-A23C45/2020	EPI_ISL_595110	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-A55F05/2020	EPI_ISL_595119	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-A55F14/2020	EPI_ISL_595120	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-A55FAB/2020	EPI_ISL_595123	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.170	GR
hCoV-19/Wales/MILK-A56247/2020	EPI_ISL_595142	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina		NS6_F22stop results in 65.6% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/OXON-B518F/2020	EPI_ISL_595326	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-47DBBE/2020	EPI_ISL_595336	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47DBDC/2020	EPI_ISL_595338	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47DBEB/2020	EPI_ISL_595339	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-47DCBB/2020	EPI_ISL_595350	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-47DCD9/2020	EPI_ISL_595351	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47DDE5/2020	EPI_ISL_595365	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47DE79/2020	EPI_ISL_595372	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-47E036/2020	EPI_ISL_595396	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47E072/2020	EPI_ISL_595399	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47E0EB/2020	EPI_ISL_595406	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47E124/2020	EPI_ISL_595410	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47E27C/2020	EPI_ISL_595429	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47E2A9/2020	EPI_ISL_595431	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47E31F/2020	EPI_ISL_595438	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47E582/2020	EPI_ISL_595470	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47E5BF/2020	EPI_ISL_595473	2020-09-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47E8B6/2020	EPI_ISL_595516	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47EA0B/2020	EPI_ISL_595537	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47EA47/2020	EPI_ISL_595541	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47EAA1/2020	EPI_ISL_595547	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47EB80/2020	EPI_ISL_595561	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-47ECD8/2020	EPI_ISL_595578	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47ED5D/2020	EPI_ISL_595585	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47EDB7/2020	EPI_ISL_595590	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47EDF3/2020	EPI_ISL_595594	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47EE0F/2020	EPI_ISL_595595	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-47EE96/2020	EPI_ISL_595604	2020-10-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-47EEA5/2020	EPI_ISL_595605	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-47EF2A/2020	EPI_ISL_595613	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6C4C/2020	EPI_ISL_595621	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6C97/2020	EPI_ISL_595622	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9F6CE2/2020	EPI_ISL_595625	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6D2B/2020	EPI_ISL_595626	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9F6D58/2020	EPI_ISL_595628	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6D67/2020	EPI_ISL_595629	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6D76/2020	EPI_ISL_595630	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6DB2/2020	EPI_ISL_595631	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6DEF/2020	EPI_ISL_595634	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6E28/2020	EPI_ISL_595636	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6E46/2020	EPI_ISL_595637	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6E73/2020	EPI_ISL_595638	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6E82/2020	EPI_ISL_595639	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9F6E91/2020	EPI_ISL_595640	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6EA0/2020	EPI_ISL_595641	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6EBF/2020	EPI_ISL_595642	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6ECE/2020	EPI_ISL_595643	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6EFB/2020	EPI_ISL_595644	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9F6F07/2020	EPI_ISL_595645	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6F25/2020	EPI_ISL_595646	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6F43/2020	EPI_ISL_595647	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F6F8F/2020	EPI_ISL_595648	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9F705E/2020	EPI_ISL_595656	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina		NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-9F715B/2020	EPI_ISL_595666	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F71A6/2020	EPI_ISL_595667	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F7355/2020	EPI_ISL_595680	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9F7373/2020	EPI_ISL_595681	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F73A0/2020	EPI_ISL_595683	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-9F73BF/2020	EPI_ISL_595684	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9F758C/2020	EPI_ISL_595687	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F765C/2020	EPI_ISL_595692	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9F76E3/2020	EPI_ISL_595695	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9F773B/2020	EPI_ISL_595699	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F8381/2020	EPI_ISL_595733	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9F83FA/2020	EPI_ISL_595737	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F92A1/2020	EPI_ISL_595739	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9F998E/2020	EPI_ISL_595740	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9F99BB/2020	EPI_ISL_595742	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/QEUH-9F99F7/2020	EPI_ISL_595743	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9F9AB8/2020	EPI_ISL_595746	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9F9B6A/2020	EPI_ISL_595749	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9FA2DD/2020	EPI_ISL_595798	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A31048/2020	EPI_ISL_595856	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A31075/2020	EPI_ISL_595858	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A310EE/2020	EPI_ISL_595864	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A31242/2020	EPI_ISL_595872	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A3127F/2020	EPI_ISL_595875	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A3138B/2020	EPI_ISL_595882	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/QEUH-A3146A/2020	EPI_ISL_595890	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A314D3/2020	EPI_ISL_595896	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A48CFF/2020	EPI_ISL_595920	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/QEUH-A4905C/2020	EPI_ISL_595950	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A4C5A5/2020	EPI_ISL_595981	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina		Insertion of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Scotland/QEUH-A4C709/2020	EPI_ISL_595993	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9FF742/2020	EPI_ISL_600412	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A006AA/2020	EPI_ISL_600415	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FF496/2020	EPI_ISL_600419	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FF95B/2020	EPI_ISL_600421	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0022E/2020	EPI_ISL_600448	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A002D3/2020	EPI_ISL_600458	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FF33F/2020	EPI_ISL_600460	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-A000F7/2020	EPI_ISL_600464	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A007D4/2020	EPI_ISL_600465	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A00428/2020	EPI_ISL_600497	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FF979/2020	EPI_ISL_600503	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A00446/2020	EPI_ISL_600506	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FF223/2020	EPI_ISL_600514	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FF8E5/2020	EPI_ISL_600520	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/ALDP-9FDB93/2020	EPI_ISL_600528	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9FA5B6/2020	EPI_ISL_600542	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9FAB0F/2020	EPI_ISL_600600	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9FA3BC/2020	EPI_ISL_600604	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9FAAE4/2020	EPI_ISL_600616	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9F6963/2020	EPI_ISL_600630	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9F4C99/2020	EPI_ISL_600660	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9F6B30/2020	EPI_ISL_600670	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/Scotland/QEUH-9F44EC/2020	EPI_ISL_600702	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F44BF/2020	EPI_ISL_600731	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Scotland/QEUH-9F42B5/2020	EPI_ISL_600761	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9F37D5/2020	EPI_ISL_600766	2020-09-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F423D/2020	EPI_ISL_600826	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9F8530/2020	EPI_ISL_600879	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-9F7540/2020	EPI_ISL_600907	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9E4D7B/2020	EPI_ISL_600937	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9E4133/2020	EPI_ISL_600948	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9E53C3/2020	EPI_ISL_600999	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/CAMC-A647DE/2020	EPI_ISL_609025	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A680B1/2020	EPI_ISL_609053	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.500	GR
hCoV-19/England/CAMC-A64A7B/2020	EPI_ISL_609054	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	G
hCoV-19/England/ALDP-A67F97/2020	EPI_ISL_609055	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A6BFFD/2020	EPI_ISL_609058	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A6BDB7/2020	EPI_ISL_609063	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A69548/2020	EPI_ISL_609093	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A6BF57/2020	EPI_ISL_609116	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A6BFB1/2020	EPI_ISL_609126	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A6BD5D/2020	EPI_ISL_609137	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/CAMC-A58A5C/2020	EPI_ISL_609159	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/CAMC-A58728/2020	EPI_ISL_609168	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/CAMC-A58351/2020	EPI_ISL_609169	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/QEUH-A5DD9A/2020	EPI_ISL_609185	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/CAMC-A573DA/2020	EPI_ISL_609205	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/QEUH-A5DE6A/2020	EPI_ISL_609206	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq		NS6_F22stop results in 65.6% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Wales/MILK-A47470/2020	EPI_ISL_609233	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-A474AD/2020	EPI_ISL_609238	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-A47777/2020	EPI_ISL_609241	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-A477A4/2020	EPI_ISL_609251	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-A47795/2020	EPI_ISL_609264	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-A47C1E/2020	EPI_ISL_609266	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/Wales/MILK-A47759/2020	EPI_ISL_609277	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/MILK-A4675A/2020	EPI_ISL_609301	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A40F1C/2020	EPI_ISL_609310	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A41151/2020	EPI_ISL_609317	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/CAMC-A4209F/2020	EPI_ISL_609327	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A41B62/2020	EPI_ISL_609331	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A40E2E/2020	EPI_ISL_609339	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A40E6A/2020	EPI_ISL_609359	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A41FA2/2020	EPI_ISL_609370	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A41BF9/2020	EPI_ISL_609391	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A421D8/2020	EPI_ISL_609394	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A422E4/2020	EPI_ISL_609404	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A41E87/2020	EPI_ISL_609417	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A40EF1/2020	EPI_ISL_609418	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A40E1F/2020	EPI_ISL_609445	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A40D8B/2020	EPI_ISL_609447	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A411D9/2020	EPI_ISL_609461	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A41388/2020	EPI_ISL_609467	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/CAMC-A417AA/2020	EPI_ISL_609471	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A416E9/2020	EPI_ISL_609484	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A41A56/2020	EPI_ISL_609498	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A420DB/2020	EPI_ISL_609502	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A420CC/2020	EPI_ISL_609515	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A40E00/2020	EPI_ISL_609529	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A3EFA8/2020	EPI_ISL_609536	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3EB1D/2020	EPI_ISL_609537	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3E62B/2020	EPI_ISL_609543	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3E8BC/2020	EPI_ISL_609574	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3FA6A/2020	EPI_ISL_609575	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.434	GR
hCoV-19/England/CAMC-A3ECB0/2020	EPI_ISL_609585	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/CAMC-A3E597/2020	EPI_ISL_609598	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A3F8AC/2020	EPI_ISL_609601	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3E755/2020	EPI_ISL_609611	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A3E97D/2020	EPI_ISL_609613	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3FBB2/2020	EPI_ISL_609614	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3E9AA/2020	EPI_ISL_609617	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A3F350/2020	EPI_ISL_609621	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3FB76/2020	EPI_ISL_609622	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3F217/2020	EPI_ISL_609623	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A3FB67/2020	EPI_ISL_609634	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3F411/2020	EPI_ISL_609645	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3E8CB/2020	EPI_ISL_609657	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3FA5B/2020	EPI_ISL_609661	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-A3F499/2020	EPI_ISL_609670	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3EE50/2020	EPI_ISL_609673	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3E98C/2020	EPI_ISL_609678	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A3E3D9/2020	EPI_ISL_609680	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A3FB94/2020	EPI_ISL_609684	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3F0E0/2020	EPI_ISL_609694	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A3F077/2020	EPI_ISL_609704	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A3FB2B/2020	EPI_ISL_609705	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3F10B/2020	EPI_ISL_609706	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A3E931/2020	EPI_ISL_609713	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/CAMC-A3F4F3/2020	EPI_ISL_609716	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A3F068/2020	EPI_ISL_609718	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A3FB85/2020	EPI_ISL_609728	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3E61C/2020	EPI_ISL_609730	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A3FA1F/2020	EPI_ISL_609749	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A3F147/2020	EPI_ISL_609758	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/CAMC-A3FB1C/2020	EPI_ISL_609760	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3FB0D/2020	EPI_ISL_609776	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3EEBA/2020	EPI_ISL_609777	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/CAMC-A3EB2C/2020	EPI_ISL_609779	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3F0FF/2020	EPI_ISL_609798	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/204100232/2020	EPI_ISL_609833	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/204100511/2020	EPI_ISL_609835	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/204100512/2020	EPI_ISL_609836	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/204100517/2020	EPI_ISL_609838	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/204241000/2020	EPI_ISL_609894	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/204241008/2020	EPI_ISL_609895	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/204241197/2020	EPI_ISL_609896	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204462836/2020	EPI_ISL_615010	2020-10-29	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204462838/2020	EPI_ISL_615011	2020-10-29	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204462840/2020	EPI_ISL_615012	2020-10-29	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204462846/2020	EPI_ISL_615016	2020-10-29	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204462847/2020	EPI_ISL_615017	2020-10-29	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204462855/2020	EPI_ISL_615023	2020-10-29	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204462857/2020	EPI_ISL_615025	2020-10-29	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204462860/2020	EPI_ISL_615028	2020-10-29	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204462873/2020	EPI_ISL_615040	2020-10-29	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204462877/2020	EPI_ISL_615044	2020-10-29	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204462884/2020	EPI_ISL_615051	2020-10-29	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204462889/2020	EPI_ISL_615054	2020-10-29	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Gibraltar/204462895/2020	EPI_ISL_615059	2020-10-29	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Sweden/20-22137/2020	EPI_ISL_615080	2020-05-25	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-22146/2020	EPI_ISL_615085	2020-05-22	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Denmark/DCGC-5393/2020	EPI_ISL_615325	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-5400/2020	EPI_ISL_615332	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-4403/2020	EPI_ISL_615401	2020-09-07	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-6240/2020	EPI_ISL_620000	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6241/2020	EPI_ISL_620001	2020-10-05	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6243/2020	EPI_ISL_620003	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6244/2020	EPI_ISL_620004	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6262/2020	EPI_ISL_620022	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-6263/2020	EPI_ISL_620023	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-6264/2020	EPI_ISL_620024	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6265/2020	EPI_ISL_620025	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6266/2020	EPI_ISL_620026	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6178/2020	EPI_ISL_620081	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6187/2020	EPI_ISL_620090	2020-10-05	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6209/2020	EPI_ISL_620112	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6211/2020	EPI_ISL_620114	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6217/2020	EPI_ISL_620120	2020-10-05	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-5912/2020	EPI_ISL_620177	2020-10-05	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/Denmark/DCGC-6042/2020	EPI_ISL_620236	2020-10-05	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6043/2020	EPI_ISL_620237	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6044/2020	EPI_ISL_620238	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6045/2020	EPI_ISL_620239	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6065/2020	EPI_ISL_620259	2020-10-05	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/Denmark/DCGC-6413/2020	EPI_ISL_620313	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-6469/2020	EPI_ISL_620369	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-6471/2020	EPI_ISL_620371	2020-10-12	Europe / Denmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-6484/2020	EPI_ISL_620384	2020-10-05	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/USA/MI-UM-10036468985/2020	EPI_ISL_628804	2020-10-15	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036518033/2020	EPI_ISL_628806	2020-10-19	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036461388/2020	EPI_ISL_628808	2020-10-15	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036484001/2020	EPI_ISL_628809	2020-10-16	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036488294/2020	EPI_ISL_628839	2020-10-16	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.186	GR
hCoV-19/USA/MI-UM-10036455460/2020	EPI_ISL_628843	2020-10-15	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036496672/2020	EPI_ISL_628844	2020-10-17	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036470386/2020	EPI_ISL_628845	2020-10-15	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036455304/2020	EPI_ISL_628846	2020-10-15	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036456115/2020	EPI_ISL_628853	2020-10-15	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036495367/2020	EPI_ISL_628856	2020-10-17	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.186	GR
hCoV-19/USA/MI-UM-10036495313/2020	EPI_ISL_628857	2020-10-17	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036501790/2020	EPI_ISL_628860	2020-10-18	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036490199/2020	EPI_ISL_628861	2020-10-16	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036501769/2020	EPI_ISL_628862	2020-10-18	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036490275/2020	EPI_ISL_628863	2020-10-16	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036515267/2020	EPI_ISL_628874	2020-10-19	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036515220/2020	EPI_ISL_628875	2020-10-19	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036507431/2020	EPI_ISL_628876	2020-10-19	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036524330/2020	EPI_ISL_628878	2020-10-19	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036515334/2020	EPI_ISL_628879	2020-10-19	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/Australia/NSW1157/2020	EPI_ISL_629010	2020-10-15	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1	GR
hCoV-19/England/MILK-ACC622/2020	EPI_ISL_629110	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC85FC/2020	EPI_ISL_629116	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACE893/2020	EPI_ISL_629123	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACE4CC/2020	EPI_ISL_629125	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC9537/2020	EPI_ISL_629126	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACE426/2020	EPI_ISL_629129	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC837A/2020	EPI_ISL_629131	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACC76B/2020	EPI_ISL_629156	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACC103/2020	EPI_ISL_629172	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/MILK-ACBE76/2020	EPI_ISL_629175	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACE286/2020	EPI_ISL_629180	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-ACED3A/2020	EPI_ISL_629213	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC7CCB/2020	EPI_ISL_629237	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC83A7/2020	EPI_ISL_629239	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACC297/2020	EPI_ISL_629282	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC7D5F/2020	EPI_ISL_629284	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-ACC3B2/2020	EPI_ISL_629285	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACBFCE/2020	EPI_ISL_629286	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-AC8389/2020	EPI_ISL_629313	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC95FB/2020	EPI_ISL_629351	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACE945/2020	EPI_ISL_629370	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC836B/2020	EPI_ISL_629371	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACBD4C/2020	EPI_ISL_629376	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC8592/2020	EPI_ISL_629378	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACC279/2020	EPI_ISL_629386	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-AC8662/2020	EPI_ISL_629387	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACBD6A/2020	EPI_ISL_629406	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACE8A2/2020	EPI_ISL_629414	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC8617/2020	EPI_ISL_629426	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACEA06/2020	EPI_ISL_629467	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC81E9/2020	EPI_ISL_629486	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-ACE9FA/2020	EPI_ISL_629491	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACEE46/2020	EPI_ISL_629523	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACE435/2020	EPI_ISL_629535	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACF276/2020	EPI_ISL_629536	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC91BB/2020	EPI_ISL_629542	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.153	GR
hCoV-19/England/MILK-ACEBB8/2020	EPI_ISL_629545	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				M.3	GR
hCoV-19/England/MILK-ACEEDD/2020	EPI_ISL_629564	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACF48F/2020	EPI_ISL_629566	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACEF16/2020	EPI_ISL_629575	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC800A/2020	EPI_ISL_629626	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD2F1F/2020	EPI_ISL_629794	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD24C5/2020	EPI_ISL_629797	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD2E4F/2020	EPI_ISL_629798	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD0272/2020	EPI_ISL_629822	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD1806/2020	EPI_ISL_629832	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD0351/2020	EPI_ISL_629836	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD0F11/2020	EPI_ISL_629838	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD2E6D/2020	EPI_ISL_629843	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD25B3/2020	EPI_ISL_629844	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD045E/2020	EPI_ISL_629869	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD2F5B/2020	EPI_ISL_629894	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD1772/2020	EPI_ISL_629896	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD1CCE/2020	EPI_ISL_629921	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-AD3A77/2020	EPI_ISL_629927	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD0EBA/2020	EPI_ISL_629934	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD2FA6/2020	EPI_ISL_629941	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD39C5/2020	EPI_ISL_629948	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD3B1A/2020	EPI_ISL_629962	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD1C82/2020	EPI_ISL_629992	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD494C/2020	EPI_ISL_634022	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD0719/2020	EPI_ISL_634024	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD493D/2020	EPI_ISL_634045	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD50FB/2020	EPI_ISL_634057	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD3707/2020	EPI_ISL_634068	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD3C62/2020	EPI_ISL_634089	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD0D62/2020	EPI_ISL_634104	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD0C92/2020	EPI_ISL_634116	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD2BDF/2020	EPI_ISL_634118	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-AD0D17/2020	EPI_ISL_634121	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD4830/2020	EPI_ISL_634146	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD49C4/2020	EPI_ISL_634159	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD0C83/2020	EPI_ISL_634170	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD4117/2020	EPI_ISL_634183	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-AD0CDE/2020	EPI_ISL_634188	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD0CB0/2020	EPI_ISL_634196	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD675F/2020	EPI_ISL_634200	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD3C26/2020	EPI_ISL_634222	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD0D44/2020	EPI_ISL_634226	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD247A/2020	EPI_ISL_634227	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD3D23/2020	EPI_ISL_634236	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD01EE/2020	EPI_ISL_634237	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD2CAF/2020	EPI_ISL_634243	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD51DA/2020	EPI_ISL_634247	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD037F/2020	EPI_ISL_634249	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-AD5055/2020	EPI_ISL_634252	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACD59D/2020	EPI_ISL_634264	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/MILK-ACD1F3/2020	EPI_ISL_634290	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACD427/2020	EPI_ISL_634294	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACD269/2020	EPI_ISL_634295	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-ACD1E4/2020	EPI_ISL_634296	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACC983/2020	EPI_ISL_634297	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-AC7C9E/2020	EPI_ISL_634349	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC7EB6/2020	EPI_ISL_634350	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACD9DD/2020	EPI_ISL_634352	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC8143/2020	EPI_ISL_634375	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC80CE/2020	EPI_ISL_634387	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC7AFE/2020	EPI_ISL_634393	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACD4EB/2020	EPI_ISL_634414	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/MILK-ACC68C/2020	EPI_ISL_634421	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACC437/2020	EPI_ISL_634423	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.153	GR
hCoV-19/England/MILK-ACC473/2020	EPI_ISL_634432	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACCC20/2020	EPI_ISL_634436	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACD5BB/2020	EPI_ISL_634453	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACD041/2020	EPI_ISL_634490	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD4029/2020	EPI_ISL_634528	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD401A/2020	EPI_ISL_634538	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-AD1086/2020	EPI_ISL_634563	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD102C/2020	EPI_ISL_634565	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD4399/2020	EPI_ISL_634566	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD1F01/2020	EPI_ISL_634588	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD43C6/2020	EPI_ISL_634589	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD0FF3/2020	EPI_ISL_634595	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD0FC6/2020	EPI_ISL_634599	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD5B09/2020	EPI_ISL_634612	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD3F69/2020	EPI_ISL_634614	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD5468/2020	EPI_ISL_634621	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-AD197C/2020	EPI_ISL_634647	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD16DF/2020	EPI_ISL_634651	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD4C25/2020	EPI_ISL_634659	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD3F1E/2020	EPI_ISL_634663	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD42D8/2020	EPI_ISL_634670	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD3FE1/2020	EPI_ISL_634695	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD1095/2020	EPI_ISL_634723	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/QEUH-AD251D/2020	EPI_ISL_634739	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/ALDP-A675A4/2020	EPI_ISL_634754	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/ALDP-AA3023/2020	EPI_ISL_634758	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/ALDP-AA2516/2020	EPI_ISL_634788	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/CAMC-AAF9C2/2020	EPI_ISL_634793	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/CAMC-AAFBAE/2020	EPI_ISL_634803	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/CAMC-AB212E/2020	EPI_ISL_634816	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/France/ARA-SC160/2020	EPI_ISL_634825	2020-04-08	Europe / France / Auvergne-Rhone-Alpes / Grenoble	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/USA/MI-UM-10036540781/2020	EPI_ISL_640146	2020-10-20	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036530676/2020	EPI_ISL_640147	2020-10-20	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036535365/2020	EPI_ISL_640148	2020-10-20	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036530731/2020	EPI_ISL_640151	2020-10-20	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036535367/2020	EPI_ISL_640152	2020-10-20	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036540841/2020	EPI_ISL_640154	2020-10-20	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036541568/2020	EPI_ISL_640160	2020-10-20	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036532868/2020	EPI_ISL_640162	2020-10-20	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036554773/2020	EPI_ISL_640165	2020-10-21	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036576559/2020	EPI_ISL_640167	2020-10-22	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036578598/2020	EPI_ISL_640169	2020-10-22	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036561032/2020	EPI_ISL_640170	2020-10-21	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036552359/2020	EPI_ISL_640171	2020-10-21	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036580137/2020	EPI_ISL_640174	2020-10-22	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036561341/2020	EPI_ISL_640176	2020-10-21	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036571011/2020	EPI_ISL_640177	2020-10-22	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036561091/2020	EPI_ISL_640180	2020-10-21	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036555954/2020	EPI_ISL_640181	2020-10-21	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036556732/2020	EPI_ISL_640182	2020-10-21	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036561289/2020	EPI_ISL_640184	2020-10-21	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036577639/2020	EPI_ISL_640190	2020-10-22	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.186	GR
hCoV-19/USA/MI-UM-10036556049/2020	EPI_ISL_640191	2020-10-21	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036541021/2020	EPI_ISL_640192	2020-10-20	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036558807/2020	EPI_ISL_640195	2020-10-21	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq		NS6_Q8stop results in 88.5% truncation of the protein sequence.	info	B.1.1.304	GR
hCoV-19/USA/MI-UM-10036551324/2020	EPI_ISL_640196	2020-10-21	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036558969/2020	EPI_ISL_640207	2020-10-21	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036556633/2020	EPI_ISL_640209	2020-10-21	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036578381/2020	EPI_ISL_640212	2020-10-22	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/Germany/BW-MVZ-LS-21/2020	EPI_ISL_640239	2020-04-15	Europe / Germany / Baden-Wurttemberg / Villingen-Schwenningen	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.1	GR
hCoV-19/Germany/BW-MVZ-LS-42/2020	EPI_ISL_640259	2020-04-14	Europe / Germany / Baden-Wurttemberg / Villingen-Schwenningen	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.1	GR
hCoV-19/USA/CA-ALSR-4129/2020	EPI_ISL_648837	2020-07-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.228	GR
hCoV-19/USA/CA-ALSR-4238/2020	EPI_ISL_648905	2020-06-19	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/Italy/APU-IZSPB_308PT/2020	EPI_ISL_653802	2020-10-24	Europe / Italy / Apulia / Bari / Monopoli	Human	Original	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1.229	GR
hCoV-19/Italy/APU-IZSPB_309PT/2020	EPI_ISL_653803	2020-10-24	Europe / Italy / Apulia / Bari / Monopoli	Human	Original	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1.229	GR
hCoV-19/Italy/APU-IZSPB_311PT/2020	EPI_ISL_653805	2020-11-03	Europe / Italy / Apulia / Bari / Monopoli	Human	Original	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1.229	GR
hCoV-19/Italy/APU-IZSPB_324PT/2020	EPI_ISL_653817	2020-04-11	Europe / Italy / Apulia / Brindisi	Human	Original	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1	GR
hCoV-19/Italy/APU-IZSPB_325PT/2020	EPI_ISL_653818	2020-04-11	Europe / Italy / Apulia / Brindisi	Human	Original	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1	GR
hCoV-19/England/204481811/2020	EPI_ISL_653997	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Spain/MD-IBV-99008729/2020	EPI_ISL_654302	2020-10-16	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.177	GR
hCoV-19/Sweden/20-53266/2020	EPI_ISL_654503	2020-10-27	Europe / Sweden	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	NS8_E110stop results in 9.9% truncation of the protein sequence. Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.1.446	GR
hCoV-19/Sweden/20-08963/2020	EPI_ISL_654952	2020-08-25	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Gap of 6 nucleotides when compared to the reference sequence.	info	AN.1	GR
hCoV-19/England/QEUH-B695CF/2020	EPI_ISL_654960	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B6679F/2020	EPI_ISL_654967	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B69E4C/2020	EPI_ISL_654992	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B669D5/2020	EPI_ISL_654993	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B68584/2020	EPI_ISL_654999	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B819F2/2020	EPI_ISL_668033	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B8197A/2020	EPI_ISL_668049	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7E4CA/2020	EPI_ISL_668060	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B7E4E8/2020	EPI_ISL_668064	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B7A9ED/2020	EPI_ISL_668085	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/QEUH-B7C0AA/2020	EPI_ISL_668159	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7BFAE/2020	EPI_ISL_668176	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7FD0A/2020	EPI_ISL_668177	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B7C295/2020	EPI_ISL_668186	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-B806DE/2020	EPI_ISL_668198	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	G
hCoV-19/England/QEUH-B823A8/2020	EPI_ISL_668230	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B7C31A/2020	EPI_ISL_668240	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B82144/2020	EPI_ISL_668260	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7C329/2020	EPI_ISL_668344	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7F5D5/2020	EPI_ISL_668381	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7FD73/2020	EPI_ISL_668387	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Norway/4913/2020	EPI_ISL_668434	2020-10-25	Europe / Norway / Nordland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.170	GR
hCoV-19/Denmark/DCGC-9292/2020	EPI_ISL_668636	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-9215/2020	EPI_ISL_668855	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-9275/2020	EPI_ISL_668882	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-9330/2020	EPI_ISL_668911	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-9384/2020	EPI_ISL_668943	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-9397/2020	EPI_ISL_668949	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-9407/2020	EPI_ISL_668956	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-9419/2020	EPI_ISL_668961	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-9421/2020	EPI_ISL_668963	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/England/CAMC-B9C578/2020	EPI_ISL_673476	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B99669/2020	EPI_ISL_673489	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B98FE7/2020	EPI_ISL_673533	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B9A2FB/2020	EPI_ISL_673537	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-B957F1/2020	EPI_ISL_673601	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-B9873A/2020	EPI_ISL_673604	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B950AB/2020	EPI_ISL_673663	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/CAMC-B9AF7C/2020	EPI_ISL_673697	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-B98DCF/2020	EPI_ISL_673721	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/CAMC-B994C9/2020	EPI_ISL_673769	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-B98794/2020	EPI_ISL_673788	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B9AF21/2020	EPI_ISL_673862	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8623E/2020	EPI_ISL_673895	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B863E0/2020	EPI_ISL_673958	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B863B3/2020	EPI_ISL_673989	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Portugal/PT0016/2020	EPI_ISL_418001	2020-03-10	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0028/2020	EPI_ISL_418013	2020-03-07	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Japan/P4-6/2020	EPI_ISL_419306	2020-03-20	Asia / Japan / Saitama	Human	Original	Pharyngeal swab		Illumina NextSeq500	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Japan/P4-7/2020	EPI_ISL_419307	2020-03-20	Asia / Japan / Saitama	Human	Original	Pharyngeal swab		Illumina NextSeq500	A5-miseq v. 20140604			B.1.1	GR
hCoV-19/Japan/P4-8/2020	EPI_ISL_419308	2020-03-19	Asia / Japan / Saitama	Human	Original	Pharyngeal swab		Illumina NextSeq500	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Japan/P5-3/2020	EPI_ISL_419311	2020-03-13	Asia / Japan / Chiba	Human	Original	Pharyngeal swab		Illumina NextSeq500	A5-miseq v. 20140604			B.1.1	GR
hCoV-19/Austria/CeMM0003/2020	EPI_ISL_419656	2020-02-26	Europe / Austria	Human	Original	Pharyngeal swab		Illumina NovaSeq	bwa			B.1.1.331	GR
hCoV-19/Australia/VIC128/2020	EPI_ISL_419730	2020-03-20	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC123/2020	EPI_ISL_419731	2020-03-20	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1	O
hCoV-19/Australia/VIC134/2020	EPI_ISL_419827	2020-03-22	Oceania / Australia / Victoria	Human	Original			Illumina iSeq	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC163/2020	EPI_ISL_419860	2020-03-18	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC183/2020	EPI_ISL_419879	2020-03-19	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC297/2020	EPI_ISL_419988	2020-03-23	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1	GR
hCoV-19/England/CAMB-74553/2020	EPI_ISL_425305	2020-03-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore MinION				B.1.1	GR
hCoV-19/England/CAMB-77031/2020	EPI_ISL_425453	2020-04-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore MinION				B.1.1	GR
hCoV-19/England/CAMB-77040/2020	EPI_ISL_425454	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore MinION				B.1.1	GR
hCoV-19/Scotland/CVR41/2020	EPI_ISL_425769	2020-03-13	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA MiSeq				B.1.1	GR
hCoV-19/Russia/StPetersburg-RII6056S/2020	EPI_ISL_430106	2020-04-15	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Australia/VIC1158/2020	EPI_ISL_430602	2020-04-09	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC V3 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.2.1, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC1281/2020	EPI_ISL_430676	2020-04-08	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC V3 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.2.1, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC1300/2020	EPI_ISL_430677	2020-04-10	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC V3 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.2.1, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC1279/2020	EPI_ISL_430678	2020-04-07	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC V3 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.2.1, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC1317/2020	EPI_ISL_430691	2020-04-11	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC V3 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.2.1, samtools v1.10			B.1	G
hCoV-19/Australia/VIC1353/2020	EPI_ISL_430716	2020-04-12	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V3 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.2.1, samtools v1.10			B.1.1	GR
hCoV-19/Thailand/TNIC-1889/2020	EPI_ISL_430837	2020-03-03	Asia / Thailand / Nonthaburi	Human	Original	Oropharyngeal	Patient came from Italy	Illumina MiSeq	CLC Genomics Workbench 12, Geneious 10.2.4			B.1.1	GR
hCoV-19/Scotland/CVR3085/2020	EPI_ISL_439026	2020-04-25	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/EDB2476/2020	EPI_ISL_439220	2020-04-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/EDB3760/2020	EPI_ISL_439318	2020-04-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-76D4A/2020	EPI_ISL_439403	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7758D/2020	EPI_ISL_439406	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7768A/2020	EPI_ISL_439443	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-779EB/2020	EPI_ISL_439484	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-76EA1/2020	EPI_ISL_439511	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-76ECF/2020	EPI_ISL_439521	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-72670/2020	EPI_ISL_439570	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-72115/2020	EPI_ISL_439576	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-72133/2020	EPI_ISL_439640	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-721D9/2020	EPI_ISL_439653	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LIVE-9945B/2020	EPI_ISL_439725	2020-04-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-99D14/2020	EPI_ISL_439815	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-81C30/2020	EPI_ISL_443060	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7E920/2020	EPI_ISL_443072	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-D49BF/2020	EPI_ISL_444163	2020-04-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D49EC/2020	EPI_ISL_444166	2020-04-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1ABEC0/2020	EPI_ISL_444342	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AC005/2020	EPI_ISL_444359	2020-04-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AC21E/2020	EPI_ISL_444384	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-80EB3/2020	EPI_ISL_444441	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-80ED1/2020	EPI_ISL_444443	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Russia/StPetersburg-RII8275S/2020	EPI_ISL_450268	2020-04-21	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Sweden/20-07299/2020	EPI_ISL_450813	2020-04-14	Europe / Sweden / Kalmar	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/England/EXET-135098/2020	EPI_ISL_457028	2020-04-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-1355B7/2020	EPI_ISL_457073	2020-04-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORW-EA136/2020	EPI_ISL_457328	2020-05-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EA29D/2020	EPI_ISL_457338	2020-05-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EAB38/2020	EPI_ISL_457354	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EABDE/2020	EPI_ISL_457360	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EAC71/2020	EPI_ISL_457366	2020-05-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EB34E/2020	EPI_ISL_457420	2020-05-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EB95B/2020	EPI_ISL_457459	2020-05-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EB9D3/2020	EPI_ISL_457465	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EC35C/2020	EPI_ISL_457520	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EC4D1/2020	EPI_ISL_457529	2020-05-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EC5DE/2020	EPI_ISL_457538	2020-05-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EC5ED/2020	EPI_ISL_457539	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EC644/2020	EPI_ISL_457543	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EC6EA/2020	EPI_ISL_457552	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EC6F9/2020	EPI_ISL_457553	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/SHEF-C4F74/2020	EPI_ISL_457606	2020-05-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BRIS-129EAC/2020	EPI_ISL_458377	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-129FC7/2020	EPI_ISL_458405	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12A5A6/2020	EPI_ISL_458410	2020-04-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/CAMB-1B1595/2020	EPI_ISL_458529	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1B143E/2020	EPI_ISL_458533	2020-05-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/CAMB-1B13C8/2020	EPI_ISL_458576	2020-05-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/NORT-2892CB/2020	EPI_ISL_458600	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2891A0/2020	EPI_ISL_458601	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-289410/2020	EPI_ISL_458612	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28960B/2020	EPI_ISL_458620	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-288FC5/2020	EPI_ISL_458668	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2898BA/2020	EPI_ISL_458675	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28910A/2020	EPI_ISL_458686	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12913A/2020	EPI_ISL_458783	2020-04-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-128E9E/2020	EPI_ISL_458829	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-126407/2020	EPI_ISL_458925	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-126443/2020	EPI_ISL_458945	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-126768/2020	EPI_ISL_458949	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12673B/2020	EPI_ISL_458950	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-126698/2020	EPI_ISL_458981	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12607C/2020	EPI_ISL_458986	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-125F9E/2020	EPI_ISL_459020	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-126100/2020	EPI_ISL_459060	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1264F8/2020	EPI_ISL_459071	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1B1182/2020	EPI_ISL_459166	2020-05-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/CAMB-1B087F/2020	EPI_ISL_459169	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1B12F8/2020	EPI_ISL_459207	2020-05-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/CAMB-1ADE28/2020	EPI_ISL_459425	2020-04-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1ADE0A/2020	EPI_ISL_459453	2020-04-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AE197/2020	EPI_ISL_459461	2020-04-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AE4CB/2020	EPI_ISL_459476	2020-04-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AE1D3/2020	EPI_ISL_459493	2020-04-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/201080001/2020	EPI_ISL_464417	2020-03-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20118111104/2020	EPI_ISL_464954	2020-03-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20118123004/2020	EPI_ISL_464958	2020-03-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Scotland/CVR3807/2020	EPI_ISL_478133	2020-05-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR3822/2020	EPI_ISL_478148	2020-05-19	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LCST-24D6F84/2020	EPI_ISL_478345	2020-06-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D707B/2020	EPI_ISL_478458	2020-04-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-284266/2020	EPI_ISL_478539	2020-03-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-28464C/2020	EPI_ISL_478559	2020-03-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-2847B2/2020	EPI_ISL_478567	2020-03-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-294EE7/2020	EPI_ISL_478622	2020-03-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-294FF3/2020	EPI_ISL_478624	2020-03-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/OXON-B044F/2020	EPI_ISL_478881	2020-04-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B04A9/2020	EPI_ISL_478883	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B0755/2020	EPI_ISL_478905	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/HECH-2599E52/2020	EPI_ISL_482084	2020-05-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/OR-PROV-014/2020	EPI_ISL_482301	2020-04-01	North America / USA / Oregon	Human	Original			Illumina NovaSeq 6000	BWA mem, Freebayes, vcffilter, bcftools consensus (AF >=50%, min DP > 100)			B.1.1	GR
hCoV-19/USA/OR-PROV-040/2020	EPI_ISL_482322	2020-03-27	North America / USA / Oregon	Human	Original			Illumina NovaSeq 6000	BWA mem, Freebayes, vcffilter, bcftools consensus (AF >=50%, min DP > 100)			B.1.1	GR
hCoV-19/USA/OR-PROV-206/2020	EPI_ISL_482448	2020-04-03	North America / USA / Oregon	Human	Original			Illumina NovaSeq 6000	BWA mem, Freebayes, vcffilter, bcftools consensus (AF >=50%, min DP > 100)			B.1.1	GR
hCoV-19/USA/CA-ALSR-0565-SAN/2020	EPI_ISL_483226	2020-05-12	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-ALSR-0593-SAN/2020	EPI_ISL_483247	2020-04-15	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-ALSR-0642-SAN/2020	EPI_ISL_483275	2020-04-23	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.132	GR
hCoV-19/USA/CA-ALSR-0781-SAN/2020	EPI_ISL_483353	2020-04-15	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-ALSR-0789-SAN/2020	EPI_ISL_483359	2020-04-07	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-ALSR-1106-SAN/2020	EPI_ISL_483530	2020-06-14	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-150029/2020	EPI_ISL_483661	2020-06-04	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.464	GR
hCoV-19/Switzerland/ZH-ETHZ-150034/2020	EPI_ISL_483662	2020-06-03	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.464	GR
hCoV-19/Switzerland/ZH-ETHZ-150040/2020	EPI_ISL_483665	2020-06-02	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.464	GR
hCoV-19/England/GSTT-265D527/2020	EPI_ISL_483973	2020-03-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/GSTT-265DE77/2020	EPI_ISL_484117	2020-03-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/GSTT-265DF38/2020	EPI_ISL_484126	2020-03-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/GSTT-265E34A/2020	EPI_ISL_484189	2020-03-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LCST-24D6E96/2020	EPI_ISL_484245	2020-06-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.200	GR
hCoV-19/England/NORT-296C81/2020	EPI_ISL_484276	2020-04-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29CC6D/2020	EPI_ISL_484295	2020-05-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29D6B9/2020	EPI_ISL_484300	2020-05-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29D8B3/2020	EPI_ISL_484305	2020-05-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29F1C5/2020	EPI_ISL_484323	2020-05-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29F1D4/2020	EPI_ISL_484324	2020-05-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29F541/2020	EPI_ISL_484325	2020-04-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-11226E/2020	EPI_ISL_484360	2020-05-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-1122D7/2020	EPI_ISL_484366	2020-05-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-112565/2020	EPI_ISL_484394	2020-04-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C1038/2020	EPI_ISL_484435	2020-06-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C3E2D/2020	EPI_ISL_484446	2020-06-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C5D1F/2020	EPI_ISL_484460	2020-06-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C8D1C/2020	EPI_ISL_484476	2020-05-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C913D/2020	EPI_ISL_484478	2020-06-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C9847/2020	EPI_ISL_484482	2020-06-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C9A8D/2020	EPI_ISL_484484	2020-06-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CAB7A/2020	EPI_ISL_484489	2020-06-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CB53F/2020	EPI_ISL_484494	2020-06-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Belgium/ULG-10221/2020	EPI_ISL_498127	2020-05-14	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Senegal/45436/2020	EPI_ISL_498238	2020-05-27	Africa / Senegal / Dakar	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/North Macedonia/3017/2020	EPI_ISL_516420	2020-06-10	Europe / North Macedonia / Skopje	Human	Original	Nasopharyngeal swab		Illumina Miseq / Respiratory Virus Oligo Panel	Illumina BaseSpace / DRAGEN_RNA_Pathogen_Detection			B.1.1	GR
hCoV-19/Switzerland/BL-ETHZ-230018/2020	EPI_ISL_516561	2020-08-02	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/England/LIVE-A818F/2020	EPI_ISL_517123	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-AA0BD/2020	EPI_ISL_517399	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/SHEF-C0D05/2020	EPI_ISL_517543	2020-08-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C0D41/2020	EPI_ISL_517544	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C33B5/2020	EPI_ISL_517546	2020-07-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C527A/2020	EPI_ISL_517550	2020-08-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C585A/2020	EPI_ISL_517552	2020-07-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C71F3/2020	EPI_ISL_517556	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-C9D57/2020	EPI_ISL_517560	2020-08-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C9D66/2020	EPI_ISL_517561	2020-08-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CF9E4/2020	EPI_ISL_517570	2020-08-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CFBC0/2020	EPI_ISL_517572	2020-08-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D116F/2020	EPI_ISL_517575	2020-08-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D16F7/2020	EPI_ISL_517576	2020-08-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Netherlands/FR-EMC-50/2020	EPI_ISL_523142	2020-05-28	Europe / Netherlands / Friesland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Netherlands/NB-EMC-234/2020	EPI_ISL_523357	2020-05-09	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Netherlands/un-EMC-758/2020	EPI_ISL_523514	2020-07-06	Europe / Netherlands	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Switzerland/BL-ETHZ-240001/2020	EPI_ISL_523856	2020-08-07	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BL-ETHZ-240010/2020	EPI_ISL_523865	2020-08-07	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BL-ETHZ-240022/2020	EPI_ISL_523873	2020-08-10	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BL-ETHZ-240045/2020	EPI_ISL_523887	2020-08-12	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/England/QEUH-95E3E3/2020	EPI_ISL_537005	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-95E529/2020	EPI_ISL_537011	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-95DFE0/2020	EPI_ISL_537015	2020-08-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-961505/2020	EPI_ISL_537051	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9619FA/2020	EPI_ISL_537075	2020-08-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-961B21/2020	EPI_ISL_537080	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-961CF1/2020	EPI_ISL_537083	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-997FF9/2020	EPI_ISL_537150	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-997F53/2020	EPI_ISL_537165	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9980B9/2020	EPI_ISL_537176	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-99807D/2020	EPI_ISL_537179	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-997DB3/2020	EPI_ISL_537196	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/QEUH-9981E3/2020	EPI_ISL_537199	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/SHEF-10B2D5E/2020	EPI_ISL_537214	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/SHEF-10B2E3D/2020	EPI_ISL_537215	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2E1F/2020	EPI_ISL_537216	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2E2E/2020	EPI_ISL_537220	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2E4C/2020	EPI_ISL_537221	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2D8B/2020	EPI_ISL_537225	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2DC7/2020	EPI_ISL_537237	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2D12/2020	EPI_ISL_537238	2020-05-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2E5B/2020	EPI_ISL_537239	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2BBE/2020	EPI_ISL_537246	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GR
hCoV-19/England/SHEF-10B2DD6/2020	EPI_ISL_537251	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B3081/2020	EPI_ISL_537252	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/SHEF-10B2DF4/2020	EPI_ISL_537253	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2D9A/2020	EPI_ISL_537255	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B3151/2020	EPI_ISL_537258	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2D7C/2020	EPI_ISL_537261	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2DE5/2020	EPI_ISL_537264	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2DA9/2020	EPI_ISL_537265	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B3018/2020	EPI_ISL_537270	2020-05-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2A84/2020	EPI_ISL_537273	2020-05-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B28A8/2020	EPI_ISL_537277	2020-04-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GR
hCoV-19/USA/CA-UCLA-231/2020	EPI_ISL_537537	2020-06-02	North America / USA / California / Los Angeles County	Human	Original			Illumina				B.1.1	GR
hCoV-19/Switzerland/BL-ETHZ-270213/2020	EPI_ISL_541459	2020-08-30	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.37	GR
hCoV-19/Switzerland/ZH-ETHZ-270143/2020	EPI_ISL_541525	2020-08-28	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.37	GR
hCoV-19/Switzerland/ZH-ETHZ-270184/2020	EPI_ISL_541531	2020-08-29	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.37	GR
hCoV-19/Switzerland/ZH-ETHZ-270186/2020	EPI_ISL_541533	2020-08-29	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.37	GR
hCoV-19/Italy/LOM-UniMI-L150/2020	EPI_ISL_542145	2020-03-13	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L314/2020	EPI_ISL_542266	2020-03-01	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L361/2020	EPI_ISL_542293	2020-03-05	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L395/2020	EPI_ISL_542317	2020-03-09	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L430/2020	EPI_ISL_542349	2020-03-19	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L439/2020	EPI_ISL_542358	2020-03-28	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L444/2020	EPI_ISL_542363	2020-03-20	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L55/2020	EPI_ISL_542402	2020-03-02	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/USA/TX-HMH-3855/2020	EPI_ISL_543256	2020-06-17	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/England/ALDP-950660/2020	EPI_ISL_555311	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-9548FD/2020	EPI_ISL_555318	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-951B06/2020	EPI_ISL_555358	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-955C3C/2020	EPI_ISL_555363	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95185A/2020	EPI_ISL_555367	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94E638/2020	EPI_ISL_555372	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94E61A/2020	EPI_ISL_555379	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-954945/2020	EPI_ISL_555407	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94F7BC/2020	EPI_ISL_555779	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94B871/2020	EPI_ISL_555780	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94BBB4/2020	EPI_ISL_555784	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94B96F/2020	EPI_ISL_555788	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94F7DA/2020	EPI_ISL_555808	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94C843/2020	EPI_ISL_555832	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94C8DA/2020	EPI_ISL_555839	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-94F233/2020	EPI_ISL_555842	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94CC0B/2020	EPI_ISL_555858	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94C5C4/2020	EPI_ISL_555874	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94F093/2020	EPI_ISL_555892	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94C834/2020	EPI_ISL_555897	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94C8BC/2020	EPI_ISL_555925	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94F497/2020	EPI_ISL_555934	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94CB2C/2020	EPI_ISL_555937	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94CB59/2020	EPI_ISL_555938	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94C9E6/2020	EPI_ISL_555942	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94CDF9/2020	EPI_ISL_555954	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94CFC6/2020	EPI_ISL_555974	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94C825/2020	EPI_ISL_555996	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-9464EB/2020	EPI_ISL_556696	2020-07-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/Wales/CAMC-945BBA/2020	EPI_ISL_556709	2020-07-13	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-9496F1/2020	EPI_ISL_556730	2020-07-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-948B8A/2020	EPI_ISL_556737	2020-07-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9457B6/2020	EPI_ISL_556749	2020-07-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-94B57A/2020	EPI_ISL_556755	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/CAMC-94BC93/2020	EPI_ISL_556756	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-94169F/2020	EPI_ISL_556834	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-942AFC/2020	EPI_ISL_556913	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-948917/2020	EPI_ISL_556932	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9452D3/2020	EPI_ISL_556933	2020-07-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-94572F/2020	EPI_ISL_556950	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8D71CB/2020	EPI_ISL_557013	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-8B7F9A/2020	EPI_ISL_557018	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8D5549/2020	EPI_ISL_557020	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8DDFBC/2020	EPI_ISL_557022	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8B41B5/2020	EPI_ISL_557025	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8B9F4D/2020	EPI_ISL_557041	2020-06-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8E2567/2020	EPI_ISL_557053	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8DBA9F/2020	EPI_ISL_557054	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-901437/2020	EPI_ISL_557061	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-9011E5/2020	EPI_ISL_557069	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-8CF83A/2020	EPI_ISL_557086	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-8BA43E/2020	EPI_ISL_557101	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8FF9A7/2020	EPI_ISL_557104	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8FE1DD/2020	EPI_ISL_557116	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-8BA0A3/2020	EPI_ISL_557122	2020-06-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8DD1F2/2020	EPI_ISL_557124	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-90DAA2/2020	EPI_ISL_557137	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8CF1A8/2020	EPI_ISL_557139	2020-06-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8B65F3/2020	EPI_ISL_557153	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-81BEA6/2020	EPI_ISL_557167	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-819066/2020	EPI_ISL_557258	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-81D8E2/2020	EPI_ISL_557281	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/Wales/MILK-848FF8/2020	EPI_ISL_557337	2020-07-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-828608/2020	EPI_ISL_557348	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-745C22/2020	EPI_ISL_557354	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-744DB7/2020	EPI_ISL_557374	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-744986/2020	EPI_ISL_557404	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-850D7B/2020	EPI_ISL_557431	2020-07-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-870CD2/2020	EPI_ISL_557441	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-6F9D67/2020	EPI_ISL_557445	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6EBBD7/2020	EPI_ISL_557554	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-7004EF/2020	EPI_ISL_557569	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-700072/2020	EPI_ISL_557573	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-7016BB/2020	EPI_ISL_557589	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-71D072/2020	EPI_ISL_557593	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-71E0EA/2020	EPI_ISL_557603	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-703534/2020	EPI_ISL_557616	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6EA7B6/2020	EPI_ISL_557617	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6E9D88/2020	EPI_ISL_557628	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-71C019/2020	EPI_ISL_557652	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-7259C7/2020	EPI_ISL_557666	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-722A6D/2020	EPI_ISL_557684	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-723598/2020	EPI_ISL_557688	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6E825D/2020	EPI_ISL_557693	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-7000BE/2020	EPI_ISL_557717	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6E82D5/2020	EPI_ISL_557719	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-71CBAF/2020	EPI_ISL_557722	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-71E0DB/2020	EPI_ISL_557727	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6C176A/2020	EPI_ISL_557747	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6BBC28/2020	EPI_ISL_557763	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6C3A41/2020	EPI_ISL_557790	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-610878/2020	EPI_ISL_557796	2020-07-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6B4EED/2020	EPI_ISL_557809	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6BBE5F/2020	EPI_ISL_557813	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6AD421/2020	EPI_ISL_557833	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-6C1B31/2020	EPI_ISL_557837	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-6118B3/2020	EPI_ISL_557848	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6B7284/2020	EPI_ISL_557851	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.200	GR
hCoV-19/England/ALDP-6C3786/2020	EPI_ISL_557860	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6B556F/2020	EPI_ISL_557863	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-6238FA/2020	EPI_ISL_557867	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.1.294	GR
hCoV-19/England/ALDP-6B7002/2020	EPI_ISL_557920	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-60EB38/2020	EPI_ISL_557926	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6BBD9E/2020	EPI_ISL_557931	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Canada/ON-UHTC-0174/2020	EPI_ISL_569949	2020-05-23	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.1	GR
hCoV-19/Canada/ON-UHTC-0186/2020	EPI_ISL_569955	2020-05-26	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.1	GR
hCoV-19/Canada/ON-UHTC-0202/2020	EPI_ISL_569972	2020-06-10	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.1	GR
hCoV-19/Canada/ON-UHTC-0197/2020	EPI_ISL_569978	2020-05-29	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.1	GR
hCoV-19/Scotland/QEUH-9C8EC5/2020	EPI_ISL_576015	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9C8760/2020	EPI_ISL_576017	2020-09-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9C8706/2020	EPI_ISL_576022	2020-09-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9C925F/2020	EPI_ISL_576038	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9CA24F/2020	EPI_ISL_576057	2020-09-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9C96AE/2020	EPI_ISL_576060	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9C929B/2020	EPI_ISL_576061	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9CA26D/2020	EPI_ISL_576063	2020-09-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9C927D/2020	EPI_ISL_576077	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9CA2C7/2020	EPI_ISL_576080	2020-09-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9C9D12/2020	EPI_ISL_576091	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Ukraine/Ivano-Frankivsk-706/2020	EPI_ISL_576147	2020-07-28	Europe / Ukraine / Ivano-Frankivsk	Human	Original	Oropharyngeal swab		Illumina iSeq100	Dragen			B.1.1	GR
hCoV-19/USA/WI-CDC-6231/2020	EPI_ISL_576180	2020-03-25	North America / USA / Wisconsin	Human	Original	Nasopharyngeal swab		Nanopore	minimap 2.17			B.1.1	GR
hCoV-19/USA/WI-CDC-6232/2020	EPI_ISL_576181	2020-03-25	North America / USA / Wisconsin	Human	Original	Nasopharyngeal swab		Nanopore	minimap 2.17			B.1.1	GR
hCoV-19/USA/WI-CDC-6236/2020	EPI_ISL_576185	2020-03-25	North America / USA / Wisconsin	Human	Original	Nasopharyngeal swab		Nanopore	minimap 2.17			B.1.1	GR
hCoV-19/Egypt/CUNCI-HGC7I010/2020	EPI_ISL_576371	2020-07-19	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.1	GR
hCoV-19/USA/WA-UW-23237/2020	EPI_ISL_576410	2020-08-06	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.228	GR
hCoV-19/USA/WA-UW-23330/2020	EPI_ISL_576426	2020-08-09	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.228	GR
hCoV-19/USA/WA-UW-23410/2020	EPI_ISL_576447	2020-08-10	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.228	GR
hCoV-19/USA/WA-UW-23445/2020	EPI_ISL_576455	2020-08-10	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.228	GR
hCoV-19/USA/un-UW-534/2020	EPI_ISL_576493	2020-03-11	North America / USA	Human	Original			Illumina	custom	Spike_F456stop results in 64.3% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-9D7810/2020	EPI_ISL_576587	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/ALDP-9D784D/2020	EPI_ISL_576590	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9D7968/2020	EPI_ISL_576602	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/ALDP-9D7A1A/2020	EPI_ISL_576606	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/ALDP-9D7A29/2020	EPI_ISL_576607	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/ALDP-9D7CAB/2020	EPI_ISL_576621	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/ALDP-9D8A82/2020	EPI_ISL_576646	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9D8BBC/2020	EPI_ISL_576654	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9D8D5C/2020	EPI_ISL_576668	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9D8EE0/2020	EPI_ISL_576682	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9D8FED/2020	EPI_ISL_576688	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/ALDP-9D8FFC/2020	EPI_ISL_576689	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/ALDP-9D9034/2020	EPI_ISL_576693	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/ALDP-9D91E6/2020	EPI_ISL_576708	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/ALDP-9D9438/2020	EPI_ISL_576729	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9D9517/2020	EPI_ISL_576735	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9D966F/2020	EPI_ISL_576752	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/ALDP-9D97D5/2020	EPI_ISL_576761	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9D97F3/2020	EPI_ISL_576762	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9D99B1/2020	EPI_ISL_576781	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/ALDP-9D9AFA/2020	EPI_ISL_576792	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9D9B15/2020	EPI_ISL_576794	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9D9EA3/2020	EPI_ISL_576823	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.307	GR
hCoV-19/England/ALDP-9D9F46/2020	EPI_ISL_576828	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9D9F73/2020	EPI_ISL_576829	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/ALDP-9DA0D9/2020	EPI_ISL_576844	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/ALDP-9DA130/2020	EPI_ISL_576850	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-9DA24C/2020	EPI_ISL_576858	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9DA455/2020	EPI_ISL_576874	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/BIRM-63C9E/2020	EPI_ISL_576877	2020-08-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63D04/2020	EPI_ISL_576880	2020-08-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63D31/2020	EPI_ISL_576881	2020-08-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63D7D/2020	EPI_ISL_576882	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63D9B/2020	EPI_ISL_576883	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63DAA/2020	EPI_ISL_576884	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63DD7/2020	EPI_ISL_576885	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63E10/2020	EPI_ISL_576887	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63E2F/2020	EPI_ISL_576888	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63E3E/2020	EPI_ISL_576889	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63E4D/2020	EPI_ISL_576890	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63E89/2020	EPI_ISL_576892	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63E98/2020	EPI_ISL_576893	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63EA7/2020	EPI_ISL_576894	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9DFC1C/2020	EPI_ISL_576927	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/CAMC-9DFCA3/2020	EPI_ISL_576930	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/CAMC-9DFCFE/2020	EPI_ISL_576934	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/CAMC-9DFEE9/2020	EPI_ISL_576943	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/CAMC-9DFF9B/2020	EPI_ISL_576947	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9917CA/2020	EPI_ISL_576993	2020-08-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9E6CE5/2020	EPI_ISL_580304	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-9EC599/2020	EPI_ISL_580305	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E68F0/2020	EPI_ISL_580319	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9EEE50/2020	EPI_ISL_580747	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9EE55B/2020	EPI_ISL_580801	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DC67B/2020	EPI_ISL_580862	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DAACC/2020	EPI_ISL_580869	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DAEFD/2020	EPI_ISL_580881	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9E1118/2020	EPI_ISL_580892	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9E1136/2020	EPI_ISL_580918	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DAB8D/2020	EPI_ISL_580920	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DC75A/2020	EPI_ISL_580957	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9DD337/2020	EPI_ISL_580975	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Canada/MB-NML-561/2020	EPI_ISL_582262	2020-04-28	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Canada/MB-NML-565/2020	EPI_ISL_582263	2020-05-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Canada/MB-NML-598/2020	EPI_ISL_582283	2020-05-07	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Canada/MB-NML-859/2020	EPI_ISL_582342	2020-03-30	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Canada/MB-NML-1041/2020	EPI_ISL_582401	2020-04-28	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Canada/MB-NML-1195/2020	EPI_ISL_582507	2020-04-25	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/United Arab Emirates/skmc-3115511/2020	EPI_ISL_582645	2020-08-28	Asia / United Arab Emirates	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1.500	GR
hCoV-19/Sweden/20-52282/2020	EPI_ISL_582799	2020-07-03	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction using torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/England/MILK-9F274F/2020	EPI_ISL_589101	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9F7DDF/2020	EPI_ISL_589105	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7C4B/2020	EPI_ISL_589106	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7A9C/2020	EPI_ISL_589107	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F2026/2020	EPI_ISL_589111	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F716A/2020	EPI_ISL_589113	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F1FC0/2020	EPI_ISL_589115	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F28F1/2020	EPI_ISL_589117	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9F7C1E/2020	EPI_ISL_589129	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F7B5D/2020	EPI_ISL_589131	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F78ED/2020	EPI_ISL_589138	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F749E/2020	EPI_ISL_589140	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7B99/2020	EPI_ISL_589144	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F7847/2020	EPI_ISL_589148	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9F20BD/2020	EPI_ISL_589153	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7A6F/2020	EPI_ISL_589163	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F2202/2020	EPI_ISL_589166	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9F2633/2020	EPI_ISL_589168	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F22B7/2020	EPI_ISL_589172	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F7452/2020	EPI_ISL_589175	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F77FF/2020	EPI_ISL_589178	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F7AC9/2020	EPI_ISL_589194	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9F7BF3/2020	EPI_ISL_589204	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7B8A/2020	EPI_ISL_589209	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7B20/2020	EPI_ISL_589216	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F2062/2020	EPI_ISL_589227	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F2493/2020	EPI_ISL_589235	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9F7B11/2020	EPI_ISL_589236	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F7A7E/2020	EPI_ISL_589250	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F96A5/2020	EPI_ISL_589252	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F7B3F/2020	EPI_ISL_589258	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E5888/2020	EPI_ISL_589270	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E5A46/2020	EPI_ISL_589291	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E58B5/2020	EPI_ISL_589328	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E5721/2020	EPI_ISL_589341	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9EE39D/2020	EPI_ISL_589346	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E5879/2020	EPI_ISL_589349	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9ED237/2020	EPI_ISL_589365	2020-05-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9ED255/2020	EPI_ISL_589366	2020-05-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E5967/2020	EPI_ISL_589381	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9ED4B9/2020	EPI_ISL_589383	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9ED0A6/2020	EPI_ISL_589386	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E5897/2020	EPI_ISL_589420	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E5976/2020	EPI_ISL_589431	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9ED61D/2020	EPI_ISL_589438	2020-05-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9ED264/2020	EPI_ISL_589457	2020-05-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E5A55/2020	EPI_ISL_589474	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9E56D9/2020	EPI_ISL_589494	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9EE087/2020	EPI_ISL_589518	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E5A82/2020	EPI_ISL_589523	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E5B8F/2020	EPI_ISL_589531	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9EF156/2020	EPI_ISL_594903	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/MILK-9EF165/2020	EPI_ISL_594904	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9EF5F0/2020	EPI_ISL_594923	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9EF684/2020	EPI_ISL_594929	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.44	GR
hCoV-19/England/MILK-9EF718/2020	EPI_ISL_594934	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.434	GR
hCoV-19/England/MILK-9EF790/2020	EPI_ISL_594939	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A4CA97/2020	EPI_ISL_596014	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A4CED7/2020	EPI_ISL_596064	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A4CF2F/2020	EPI_ISL_596068	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A4CF7A/2020	EPI_ISL_596072	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A4D252/2020	EPI_ISL_596105	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A4D3F5/2020	EPI_ISL_596114	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-A635F3/2020	EPI_ISL_596123	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/QEUH-A63757/2020	EPI_ISL_596141	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A63845/2020	EPI_ISL_596154	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A63890/2020	EPI_ISL_596157	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A63933/2020	EPI_ISL_596166	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A6399D/2020	EPI_ISL_596172	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A639BB/2020	EPI_ISL_596174	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A63B97/2020	EPI_ISL_596188	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/SHEF-C5BD9/2020	EPI_ISL_596198	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CD4C7/2020	EPI_ISL_596213	2020-09-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CF6B0/2020	EPI_ISL_596218	2020-09-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Russia/SPE-RII-32307S/2020	EPI_ISL_596230	2020-08-31	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/SPE-RII-35589S/2020	EPI_ISL_596249	2020-09-28	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1.373	GR
hCoV-19/Russia/SPE-RII-MH1049S/2020	EPI_ISL_596256	2020-09-06	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1.373	GR
hCoV-19/Russia/SVE-RII-MH1433S/2020	EPI_ISL_596273	2020-09-10	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/SVE-RII-MH1441S/2020	EPI_ISL_596276	2020-09-06	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/SPE-RII-MH1512S/2020	EPI_ISL_596285	2020-09-11	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1.373	GR
hCoV-19/Russia/SPE-RII-MH1515S/2020	EPI_ISL_596286	2020-09-11	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1.373	GR
hCoV-19/Russia/SPE-RII-MH1616S/2020	EPI_ISL_596297	2020-09-07	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/MOW-RII-MH1979S/2020	EPI_ISL_596325	2020-05-28	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/MOW-RII-MH1992S/2020	EPI_ISL_596336	2020-06-05	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/MOW-RII-MH1995S/2020	EPI_ISL_596339	2020-06-06	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/MOW-RII-MH2005S/2020	EPI_ISL_596347	2020-05-25	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/MOW-RII-MH2006S/2020	EPI_ISL_596348	2020-05-28	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/MOW-RII-MH2010S/2020	EPI_ISL_596351	2020-06-05	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/SPE-RII-MH960S/2020	EPI_ISL_596366	2020-09-03	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/SPE-RII-MH968S/2020	EPI_ISL_596367	2020-09-04	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.373	GR
hCoV-19/Russia/SPE-RII-MH977S/2020	EPI_ISL_596369	2020-09-04	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1.373	GR
hCoV-19/Russia/SPE-RII-MH982S/2020	EPI_ISL_596371	2020-09-04	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1.373	GR
hCoV-19/Singapore/1083/2020	EPI_ISL_596473	2020-10-02	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Singapore/1090/2020	EPI_ISL_596480	2020-10-02	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/USA/MI-UM-10036423734/2020	EPI_ISL_596626	2020-10-13	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/England/CAMC-A58193/2020	EPI_ISL_596938	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A580B4/2020	EPI_ISL_596944	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A58D71/2020	EPI_ISL_596960	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A58D80/2020	EPI_ISL_596983	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A588DA/2020	EPI_ISL_596999	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-A066B3/2020	EPI_ISL_600001	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A06880/2020	EPI_ISL_600009	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A060D3/2020	EPI_ISL_600018	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A05AE5/2020	EPI_ISL_600022	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A0561E/2020	EPI_ISL_600024	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A05432/2020	EPI_ISL_600037	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-A0558A/2020	EPI_ISL_600078	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-A06097/2020	EPI_ISL_600085	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/MILK-A0606A/2020	EPI_ISL_600095	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A066A4/2020	EPI_ISL_600099	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A05F7D/2020	EPI_ISL_600106	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A05BB5/2020	EPI_ISL_600110	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A00613/2020	EPI_ISL_600128	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-9FFCDA/2020	EPI_ISL_600142	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FFD04/2020	EPI_ISL_600143	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A0033A/2020	EPI_ISL_600146	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FFD31/2020	EPI_ISL_600154	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FF94C/2020	EPI_ISL_600158	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.153	GR
hCoV-19/England/QEUH-9FF487/2020	EPI_ISL_600163	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FFD22/2020	EPI_ISL_600164	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A001E5/2020	EPI_ISL_600185	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A00455/2020	EPI_ISL_600186	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A001D6/2020	EPI_ISL_600192	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FF205/2020	EPI_ISL_600199	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FFAB2/2020	EPI_ISL_600204	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A0032B/2020	EPI_ISL_600218	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FFAC1/2020	EPI_ISL_600223	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FF751/2020	EPI_ISL_600226	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FF1CC/2020	EPI_ISL_600227	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-9FFCAD/2020	EPI_ISL_600228	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0081D/2020	EPI_ISL_600249	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A00929/2020	EPI_ISL_600250	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FF399/2020	EPI_ISL_600259	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FFB46/2020	EPI_ISL_600261	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A00947/2020	EPI_ISL_600262	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FFBEC/2020	EPI_ISL_600264	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A00051/2020	EPI_ISL_600274	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FF37B/2020	EPI_ISL_600276	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FFD5F/2020	EPI_ISL_600280	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FF171/2020	EPI_ISL_600282	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FF6EB/2020	EPI_ISL_600284	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FFF4A/2020	EPI_ISL_600287	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FF93D/2020	EPI_ISL_600290	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A00974/2020	EPI_ISL_600298	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FF302/2020	EPI_ISL_600312	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FF241/2020	EPI_ISL_600321	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A00112/2020	EPI_ISL_600322	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9FF7E8/2020	EPI_ISL_600329	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FFB73/2020	EPI_ISL_600330	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FF5FD/2020	EPI_ISL_600336	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A00015/2020	EPI_ISL_600337	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FF733/2020	EPI_ISL_600347	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FFF77/2020	EPI_ISL_600356	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FFD40/2020	EPI_ISL_600358	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FF1BD/2020	EPI_ISL_600364	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FF1F9/2020	EPI_ISL_600368	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FFFB3/2020	EPI_ISL_600372	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0030D/2020	EPI_ISL_600382	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FFD7D/2020	EPI_ISL_600392	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9FF2C9/2020	EPI_ISL_600397	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FFD13/2020	EPI_ISL_600399	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-9E4801/2020	EPI_ISL_601008	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9E53B4/2020	EPI_ISL_601025	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Scotland/QEUH-9E46F8/2020	EPI_ISL_601044	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9E44A3/2020	EPI_ISL_601065	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-9DCAE8/2020	EPI_ISL_601106	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9DB014/2020	EPI_ISL_601159	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Scotland/QEUH-9DCAF7/2020	EPI_ISL_601163	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9DABAB/2020	EPI_ISL_601170	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-9DC462/2020	EPI_ISL_601175	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-9DED47/2020	EPI_ISL_601200	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E0B2A/2020	EPI_ISL_601234	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DA534/2020	EPI_ISL_601254	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DA604/2020	EPI_ISL_601260	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DA613/2020	EPI_ISL_601286	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E0850/2020	EPI_ISL_601287	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9E046B/2020	EPI_ISL_601302	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-9E050E/2020	EPI_ISL_601312	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9E0BA2/2020	EPI_ISL_601317	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E0AB4/2020	EPI_ISL_601329	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E02CB/2020	EPI_ISL_601330	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E0AD2/2020	EPI_ISL_601338	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DA65F/2020	EPI_ISL_601364	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E0CCD/2020	EPI_ISL_601371	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E09A8/2020	EPI_ISL_601379	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DC295/2020	EPI_ISL_601393	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DC013/2020	EPI_ISL_601403	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DB06F/2020	EPI_ISL_601430	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E06A1/2020	EPI_ISL_601431	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DA701/2020	EPI_ISL_601435	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E0A87/2020	EPI_ISL_601442	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9E0780/2020	EPI_ISL_601444	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/MILK-9E04D4/2020	EPI_ISL_601450	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E0498/2020	EPI_ISL_601452	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DA81D/2020	EPI_ISL_601453	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DBDD1/2020	EPI_ISL_601462	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DBE29/2020	EPI_ISL_601471	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E03E6/2020	EPI_ISL_601476	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DA5BC/2020	EPI_ISL_601477	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9D2174/2020	EPI_ISL_601493	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9D1FA8/2020	EPI_ISL_601501	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9D4D7E/2020	EPI_ISL_601533	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9D1DBD/2020	EPI_ISL_601550	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-9D50B0/2020	EPI_ISL_601565	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9D1DDB/2020	EPI_ISL_601567	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9D4A2C/2020	EPI_ISL_601574	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9D2323/2020	EPI_ISL_601578	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9D4655/2020	EPI_ISL_601581	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9D1CB0/2020	EPI_ISL_601589	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9D21ED/2020	EPI_ISL_601591	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-9D2156/2020	EPI_ISL_601594	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9D452B/2020	EPI_ISL_601601	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Wales/MILK-9D4C62/2020	EPI_ISL_601607	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9D2226/2020	EPI_ISL_601628	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9D47BC/2020	EPI_ISL_601632	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9D4567/2020	EPI_ISL_601642	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/MILK-9D4EF3/2020	EPI_ISL_601651	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9D2129/2020	EPI_ISL_601664	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/CAMC-9D2147/2020	EPI_ISL_601668	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9D4D6F/2020	EPI_ISL_601670	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-9D4DAB/2020	EPI_ISL_601679	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-9D4D14/2020	EPI_ISL_601687	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9D4E5D/2020	EPI_ISL_601699	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9D1D9F/2020	EPI_ISL_601747	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-9D4C08/2020	EPI_ISL_601750	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9D48F5/2020	EPI_ISL_601753	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9D49E3/2020	EPI_ISL_601757	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9D48C8/2020	EPI_ISL_601763	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-9D1DAE/2020	EPI_ISL_601771	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9D4707/2020	EPI_ISL_601776	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9D3CBE/2020	EPI_ISL_601782	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9D003D/2020	EPI_ISL_601791	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9D0844/2020	EPI_ISL_601814	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-9CFC4C/2020	EPI_ISL_601826	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9D062C/2020	EPI_ISL_601847	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9CE25A/2020	EPI_ISL_601873	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-9CE30C/2020	EPI_ISL_601892	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-9CF3B0/2020	EPI_ISL_601895	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9CE612/2020	EPI_ISL_601914	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-9CF0D7/2020	EPI_ISL_601922	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9CE6A9/2020	EPI_ISL_601934	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9CF81B/2020	EPI_ISL_601942	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9CF7E1/2020	EPI_ISL_601951	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9CF80C/2020	EPI_ISL_601997	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C7F1E/2020	EPI_ISL_602030	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9C9A57/2020	EPI_ISL_602036	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C9899/2020	EPI_ISL_602037	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CA889/2020	EPI_ISL_602038	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9CA6BC/2020	EPI_ISL_602039	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CA0DC/2020	EPI_ISL_602042	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/Scotland/QEUH-9B5177/2020	EPI_ISL_602044	2020-09-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9B4FC9/2020	EPI_ISL_602063	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9B513B/2020	EPI_ISL_602067	2020-09-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9B710C/2020	EPI_ISL_602105	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9B7245/2020	EPI_ISL_602111	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9B76EF/2020	EPI_ISL_602113	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9B7E9C/2020	EPI_ISL_602117	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B8745/2020	EPI_ISL_602136	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B8754/2020	EPI_ISL_602137	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B8833/2020	EPI_ISL_602138	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9B8824/2020	EPI_ISL_602139	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9B81FC/2020	EPI_ISL_602143	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-9B8842/2020	EPI_ISL_602144	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/Switzerland/BE-ETHZ-330421/2020	EPI_ISL_614908	2020-10-18	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.144	GR
hCoV-19/Switzerland/VD-ETHZ-330059/2020	EPI_ISL_614953	2020-10-16	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.153	GR
hCoV-19/Gibraltar/204462808/2020	EPI_ISL_614983	2020-10-29	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.434	GR
hCoV-19/Gibraltar/204462822/2020	EPI_ISL_614997	2020-10-29	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Denmark/DCGC-3121/2020	EPI_ISL_615938	2020-08-31	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.144	GR
hCoV-19/Denmark/DCGC-3153/2020	EPI_ISL_615973	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3175/2020	EPI_ISL_615997	2020-08-24	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3180/2020	EPI_ISL_616002	2020-08-31	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3206/2020	EPI_ISL_616029	2020-08-31	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.153	GR
hCoV-19/Denmark/DCGC-3364/2020	EPI_ISL_616121	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3369/2020	EPI_ISL_616126	2020-08-31	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3395/2020	EPI_ISL_616154	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		NS7a_E95stop results in 22.3% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/Denmark/DCGC-3406/2020	EPI_ISL_616165	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3452/2020	EPI_ISL_616216	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2576/2020	EPI_ISL_616407	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2578/2020	EPI_ISL_616409	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2895/2020	EPI_ISL_616411	2020-08-17	Europe / Denmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2897/2020	EPI_ISL_616413	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2898/2020	EPI_ISL_616414	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2692/2020	EPI_ISL_616424	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2693/2020	EPI_ISL_616425	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2694/2020	EPI_ISL_616426	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2697/2020	EPI_ISL_616429	2020-08-17	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2711/2020	EPI_ISL_616444	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2713/2020	EPI_ISL_616446	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2745/2020	EPI_ISL_616490	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2626/2020	EPI_ISL_616505	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2627/2020	EPI_ISL_616506	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2628/2020	EPI_ISL_616507	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2629/2020	EPI_ISL_616508	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2630/2020	EPI_ISL_616509	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2906/2020	EPI_ISL_616540	2020-08-24	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2916/2020	EPI_ISL_616551	2020-08-17	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2923/2020	EPI_ISL_616558	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2884/2020	EPI_ISL_616579	2020-08-24	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2764/2020	EPI_ISL_616598	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2766/2020	EPI_ISL_616600	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2768/2020	EPI_ISL_616602	2020-08-24	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION		NS7a_Q94stop results in 23.1% truncation of the protein sequence.	info	B.1.1.170	GR
hCoV-19/Denmark/DCGC-2777/2020	EPI_ISL_616612	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.37	GR
hCoV-19/Denmark/DCGC-2789/2020	EPI_ISL_616624	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2795/2020	EPI_ISL_616630	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2803/2020	EPI_ISL_616639	2020-08-24	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2807/2020	EPI_ISL_616643	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2830/2020	EPI_ISL_616656	2020-08-24	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2834/2020	EPI_ISL_616660	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2835/2020	EPI_ISL_616661	2020-08-24	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2843/2020	EPI_ISL_616670	2020-08-24	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2845/2020	EPI_ISL_616672	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2853/2020	EPI_ISL_616681	2020-08-17	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2959/2020	EPI_ISL_616721	2020-08-24	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2971/2020	EPI_ISL_616733	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2974/2020	EPI_ISL_616736	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2978/2020	EPI_ISL_616740	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.37	GR
hCoV-19/Denmark/DCGC-2989/2020	EPI_ISL_616753	2020-08-24	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.170	GR
hCoV-19/Denmark/DCGC-2992/2020	EPI_ISL_616756	2020-08-24	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2994/2020	EPI_ISL_616758	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2995/2020	EPI_ISL_616759	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3214/2020	EPI_ISL_616770	2020-08-24	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-5972/2020	EPI_ISL_621081	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	G
hCoV-19/Denmark/DCGC-5973/2020	EPI_ISL_621082	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6113/2020	EPI_ISL_621147	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-6335/2020	EPI_ISL_621192	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-4844/2020	EPI_ISL_621529	2020-09-21	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/USA/MI-UM-10036478916/2020	EPI_ISL_628824	2020-10-16	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036454976/2020	EPI_ISL_628834	2020-10-15	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036456089/2020	EPI_ISL_628835	2020-10-15	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036507377/2020	EPI_ISL_628881	2020-10-19	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036524165/2020	EPI_ISL_628882	2020-10-19	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.304	GR
hCoV-19/Norway/4235/2020	EPI_ISL_635166	2020-10-09	Europe / Norway / Rogaland	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1	GR
hCoV-19/Norway/4633/2020	EPI_ISL_635175	2020-10-18	Europe / Norway / Vestland	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.37	GR
hCoV-19/Norway/4621/2020	EPI_ISL_635176	2020-10-06	Europe / Norway / Vestland	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.170	GR
hCoV-19/Slovenia/V0-14718/2020	EPI_ISL_635271	2020-04-23	Europe / Slovenia	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes 3.14	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	G
hCoV-19/USA/CA-ALSR-2270/2020	EPI_ISL_635403	2020-07-07	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-ALSR-2276/2020	EPI_ISL_635405	2020-07-07	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/Mexico/BCN-ALSR-2559/2020	EPI_ISL_635562	2020-07-04	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-ALSR-2761/2020	EPI_ISL_635664	2020-07-15	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.228	GR
hCoV-19/USA/CA-ALSR-3019/2020	EPI_ISL_635791	2020-07-30	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-ALSR-3032/2020	EPI_ISL_635801	2020-08-27	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.228	GR
hCoV-19/USA/CA-ALSR-3135/2020	EPI_ISL_635867	2020-08-24	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.228	GR
hCoV-19/USA/CA-ALSR-3154/2020	EPI_ISL_635882	2020-08-24	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.228	GR
hCoV-19/USA/CA-ALSR-3163/2020	EPI_ISL_635891	2020-08-26	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.228	GR
hCoV-19/USA/CA-ALSR-3377/2020	EPI_ISL_635990	2020-05-30	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/mink/Denmark/mDK-5/2020	EPI_ISL_641399	2020-10-29	Europe / Denmark	Neovison vison	unknown			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.170	GR
hCoV-19/mink/Denmark/mDK-21/2020	EPI_ISL_641414	2020-10-26	Europe / Denmark	Neovison vison	unknown			Nanopore MinION				B.1.1.170	GR
hCoV-19/Belgium/ULG-10717/2020	EPI_ISL_641559	2020-09-14	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/England/QEUH-B13B2C/2020	EPI_ISL_641611	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-B13EC9/2020	EPI_ISL_641627	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B12D72/2020	EPI_ISL_641635	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B13C74/2020	EPI_ISL_641637	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B13D08/2020	EPI_ISL_641659	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B13B1D/2020	EPI_ISL_641697	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B136C1/2020	EPI_ISL_641725	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B141DE/2020	EPI_ISL_641737	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B1080A/2020	EPI_ISL_641740	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B13CCF/2020	EPI_ISL_641744	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B13E23/2020	EPI_ISL_641755	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B13579/2020	EPI_ISL_641764	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B14077/2020	EPI_ISL_641771	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B13D17/2020	EPI_ISL_641775	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B1061F/2020	EPI_ISL_641794	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/CA-ALSR-4461/2020	EPI_ISL_649043	2020-07-08	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/Italy/APU-IZSPB-172APT/2020	EPI_ISL_649191	2020-08-20	Europe / Italy / Apulia	Human	Vero	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1.229	GR
hCoV-19/England/ALDP-B4903D/2020	EPI_ISL_649226	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B48DBF/2020	EPI_ISL_649233	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B49325/2020	EPI_ISL_649265	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B48F31/2020	EPI_ISL_649273	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B47F7E/2020	EPI_ISL_649302	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/MILK-B50570/2020	EPI_ISL_649320	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B4846F/2020	EPI_ISL_649330	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B504DD/2020	EPI_ISL_649362	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B48775/2020	EPI_ISL_649402	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B484BA/2020	EPI_ISL_649446	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B48E34/2020	EPI_ISL_649478	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B4849C/2020	EPI_ISL_649480	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/Scotland/QEUH-B0F2A6/2020	EPI_ISL_649519	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-A8BDEE/2020	EPI_ISL_649568	2020-10-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B076B1/2020	EPI_ISL_649632	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-AE2F2B/2020	EPI_ISL_649634	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-AE1F0E/2020	EPI_ISL_649645	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-AD5B27/2020	EPI_ISL_649675	2020-10-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Italy/APU-IZSPB-182PT/2020	EPI_ISL_649785	2020-08-28	Europe / Italy / Apulia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1.229	GR
hCoV-19/England/204381369/2020	EPI_ISL_649859	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/204381377/2020	EPI_ISL_649861	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/204391040/2020	EPI_ISL_649880	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/204720609/2020	EPI_ISL_649891	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.434	GR
hCoV-19/Italy/APU-IZSPB-190PT/2020	EPI_ISL_649938	2020-08-28	Europe / Italy / Apulia / Bari	Human	Original	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1.229	GR
hCoV-19/Italy/APU-IZSPB-192PT/2020	EPI_ISL_649939	2020-08-28	Europe / Italy / Apulia / Bari	Human	Original	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1.229	GR
hCoV-19/France/ARA-SC320/2020	EPI_ISL_649953	2020-03-21	Europe / France / Auvergne-Rhone-Alpes / Saint-Etienne	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/USA/MI-UM-10036598438/2020	EPI_ISL_649983	2020-10-23	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036587385/2020	EPI_ISL_649988	2020-10-23	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036587181/2020	EPI_ISL_649989	2020-10-23	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036587103/2020	EPI_ISL_649991	2020-10-23	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036598494/2020	EPI_ISL_649992	2020-10-23	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036597152/2020	EPI_ISL_649996	2020-10-23	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036579461/2020	EPI_ISL_649998	2020-10-22	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/USA/MI-UM-10036740029/2020	EPI_ISL_649999	2020-11-02	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.304	GR
hCoV-19/Italy/APU-IZSPB_297PT/2020	EPI_ISL_653791	2020-11-03	Europe / Italy / Apulia / Bari / Altamura	Human	Original	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1.229	GR
hCoV-19/Italy/APU-IZSPB_171PT/2020	EPI_ISL_653823	2020-08-17	Europe / Italy / Apulia / Foggia / Manfredonia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1	GR
hCoV-19/England/QEUH-B6887C/2020	EPI_ISL_655001	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B6BDA7/2020	EPI_ISL_655029	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/QEUH-B66AE1/2020	EPI_ISL_655043	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B6851B/2020	EPI_ISL_655045	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B69556/2020	EPI_ISL_655047	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B69E79/2020	EPI_ISL_655057	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B68B91/2020	EPI_ISL_655061	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B6889A/2020	EPI_ISL_655088	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B68B64/2020	EPI_ISL_655121	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B681CC/2020	EPI_ISL_655153	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/QEUH-B6C8C3/2020	EPI_ISL_655157	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B6AC50/2020	EPI_ISL_655160	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B69C24/2020	EPI_ISL_655182	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B69B90/2020	EPI_ISL_655188	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B6AD02/2020	EPI_ISL_655196	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B6B9FE/2020	EPI_ISL_655200	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B6B958/2020	EPI_ISL_655207	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B66780/2020	EPI_ISL_655252	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B68A49/2020	EPI_ISL_655253	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B6C948/2020	EPI_ISL_655257	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B62E8F/2020	EPI_ISL_655289	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B5E75E/2020	EPI_ISL_655320	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B5B44B/2020	EPI_ISL_655370	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B5B065/2020	EPI_ISL_655417	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B5B6CD/2020	EPI_ISL_655424	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/ALDP-B5B0CF/2020	EPI_ISL_655449	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/ALDP-B6304C/2020	EPI_ISL_655454	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B62F40/2020	EPI_ISL_655514	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B5B241/2020	EPI_ISL_655566	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.170	GR
hCoV-19/England/ALDP-B5B3E4/2020	EPI_ISL_655590	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B5B6FA/2020	EPI_ISL_655591	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.307	GR
hCoV-19/England/ALDP-B5B478/2020	EPI_ISL_655631	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B5AFD2/2020	EPI_ISL_655632	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-B5C7BA/2020	EPI_ISL_655686	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B65E6E/2020	EPI_ISL_655695	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B5C91E/2020	EPI_ISL_655797	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B5BE5C/2020	EPI_ISL_655901	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2E827/2020	EPI_ISL_660000	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B2DFBA/2020	EPI_ISL_660025	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B2D293/2020	EPI_ISL_660027	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B3043D/2020	EPI_ISL_660061	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Sweden/20-22286/2020	EPI_ISL_660384	2020-03-12	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.438	GR
hCoV-19/Sweden/20-22294/2020	EPI_ISL_660391	2020-03-26	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.438	GR
hCoV-19/Sweden/20-22302/2020	EPI_ISL_660399	2020-04-01	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.438	GR
hCoV-19/Sweden/20-22315/2020	EPI_ISL_660407	2020-04-07	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.438	GR
hCoV-19/Sweden/20-22316/2020	EPI_ISL_660408	2020-04-07	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.438	GR
hCoV-19/Ecuador/USFQ-228/2020	EPI_ISL_660529	2020-10-01	South America / Ecuador / Tungurahua / Ambato	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic Network			B.1.1	GR
hCoV-19/England/204490924/2020	EPI_ISL_660760	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/Denmark/DCGC-9503/2020	EPI_ISL_669006	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-9537/2020	EPI_ISL_669026	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-9540/2020	EPI_ISL_669029	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-9593/2020	EPI_ISL_669053	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-9657/2020	EPI_ISL_669091	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-9663/2020	EPI_ISL_669095	2020-11-09	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-9722/2020	EPI_ISL_669128	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-9744/2020	EPI_ISL_669141	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-9809/2020	EPI_ISL_669197	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-9820/2020	EPI_ISL_669202	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-9850/2020	EPI_ISL_669227	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	G
hCoV-19/Denmark/DCGC-9853/2020	EPI_ISL_669229	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-9921/2020	EPI_ISL_669272	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-9980/2020	EPI_ISL_669307	2020-11-09	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-10007/2020	EPI_ISL_669330	2020-11-09	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	G
hCoV-19/Denmark/DCGC-10031/2020	EPI_ISL_669348	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-10058/2020	EPI_ISL_669368	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-10117/2020	EPI_ISL_669406	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-10128/2020	EPI_ISL_669410	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-10172/2020	EPI_ISL_669435	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-10196/2020	EPI_ISL_669447	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-11068/2020	EPI_ISL_669599	2020-11-02	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-10267/2020	EPI_ISL_669735	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-10279/2020	EPI_ISL_669873	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-10296/2020	EPI_ISL_669882	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/Denmark/DCGC-10431/2020	EPI_ISL_669965	2020-11-02	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-10437/2020	EPI_ISL_669969	2020-11-02	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-10458/2020	EPI_ISL_669987	2020-11-02	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-10459/2020	EPI_ISL_669988	2020-11-02	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.153	GR
hCoV-19/England/CAMC-B099F2/2020	EPI_ISL_673013	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B08F79/2020	EPI_ISL_673033	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B0A44B/2020	EPI_ISL_673062	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B0935E/2020	EPI_ISL_673109	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B0A593/2020	EPI_ISL_673129	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B095FE/2020	EPI_ISL_673179	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-B09C80/2020	EPI_ISL_673191	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B09FF0/2020	EPI_ISL_673232	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B9960F/2020	EPI_ISL_673274	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.434	GR
hCoV-19/England/CAMC-B9961E/2020	EPI_ISL_673292	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B990E3/2020	EPI_ISL_673337	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/CAMC-B99FC8/2020	EPI_ISL_673353	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B99D37/2020	EPI_ISL_673383	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B9A264/2020	EPI_ISL_673385	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B85ED1/2020	EPI_ISL_674034	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8D273/2020	EPI_ISL_674066	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B840BE/2020	EPI_ISL_674195	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B84B44/2020	EPI_ISL_674204	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8C07A/2020	EPI_ISL_674213	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B84EF0/2020	EPI_ISL_674292	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B8C2DE/2020	EPI_ISL_674358	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B83F0D/2020	EPI_ISL_674369	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B84036/2020	EPI_ISL_674445	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B84449/2020	EPI_ISL_674470	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8C0C5/2020	EPI_ISL_674494	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B8EBFF/2020	EPI_ISL_674503	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8EAA7/2020	EPI_ISL_674593	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8EC1A/2020	EPI_ISL_674640	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8DE51/2020	EPI_ISL_674664	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.153	GR
hCoV-19/England/QEUH-B7CE19/2020	EPI_ISL_674667	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8EA4D/2020	EPI_ISL_674673	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8E0B4/2020	EPI_ISL_674679	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7D6E3/2020	EPI_ISL_674716	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8EBE0/2020	EPI_ISL_674730	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8DBF0/2020	EPI_ISL_674789	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B982A2/2020	EPI_ISL_674868	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B95A9E/2020	EPI_ISL_674905	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B98266/2020	EPI_ISL_674950	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A018B2/2020	EPI_ISL_680000	2020-09-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/QEUH-B2C08B/2020	EPI_ISL_680051	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.44	GR
hCoV-19/England/QEUH-B2C0F4/2020	EPI_ISL_680058	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.44	GR
hCoV-19/England/QEUH-B2CFE8/2020	EPI_ISL_680094	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-2342DE/2020	EPI_ISL_680366	2020-10-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Scotland/EDB10169/2020	EPI_ISL_680491	2020-11-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/PHWC-48D368/2020	EPI_ISL_680612	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48D377/2020	EPI_ISL_680613	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48D7B7/2020	EPI_ISL_680678	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48D82D/2020	EPI_ISL_680685	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48D8A5/2020	EPI_ISL_680693	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48DA81/2020	EPI_ISL_680719	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48DAEB/2020	EPI_ISL_680725	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48DCA9/2020	EPI_ISL_680743	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48DEA3/2020	EPI_ISL_680771	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.170	GR
hCoV-19/Wales/PHWC-48DED0/2020	EPI_ISL_680774	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Wales/PHWC-48E3FE/2020	EPI_ISL_680854	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48E6E6/2020	EPI_ISL_680898	2020-11-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-48EA26/2020	EPI_ISL_680949	2020-11-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48EA44/2020	EPI_ISL_680951	2020-11-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48EC8A/2020	EPI_ISL_680986	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
